<SEC-DOCUMENT>0001437749-21-028699.txt : 20211216
<SEC-HEADER>0001437749-21-028699.hdr.sgml : 20211216
<ACCEPTANCE-DATETIME>20211216082539
ACCESSION NUMBER:		0001437749-21-028699
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20211213
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Completion of Acquisition or Disposition of Assets
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20211216
DATE AS OF CHANGE:		20211216

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ULTRALIFE CORP
		CENTRAL INDEX KEY:			0000875657
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				161387013
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20852
		FILM NUMBER:		211496084

	BUSINESS ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513
		BUSINESS PHONE:		3153327100

	MAIL ADDRESS:	
		STREET 1:		2000 TECHNOLOGY PARKWAY
		CITY:			NEWARK
		STATE:			NY
		ZIP:			14513

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ULTRALIFE BATTERIES INC
		DATE OF NAME CHANGE:	19940224
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ulbi20211213_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:utreg="http://www.xbrl.org/2009/utr" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:us-roles="http://fasb.org/us-roles/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:thunderdome="http://www.RDGFilings.com" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:rr="http://xbrl.sec.gov/rr/2018-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:ulbi="http://www.ulbi.com/20211213"><head>
	<title>ulbi20211213_8k.htm</title>

	<!-- Generated by ThunderDome Portal - 12/16/2021 1:11:21 PM -->
<meta http-equiv="Content-Type" content="text/html" /></head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;"><div style="display: none">
<ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="d20218K" name="dei:AmendmentFlag">false</ix:nonNumeric>
<ix:nonNumeric contextRef="d20218K" name="dei:EntityCentralIndexKey">0000875657</ix:nonNumeric>

</ix:hidden>
<ix:references>
<link:schemaRef xlink:href="ulbi-20211213.xsd" xlink:type="simple" />
</ix:references>
<ix:resources>
<xbrli:context id="d20218K">
<xbrli:entity>
<xbrli:identifier scheme="http://www.sec.gov/CIK">0000875657</xbrli:identifier>
</xbrli:entity>
<xbrli:period>
<xbrli:startDate>2021-12-13</xbrli:startDate>
<xbrli:endDate>2021-12-13</xbrli:endDate>
</xbrli:period>
</xbrli:context>


</ix:resources>
</ix:header>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>UNITED STATES</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Washington, D.C. 20549</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><b>FORM <ix:nonNumeric contextRef="d20218K" name="dei:DocumentType"><b>8-K</b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CURRENT REPORT</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate"><b>December 13, 2021</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Date of Report (Date of Earliest Event Reported)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:18pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityRegistrantName"><b>ULTRALIFE CORPORATION</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Exact name of registrant as specified in its charter)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode"><b>Delaware</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityFileNumber"><b>000-20852</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:EntityTaxIdentificationNumber"><b>16-1387013</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(State of incorporation)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Commission File Number)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(IRS Employer Identification No.)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressAddressLine1"><b>2000 Technology Parkway</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressCityOrTown"><b>Newark</b></ix:nonNumeric>, <ix:nonNumeric contextRef="d20218K" format="ixt-sec:stateprovnameen" name="dei:EntityAddressStateOrProvince"><b>New York</b></ix:nonNumeric> <ix:nonNumeric contextRef="d20218K" name="dei:EntityAddressPostalZipCode"><b>14513</b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Address of principal executive offices) (Zip Code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>(<ix:nonNumeric contextRef="d20218K" name="dei:CityAreaCode"><b>315</b></ix:nonNumeric>) <ix:nonNumeric contextRef="d20218K" name="dei:LocalPhoneNumber"><b>332-7100</b></ix:nonNumeric></b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Registrant&#8217;s telephone number, including area code)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>None</b></div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Former name or former address, if changed since last report)</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Securities registered pursuant to Section 12(b) of the Act:</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&#xa0;</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><ix:nonNumeric contextRef="d20218K" name="dei:Security12bTitle"><b>Common Stock</b></ix:nonNumeric>, $0.10 par value per share</b></div>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" name="dei:TradingSymbol"><b>ULBI</b></ix:nonNumeric></div>
			</td>
			<td style="vertical-align:bottom;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName"><b>NASDAQ</b></ix:nonNumeric></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Title of each class)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Trading Symbol)</div>
			</td>
			<td style="vertical-align:top;width:33.3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Name of each exchange on which registered)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric>&#xa0;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric>&#xa0;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric>&#xa0;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
			</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:top;width:100%;">&#xa0;</td>
		</tr>
		<tr>
			<td colspan="3" style="vertical-align:middle;width:100%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric>&#xa0;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company <ix:nonNumeric contextRef="d20218K" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 1.01 Entry Into a Material Definitive Agreement</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Acquisition of Excell Battery Group</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 13, 2021, 1336889 B.C. Unlimited Liability Company, a British Columbia unlimited liability corporation and wholly-owned subsidiary of Ultralife Canada Holding Corp., a Delaware corporation (&#8220;UCHC&#8221;) and wholly-owned subsidiary of Ultralife Excell Holding Corp., a Delaware corporation (&#8220;UEHC&#8221;) and wholly-owned subsidiary of Ultralife Corporation, a Delaware corporation (&#8220;Ultralife&#8221; or the &#8220;Company&#8221;), completed the acquisition of all issued and outstanding shares of Excell Battery Canada Inc., a British Columbia corporation (&#8220;Excell Canada&#8221;), for a purchase price of $16.45 million, subject to customary working capital and net cash adjustments (the &#8220;Excell Canada Acquisition&#8221;), and, concurrently, 1336902 B.C. Unlimited Liability Company, a British Columbia unlimited liability corporation and wholly-owned subsidiary of UCHC, completed the acquisition of all issued and outstanding shares of 656700 B.C. LTD, a British Columbia corporation and sole owner of all issued and outstanding shares of Excell Battery Corporation USA, a Texas corporation (&#8220;Excell USA&#8221;, and together with Excell Canada, &#8220;Excell Battery Group&#8221; or &#8220;Excell&#8221;), for a purchase price of $7.05 million, subject to customary working capital and net cash adjustments (the &#8220;Excell USA Acquisition&#8221;, and together with the Excell Canada Acquisition, the &#8220;Excell Acquisition&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Excell Canada Acquisition was completed pursuant to a Share Purchase Agreement&#xa0;dated December 13, 2021 (the &#8220;Excell Canada Acquisition Agreement&#8221;) by and among 1336889 B.C. Unlimited Liability Company, Mark Kroeker, Randolph Peters, Brian Larsen, M. &amp; W. Holdings Ltd., Karen Kroeker, Heather Peterson, Michael Kroeker, Nicholas Kroeker, Brentley Peters, Craig Peters, Kurtis Peters, Heather Larsen, Ian Kane, Carol Peters, and 0835205 B.C. LTD (the &#8220;Excell Canada Sellers&#8221;), Mark Kroeker in his capacity as the Excell Canada Sellers&#8217; Representative, and Excell Canada.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Excell USA Acquisition was completed pursuant to a Share Purchase Agreement&#xa0;dated December 13, 2021 (the &#8220;Excell USA Acquisition Agreement&#8221;, and together with the Excell Canada Acquisition Agreement, the &#8220;Excell Acquisition Agreements&#8221;) by and among 1336902 B.C. Unlimited Liability Company, M. &amp; W. Holdings Ltd., Ian Kane, Sanford Capital Ltd., Arcee Enterprises Inc., and 0835205 B.C. Ltd. (the &#8220;Excell USA Sellers&#8221;, and together with the Excell Canada Sellers, the &#8220;Sellers&#8221;), Mark Kroeker in his capacity as the Excell USA Sellers&#8217; Representative, and 656700 B.C. LTD.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The aggregate purchase price for the Excell Acquisition was funded by the Company through a combination of cash on hand and borrowings under the Amended Credit Facilities (as defined below).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Excell Acquisition Agreements contain customary terms and conditions including representations, warranties and indemnification provisions. A portion of the consideration paid to the Sellers will be held in escrow for post-closing adjustments and indemnification purposes.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The foregoing description of the Excell Acquisition Agreements does not purport to be complete and is qualified in its entirety by reference to the full text of the Excell Acquisition Agreements, copies of which are filed as Exhibits&#xa0;2.1 and 2.2 hereto and are incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>Amended Credit Agreement</i></b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On December 13, 2021, Ultralife, Southwest Electronic Energy Corporation, a Texas corporation (&#8220;SWE&#8221;), CLB, INC., a Texas corporation and wholly owned subsidiary of SWE (&#8220;CLB&#8221;), UEHC, UCHC and Excell USA, as borrowers, entered into the Second Amendment Agreement with KeyBank National Association (&#8220;KeyBank&#8221; or the &#8220;Bank&#8221;), as lender and administrative agent, to amend the Credit and Security Agreement dated May 31, 2017 as amended by the First Amendment Agreement by and among Ultralife, SWE, CLB and KeyBank dated May 1, 2019 (the &#8220;Credit Agreement&#8221;, and together with the Second Amendment Agreement, the &#8220;Amended Credit Agreement&#8221;).</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Amended Credit Agreement, among other things, provides for a 5-year, $10 million senior secured term loan (the &#8220;Term Loan Facility&#8221;) and extends the term of the $30 million senior secured revolving credit facility (the &#8220;Revolving Credit Facility&#8221;, and together with the Term Loan Facility, the &#8220;Amended Credit Facilities&#8221;) through May 30, 2025. Up to six months prior to May 30, 2025, the Revolving Credit Facility may be increased to $50.0 million with the Bank&#8217;s concurrence.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Upon closing of the Excell Acquisition on December 13, 2021, the Company drew down the full amount of the Term Loan Facility and $10 million under the Revolving Credit Facility. The remaining availability under the Revolving Credit Facility is subject to certain borrowing base limits based on trade receivables and inventories.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is required to repay the borrowings under the Term Loan Facility in equal consecutive monthly payments commencing on February 1, 2022, in arrears, together with applicable interest. All unpaid principal and accrued and unpaid interest with respect to the Term Loan Facility is due and payable in full on January 1, 2027. All unpaid principal and accrued and unpaid interest with respect to the Revolving Credit Facility is due and payable in full on May 30, 2025. The Company may voluntarily prepay principal amounts outstanding at any time subject to certain restrictions.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In addition to the customary affirmative and negative covenants, the Company must maintain a consolidated senior leverage ratio, as defined in the Amended Credit Agreement, of equal to or less than 3.5 to 1.0 for the fiscal quarters ending December 31, 2022 and March 31, 2023, and equal to or less than 3.0 to 1.0 for the fiscal quarters ending June 30, 2023 and thereafter.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Borrowings under the Credit Facilities are secured by substantially all the assets of the Company and its subsidiaries.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Interest will accrue on outstanding indebtedness under the Credit Facilities at the Base Rate or the Overnight LIBOR Rate, as selected by the Company, plus the applicable margin. The Base Rate is the higher of (a) the Prime Rate, (b) the Federal Funds Effective Rate plus 50 basis points, and (c) the Overnight LIBOR Rate plus one hundred basis points. The applicable margin ranges from zero to negative 50 basis points for the Base Rate and from 185 to 215 basis points for the Overnight LIBOR Rate and are determined based on the Company&#8217;s senior leverage ratio. The Second Amendment Agreement includes standard market provisions permitting the Bank to transition from LIBOR to a SOFR based rate, in its discretion</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company must pay a fee of 0.15% to 0.25% based on the average daily unused availability under the Revolving Credit Facility.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Payments must be made by the Company to the extent borrowings exceed the maximum amount then permitted to be drawn on the Credit Facilities and from the proceeds of certain transactions. Upon the occurrence of an event of default, the outstanding obligations may be accelerated and the Bank will have other customary remedies including resort to the security interest the Company provided to the Bank.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The foregoing description of the Amended Credit Agreement does not purport to be complete, and is qualified in its entirety by reference to the full text of the Amended Credit Agreement, a copy of which is filed as Exhibit&#xa0;10.1 hereto and is incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Amended Credit Agreement has been filed to provide investors and security holders with information regarding its terms, provisions, conditions, and covenants and is not intended to provide any other factual information respecting the Company or its subsidiaries. In particular the Amended Credit Agreement contains representations and warranties made to and solely for the benefit of the parties thereto, allocating among themselves various risks of the transaction. The assertions embodied in those representations and warranties may be qualified or modified by information in disclosure schedules that the parties have exchanged in connection with executing the Amended Credit Agreement. Moreover, information concerning the subject matter of the representations and warranties may change after the date of the Amended Credit Agreement, which subsequent information may or may not be fully reflected in the Company&#8217;s public disclosures. Accordingly, investors and security holders should not rely on the representations and warranties in these documents as characterizations of the actual state of any fact or facts.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 2.01 Completion of Acquisition or Disposition of Assets</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information related to the&#xa0;Excell Acquisition Agreements&#xa0;disclosed in&#xa0;Item 1.01&#xa0;of this Current Report on Form 8-K is incorporated into this Item 2.01 by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 2.03 Creation of a Direct Financial Obligation</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information related to the&#xa0;Amended Credit Agreement as defined and disclosed in&#xa0;Item 1.01&#xa0;of this Current Report on Form 8-K is incorporated into this Item 2.03 by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&#xa0;</div>
</div>
</div>
</div>

<div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 7.01 Regulation FD</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On December 14, 2021, Ultralife Corporation issued a press release announcing the completion of the Excell Acquisition. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The information set forth in this Item 7.01 and Exhibit 99.1 is being furnished to and not filed with the Securities and Exchange Commission and shall not be deemed as incorporated by reference in any filing under the Securities Exchange Act of 1934, as amended, or the Securities Act of 1933, as amended, except to the extent specifically provided in any such filing.</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Item 9.01 Financial Statements, Pro Forma Financials and Exhibits</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tbody><tr style="vertical-align: top;">
			<td style="width: 18pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(a)</div>
			</td>
			<td style="width: auto;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Financial Statements of Business Acquired</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The financial statements required by this item are not being filed herewith. The Company will file the required financial statements as an amendment to this Current Report on Form 8-K as soon as practicable after the date hereof and not later than 71 days after the date this Current Report on Form 8-K would otherwise be required to be filed.</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px; font-family: Times New Roman; font-size: 10pt;">

		<tbody><tr style="vertical-align: top; font-family: Times New Roman; font-size: 10pt;">
			<td style="width: 18pt; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">(b)</div>
			</td>
			<td style="width: auto; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">Pro Forma Financial Information</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The pro forma financial information required by this item is not being filed herewith. The Company will file the required pro forma financial information as an amendment to this Current Report on Form 8-K as soon as practicable after the date hereof and not later than 71 days after the date this Current Report on Form 8-K would otherwise be required to be filed.</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">(d) Exhibits</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">

		<tbody><tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit</b></div>

			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Number</b></div>
			</td>
			<td style="vertical-align: bottom; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Exhibit Description</b></div>
			</td>
			<td style="vertical-align: bottom; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.1*</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316642.htm" style="-sec-extract:exhibit;">Share Purchase Agreement, dated December 13, 2021, by and among 1336889 B.C. Unlimited Liability Company, Mark Kroeker, Randolph Peters, Brian Larsen, M. &amp; W. Holdings Ltd., Karen Kroeker, Heather Peterson, Michael Kroeker, Nicholas Kroeker, Brentley Peters, Craig Peters, Kurtis Peters, Heather Larsen, Ian Kane, Carol Peters, 0835205 B.C. LTD, and Excell Battery Canada Inc.</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2.2*</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316643.htm" style="-sec-extract:exhibit;">Share Purchase Agreement, dated December 13, 2021, by and among 1336902 B.C. Unlimited Liability Company, M. &amp; W. Holdings Ltd., Ian Kane, Sanford Capital Ltd., Arcee Enterprises Inc., 0835205 B.C. Ltd., and 656700 B.C. LTD</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.1*</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316662.htm" style="-sec-extract:exhibit;">Second Amendment Agreement, dated December 13, 2021, by and among Ultralife Corporation, Southwest Electronic Energy Corporation, CLB, INC., Ultralife Excell Holding Corp., Ultralife Canada Holding Corp., Excell Battery Corporation USA, and KeyBank National Association</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.2</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316663.htm" style="-sec-extract:exhibit;">Pledge Agreement, dated December 13, 2021, by and among Ultralife Corporation, Southwest Electronic Energy Corporation, CLB, INC., Ultralife Excell Holding Corp., Ultralife Canada Holding Corp., Excell Battery Corporation USA, and KeyBank National Association</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.3</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316664.htm" style="-sec-extract:exhibit;">Assumption and Joinder Agreement, dated December 13, 2021, by and among Ultralife Corporation, Southwest Electronic Energy Corporation, CLB, INC., Ultralife Excell Holding Corp., Ultralife Canada Holding Corp., Excell Battery Corporation USA, and KeyBank National Association</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">10.4</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316665.htm" style="-sec-extract:exhibit;">Term Loan, dated December 13, 2021, by and among Ultralife Corporation, Southwest Electronic Energy Corporation, CLB, INC., Ultralife Excell Holding Corp., Ultralife Canada Holding Corp., Excell Battery Corporation USA, and KeyBank National Association</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">99.1</div>
			</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><a href="ex_316038.htm" style="-sec-extract:exhibit;">Press Release of Ultralife Corporation dated December 14, 2021</a></div>
			</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr style="font-family: Times New Roman; font-size: 10pt;">
			<td style="vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">104</td>
			<td style="vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 2%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 68%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
			<td style="vertical-align: top; width: 18%; font-family: Times New Roman; font-size: 10pt;">&#xa0;</td>
		</tr>

</tbody></table>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">* Certain exhibits and schedules have been&#xa0;omitted&#xa0;pursuant to&#xa0;Item 601(b)(2) of Regulation S-K. The Company hereby undertakes to furnish supplementally a copy of any omitted exhibit or schedule upon request by the U.S. Securities and Exchange Commission.</div>

<div style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">&#xa0;</div>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&#xa0;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000" />
<div class="PGHDR" style="text-align: left; width: 100%">&#xa0;</div>
</div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SIGNATURES</b></div>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</div>

<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#xa0;</div>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">

		<tbody><tr>
			<td style="vertical-align: bottom; width: 50%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Date: December 15, 2021</div>
			</td>
			<td style="vertical-align: bottom; width: 3%;">&#xa0;</td>
			<td style="vertical-align: bottom; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>ULTRALIFE CORPORATION</b></div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 47%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 47%;">&#xa0;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">By:</div>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">/s/ Philip A. Fain</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Philip A. Fain</div>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 50%;">&#xa0;</td>
			<td style="vertical-align: top; width: 3%;">&#xa0;</td>
			<td style="vertical-align: top; width: 47%;">
			<div style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Chief Financial Officer and Treasurer</div>
			</td>
		</tr>

</tbody></table>

<div style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&#xa0;</div>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&#xa0;</div>
</div>
</div>
</div>


</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ex_316642.htm
<DESCRIPTION>EXHIBIT 2.1
<TEXT>
<html><head>
	<title>ex_316642.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 7:57:56 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 2.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SHARE PURCHASE AGREEMENT</b><br>
<br>
<b>By and Among</b><br>
<br>
<b>1336889 B.C. UNLIMITED LIABILITY COMPANY,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Buyer</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>MARK KROEKER,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>RANDOLPH PETERS,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>BRIAN LARSEN,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>M. &amp; W. HOLDINGS LTD.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>KAREN KROEKER</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>HEATHER PETERSON,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>MICHAEL KROEKER,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>NICHOLAS KROEKER,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>BRENTLEY PETERS,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CRAIG PETERS,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>KURTIS PETERS,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>HEATHER LARSEN,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IAN KANE,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>CAROL PETERS</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>0835205 B.C. LTD.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Sellers </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>MARK KROEKER,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Sellers</b>&#8217;<b> Representative</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXCELL BATTERY CANADA INC.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Company</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Dated December 13, 2021</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TABLE OF CONTENTS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">ii</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SHARE PURCHASE AGREEMENT</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article I</font> - DEFINED TERMS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">1.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Defined Terms Used in this Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article II -</font> PURCHASE AND SALE OF SHARES</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Purchase and Sale of the Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payments at the Closing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">10</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing Deliveries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing Net Purchase Price</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Post-Closing Adjustment</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">13</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">2.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Withholding</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article III</font> - REPRESENTATIONS AND WARRANTIES OF<font style="text-transform:uppercase;"> the</font> COMPANY</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">15</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Company Power</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subsidiaries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial Statements</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Undisclosed Liabilities</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indebtedness</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.8</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Developments</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.9</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.10</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">20</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.11</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Properties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.12</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">23</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.13</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Contracts and Arrangements</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.14</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governmental Approvals; Compliance with Laws</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.15</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance Coverage</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.16</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Benefits</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">28</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.17</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labour and Employment Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">29</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.18</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Brokers or Finders</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">30</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.19</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transactions with Affiliates</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">31</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.20</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">31</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.21</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Records</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">32</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.22</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Customers and Suppliers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">32</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.23</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assets; Solvency</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.24</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.25</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competition Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">3.26</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COVID-19 Compliance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">34</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article IV -</font> REPRESENTATIONS AND WARRANTIES OF THE <font style="text-transform:uppercase;">SellerS</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">4.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">4.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">4.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Proceedings</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">4.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Banking; Brokerage Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">4.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Residency</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article V</font> - REPRESENTATIONS AND WARRANTI<font style="text-transform:uppercase;">ES OF the Buyer</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Power</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consents and Approvals</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competition Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transferred Information</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">5.8</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Banking; Brokerage Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VI - ADDITIONAL AGREEMENTS</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Announcement; Confidentiality</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-Competition and Non-Solicitation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preservation of Books and Records</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act Notification.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Privileged Communications</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transferred Information.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Excluded Accounts Receivable.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">41</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.8</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">41</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.9</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Further Assurances</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">45</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">6.10</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">D&amp;O Policy; Indemnification of Directors and Officers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">45</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 10%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VII</font> - INDEMNIFICATION</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">46</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Representations, Warranties and Covenants</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">46</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Survival Period</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">46</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnification Provisions for Buyer&#8217;s Benefit</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">46</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnification Provisions for the Seller&#8217;s Benefit; Limitations</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Matters Involving Third Parties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Direct Claims</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Further Limitations and Qualifications</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.8</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subrogation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">7.9</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Treatment of Indemnification Payments</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">ii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 10%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VIII - MISCELL</font>ANEOUS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.1</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Entire Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.2</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Third-Party Beneficiaries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.3</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amendments, Waivers, Consents and Assignability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.4</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notices and Demands</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.5</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Severability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">53</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.6</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Counterparts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">53</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.7</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Headings; Interpretation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.8</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exhibits and Schedules</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.9</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governing Law; Venue</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.10</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consent to Jurisdiction</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.11</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Incorporation by Reference</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.12</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Specific Performance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.13</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WAIVER OF JURY TRIAL</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 10%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 27pt;">8.14</p>
			</td>
			<td style="vertical-align: middle; width: 85%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sellers&#8217;&nbsp;Representative</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">56</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">iii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXHIBITS AND SCHEDULES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXHIBIT A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Calculation of Closing Net Purchase Price and Working Capital</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DISCLOSURE SCHEDULES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 2.1</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Allocation of Purchase Price</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.2</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization and Non-Contravention</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.3</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.5(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial Statements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.5(c)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts Receivable or Loans Receivable from Affiliated Persons</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.7</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indebtedness</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.8</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Developments</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.9</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.10(f)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Liens for Taxes</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.10(i)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joint Venture, Partnership or Other Arrangements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.11</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Properties</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.12</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.13</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Contracts and Arrangements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.14(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governmental Approvals; Compliance with Laws</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.15</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance Coverage</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.16</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Matters</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.17</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labour and Employment Matters</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.19</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transaction with Affiliates</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Permits</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(d)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Release of Hazardous Substances</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(e)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Off-Site Hazardous Materials Facilities or Locations</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.22(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Customers</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">iv</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.22(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Suppliers</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.23(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assets</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.23(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventory</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.26</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COVID-19 Compliance</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 4.1</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">v</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b>SHARE PURCHASE AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>THIS SHARE PURCHASE AGREEMENT</b> (this &#8220;<u>Agreement</u>&#8221;) is made as of December 13, 2021, by and among 1336889 B.C. UNLIMITED LIABILITY COMPANY, a British Columbia unlimited liability company (the &#8220;<u>Buyer</u>&#8221;), MARK KROEKER (&#8220;<u>Mark</u>&#8221;), RANDOLPH PETERS (&#8220;<u>Randolph</u>&#8221;), BRIAN LARSEN (&#8220;<u>Brian</u>&#8221;), M. &amp;. W. HOLDINGS LTD. (&#8220;<u>M&amp;W</u>&#8221;), KAREN KROEKER (&#8220;<u>Karen</u>&#8221;), HEATHER PETERSON (&#8220;<u>HeatherP</u>&#8221;), MICHAEL KROEKER (&#8220;<u>Michael</u>&#8221;), NICHOLAS KROEKER (&#8220;<u>Nicholas</u>&#8221;), BRENTLEY PETERS (&#8220;<u>Brentley</u>&#8221;), CRAIG PETERS (&#8220;<u>Craig</u>&#8221;), KURTIS PETERS (&#8220;<u>Kurtis</u>&#8221;), HEATHER LARSEN (&#8220;<u>HeatherL</u>&#8221;), IAN KANE (&#8220;<u>Ian</u>&#8221;), CAROL PETERS (&#8220;<u>Carol</u>&#8221;), 0835205 B.C. LTD. (&#8220;<u>LarsenCo</u>&#8221;, and collectively with Mark, Randolph, Brian, M&amp;W, Karen, HeatherP, Michael, Nicholas, Brentley, Craig, Kurtis, HeatherL, Ian and Carol, the &#8220;<u>Sellers</u>&#8221;, and each individually a &#8220;<u>Seller</u>&#8221;), MARK KROEKER, in his capacity as the Sellers&#8217; Representative, and EXCELL BATTERY CANADA INC., a British Columbia corporation (the &#8220;<u>Company</u>&#8221; and, together with the Sellers and the Buyer, the &#8220;<u>Parties</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS, </b>as of the date hereof, the Sellers own 100% of the issued and outstanding shares of the Company (the &#8220;<u>Shares</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS</b>, the Buyer desires to purchase from the Sellers, and the Sellers desire to sell to the Buyer, the Shares, subject to the terms and conditions set forth herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>NOW, THEREFORE</b>, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE I</u></b><b><u>&nbsp;- DEFINED TERMS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Defined Terms Used in this Agreement</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">As used in this Agreement, the following terms have the meanings ascribed thereto below:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Accounting Principles</u>&#8221; means ASPE consistently applied using the same accounting principles, practices, procedures, policies, assumptions and methods (with consistent classifications, judgments, inclusions, exclusions and valuation and estimation methodologies) used in the preparation of the Historical Financials.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Adjustment Time</u>&#8221; means the close of business on the day immediately prior to the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Affiliate</u>&#8221; means, with respect to any specified Person, a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Person specified. For purposes of this definition, &#8220;control&#8221; (including the correlative terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting equity interest, by contract or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Agreement</u>&#8221; shall have the meaning ascribed in the Preamble.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>ASPE</u>&#8221; means generally accepted accounting principles in Canada from time to time applying the standards prescribed in Part II of the CPA Canada Handbook &#8211; Accounting (Accounting Standards for Private Enterprises).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">&#8220;<u>Balance Sheet Date</u>&#8221; shall have the meaning ascribed in <u>Section 3.5</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Basket</u>&#8221; shall have the meaning ascribed in <u>Section 7.3.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Business</u>&#8221; shall have the meaning ascribed in <u>Section 6.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Business Day</u>&#8221; means a day other than Saturday, Sunday or any day on which banks located in Vancouver, British Columbia, Toronto, Ontario, and Rochester, New York are authorized or obligated to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Buyer</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Buyer Indemnified Parties</u>&#8221; shall have the meaning ascribed in <u>Section 7.3</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Buyer Post-Closing Prepared Tax Returns</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(a)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Buyer Pre-Closing Prepared Tax Returns</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(a)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Buyer Transaction Expenses</u>&#8221; shall mean the fees, costs and expenses incurred by the Buyer in connection with the transactions contemplated by this Agreement and the other Transaction Documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Cash</u>&#8221; shall mean the aggregate amount of the Company&#8217;s cash and cash equivalents <u>plus</u>, without duplication, security deposits and checks, wire transfers, ACH transactions and credit card payments in transit to the Company as of the measurement date therefor, and <u>minus</u>, without duplication, outstanding checks, wire transfers, ACH transactions and credit card payments in transit by the Company to the extent there has been a reduction in accounts payable in the calculation of Working Capital on account thereof, as determined in accordance with the Accounting Principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Closing</u>&#8221; shall have the meaning ascribed in <u>Section 2.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Closing Balance Sheet</u>&#8221; shall have the meaning ascribed in <u>Section 2.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Closing Cash</u>&#8221; shall mean the aggregate amount of Cash held by the Company, as of the Adjustment Time, determined in accordance with the Accounting Principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Closing Date</u>&#8221; shall have the meaning ascribed in <u>Section 2.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Closing Net Purchase Price</u>&#8221; means an amount equal to the Purchase Price <u>minus</u> (i) the Estimated Indebtedness, the Estimated Company Transaction Expenses, the Estimated Working Capital Deficiency (if any) <u>plus</u> (ii) the Estimated Working Capital Surplus (if any) and the Estimated Closing Cash.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Company</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Company Data</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Company Database</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt;">&#8220;<u>Company Intellectual Property</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Company Transaction Expenses</u>&#8221; shall mean all expenses of the Company incurred prior to the Closing in connection with the transactions contemplated by this Agreement and the other Transaction Documents that have not been paid as of the Closing and are not included or reflected in the calculation of Working Capital, including without limitation (i) all legal fees, accountants and other service providers payable by or on behalf of the Company and (ii) the amount of stay bonuses, sales bonuses, transaction or similar bonuses, change of control payments, retention payments or other similar payments that are accelerated, accrue or become payable to, or in respect of any current or former employee, individual independent contractor or other service provider, officer or director of the Company or any other Person, in each case, pursuant to agreements or plans in place prior to the Closing Date in connection with the consummation of the transactions contemplated hereby and payable by the Company, including, in each case, the employer portion of any employment, payroll, unemployment, withholding Taxes or similar Taxes paid, payable or incurred by the Company in connection therewith, but for greater certainty, excludes any such amounts that become due and payable after the Closing as a result of actions of the Company, the Buyer or any such employee, individual independent contractor or other service provider, officer or director of the Company or other Person after the Closing;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Competitive Business</u>&#8221; shall mean any business that competes with the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Confidential Data</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>COVID-19 Government Assistance</u>&#8221; shall mean any Tax amounts related to the Canada Emergency Wage Subsidy, the Temporary Wage Subsidy, the Canada Emergency Rent Subsidy, the Canada Recovery Hiring Program and Canada Emergency Business Account Loan, including any interest, penalties, or additions to Tax attributable thereto (or attributable to excessive amounts received thereto).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Current Assets</u>&#8221; means, as of the Adjustment Time, accounts receivable, inventory, income Taxes receivable or recoverable and prepaid expenses, but excluding (a) the portion of any prepaid expense of which the Buyer will not receive the benefit following the Closing, (b) deferred Tax assets, (c) Cash, (d) receivables from any of the Company&#8217;s Affiliates, directors, employees, officers or shareholders and any of their respective Affiliates, and (e) Excluded Accounts Receivables, determined without duplication and in accordance with <u>Exhibit A</u> and the Accounting Principles (provided that, in the event of any conflict or inconsistency between the Accounting Principles and <u>Exhibit A</u>, <u>Exhibit A</u> shall prevail).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Current Liabilities</u>&#8221; means, as of the Adjustment Time, accounts payable, accrued Taxes and accrued expenses, but excluding (a) payables to any of the Company&#8217;s Affiliates, directors, employees, officers or shareholders and any of their respective Affiliates, (b) deferred Tax liabilities, (c) Company Transaction Expenses, and (d) any Indebtedness of the Company, determined without duplication and in accordance with <u>Exhibit A</u> and the Accounting Principles. (provided that, in the event of any conflict or inconsistency between the Accounting Principles and <u>Exhibit A</u>, <u>Exhibit A</u> shall prevail).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Customers</u>&#8221; shall have the meaning ascribed in <u>Section 3.22(a).</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Disclosure Schedule</u>&#8221; shall have the meaning ascribed in <u>Article III</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Dispute Period</u>&#8221; has the meaning ascribed in <u>Section 7.5(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Employee Benefit Plan</u>&#8221; shall have the meanings ascribed in <u>Section 3.16</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Encumbrances</u>&#8221; shall mean any charge, claim, community property interest, pledge, condition, equitable interest, lien (statutory or other), option, security interest, mortgage, easement, encroachment, right of way, right of first refusal, or restriction of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Environmental Claim</u>&#8221; shall mean any legal claim, legal demand or Legal Proceeding arising under Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Environmental Laws</u>&#8221; shall mean any applicable law, including without limitation, federal, provincial and municipal laws, regulations and by-laws and any order or binding agreement with any Governmental Authority: (a) relating to pollution (or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health and safety, or the environment (including ambient air, soil, surface water or groundwater, or subsurface strata); or (b) concerning the presence of, exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge, Release, transportation, processing, manufacturing, labeling, warning, testing, production, disposal, risk management, control, clean up or remediation of any Hazardous Materials; or (c) any product responsibility, extended producer responsibility or stewardship requirements, in each case, concerning the recycling or disposal of batteries or waste batteries.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Environmental Notice</u>&#8221;&nbsp;shall mean any written directive, notice of violation, infraction, investigation, remediation, corrective obligation, complaint, penalty or notice respecting any Environmental Claim relating to actual or alleged non-compliance with any Environmental Laws or any term or condition of any Environmental Permit.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Environmental Permit</u>&#8221;&nbsp;shall mean any Permit, license, sublicense, approval, certification, registration, exemption, variance, permissive use, letter, clearance, consent, waiver, closure, exemption, decision, approval, other authorization of any nature or other action required under or issued, granted, given, authorized by or made pursuant to Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Escrow Agent</u>&#8221; means Cassels Brock &amp; Blackwell LLP.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Escrow Agreement</u>&#8221; means the escrow agreement by and among the Buyer, the Sellers&#8217; Representative and the Escrow Agent to be entered into as of the Closing Date, in a form acceptable to the parties thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Escrow Amount</u>&#8221; means the Indemnification Escrow Amount <u>plus</u> the Working Capital Escrow Amount.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Estimated Closing Cash</u>&#8221; shall mean the estimated Closing Cash as of the Adjustment Time, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Estimated Company Transaction Expenses</u>&#8221; shall mean the estimated Company Transaction Expenses that are unpaid as of the Closing, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Estimated Indebtedness</u>&#8221; shall mean the estimated Indebtedness of the Company as of the Adjustment Time, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Estimated Working Capital Deficiency</u>&#8221; shall mean the estimated Working Capital Deficiency of the Company as of the Adjustment Time (determined in accordance with <u>Exhibit A</u> and the Accounting Principles), as set forth in <u>Exhibit A</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Estimated Working Capital Surplus</u>&#8221; shall mean the estimated Working Capital Surplus of the Company as of the Adjustment Time (determined in accordance with <u>Exhibit A</u> and the Accounting Principles), as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Excluded Accounts Receivable</u>&#8221; means without duplication, any accounts receivable of the Company as of the Adjustment Time and that are not included or reflected in the calculation of Working Capital.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Closing Cash</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Company Transaction Expenses</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Indebtedness</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Net Purchase Price</u>&#8221; shall mean an amount equal to the Purchase Price <i><u>minus</u></i> (i)&nbsp;the Final Indebtedness, the Final Company Transaction Expenses and the Final Working Capital Deficiency (if any), <i><u>plus</u></i> (ii) the Final Working Capital Surplus (if any) and<i> </i>the Final Closing Cash.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Working Capital Deficiency</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Final Working Capital Surplus</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Financial Statements</u>&#8221; shall have the meaning ascribed in <u>Section 3.5</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Fundamental Representations of the Buyer</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Fundamental Representations of the Seller</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>General Release</u>&#8221; shall have the meaning ascribed in <u>Section 2.4(a)(xi)</u>.<u> </u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Governmental Authority</u>&#8221; means any federal, provincial, territorial, local, municipal or foreign government (including any political subdivision thereof, court, administrative agency, regulatory body, board, organization, authority), or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of law), or any arbitrator, court or tribunal of competent jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>GST</u>&#8221; shall have the meaning ascribed in <u>Section 3.10(o)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Hazardous Material</u>&#8221; means any substance or material meeting any one or more of the following criteria: (i) it is or contains a substance designated as a hazardous waste, hazardous substance, hazardous material, pollutant, contaminant or toxic substance under any Environmental Laws; (ii) it is toxic, explosive, corrosive, reactive, ignitable, infectious, radioactive, mutagenic, dangerous or otherwise hazardous; (iii) its presence at some quantity requires investigation, notification or remediation under any Environmental Law; or (iv) it is or contains, without limiting the foregoing clauses (i)-(iii), asbestos, polychlorinated biphenyls, petroleum hydrocarbons, petroleum derived substances or waste, crude oil or any fraction thereof, nuclear fuel or waste, natural gas or synthetic gas.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Historical Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Indebtedness</u>&#8221; shall mean with respect to any Person, without duplication: (i) any indebtedness for borrowed money (including credit card liabilities or obligations) or issued in substitution for or exchange of indebtedness for borrowed money, whether current, short-term or long-term, secured or unsecured, including principal, premium (if any) and accrued interest; (ii) any indebtedness or obligation evidenced by any bond, debenture, note, debt security, unfunded letter of credit or other similar instrument, including principal, premium (if any) and accrued interest; (iii) any obligations for earn-outs or other similar payments owed in connection with any acquisitions; (iv) obligations for the deferred purchase price of property or services (other than Current Liabilities taken into account in the calculation of Working Capital); (v) capital lease obligations; (vi) any guaranty of any other Person for the obligations and indebtedness set forth in subsections (i) through (v) herein; and (vii) any accrued and unpaid interest on, and any prepayment premiums, penalties or similar contractual charges in respect of, any of the foregoing obligations computed as though payment is being made in respect thereof at the Adjustment Time. Notwithstanding the foregoing, &#8220;Indebtedness&#8221; shall not include any amounts included as Company Transaction Expenses and any Current Liabilities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Indemnification Escrow Amount</u>&#8221; means $1,974,000.00.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Indemnification Escrow Fund</u>&#8221; means the Indemnification Escrow Amount (such amount, including any interest or other amounts earned thereon and less any disbursements therefrom in accordance with the Escrow Agreement).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Indemnified Party</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Indemnifying Party</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Independent Accounting Firm</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Inventory</u>&#8221; shall have the meaning ascribed in <u>Section 3.23(b).</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Item of Dispute</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Interim Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Knowledge</u>&#8221; shall have the meaning ascribed in <u>Article III</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Kroeker Trust Seller(s)</u>&#8221; shall have the meaning ascribed in <u>Article IV</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Law</u>&#8221; means any applicable (a) international, multinational, foreign, federal, provincial, territorial, local or municipal law, rule, statute, constitution, treaty, regulation, judgment, injunction, common law, order, directive, ordinance, code, decree, other requirements having the force of law, and any legally-binding requirements in a Permit or restriction of any Governmental Authority or (b) governmental order.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Leases</u>&#8221; shall have the meaning ascribed in <u>Section 3.11</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Legal Proceeding</u>&#8221;<b><i> </i></b>shall mean any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative or appellate proceeding), hearing or formal inquiry or audit commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Authority or any arbitrator or arbitration panel.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Loss</u>&#8221; or &#8220;<u>Losses</u>&#8221; shall mean any losses, Taxes, liabilities, costs, fines, penalties, interests, expenses (including the reasonable fees of lawyers, accountants, consultants, experts, and other professionals) and damages, but excluding any and all aggravated or punitive losses, claims for loss profits, diminution in value, &#8220;multiple of profits&#8221;, &#8220;multiple of cash flow&#8221; or similar losses (in each case, except arising out of Third Party Claims) as well as any consequential or indirect damages, except to the extent such consequential or indirect damages were reasonably foreseeable, incurred by any Party entitled to indemnification under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Material Adverse Effect</u>&#8221; means any event, circumstance, change, occurrence or effect (collectively, &#8220;<u>Events</u>&#8221;) that, individually, has had a continuing material and adverse effect upon the assets, liabilities, financial condition or operating results of the Company; <i>provided</i>, <i>however</i>, that none of the following shall be deemed to constitute, and no adverse Event arising from or relating to the following shall be taken into account in determining whether there has been, a Material Adverse Effect: (a) general economic or political conditions, including capital, credit and financial markets and such conditions related to the business thereof, (b) general changes in the industries or lines of business in which the Company operates, except such general changes that have a disproportionate impact on the Company compared to other participants in such industries or lines of business, (c) changes in the Law or in ASPE or generally accepted accounting principles outside of Canada, or the interpretation, application or non-application thereof, (d) the taking of or failure to take any action permitted by this Agreement and the other agreements contemplated hereby, (e) failures to meet financial projections, estimates or forecasts of revenues, earnings or other measures of financial or operating performance of any period, except that the underlying causes of such failures shall not be excluded when determining whether there has been a Material Adverse Effect, (f) any &#8220;act of God,&#8221; including, but not limited to, weather, fires, natural disasters, earthquakes, pandemics (including the COVID-19 coronavirus pandemic), acts of war, terrorism, civil unrest or sabotage, or (g) changes resulting from the announcement of the execution of this Agreement or the transactions contemplated hereunder or the consummation of such transactions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Negative Adjustment Amount</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Notice</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Notice of Disagreement</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Party</u>&#8221; or &#8220;<u>Parties</u>&#8221; shall mean those entities or individuals identified in the first paragraph of the Preamble.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Permits</u>&#8221; shall have the meaning ascribed in <u>Section 3.14</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Permitted Encumbrances</u>&#8221; means each of the following: (a) Encumbrances incurred or deposits made in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other types of social security or to secure the performance of tenders, statutory obligations, surety and appeal bonds, bids, leases, government contracts, performance and return of money bonds and similar obligations; (b) mechanics&#8217;, carriers&#8217;, workers&#8217;, repairers&#8217;, materialmen&#8217;s, warehousemen&#8217;s, landlords&#8217; and other similar Encumbrances which (1) purely arise due to statutory provisions, (2) arise in the ordinary course of business and (3) relate to charges that are not overdue, delinquent or disputed, or if overdue or delinquent, the validity of which the Company is contesting in good faith by proper Legal Proceedings; (c) permits, licenses, agreements, easements, servitudes, restrictive covenants, rights-of-way, requirements and restrictions of zoning, building and other Laws, rules and regulations which do not arise as a result of a violation of Law or which do not materially impair the current use or marketability of the applicable property; (d) Encumbrances related to Taxes which are not due or delinquent or, if due or delinquent, the validity of which the Company is or will be contesting in good faith by proper Legal Proceedings; (e) undetermined or inchoate Encumbrances arising in the ordinary course of or incidental to the Business which have not been filed pursuant to Law against the Company or in respect of which no steps or proceedings to enforce such Encumbrances have been initiated or which relate to obligations which are not due or delinquent or, if due or delinquent, which the Company is contesting in good faith by appropriate proceedings; (f) all instruments registered against the title to any real property prior to Closing; and (g) any Encumbrances arranged by or on behalf of Buyer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Person</u>&#8221; shall mean an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association or other entity.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Personal Information</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Peters Trust Seller(s)</u>&#8221; shall have the meaning ascribed in <u>Article IV</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Positive Adjustment Amount</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(d)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Pre-Closing Tax Period</u>&#8221; shall mean any Tax period ending on or prior to the Closing Date and that portion of any Straddle Period ending on the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Privacy Commitments</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Privacy Laws</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Privacy Policy</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Privileged Communications</u>&#8221; means all privileged communications prior to and after Closing and arising out of or relating to the negotiation, documentation and consummation of this Agreement and the other documents and instruments contemplated hereby (including the Transaction Documents), and the completion of the transactions contemplated hereby and thereby, between or among the Sellers and their agents and representatives, on the one hand, and the Sellers&#8217; legal counsel, on the other hand.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Process</u>&#8221; or &#8220;<u>Processing</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>PST</u>&#8221; shall have the meaning ascribed in <u>Section 3.10(o)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Purchase Price</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Qualifying Claim</u>&#8221; shall have the meaning ascribed in <u>Section 7.3.</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Regulatory Representations</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Release</u>&#8221; means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including, without limitation, ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of Hazardous Materials through or in the air, soil, surface water, groundwater or property.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Seller Indemnified Parties</u>&#8221; shall have the meaning ascribed in <u>Section 7.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Sellers</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Sellers</u><u>&#8217;</u><u> Representative</u>&#8221; shall have the meaning ascribed in <u>Section 8.14(a)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Share Purchase</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Shares</u>&#8221; shall have the meaning ascribed in the Recitals.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Specified Employee</u>&#8221; shall have the meaning ascribed in <u>Section 6.2(a)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Straddle Period</u>&#8221; shall mean any Tax period beginning before the Closing Date and ending on or after the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to a specified Person, any corporation or other Person of which securities or other interests having the power to elect a majority of that corporation&#8217;s or other Person&#8217;s board of directors or similar governing body, or otherwise having the power to direct the business and policies of that corporation or other Person (other than securities or other interests having such power only upon the happening of a contingency that has not occurred) are held by the specified Person or one or more of its Subsidiaries. When used in this Agreement without reference to a particular Person, &#8220;Subsidiary&#8221; means a Subsidiary of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Suppliers</u>&#8221; shall have the meaning ascribed in <u>Section 3.22(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Target Working Capital</u>&#8221; shall mean $3,469,652.00.<b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Tax</u>&#8221; or &#8220;<u>Taxes</u>&#8221; shall mean all taxes and similar charges, fees, duties, levies, or other assessments (including income, gross receipts, net proceeds, ad valorem, withholding, turnover, real or personal property (tangible and intangible), occupation, customs, import and export, sales, use, franchise, excise, goods and services, employer health, harmonized sales, retail sales, land transfer, disability, value added, stamp, user, transfer, registration, recording, fuel, profit, excess profits, occupational, interest equalization, windfall profits, severance, payroll, Canada Pension Plan contributions, Employment Insurance premiums, Employer Health Tax premiums, Workplace Safety and Insurance premiums or other taxes or fees) that are imposed by any Governmental Authority, in each case including any interest, penalties, or additions to tax attributable thereto (or attributable to the nonpayment thereof and for greater certainty includes Canada Pension Plans, employment insurance premiums, and COVID-19 Government Assistance).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Tax Act</u>&#8221; means the <i>Income Tax Act</i> (Canada), and the regulations thereunder, as amended from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Tax Authority</u>&#8221; shall mean any Governmental Authority, board, bureau, body, department or authority of any Canadian federal, provincial, territorial or local jurisdiction or any foreign jurisdiction, having or purporting to exercise jurisdiction with respect to any Tax.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Tax Contest</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(b)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Tax Return</u>&#8221; shall mean any return, declaration, report, election, claim for refund or information return or statement of any kind relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof, filed or required to be filed with any Tax Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Term</u>&#8221; means the period beginning on the Closing Date and ending on the later of (A) in the case of Ian, the one (1) year anniversary of the Closing Date, (B) in the case of the other Sellers (other than Ian), the five (5) year anniversary of the Closing Date, and (C) to the extent any Seller becomes an employee of the Company, the one (1) year anniversary of the termination of such employment with the Company, for any reason.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Territory</u>&#8221; shall have the meaning ascribed in <u>Section 6.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Third-Party Claim</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transaction</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transaction Documents</u>&#8221; shall mean this Agreement, the Escrow Agreement and the General Releases.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transfer Taxes</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(g)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Transferred Information</u>&#8221; means the Personal Information to be disclosed or transferred to the Buyer or any of its representatives or agents by or on behalf of the Sellers or the Company as a result of, or in conjunction with, the transactions contemplated by this Agreement, and includes all such Personal Information disclosed to the Buyer or any of its representatives or agents prior to the execution of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Working Capital</u>&#8221; means as of the Adjustment Time, the Current Assets of the Company <u>minus</u> the Current Liabilities of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Working Capital Deficiency</u>&#8221; means the amount, if any, by which the Target Working Capital exceeds the Working Capital.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Working Capital Escrow Amount</u>&#8221; means $173,483.00.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Working Capital Escrow Fund</u>&#8221; means the Working Capital Escrow Amount (such amount, including any interest or other amounts earned thereon and less any disbursements therefrom in accordance with the Escrow Agreement</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">&#8220;<u>Working Capital Surplus</u>&#8221; means the amount, if any, by which the Working Capital exceeds the Target Working Capital.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE II&nbsp;</u></b><b><u>- PURCHASE AND SALE OF SHARES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase and Sale of the Shares </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">At the Closing, on the terms and subject to the conditions set forth in this Agreement, the Sellers shall sell the Shares and the Buyer shall purchase the Sellers&#8217; right, title and interest in and to such Shares, free and clear of all Encumbrances (other than Permitted Encumbrances and transfer restrictions imposed by applicable securities Laws and those put in place by the Buyer at Closing) (the &#8220;<u>Share Purchase</u>&#8221;), in exchange for an aggregate cash payment of $16,450,000.00 (the &#8220;<u>Purchase Price</u>&#8221;), as further adjusted pursuant to <u>Article II</u> (collectively, the &#8220;<u>Transaction</u>&#8221;). The Purchase Price shall be allocated among the Shares as set forth in <u>Schedule 2.1</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Transaction shall occur at a closing (the &#8220;<u>Closing</u>&#8221;) to take place on the date hereof remotely via electronic exchange of documents and signatures, or at such other time or such other place as the Parties hereto may mutually determine (the &#8220;<u>Closing Date</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments at the Closing</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">At the Closing:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver or shall cause to be delivered to the Sellers&#8217; legal counsel, in trust for the Sellers, in accordance with <u>Section 2.1</u>, by wire transfer of immediately available funds to a bank account designated in writing by the Sellers&#8217; legal counsel, the Closing Net Purchase Price less the Escrow Amount;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid to each holder of Indebtedness of the Company from which the Buyer shall have received a payoff letter in accordance with the second to the last sentence of this <u>Section 2.3</u>, the amount of Indebtedness to be repaid as of the Adjustment Time pursuant to such payoff letters;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid the Company Transaction Expenses for which the Buyer shall have received an invoice in accordance with the second to last sentence of this <u>Section 2.3</u>, the amount to be paid at the Closing pursuant to such invoices;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deposit the Escrow Amount by wire transfer of immediately available funds into an escrow account to be established pursuant to the Escrow Agreement, to satisfy (or partially satisfy) (i) the Sellers&#8217; payment obligations under <u>Section 2.6</u> and (ii) the Sellers&#8217; payment obligations under <u>Article VII</u>; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid at the Buyer&#8217;s sole cost (and not as a portion of the Purchase Price) the Buyer Transaction Expenses to the appropriate party to which such payments are due.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">With respect to Company Transaction Expenses and Indebtedness of the Company, the Buyer shall contribute to the Company funds as a non-interest-bearing loan that are sufficient to enable the Company to pay such Company Transaction Expenses and Indebtedness of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In order to facilitate the payments pursuant to <u>Section 2.3(b)</u> and <u>Section 2.3(c)</u>, the Company shall on or prior to the Closing Date, deliver to the Buyer (x)&nbsp;payoff letters, each on terms and in a form reasonably acceptable to the Buyer, from each holder of Indebtedness of the Company that is to be repaid on the Closing Date pursuant to <u>Section 2.3(b)</u> and shall have made arrangements reasonably satisfactory to the Buyer for such holders of such Indebtedness to deliver all related lien releases to the Buyer as soon as practicable after the Closing and (y) invoices for each of the Company Transaction Expenses that is to be paid at Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing Deliveries</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Sellers shall deliver, or shall cause to be delivered (unless previously delivered), the following to the Buyer, in each case in form and substance reasonably acceptable to the Buyer:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the original share certificates representing the Shares and duly executed copies of instruments of transfer and any other documents necessary to transfer to the Buyer good and valid title to the Shares, free and clear of all Encumbrances (other than Permitted Encumbrances);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of the Company, certifying as to the resolutions of the board of directors of the Company approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of each non-individual Seller, certifying as to the resolutions of the board of directors or trustees of such Seller approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a copy of the certificate of amalgamation of the Company and a copy of the notice of articles of the Company, each together with all amendments thereto and certified by an officer of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the original minute books of the Company to the extent not in the possession of the Company at the Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;certificates of good standing with respect to each of the corporate Sellers and the Company, in each case issued in their respective jurisdictions of existence;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;written resignations, effective as of the Closing, from each Person who serves as a director or officer of the Company as of immediately prior to the Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;any and all consents or waivers required from third parties relating to this Agreement or the other Transaction Documents or any of the other transactions contemplated hereby or thereby, including, but not limited to, any consents related to any &#8220;change of control&#8221; of the Company, provided that, if and to the extent that any such consents or waivers are not obtained or delivered prior to Closing and the Buyer consummates the transactions contemplated by this Agreement notwithstanding same, the Buyer shall be deemed to have waived the requirement for such consents or waivers and the Sellers shall be forever released and discharged from the obligation to obtain or deliver such consents or waivers, provided that this shall not limit any continuing obligations of the Sellers under <u>Section 6.9</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ix)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, executed by the Sellers&#8217; Representative;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;evidence of the termination of any shareholder agreements in respect of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(xi)&nbsp;&nbsp;&nbsp;&nbsp;a general release in a form acceptable to the parties thereto (the &#8220;<u>General Release</u>&#8221;) executed by the Sellers in favour of the Company; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(xii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate from each Seller stating that such Seller is not a non-resident of Canada within the meaning of the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Buyer shall deliver, or cause to be delivered (unless previously delivered), the following to the Sellers&#8217; Representative, in each case in form and substance reasonably acceptable to the Sellers:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of the Buyer, certifying as to the resolutions of the board of directors of the Buyer approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, executed by the Buyer and the Escrow Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the General Release, executed by the Buyer and the Company in favour of the Sellers; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of good standing issued by the British Columbia Registrar of Companies, certifying that the Buyer is in active status or good standing in British Columbia.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the following shall occur:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall purchase the Shares by paying, or causing to be paid, (x) to the Sellers the Closing Net Purchase Price less the Escrow Amount by wire transfer of immediately available funds to the Sellers&#8217; legal counsel, in trust for the Sellers, to the bank account designated by the Sellers&#8217; legal counsel prior to the Closing and (y) to the Escrow Agent the Escrow Amount by wire transfer of immediately available funds;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall make each other payment as set forth in <u>Section 2.3</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the Sellers shall sell, assign, transfer, convey and deliver, and effective at Closing hereby does sell, assign, transfer, convey and deliver, the Shares owned by the Sellers to the Buyer, and the books and records of Company shall be updated to reflect such transfer;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Company and the Sellers shall deliver to the Buyer such other supporting documents and certificates as the Buyer may reasonably request;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver to the Sellers&#8217; Representative such other supporting documents and certificates as the Sellers may reasonably request; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver, or cause to be delivered, the Escrow Amount to the Escrow Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing Net Purchase Price </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The Sellers and the Buyer have estimated, in good faith, the Closing Net Purchase Price, based on the calculations set out in <u>Exhibit A</u>. <u>Exhibit A</u> sets out the Sellers&#8217; and the Buyer&#8217;s good faith estimates of (i) the Estimated Company Transaction Expenses, (ii) the Estimated Working Capital Deficiency, if any, (iii) the Estimated Working Capital Surplus, if any, (iv) the Estimated Indebtedness<b>,</b> (v) the Estimated Closing Cash, and (v) the Closing Net Purchase Price, in each case as of the Adjustment Time and, if applicable, determined in accordance with the Accounting Principles.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Post-Closing Adjustment</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Promptly, but in any event within 60 days after the Closing Date, the Buyer shall (X) prepare and deliver to the Sellers&#8217; Representative a balance sheet of the Company (the &#8220;<u>Closing Balance Sheet</u>&#8221;) (prepared in accordance with <u>Exhibit A</u> and the Accounting Principles, <i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail), which will reflect in reasonable detail the Buyer&#8217;s determination of the Final Net Purchase Price and (i) the unpaid Company Transaction Expenses (which shall be included as a liability of the Company on the Closing Balance Sheet), (ii) the Working Capital Deficiency, if any, (iii) the Working Capital Surplus, if any, (iv) the Indebtedness of the Company, and (v) the Closing Cash, in each case as of the Adjustment Time, and (Y) deliver to the Sellers&#8217; Representative the Closing Balance Sheet, together with a certificate of the Buyer executed on its behalf by its Chief Financial Officer confirming that the Closing Balance Sheet was properly prepared in good faith and in accordance with <u>Exhibit A</u> and the Accounting Principles, <i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail. For the avoidance of doubt, the provisions of <u>Exhibit A</u> shall be interpreted so as to avoid double counting (whether positive or negative), of any item to be included in the Closing Balance Sheet, including Working Capital, Company Transaction Expenses, Closing Cash and Indebtedness.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If the Sellers&#8217; Representative in good faith disagrees with the Buyer&#8217;s determination of the Final Net Purchase Price, the Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and/or Closing Cash in each case as reflected on the Closing Balance Sheet, the Sellers&#8217; Representative may, within 30 days after receipt of the Closing Balance Sheet, deliver a written notice (the &#8220;<u>Notice of Disagreement</u>&#8221;) to the Buyer setting forth each item of dispute (each an &#8220;<u>Item of Dispute</u>&#8221;), the reasonable basis for such dispute and the Sellers&#8217; Representative&#8217;s calculation of such Item of Dispute. If the Buyer does not receive a Notice of Disagreement within 30 days after delivery by the Buyer of the Closing Balance Sheet, the Closing Balance Sheet shall be conclusive and binding upon each of the Parties. If the Buyer receives a Notice of Disagreement from the Sellers&#8217; Representative within 30 days after delivery by the Buyer of the Closing Balance Sheet, the Buyer and the Sellers&#8217; Representative shall attempt in good faith to resolve each Item of Dispute, and, if any Item of Dispute is so resolved, the Closing Balance Sheet shall be modified to the extent necessary to reflect such resolution. During the period between the Buyer&#8217;s delivery of the Closing Balance Sheet pursuant to <u>Section 2.6(a)</u> and the final determination of the same pursuant to <u>Section 2.6(b)</u>, the Buyer shall provide the Sellers&#8217; Representative and its representatives with reasonable access to the books, records, personnel and representatives of the Company, and such other information related to the Company as the Sellers&#8217; Representative or its representatives may reasonably request, so as to enable the Sellers&#8217; Representative and its representatives to analyze the Closing Balance Sheet and the underlying calculations and documents related thereto. If any Item of Dispute remains unresolved as of the 30<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day after timely delivery by the Seller of the Notice of Disagreement, the Buyer and the Sellers&#8217; Representative shall jointly retain an impartial, nationally recognized firm of chartered professional accountants agreeable to both the Buyer and Sellers&#8217; Representative (the &#8220;<u>Independent Accounting Firm</u>&#8221;) to resolve such remaining disagreement, it being understood that any item not included as an Item of Dispute on the Notice of Disagreement shall be conclusive and binding upon each of the Parties as set forth on the Closing Balance Sheet. The Buyer and the Sellers&#8217; Representative shall request that the Independent Accounting Firm render a determination as to each unresolved Item of Dispute as soon as practicable after its retention and in no event greater than 30 days after the engagement of the Independent Accounting Firm, and each of the Buyer, the Sellers&#8217; Representative and each of their respective agents and representatives shall cooperate with the Independent Accounting Firm, and shall provide the Independent Accounting Firm with reasonable access to their respective books, records, personnel and representatives and such other information as the Independent Accounting Firm may reasonably request, so as to enable it to make such determination as quickly and accurately as practicable. The Independent Accounting Firm shall consider only those Items of Dispute and amounts related thereto that were set forth in the Closing Balance Sheet and the Notice of Disagreement and that remain unresolved by the Buyer and the Sellers&#8217; Representative, and in resolving any Item of Dispute, the Independent Accounting Firm may not assign a value to any item greater than the greatest value for such item claimed by either Party nor less than the smallest value for such item claimed by either Party. The Independent Accounting Firm&#8217;s determination(s) shall be based upon the definitions of Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and Closing Cash (as applicable) included herein and in accordance with <u>Exhibit A</u> and the Accounting Principles (<i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail). The Independent Accounting Firm&#8217;s determination of each Item of Dispute submitted to it shall be in writing, shall conform with this <u>Section 2.6</u> and, absent manifest error, shall be conclusive and binding upon each of the Parties, and the Closing Balance Sheet shall be modified to the extent necessary to reflect such determination(s). The Independent Accounting Firm shall allocate its fees, costs and expenses between the Buyer on the one hand, and the Sellers on the other hand, based upon the percentage which the portion of the contested amount not awarded to each such Person bears to the amount actually contested by such Person. The Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and Closing Cash, in each case as of the Adjustment Time and as finally determined pursuant to this <u>Section 2.6</u>, are referred to herein as the &#8220;<u>Final Company Transaction Expenses</u>,&#8221; &#8220;<u>Final Working Capital Deficiency</u>,&#8221; &#8220;<u>Final Working Capital Surplus</u>,&#8221; &#8220;<u>Final Indebtedness</u>,&#8221; and &#8220;<u>Final Closing Cash</u>,&#8221; respectively.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Negative Adjustment</u>. If the Closing Net Purchase Price exceeds the Final Net Purchase Price as finally determined in accordance with this <u>Section 2.6</u> (such excess amount, the &#8220;<u>Negative Adjustment Amount</u>&#8221;), then the Sellers&#8217; Representative shall promptly (but in any event within five (5) Business Days following the final determination of the Final Net Purchase Price) pay an amount equal to such insufficiency to the Buyer (i) from the Working Capital Escrow Fund; and (ii) to the extent the amount of the Negative Adjustment Amount exceeds the amount available in the Working Capital Escrow Fund, from the Indemnification Escrow Fund or from Sellers, at the discretion of Buyer; in accordance with the Escrow Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Positive Adjustment</u>. If the Final Net Purchase Price exceeds the Closing Net Purchase Price as finally determined in accordance with this <u>Section 2.6</u> (such excess amount, the &#8220;<u>Positive Adjustment Amount</u>&#8221;), then the Buyer shall promptly (but in any event within five (5) Business Days following the final determination of the Final Net Purchase Price) pay the Positive Adjustment Amount to the Sellers&#8217; legal counsel, in trust for the Sellers, by wire transfer of immediately available funds to the account designated by the Sellers&#8217; legal counsel.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Release of Working Capital Escrow Fund</u>. Within five (5) Business Days after the date on which the Final Net Purchase Price is finally determined pursuant to this <u>Section 2.6</u>, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to deliver any portion of the Working Capital Escrow Fund not distributed to the Buyer pursuant to <u>Section 2.6(c)</u> (if any) to the Sellers&#8217; legal counsel, in trust for the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Any payments made to any Party pursuant to this <u>Section 2.6</u> shall be treated as an adjustment of the Purchase Price for all Tax purposes to the greatest extent permitted by law and shall be reported as such by the Parties on their Tax Returns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Withholding</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding anything to the contrary in this Agreement, Buyer and its agents shall be entitled to deduct and withhold from any consideration otherwise payable or deliverable to Sellers or any other Person pursuant to this Agreement or the Transaction Documents such amounts that are required to be deducted or withheld pursuant to the Tax Act or any Tax Law. To the extent such amounts are so deducted or withheld, such amounts shall be treated for all purposes as having been paid to the Person to whom such amounts would otherwise have been paid absent such deduction or withholding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE III</u></b><b><u>&nbsp;- REPRESENTATIONS AND WARRANTIES OF THE COMPANY</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In order to induce the Buyer to enter into this Agreement and consummate the transactions contemplated hereby, the Company hereby represents and warrants to the Buyer that, except as and to the extent disclosed in a written Disclosure Schedule delivered by the Sellers&#8217; Representative to the Buyer simultaneously with the execution and delivery of this Agreement (the &#8220;<u>Disclosure Schedule</u>&#8221;), the statements contained in this <u>Article III</u> are true and correct as of the Closing. The Disclosure Schedule (a)&nbsp;shall be arranged in sections corresponding to the applicable sections of this Agreement, and (b) shall not be construed as indicating that any matter disclosed therein is required to be disclosed, nor shall such disclosure be construed as an admission that such information is material to the Company. References to the &#8220;Knowledge&#8221; of the Company or the Sellers are deemed to mean the actual knowledge of Mark Kroeker, Ian Kane and Carmena Gee after making reasonable inquiry into the subject matter in question. For the purposes hereof, &#8220;reasonable inquiry into the subject matter in question&#8221; will be satisfied by such individual via a question and answer period conducted by any such individual with senior management personnel of the Company who would reasonably be expected to have knowledge of the relevant subject matter and reasonable subsequent inquiry based on the content of such question and answer period.For the avoidance of doubt, to the extent that a representation or warranty refers to a prior time period, all references to the &#8220;Company&#8221; as used in such representation or warranty shall include the Company as in existence during that time period, including prior names and corporate and limited liability company or entity forms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Company Power</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is a corporation duly organized, validly existing and in good standing under the laws of the Province of British Columbia. The Company has all requisite corporate power and authority to own its properties, to carry on its business as presently conducted, to enter into and perform this Agreement and the Transaction Documents to which it is a party and to carry out the transactions contemplated hereby and thereby. The Company is duly licensed or qualified to do business in each jurisdiction wherein the character of its property, or the nature of the activities presently conducted by it, makes such qualification necessary. The Company is not in violation of any term or provision of its organizational documents, each as in effect as of this date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Transaction Documents to which the Company is a party (when executed by the Company and the other parties thereto) are valid and binding obligations of the Company, enforceable in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws, from time to time in effect, which affect enforcement of creditors&#8217; rights generally. The execution, delivery and performance of the Transaction Documents to which the Company is a party and the sale and delivery of the Shares in accordance with this Agreement, have been duly authorized by all necessary corporate or other action of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.2</u>, the execution, delivery and performance of the Transaction Documents to which the Company is a party by the Company, including, without limitation, the sale and delivery of the Shares in accordance with this Agreement and the performance by the Company of any transactions contemplated by the Transaction Documents to which the Company is a party will not: (i) violate or result in a default (whether after the giving of notice, lapse of time or both) under any contract or obligation to which the Company is a party or by which it or its assets are bound, or any provision of the organizational documents of the Company, or cause the creation of any Encumbrance (other than Permitted Encumbrances) upon any of the assets of the Company; (ii) violate, conflict with or result in a default (whether after the giving of notice, lapse of time or both) under, any provision of any material Law, or any order of, or any restriction imposed by any court or other Governmental Authority applicable to the Company; (iii) require from the Company any notice to, declaration or filing with, or consent or approval of any Governmental Authority or other third party; or (iv) accelerate any obligation under, or give rise to a right of termination of, any material agreement, permit, license or authorization to which the Company is a party or by which it is bound.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Shares</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The authorized capital of the Company is set out in <u>Schedule 3.3</u>. All Shares of the Company are held beneficially and of record by the Sellers as disclosed on <u>Schedule 3.3</u>. Except as disclosed in <u>Schedule 3.3</u> and in the Transaction Documents, there are no outstanding subscriptions, options, warrants, phantom rights, commitments, agreements, arrangements or commitments of any kind for or relating to the issuance, or sale of, or outstanding securities convertible into or exchangeable for, any shares of any class or other equity interests of the Company. Except as set forth in <u>Schedule 3.3</u> or as expressly provided for in this Agreement, the Company does not have any obligation to purchase, redeem, or otherwise acquire any of its equity interests or any interests therein. All of the outstanding equity interests of the Company are duly authorized, validly issued, fully paid and non-assessable and were issued in compliance with all applicable securities Laws. There are no preemptive rights, rights of first refusal, put or call rights or obligations or anti-dilution rights with respect to the issuance, sale or redemption of the Company&#8217;s equity interests, other than rights set forth herein. Other than the rights set forth in <u>Schedule 3.3</u>, there are no rights to have the Company&#8217;s equity interests registered for sale to the public pursuant to the Laws of any jurisdiction, and there are no agreements relating to the voting of the Company&#8217;s voting securities or restrictions on the transfer of the Company&#8217;s equity interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsidiaries</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company does not own or control, directly or indirectly, any interest in any other corporation, partnership, limited liability company, association or other business entity. At the Closing, the Company will not have any Subsidiaries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Financial Statements</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered to the Buyer the following financial statements, copies of which are attached as <u>Schedule 3.5(a)</u>:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;reviewed financial statements of the Company consisting of the balance sheets of the Company as of January 31, 2021, 2020 and 2019 and the related statements of earnings and retained earnings and cash flows for the years then ended (the &#8220;<u>Historical Financials</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;internally prepared financial statements of the Company consisting of the balance sheets of the Company as of October 31, 2021 and the related income statements for the nine and 12 months, respectively, then ended (the &#8220;<u>Interim Financials</u>&#8221; and together with the Historical Financials, the &#8220;<u>Financial Statements</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.5(a)</u>, the Financial Statements have been prepared in accordance with ASPE applied on a consistent basis throughout the period involved, except as may be indicated in the notes thereto and subject, in the case of the Interim Financials, to year-end adjustments and the absence of notes (if any). The Financial Statements fairly present, in all material respects, in accordance with ASPE (except as provided above), the financial condition of the Company as of the respective dates they were prepared and the results of the operations of the Company for the periods indicated.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the reserve for bad debts set forth in the Interim Financials or that would, consistent with ASPE, be included in the next year-end financial statements of the Company, all of the accounts receivable of the Company are valid and, to the Sellers&#8217; and Company&#8217;s Knowledge, payable claims in accordance with their terms at their recorded amounts and subject to no known set off or counterclaim. Since January 31, 2021 (the &#8220;<u>Balance Sheet Date</u>&#8221;), the Company has collected its accounts receivable in the ordinary course of its business and in a manner which is consistent with past practices. Except as disclosed in <u>Schedule 3.5(c)</u>, the Company does not have any accounts receivable or loans receivable from any Person which is affiliated with it or any of its directors, officers, employees or shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Undisclosed Liabilities</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as stated or adequately reserved against in the Financial Statements, incurred as a result of or arising out of the transactions contemplated under the Transaction Documents, or which have been incurred in the ordinary course of business since the Balance Sheet Date or are not, individually or in the aggregate, material in amount, the Company does not have any material liability or obligation of any nature, whether accrued, absolute, contingent or otherwise, or known or unknown that is required by ASPE to be reflected on a balance sheet of the Company or disclosed in the notes thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except for Indebtedness set forth on <u>Schedule 3.7</u>, the Company has no Indebtedness outstanding. The Company has not assumed, guaranteed, endorsed or otherwise become directly or contingently liable on or for any Indebtedness of any other Person. The Company is not in default with respect to any outstanding Indebtedness or any instrument relating thereto, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, is there any event which, with the passage of time or giving of notice, or both, would result in a default, and no such Indebtedness or any instrument or agreement relating thereto purports to limit the issuance of any securities by the Company or the operation of the Company&#8217;s business. Complete and correct copies of all instruments (including all amendments, supplements, waivers and consents) relating to any outstanding Indebtedness of the Company have been furnished to or made available to the Buyer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Certain Developments</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 3.8</u>, since the Balance Sheet Date, the Company has conducted its business only in the ordinary course consistent with past practice in all material respects and except for general industry and economic conditions and transactions expressly contemplated by this Agreement, there has been:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;no occurrence or event which, in the aggregate, has or would be reasonably expected to have a Material Adverse Effect on the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;no declaration, setting aside or payment of any non-cash dividend or other non-cash distribution with respect to, or any direct or indirect redemption or acquisition of, any of the shares of the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;no waiver of any material right of the Company or cancellation of any material debt or claim held by the Company;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;no increase in the compensation paid or payable or employee benefits provided to any officer, employee or agent of the Company other than in the ordinary course of business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;no material loss, destruction or damage to any property of the Company, whether or not insured;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;no entry into or agreement to enter into a collective bargaining agreement or similar labour contract, no labour dispute involving the Company and no material change in the personnel of the Company or the terms and conditions of their employment, other than in the ordinary course of business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;no adoption, amendment or modification of any Employee Benefit Plan, except as required by Law or the terms of such Employee Benefit Plan, and no action to accelerate the vesting of, or payment of, any compensation or benefit under any Employee Benefit Plan or to fund or in any other way secure the payment of compensation or benefits under any Employee Benefit Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;no material acquisition or disposition or abandonment of any assets (or any contract or arrangement therefor) except in the ordinary course of business nor any other transaction by the Company otherwise than for fair value in the ordinary course of business, except between Affiliates of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp; no change in accounting methods or practices of the Company, except as required by Law or as disclosed in the notes to the Historical Financials;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;no loss, or any material development that would reasonably be expected by the Company to result in a loss, of any significant supplier, customer, distributor or account of the Company (other than the completion in the ordinary course of business of specific projects for customers);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;no termination of any material contract or agreement to which the Company is a party or by which it is bound;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;no Encumbrance placed on any of the properties of the Company other than Permitted Encumbrances or in the ordinary course of business for equipment leased, consistent with past practices;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;no payment or discharge of a material lien or material liability of the Company, other than in the ordinary course of business consistent with past practices, purchase money liens and liens for taxes not yet due and payable;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;no contingent liability incurred by the Company as guarantor or otherwise with respect to the obligations of others;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;no obligation or liability incurred by the Company to any of its officers, directors, shareholders or employees, or any loans or advances made by the Company to any of its officers, directors, shareholders or employees, except compensation and expense allowances payable to officers, directors or employees in the ordinary course of business;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;no new arrangements relating to any royalty or similar payment based on the revenues, profits or sales volume of the Company, whether as part of the terms of the shares in the Company&#8217;s capital or by any separate agreement (other than variable incentive compensation provided to new employees of the Company);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp;&nbsp;no amendment to the Company&#8217;s organizational documents other than as expressly contemplated by this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(r)&nbsp;&nbsp;&nbsp;&nbsp;no settlement or compromise of any material claim, written notice, audit report or assessment in respect of Taxes; no change in any annual Tax accounting period; no change of any method of Tax accounting; no entrance into any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement or closing agreement, in each case, the primary subject matter of which is Tax; no surrender of any right to claim a material Tax refund; nor consent to any extension or waiver of the statute of limitations period applicable to any Tax claim or assessment (excluding extensions pursuant to normal course extensions of time to file Tax Returns); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(s)&nbsp;&nbsp;&nbsp;&nbsp;no commitment to do any of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 3.9</u>, there is no litigation or Legal Proceeding pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened, by or against the Company or affecting any of the Company&#8217;s properties or assets, or against any director, officer, or shareholder of the Company in his or her capacity as such, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, has there occurred any event nor does there exist any condition on the basis of which any litigation, Legal Proceeding or investigation might properly be instituted with any substantial chance of recovery. To the Sellers&#8217; and the Company&#8217;s Knowledge, no event has occurred and no claim, dispute or other condition or circumstance exists, that would reasonably be expected to, give rise to or serve as a basis for the commencement of any such Legal Proceeding. Neither the Company nor any director, officer, or shareholder of the Company in his or her capacity as such is a party to or in default with respect to any order, writ, injunction, decree, ruling or decision of any court, commission, board or other Governmental Authority. <u>Schedule 3.9</u> includes a description of all litigation, claims or Legal Proceedings involving the Company occurring, arising or existing during the two years prior to the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has duly and timely filed with the appropriate Tax Authorities all Tax Returns required to be filed. All such Tax Returns are complete and accurate in all respects. All Taxes due and owing by the Company (whether or not shown on any Tax Returns) have been paid. The Company is not currently the beneficiary of any extension of time to file any Tax Return (excluding extensions of time to file Tax Returns that are requested by the Company in the ordinary course). The amounts provided as current liability on the Financial Statements for all Taxes are, and the amount taken into account in calculating the Working Capital for all Taxes will be, adequate to cover all unpaid liabilities for all Taxes, whether or not disputed, that have accrued with respect to or are applicable to the period ended on and included the date thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has complied in all material respects with all applicable Laws relating to the reporting, payment, and withholding of Taxes and all Taxes which such Company is required by Law to withhold or collect, including sales and use taxes, goods and services taxes, harmonized sales and all amounts required to be withheld for Taxes of any employee, independent contractor, non-resident of Canada, creditor, customer, shareholder, or other Person have been duly withheld or collected and, to the extent required, have been paid over to the proper Tax Authorities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No deficiencies for Taxes with respect to the Company have been claimed, proposed or assessed in writing by any Tax Authority, which remain outstanding. The Company (or any predecessor of the Company) has not waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency (excluding extensions as a result of normal course extensions of time to file Tax Returns), nor has any request been made in writing for any such extension or waiver, where the applicable statute of limitations remains outstanding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;None of the Tax Returns of the Company has ever been audited or investigated by any Tax Authority, and no facts exist which would constitute grounds for the assessment of any additional Taxes by any Tax Authority with respect to the taxable years covered in such Tax Returns and any filings. No proceeding by any Tax Authority is pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened with respect to Taxes of the Company. No material issues have been raised in any examination by any Tax Authority of the Company which, by application of similar principles, would reasonably be expected to result in a proposed adjustment to the liability for Taxes for any other period not so examined, and no position has been taken on any Tax Return of the Company for a taxable year for which the statute of limitations for the assessment of any Tax with respect thereto has not expired that is contrary to any publicly announced position of a Tax Authority or that is substantially similar to any position which a Tax Authority has successfully challenged in the course of an examination of a Tax Return of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;No claim has ever been made in writing by a Tax Authority in a jurisdiction where the Company does not file Tax Returns that the Company is or may be subject to taxation by that jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;There are no liens encumbering any of the assets of the Company for Taxes (other than Encumbrances related to Taxes which are not due or delinquent or if due or delinquent, the validity of which the Company is contesting in good faith by proper Legal Proceedings) and which is set forth on <u>Schedule 3.10(f)</u>).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not, and has never been, a party to or bound by any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement or similar agreement in each case, excluding agreements entered into in the ordinary course of business the primary subject matter of which is not Taxes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not a party to or otherwise subject to any arrangement having the effect of or giving rise to the recognition of a deduction or loss in a taxable period ending on or before the Closing Date, and a corresponding recognition of taxable income or gain in a taxable period ending after the Closing Date, or any other arrangement that would have the effect of or give rise to the recognition of taxable income or gain in a taxable period ending after the Closing Date without the receipt of or entitlement to a corresponding amount of cash. The Company has not used any improper Tax accounting method.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <u>Schedule 3.10(i)</u>, the Company has not been a party in the last three (3) calendar years to any joint venture, partnership or other arrangement which is treated as a partnership for federal income Tax purposes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;All provincial and federal income Tax Returns of the Company have been provided to the Buyer prior to the date hereof for the taxable periods ended within the last two calendar years, and all such provincial and federal income Tax Returns of the Company are correct and complete in all material respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not requested or received a ruling from any Tax Authority or signed a closing or other agreement with any Tax Authority which would affect any taxable period after the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, no facts, circumstances or events exist or have existed that have resulted in or may result in the application of any of sections 67,17, 78, 79, 80 to 80.04 of the Tax Act or any similar applicable provincial or territorial provision to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;In the last three calendar years, the Company has not acquired property from any Person in circumstances where the Company did or would reasonably be expected to be liable for any Taxes of such Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;The value of the consideration paid or received by the Company for any acquisition, sale, transfer or provision of property (including intangibles) or any provision of services (including financial transactions) from or to a Person with whom the Company was not dealing at arm&#8217;s length (within the meaning of the Tax Act) was equal to the estimated fair market value of such property acquired, provided or sold or services purchased or provided.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;The Company is duly registered with the Canada Revenue Agency under the <i>Excise Tax Act</i> (Canada) for purposes of the goods and services and harmonized sales tax (&#8220;<u>GST</u>&#8221;) and under the <i>Provincial Sales Tax Act</i> (British Columbia) for purposes of provincial sales tax (&#8220;<u>PST</u>&#8221;). All input tax credits claimed by any such company for GST or PST purposes were calculated in accordance with applicable Law. The Company has complied, with all registration, reporting, payment, collection and remittance requirements in respect of GST and PST.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;Records or documents that meet the requirements of paragraphs 247(4)(a) to (c) of the Tax Act or any similar applicable provincial or territorial provision have been made and obtained by the Company with respect to all material transactions between such Company and any non-resident Person with whom the Company was not dealing at arm&#8217;s length (within the meaning of the Tax Act) during a taxation year commencing after 1998 and ending on or before the date of Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a Canadian controlled private corporations for the purposes of the Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(r)&nbsp;&nbsp;&nbsp;&nbsp;A trust that is not resident in Canada has never been a registered shareholder of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(s)&nbsp;&nbsp;&nbsp;&nbsp;The Shares are not &#8220;taxable Canadian property&#8221;, as that term is defined in the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(t)&nbsp;&nbsp;&nbsp;&nbsp;All Tax credits and refunds, including refundable and non-refundable investment Tax credits in respect of scientific research and experimental development claimed by the Company, if any, were claimed and calculated in accordance with applicable Law and accepted practices of the applicable Tax Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(u)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received any requirement from any Tax Authority pursuant to section 224 of the Tax Act or any similar applicable provincial or territorial provision which remains unsatisfied in any respect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not made an &#8220;excessive eligible dividend designation&#8221; as defined in the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(w)&nbsp;&nbsp;&nbsp;&nbsp;With respect to the declaration and payment of all dividends on or prior to the Closing Date that were designated to be capital dividends (as provided pursuant to subsection 83(2) of the Tax Act), then (i) all such dividends so designated were recorded on Form T2054 (as prescribed under the regulations to the Tax Act) and which Form T2054 was filed with the Canada Revenue Agency (and any applicable provincial Tax Authority) in the prescribed manner on or before the particular time on which any part of the dividend was paid, and (ii) as a consequence of the declaration of such capital dividends and the filing of the Form T2054, the Company was not subject to any Tax pursuant to the provisions of Part III of the Tax Act (and applicable provisions of a provincial Tax statute).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not be required to include in any taxable period ending after the Closing Date any taxable income attributable to income that accrued (or cash that was received), but was not recognized, in any taxable period ending on or before the Closing Date as a result of a reserve, deduction, election, prepaid amount, an agreement with Tax Authorities, any subsidy or deemed overpayment of Tax related to COVID-19, or for any other reason.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(y)&nbsp;&nbsp;&nbsp;&nbsp;Any amounts claimed by the Company under the Canada Emergency Wage Subsidy or the Canada Emergency Rent Subsidy under section 125.7 of the Tax Act or any similar provincial provision and any other amounts claimed by the Company under a subsidy or deferral in respect of COVID-19 in respect of any period (or portion thereof) ending on or before the Closing Date were claimed by the Company in accordance with the Tax Act and all other applicable Laws</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(z)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not claimed any reserve under any one or more of subparagraph 40(1)(a)(iii), or paragraph 20(1)(m) or 20(1)(n) of the Tax Act or any similar provincial or territorial provision, if any such amount would reasonably be expected to be included in the income of the Company for any period ending after the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.11<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Title to Properties</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><u>Schedule 3.11</u> lists all personal property with a value of at least $50,000.00 necessary to the conduct of the Company&#8217;s business and all personal property leased to the Company which is necessary to conduct the Company&#8217;s business. All leases relating to leased real property, including the identification of the lessor thereunder, are identified on <u>Schedule 3.11</u> (the &#8220;<u>Leases</u>&#8221;) and true and complete copies thereof have been delivered or made available to the Buyer. Except as set forth on <u>Schedule 3.11</u>, assuming good title in the lessor, the Company has a valid and enforceable leasehold interest in all of its leased real property, free and clear of all Encumbrances other than Permitted Encumbrances or as set forth in the applicable Lease, except to the extent that enforceability may be subject to, and limited by applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles. The Company has good title to or a valid and enforceable leasehold interest (except to the extent that enforceability may be subject to, and limited by applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles) in all material personal property used in or necessary to the Business and the same is in good condition and repair in all material respects given its age and usage (ordinary wear and tear excepted). The Company is not in material violation of any zoning, building or safety ordinance, regulation or requirement or other Law applicable to the operation of its leased properties, or any restrictive covenant or deed restriction applicable thereto, nor has the Company received written notice of any violation with which it has not complied in all material respects. The Company has not received any written notice of condemnation or taking of any of its leased properties. With respect to each of the Leases: (i) such Lease has been duly authorized and executed by the Company and, assuming good title of the applicable landlord, is in full force and effect; (ii) the Company is not in material default under such Lease, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, has any event occurred which would reasonably be expected to give rise to such a default by the Company; (iii) to the Sellers&#8217; and the Company&#8217;s Knowledge, no lessor is in material default under such Lease and such lease is the only agreement in effect under which the lessor has leased the premises described therein; (iv) there is no outstanding material dispute between the lessor and the Company under any Lease; and (v) the rent and other sums due and payable by the Company to the lessor under such Lease are current in all material respects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.12<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.12</u> lists all patents, patent applications, trademarks, trademark applications, trade names, service marks, service names, domain names, custom software, copyrights, and applications and registrations therefor owned by the Company or used by the Company in the Business (other than intellectual property used by the Company which comes as a result of a shrink-wrap or off-the-shelf software license) (collectively, the &#8220;<u>Company Intellectual Property</u>&#8221;). Other than as described on <u>Schedule 3.12</u>, the Company owns all of the Company Intellectual Property and the Company Intellectual Property is not subject to the payment of any continuing fees, royalties, or other compensation in consideration to any third party, and was developed, created, and designed by employees of the Company acting within the scope of their employment or by consultants or contractors who have assigned all of their right, title, and interest in and to such Company Intellectual Property to the Company and have waived their moral rights in any Company Intellectual Property. Upon the consummation of the transactions contemplated hereby, the Company will continue to own and have the right to use the Company Intellectual Property. No claims have been asserted in writing and no claims are pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened by any Person, as to the use of any such Company Intellectual Property or challenging or questioning the validity or effectiveness of any state or federal registration of the Company Intellectual Property. Other than as described on <u>Schedule 3.12</u>, the Company&#8217;s use of the Company Intellectual Property does not, to the Sellers&#8217; and the Company&#8217;s Knowledge, infringe the rights of any Person. The Company&#8217;s operation of its Business prior to Closing, to the Sellers&#8217; and the Company&#8217;s Knowledge, has not infringed on the intellectual property of any other Person.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Privacy Commitments.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;No material breach or violation of any security policy of the Company has occurred or, to the Sellers&#8217; and the Company&#8217;s Knowledge, is threatened. To the Sellers&#8217; and the Company&#8217;s Knowledge, there has been no unauthorized or illegal use of or access to any of the data or information in any Company Database. Since December 31, 2016, the Company has complied in all material respects with all Privacy Laws, privacy rights of third parties, contractual obligations and Privacy Policies pertaining to privacy and Personal Information, and the collection, use storage, registration and transfer thereof (collectively, &#8220;<u>Privacy Commitments</u>&#8221;). Since December 31, 2016, the Company has also complied in all material respects with all privacy policies of third parties with which the Company is obligated to comply. The execution, delivery and performance of this Agreement complies with all Privacy Commitments applicable to the Company. &nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The Company has at all times since December 31, 2016 made all material disclosures to third persons required by applicable Privacy Laws, obtained all consents of data subjects as required under Privacy Laws and none of such disclosures made or contained in any Privacy Policy or in any such materials has been inaccurate, misleading, or deceptive or in violation of any Privacy Laws in any material respects. No action is pending and, to the Sellers&#8217; and the Company&#8217;s Knowledge, no Person has threatened to commence any action against the Company concerning any claim that the Company has violated any law, rule or regulation in connection with or relating to the Company Databases or Personal Information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The Company has maintained complete records concerning its compliance with Privacy Laws, including mandatory disclosures in requests for consent, records of consent received, withdrawals of consent, electronic message disclosures, electronic message unsubscribe requests, and records of dates of implementation of electronic message unsubscribe requests.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp; &nbsp; &nbsp; &#8220;<u>Company Data</u>&#8221; means all data collected, generated, or received by or on behalf of the Company in connection with the services rendered by the Company including Confidential Data, collected, held, or otherwise managed by or on behalf of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp; &nbsp; &nbsp; &#8220;<u>Company Database</u>&#8221; mean the distinct electronic or other databases containing (in whole or in part) Personal Information maintained by or for the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp; &nbsp; &nbsp;&#8220;<u>Confidential Data</u>&#8221; means information, including Personal Information, in whatever form that the Company is obligated, by law or contract, to protect from unauthorized access, use, disclosure, modification or destruction together with any data owned or licensed by the Company that is not intentionally shared with the general public or that is classified by the Company with a designation that precludes sharing with the general public.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp; &#8220;<u>Personal Information</u>&#8221; has the meaning ascribed thereto in the <i>Personal Information Protection Act</i> (British Columbia&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp; &nbsp; &nbsp; &#8220;<u>Privacy Laws</u>&#8221; means each applicable law, rule and regulation applicable to the protection or Processing or both of Personal Information including without limitation, to the extent applicable: <i>Personal Information Protection and Electronic Documents Act</i> (Canada), the <i>Personal Information Protection Act</i> (British Columbia) and <i>An Act to promote the efficiency and adaptability of the Canadian economy by regulating certain activities that discourage reliance on electronic means of carrying out commercial activities, and to amend the Canadian Radio-television and Telecommunications Commission Act, the Competition Act, the Personal Information Protection and Electronic Documents Act and the Telecommunications Act </i>(Canada).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp; &nbsp; &nbsp; &#8220;<u>Privacy Policy</u>&#8221; means a policy of the Company (or a third party that supplies Personal Information to the Company where the Company is obligated by law or contract to apply the terms of such policy of such third party data supplier) made available in connection with the collection of information provided by or on behalf of individuals that is labeled as a &#8220;Privacy Policy,&#8221; is reached on a website by a link that includes the label &#8220;Privacy&#8221; or that is a written policy or disclosure that describes the purposes for which and how information provided by or on behalf of individuals will be collected, held, used, processed and disclosed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vii)&nbsp; &nbsp; &nbsp;&#8220;<u>Process</u>&#8221; or &#8220;<u>Processing</u>&#8221; means, with respect to Company Data, the use, collection, processing, storage, recording, organization, adaption, alteration, transfer, retrieval, consultation, disclosure, dissemination or combination of such Company Data.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.13<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Contracts and Arrangements</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except as set forth in the Transaction Documents or in <u>Schedule 3.13</u> (true and correct copies of which have previously been provided or made available to the Buyer), the Company is not a party or subject to or bound by:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;any contract, lease or agreement involving a potential commitment or payment by the Company in excess of $50,000 annually;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;any contract containing covenants directly or explicitly limiting in any material respect the freedom of the Company to compete in any line of business or with any Person (other than confidentiality agreements containing non-competition or non-solicitation covenants on the part of the Company that were entered into by the Company in the ordinary course of business);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;any indenture, mortgage, promissory note, loan agreement, guaranty or other agreement or commitment for borrowing or any pledge or security arrangement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;any employment, consulting or other service agreements with present or former officers, directors, employees, consultants, shareholders of the Company or any other service provider of the Company that includes any change of control payments severance, termination, or retention obligations or similar accounts payable by the Company or its Affiliates in connection with the transactions contemplated by this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;any redemption or purchase agreements or other agreements affecting or relating to the shares of the Company, including, without limitation, any agreement with any shareholder of the Company which includes anti-dilution rights, registration rights, voting arrangements, operating covenants or similar provisions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;any collective bargaining agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any contract or agreement involving fixed price or fixed volume arrangements;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;any joint venture, franchise, partnership, manufacturer, development or agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;any supply agreement pursuant to which the Company is required to supply materials in excess of $50,000 annually;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;any acquisition, merger or similar agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;any contract with any Governmental Authority;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;any contract providing for indemnification of any Person by the Company (excluding confidentiality agreements, customer and vendor contracts and purchase orders including indemnification provisions entered into in the ordinary course of business);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;any material contract that can be terminated, or the provisions of which are altered, as a result of the consummation of the transactions contemplated by this Agreement or any of the other Transaction Documents to which the Company is a party;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;any contract entered into in connection with any settlement or other resolution of any action pursuant to which the Company has any ongoing payment obligation after the Closing; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;any other material contract not executed in the ordinary course of business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">All contracts, agreements, leases and instruments set forth on <u>Schedule 3.13</u> are valid and are in full force and effect and constitute legal, valid and binding obligations of the Company and, to the Knowledge of the Sellers and the Company, the other parties, and are enforceable in accordance with their respective terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws, from time to time in effect, which affect enforcement of creditors&#8217; rights generally. Except as set forth on <u>Schedule 3.13</u>, there has not been any written notice or, to the Sellers&#8217; and the Company&#8217;s Knowledge, oral notice or threat to terminate any material contracts, agreements, leases or instruments. Neither the Company nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, any other party to such contract is in material default in complying with any provisions of any such contract, agreement, lease or instrument, and, to the Sellers&#8217; and the Company&#8217;s Knowledge, no condition or event or fact exists which, with notice, lapse of time or both, would constitute a material default thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.14<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governmental Approvals; Compliance with Laws</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is in compliance in all material respects with all applicable Laws. The Company has all of the material permits, licenses, orders, franchises and other rights and privileges of all federal, provincial, territorial, local or foreign Governmental Authority or regulatory bodies necessary for the Company to conduct its business as presently conducted (&#8220;<u>Permits</u>&#8221;). All such Permits are in full force and effect in all material respects, and no suspension or cancellation of any of them is, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened. Except as set forth on <u>Schedule 3.14(a)</u>, the operation of the Business as currently conducted is not, and has not been, in material default or violation of, nor is the Company in material default or violation under, any Permit, and, to the Knowledge of the Sellers and the Company, no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation of any terms, condition or provision of any Permit. Except as set forth on <u>Schedule 3.14(a),</u> the Company has not entered into or been subject to any judgment, consent decree, compliance order or administrative order with respect to any Permit or any material aspect of the business, affairs, properties or assets of the Company or received any request for information, written notice, demand letter, administrative inquiry or formal or informal complaint or claim from any regulatory agency with respect to any Permit or any material aspect of the business, affairs, properties or assets of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company, nor any director, officer, agent, employee or other Person acting on behalf of the Company (in their capacity as director, officer, agent, or employee), has: (i) used any corporate funds of the Company for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity in respect of the business, or failed to disclose fully any such contribution in violation of applicable Laws; (ii) directly or indirectly, paid or delivered any fee, commission or other sum of money or item of property, however characterized, to any finder, agent or other party acting on behalf of or under the auspices of a governmental official or Governmental Authority, in Canada or any other country, which is in any manner illegal under any Law of Canada or any other country having jurisdiction; (iii) made any unlawful payment or given any other unlawful consideration to any customer, agent, distributor or supplier of the Company or any director, officer, agent, or employee of such customer or supplier; (iv) violated or taken any act that would violate any provision of the <i>Corruption of Foreign Public Officials Act</i> (Canada), <i>the Special Economic Measures Act</i> (Canada), the <i>Freezing Assets of Corrupt Foreign Public Officials Act</i> (Canada) or other similar Laws of other jurisdictions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.15<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance Coverage</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><u>Schedule 3.15</u> hereto contains (i) a list of all insurance policies currently in effect that insure the physical properties, business, operations and assets of the Company, (ii) a description of all material claims of the Company that are currently pending or that have been made with an insurance carrier since January 1, 2018, and (iii) a description of any self-insurance, co-insurance or retention arrangement by or affecting the Company, including any reserves established thereunder. Each policy set forth in <u>Schedule 3.15</u> is valid and binding and in full force and effect (subject to bankruptcy, insolvency, reorganization, moratorium or similar laws now or hereinafter in effect relating to creditors&#8217; rights generally and to the application of equitable principles (regardless of whether enforcement is sought in a proceeding at law or in equity)) and there is no claim pending under any such policies as to which coverage has been denied or disputed. No written notice of cancellation or termination has been received by the Company within the preceding five years<b> </b>with respect to any policy which has not been replaced on substantially similar terms prior to the date of such cancellation or termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="27" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.16<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Benefits</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.16(a)</u> contains a complete and accurate list of each plan, program, policy, contract, agreement or arrangement relating to retirement, compensation, bonus, incentive, equity or equity-based compensation, change in control, severance, termination, retention, deferred compensation, profit-sharing, vacation or sick pay, medical, retiree medical, paid time off, vehicle, life insurance, hospital, dental care, vision care, drug, short term or long term disability, supplemental employment insurance, fringe-benefits, and any other agreement, plan, policy or program pertaining to compensation or benefits, whether or not reduced to writing, and whether insured or self-insured, that is in effect and covering or otherwise providing compensation or benefits to or for the benefit of one or more employees, former employees, or current or former directors or other service providers of the Company, or the beneficiaries or dependents of any such Persons, however excluding any public statutory plans that the Company is required to comply with (including the Canada Pension Plan and plans administered under applicable provincial health tax, workers&#8217; compensation and employment insurance legislation) (hereinafter collectively referred to as the &#8220;<u>Employee Benefit Plans</u>&#8221; and individually as an &#8220;<u>Employee Benefit Plan</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered or made available to the Buyer true and correct copies of each Employee Benefit Plan that has been reduced to writing, and with respect to each such Employee Benefit Plan true, and correct copies of, where applicable, (i) the most recent filed or circulated annual report and summary plan descriptions, if any (and any summary of material modifications thereof) benefits booklets or manuals, (ii) each trust, insurance, annuity or other funding contract related thereto and (iii) the most recent financial statements and actuarial or other valuation reports prepared with respect thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each Employee Benefit Plan is funded, maintained and administered in material compliance with the terms of such Employee Benefit Plan and all applicable Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Employee Benefit Plan:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp; there are no actions pending (other than routine claims for benefits) or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened against such Employee Benefit Plan, the Company, or against any fiduciary of such Employee Benefit Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;full payment has been timely made, or otherwise properly accrued on the books and records of the Company, of all amounts that the Company is required, under the terms of the Employee Benefit Plans or applicable Law, to have paid as contributions to such Employee Benefit Plans on or prior to the date hereof (excluding any amounts not yet due);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;no Employee Benefit Plan is or is intended to be a &#8220;registered pension plan&#8221;, &#8220;deferred profit sharing plan&#8221;, a &#8220;retirement compensation arrangement&#8221;, a &#8220;registered retirement savings plan,&#8221; or a &#8220;tax free savings account,&#8221; as those terms are defined in the Tax Act. No Employee Benefit Plan is a multi-employer pension plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;neither the Company, nor to the Sellers&#8217; and the Company&#8217;s Knowledge, any other Person, has taken any action, or failed to take any action, which action or failure would reasonably be expected to subject the Company, or any of its employees, to any material liability for breach of any fiduciary duty, with respect to or in connection with such Employee Benefit Plan;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="28" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <u>Schedule 3.16</u>, the Company is not required to provide any benefits for any Person upon or following retirement or termination of employment except as may be required by applicable Laws; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.16</u>, there are no: (i)&nbsp;bonus, golden parachute, retirement, retention, change of control, termination, severance, unemployment compensation, or other compensation or benefit or enhanced benefit arrangements with respect to any current or former director, employee or consultant or other service provider of the Company, (ii)&nbsp;material increases in compensation or benefits otherwise payable under any Employee Benefit Plan, (iii)&nbsp;entitlements of any employee of the Company to any job security or similar benefit or enhanced benefits, (iv)&nbsp;acceleration of the time of payment or vesting of any compensation or benefits otherwise payable under any Employee Benefit Plan, or termination of such Employee Benefit Plan other than at the sole and unfettered discretion of the Company, (v) funding of any compensation or benefits, or (vi) breach or violation of or default under or any limit on the Company&#8217;s right to amend, modify or terminate any Employee Benefit Plan, in each case, resulting from the execution and delivery of this Agreement, the performance of the Company&#8217;s obligations under this Agreement or the consummation of any of the transactions contemplated in this Agreement or the other Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.17<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Labour and Employment Matters</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.17</u> sets forth a complete and correct list of all employees, consultants, and independent contractors by unique identifier that identifies their work location; whether they are full-time or part-time; their position or title; their number of years of service; their current base salary, wage rate, commission, incentives, consulting fees, profit-sharing, deferred compensation, variable remuneration and any other compensation as well as any bonus or commission paid to them for the prior calendar year; whether they are on leave of absence and, if so, the type of leave and expected return to work date (if known); any perquisites; any accrued vacation, overtime or sick day entitlement and whether such employee, consultant or independent contractor is subject to a written employee/consultant/contractor agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set out in <u>Schedule 3.17</u>, no employee, consultant, or contractor has any agreement as to length of notice or severance, retention bonus, change of control, or golden parachute.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as set out in <u>Schedule 3.17</u>, the negotiation and execution of this Agreement, or the consummation of the Transactions will not entitle any current or former employee to severance, retention, bonus, or other similar payment or right, or accelerate the time of payment or vesting or increase the amount of compensation due to any such employee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;All accruals for unpaid vacation pay, sick pay and overtime, premiums for employment insurance, Employee Benefit Plan premiums, Canada Pension Plan premiums, accrued wages, salaries and incentive payments have been reflected in the Company&#8217;s books and records;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;There are no unionized employees. The Company is not bound by or subject to or negotiating any collective bargaining agreement, application for certification, notice to bargain, voluntary recognition, or any other labour agreement. The Company has not made any commitments to voluntarily recognize or negotiate with any union or employee association. There is no union organization activity or any application for certification of a collective bargaining agent involving any of the employees of the Company pending or, and, during the three (3) year period ending on the date hereof, to the Knowledge of the Sellers and the Company, no such organizing activity has been threatened. The Company has not engaged in and, to the Sellers and the Company&#8217;s Knowledge, has not been alleged to have engaged in any unfair labour practices for the past three years.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Company and the conduct of the Business are in compliance, in all material respects, with all Laws relating to the employment of labour, including all such Laws relating to employment standards such as, wages, hours, overtime, vacation, public holidays, leaves of absence, human rights and harassment and discrimination prevention, immigration, occupational safety and health, accessibility, privacy, mass termination, pay equity, workers&#8217; compensation and the collection and payment of deductions, withholdings and premiums associated with Canada Pension Plan, Employment Insurance, income tax, Employer Health Tax, and workers&#8217; compensation insurance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Company has, for each of its employees, completed documentation which verifies the identity and work authorization status of each of its employees in compliance with applicable immigration Laws and related regulations thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;During the three year period ending on the date hereof, there has been no &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; with respect to the Company. The Business has not, during the last three (3) years, experienced any and, to the Sellers&#8217; and the Company&#8217;s Knowledge, there are no currently threatened, strikes, slowdowns, picketing or work stoppages. There is no material charge, grievance proceeding or other claim pending, or to the Knowledge of the Sellers and the Company threatened, against or affecting the Company relating to the alleged violation of any Law pertaining to labour relations or employment, discrimination or harassment or termination of employment, including any charge or complaint filed by an employee with the provincial Ministry of Labour or any comparable Governmental Authority. The Company has delivered or otherwise made available to the Buyer, true, correct and complete copies of all current employee manuals and handbooks relating to the employment of employees, including all amendments thereof and modifications thereto. There are no outstanding orders against the Company under applicable employment standards or health and safety legislation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, those individuals who have been classified as consultants or independent contractors have been properly classified and the Company has not received any written notice from any Governmental Authority disputing that classification. No consultant or independent contractor has raised any type of claim regarding classification or asserted that he or she should be classified and treated as an employee. No consultant or independent contractor has been promised employment, contingent or otherwise, with the Company now or in the future.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;There are no outstanding assessments or other amounts due and owing by the Company under any workplace safety and insurance or workers&#8217; compensation insurance requirements. To the Sellers&#8217; and the Company&#8217;s knowledge, there are no facts or circumstances (including claims and potential claims) that would reasonably be expected to result in a material increase in the Company&#8217;s accident cost experience. There are no charges against the Company pending, or to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened or anticipated under applicable health and safety legislation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.18<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>No Brokers or Finders</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except for Legacy Business Advisory Services Inc., no Person has, as a result of the transactions contemplated by this Agreement, any right, interest or claim against or upon the Company for any commission, fee or other compensation as a finder or broker because of any act or omission by the Company or its shareholders or Affiliates.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.19<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transactions with Affiliates</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 3.19</u>, and except for the Transaction Documents, no present officer, director or shareholder of the Company, nor any Affiliate of the Company, is currently a party to any transaction or contract with the Company, other than (i)&nbsp;payment of compensation for employment or as an independent contractor or reimbursement of expenses to employees, independent contractors or directors consistent with past practice or as is required by law, and other matters incidental to employment with or board membership with the Company, and (ii) contracts which will be terminated at or prior to the Closing without penalty.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.20<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company is currently and has been in material compliance with all Environmental Laws and has not, and the Company has not received from any Person or Governmental Authority in relation to the Company or any property currently or formerly owned, operated or leased by the Company, any actual, pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened: (i) Environmental Notice or Environmental Claim; and (ii) written request for information pursuant to Environmental Laws, which, in each case, either remains pending or unresolved, or is the source of ongoing obligations or requirements as of the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has obtained and is in material compliance with all Environmental Permits (of which there are none, except for those disclosed in <u>Schedule 3.20(b)</u>) necessary for the ownership, lease, operation or use of the business or assets of the Company and all such Environmental Permits are in full force and effect, and there is no condition, event or circumstance that would reasonably be anticipated to prevent or impede the ownership, lease, operation or use of the business or assets of the Company as currently carried out.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No real property currently or formerly owned, operated or leased by the Company is listed on, or to the Sellers&#8217; and the Company&#8217;s Knowledge, has been proposed for listing on, any list of known or suspected contaminated sites under any Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.20(d)</u>, there has been no Release of Hazardous Materials in contravention of Environmental Laws with respect to the business or assets of the Company or any real property currently or formerly owned, operated or leased by the Company, and the Company has not received an Environmental Notice that any real property currently or formerly owned, operated or leased in connection with the business of the Company (including soils, groundwater, surface water, buildings and other structure located on any such real property) has been contaminated with any Hazardous Material which, in each case, would reasonably be expected to result in an Environmental Claim against, or a violation of Environmental Laws or term of any Environmental Permits by, the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.20(e)</u> contains a complete and accurate list of all off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Company and any predecessors as to which the Company may retain liability, and to the Sellers&#8217; and the Company&#8217;s Knowledge, none of these facilities or locations has been placed or proposed for placement on any list of known or suspected contaminated sites under any Environmental Laws, and the Company has not received any Environmental Notice regarding potential liabilities with respect to such off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Company in respect of the transportation of Hazardous Materials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="31" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, the Company has not retained or assumed, by contract or operation of law, any liabilities or obligations of third parties under Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers and the Company have provided or otherwise made available to the Buyer: (i) any and all material environmental reports, studies, audits, investigations, records, sampling data, site assessments, risk assessments, economic models and other similar documents and reports with respect to the business or assets of the Company or any currently or formerly owned, operated or leased real property which are in the possession or control of the Company or the Sellers related to compliance with Environmental Laws, Environmental Claims or an Environmental Notice or the presence of, exposure to or Release of Hazardous Materials; and (ii) any and all material documents concerning planned or anticipated capital expenditures required to reduce, offset, limit or otherwise control pollution and/or emissions, manage waste or otherwise ensure compliance with current or future Environmental Laws (including, without limitation, costs of remediation, pollution control equipment, transportation of Hazardous Materials and dangerous goods, producer responsibility or stewardship requirements and operational changes).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, there is no condition, event or circumstance concerning the release or regulation of Hazardous Materials that would reasonably be anticipated, as of the Closing Date, to prevent, impede or materially increase the costs associated with the ownership, lease, operation, performance or use of the business or assets of the Company as currently carried out.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.21<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Records</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The minute books of the Company accurately reflect in all material respects all corporate or other action taken by its shareholders and board of directors and committees. The copies of the minutes of the Company, as made available to the Buyer for review, are true and complete copies of the originals of such documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.22<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Customers and Suppliers</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.22(a)</u> sets forth a list of top 10 customers from whom the Company made annual sales exceeding $50,000 during the fiscal year ended January 31, 2021 and reasonably expected to exceed $50,000 during the fiscal year ended January 31, 2022 and the dollar amount of sales to such customers for such fiscal year (the &#8220;<u>Customers</u>&#8221;). The Company&#8217;s relationships with the Customers are, to the Knowledge of the Sellers and the Company, good commercial working relationships, and, within the last 12 months, no Customer has canceled, materially modified, or otherwise terminated its relationship with the Company, or materially decreased its orders from the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.22(b)</u> sets forth a list of top 10 suppliers from whom the Company made annual purchases exceeding $50,000 during the fiscal year ended January 31, 2021 and reasonably expected to exceed $50,000 during the fiscal year ended January 31, 2022 and the dollar amount of purchases from such suppliers for such fiscal year (the &#8220;<u>Suppliers</u>&#8221;). The Company&#8217;s relationships with the Suppliers are, to the Knowledge of the Sellers and the Company, good commercial working relationships, and, within the last 12 months, no Supplier has canceled, materially modified, or otherwise terminated its relationship with the Company, or materially decreased its services, supplies or materials to the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="32" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.23<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Assets; Solvency</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.23(a)</u>, the assets owned by the Company, or to which the Company has access, include all rights and property necessary to enable the Company to conduct the business of the Company, as conducted on the date hereof, in all material respects. The Company owns (with good title, except for Permitted Encumbrances) all of the properties and assets (whether real, personal or mixed and whether tangible or intangible) that it purports to own in accordance with <u>Schedule 3.23(a)</u>, including all the properties and assets reflected as being owned by the Company in its financial books and records. Except with respect to liens associated with the Indebtedness set forth on <u>Schedule 3.7</u>, the Company has legal and beneficial ownership of such assets free and clear of all liens other than Permitted Encumbrances.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.23(b)</u>, the inventory of the Company, wherever located, including the supplies inventory (collectively, the &#8220;<u>Inventory</u>&#8221;), is in all material respects in good, useable and/or salable condition and consists of items of a quality and quantity previously used and/or sold by the Company in the ordinary course of business determined and expensed consistent with the Company&#8217;s past practice and contains no significant amount of excess, dated or obsolete inventory except for Inventory that has been appropriately written off, written down to net realizable value or otherwise adequately reserved for in the Interims. The Company has not had any material liability arising out of any injury to individuals or property as a result of the ownership, possession, distribution, sale, use or consumption of any product formulated, designed, manufactured, delivered or sold, or services rendered by or on behalf of the Company, and, to the Knowledge of the Sellers and the Company, there are no facts and/or circumstances that could give rise to any such liability. In the past three (3) years, the Company has not had any material liability to replace or recall any Inventory or other damages in connection therewith, and, to the Knowledge of the Sellers and the Company, there are no facts and/or circumstances that could give rise to any such liability.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not: (i) made a general assignment for the benefit of creditors; (ii) filed any voluntary petition in bankruptcy or suffered the filing of any involuntary petition by its creditors; (iii) suffered the appointment of a receiver to take possession of all, or substantially all, of its assets; (iv) suffered the attachment or other judicial seizure of all, or substantially all, of its assets; (v) admitted its inability to pay its debts as they come due; or (vi) made an offer of settlement, extension or composition to its creditors generally.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.24<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is not engaged in the activities of a &#8220;cultural business&#8221; as defined in the <i>Investment Canada Act</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.25<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Competition Act</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">For the purposes of the threshold set out at Section 110(3) of the <i>Competition Act</i> (Canada), the Company and its affiliates (as such term is used in the <i>Competition Act</i> (Canada)) do not have aggregate assets in Canada that exceed Cdn$93,000,000, nor do they have aggregate gross revenues from sales in or from Canada generated from their assets in Canada that exceed Cdn$93,000,000, all as determined in accordance with Part IX of the <i>Competition Act</i> (Canada).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="33" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.26<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>COVID-19 Compliance</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.26</u> sets forth all governmental programs that the Company has availed itself of that provide financial or other relief in connection with the COVID-19 pandemic. <u>Schedule 3.26</u> sets forth the status of the Company under each program, including acceptance or rejection of its application, amount of funds received, and any other relief received. In respect of the government programs disclosed on <u>Schedule 3.26</u>, the Company has (i) not made a claim for, nor received, any such government sponsored financial aid that it is not entitled to receive, and (ii) not received any written notice, claims or written correspondence indicating, or has any reason to believe, that the Company would be denied any such government sponsored financial aid.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has implemented all applicable workplace, operational and other guidelines, directives, recommendations, precautions and measures regarding the COVID-19 pandemic required of the Company by applicable Laws, including social distancing measures, increased sanitization measures, measures to protect employee and partner health, measures to prevent crowds, and measures to prevent unnecessary contact, and the Company has at all times complied and is in compliance, in all material respects, with all applicable Laws regarding the COVID-19 pandemic. The Company has not experienced any occurrence of (i) to the Knowledge of the Sellers and the Company, any diagnosis of COVID-19 with respect to any employee or independent contractor of the Company that was subject to exposure on any of the Company&#8217;s locations or premises, or (ii) during the course of the COVID-19 pandemic, other than mandatory shutdowns pursuant to applicable Law, any shutdown of or ceasing of operations at any of the Company&#8217;s locations or premises.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered or made available to the Buyer correct and complete copies of all written policies of the Company relating to the COVID-19 pandemic and compliance with the applicable Laws referred to in <u>Section 3.26(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE IV</u></b><b><u>&nbsp;- REPRESENTATIONS AND WARRANTIES OF THE SELLERS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In order to induce the Buyer to enter into this Agreement and consummate the transactions contemplated hereby, each of the Sellers, severally (and not jointly and severally), except among Karen, HeatherP, Michael and Nicholas (each a &#8220;<u>Kroeker Trust Seller</u>&#8221;, and collectively, the &#8220;<u>Kroeker Trust Sellers</u>&#8221;) and among Brentley, Craig and Kurtis (each a &#8220;<u>Peters Trust Seller</u>&#8221;, and collectively, the &#8220;Peters <u>Trust Sellers</u>&#8221;), which each Kroeker Trust Seller shall jointly and severally among the Kroeker Trust Sellers, and each Peters Trust Seller shall jointly and severally among the Peters Trust Sellers, hereby represent and warrant to the Buyer that, except as and to the extent disclosed in the Disclosure Schedule, the statements contained in this <u>Article IV</u> are complete and accurate as of the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 4.1</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Such Seller has full right, authority and power to enter into this Agreement, the Transaction Documents to which Such Seller is a party and all agreements, documents and instruments executed by such Seller pursuant hereto and to carry out the transactions contemplated hereby and thereby. This Agreement, the Transaction Documents to which such Seller is a party and all agreements, documents and instruments executed by such Seller pursuant hereto are valid and binding obligations of such Seller enforceable in accordance with their respective terms, except to the extent that enforceability may be subject to, and limited by, applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and performance by such Seller of this Agreement, the Transaction Documents to which such Seller is a party and all agreements, documents and instruments to be executed and delivered by such Seller pursuant hereto do not and will not: (a) violate or result in a violation of, or constitute or result in a default (whether after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any material contract, agreement, obligation, permit, license or authorization to which such Seller is a party or by which such Seller or its assets are bound; (b) violate or result in a violation of, or constitute a default (whether after the giving of notice, lapse of time or both) under, any provision of any material Law, or any order of, or any restriction imposed by, any court or governmental agency applicable to such Seller; or (c) require from such Seller any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third party (that has not already been obtained).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Shares</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">As of the date hereof, such Seller is the only record and beneficial owner of the Shares to be sold, conveyed, assigned and transferred to the Buyer pursuant to the terms and conditions of this Agreement. Such Seller has good and valid title to such Shares, free and clear of all Encumbrances (except for Permitted Encumbrances). Such Seller is not a party to (a) any option, warrant, purchase right, or other contract or commitment that could require such Seller to sell, transfer or otherwise dispose of any Shares (other than this Agreement) or (b) any voting trust, proxy or other contract with respect to the voting of any Shares.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Proceedings</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">There are no Legal Proceedings pending, threatened by or, to the Knowledge of such Seller, threatened against such Seller or any Affiliate of such Seller that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Banking; Brokerage Fees</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except to Legacy Business Advisory Services Inc., such Seller has not incurred nor become liable for any investment banking fees, brokerage commissions, broker&#8217;s or finder&#8217;s fees or similar compensation (exclusive of professional fees to lawyers and accountants) in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Residency </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Such Seller is not a non-resident of Canada within the meaning of the Tax Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE V&nbsp;</u></b><b><u>- REPRESENTATIONS AND WARRANTIES OF THE BUYER </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer hereby represents, warrants and covenants on behalf of itself only that, the statements contained in this <u>Article V</u> are complete and accurate as of the Closing:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Power</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer is validly existing and in good standing under the Laws of the Province of British Columbia, and has the requisite corporate power and authority to own, lease and operate its properties and assets, to carry on its business as now being conducted and to enter into and perform this Agreement and the Transaction Documents to which it is a party and to carry out the transactions contemplated hereby and thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="35" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has full right, authority and power to enter into this Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto and to carry out the transactions contemplated hereby and thereby. This Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto are valid and binding obligations of the Buyer enforceable in accordance with their respective terms. The execution, delivery and performance of this Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto have been duly authorized by all necessary action under the Buyer&#8217;s organizational documents. The execution, delivery and performance by the Buyer of this Agreement, the Transaction Documents and all agreements, documents and instruments to be executed and delivered by the Buyer pursuant hereto do not and will not: (a) violate or result in a violation of, or constitute or result in a default (whether after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any material contract, agreement, obligation, permit, license or authorization to which the Buyer is a party or by which the Buyer or its assets are bound, or any provision of the Buyer&#8217;s organizational documents; (b) violate or result in a violation of, or constitute a default (whether after the giving of notice, lapse of time or both) under, any provision of any Law, or any order of, or any restriction imposed by, any court or governmental agency applicable to the Buyer; or (c) other than a post-Closing notification under the Investment Canada Act, require from the Buyer any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third party (that has not already been obtained).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Consents and Approvals</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No consent, approval, waiver, exception, authorization, notice or filing is required to be obtained by the Buyer from, or to be given by the Buyer to, or be made by the Buyer with, any Governmental Authority in connection with the execution, delivery and performance by the Buyer of this Agreement and the Transaction Documents to which it is a party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No consent, approval, waiver, authorization, notice, exemption or filing is required to be obtained by the Buyer from, or to be given by the Buyer to, or made by the Buyer with, any Person which is not a Governmental Authority in connection with the execution, delivery and performance by the Buyer of this Agreement and the Transaction Documents to which it is a party</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is no action pending or, to the knowledge of the Buyer, threatened against the Buyer and the Buyer is not subject to any outstanding order with respect to execution of this Agreement and the other Transaction Documents to which it is a party or the consummation by the Buyer of the transactions contemplated hereby and thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Competition Act</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The assets and gross revenues of the Buyer and its affiliates (as such term is used in the <i>Competition Act</i> (Canada)) are such that, after taking into account the assets and gross revenues of the Company, do not exceed the monetary threshold set forth in section 110(3) of the <i>Competition Act</i> (Canada).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="36" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer is a &#8220;non-Canadian&#8221; and is a &#8220;WTO investor&#8221; for the purposes of and within the meaning of the <i>Investment Canada Act</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transferred Information</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has collected, used and disclosed the Transferred Information solely for the purpose of reviewing and completing the transactions contemplated by this Agreement, including for the purpose of determining to complete such transactions, or as otherwise authorized or permitted by applicable Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Banking; Brokerage Fees</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has not incurred or become liable for any investment banking fees, brokerage commissions, broker&#8217;s or finder&#8217;s fees or similar compensation (exclusive of professional fees to lawyers and accountants) in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VI&nbsp;</u></b><b><u>- ADDITIONAL AGREEMENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Announcement; Confidentiality</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;None of the Company, the Sellers, or the Buyer will issue any press release or otherwise make any public statement with respect to this Agreement and the transactions contemplated hereby without the prior consent of the other parties hereto (which consent will not be unreasonably withheld), except as may be required by applicable Law, including, without limitation, any securities filings which are to be made by a Party. Notwithstanding anything in this <u>Section 6.1</u> to the contrary, the Sellers&#8217; Representative and the Buyer will, to the extent practicable, consult with each other before issuing, and provide each other a reasonable prior opportunity to review and comment upon, any such press release or other public statements with respect to this Agreement and the transactions contemplated hereby, whether or not required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Until the fifth anniversary of the Closing Date, the Sellers each respectively agrees that, without the prior written consent of the Buyer, (i) it shall, and shall cause each of its Affiliates to, keep confidential all confidential, non-public or proprietary information and materials regarding the Buyer, the Company and their respective Affiliates (except to the extent (a) disclosure of such information is required by applicable Law, (b) such information becomes available to such Person after the Closing Date from a source (which is not known by such Person to have made the disclosure in violation of any confidentiality obligations), or (c) such information becomes publicly known except through the actions or inactions of any such Person in violation of this <u>Section 6.1(b)</u>), (ii) it shall take reasonable and appropriate steps (and cause each of its Affiliates to take reasonable and appropriate steps) to safeguard such information and to protect it against disclosure, misuse, espionage, loss and theft, in each case at the Buyer&#8217;s or the Company&#8217; expense, and (iii) in the event such Person or any of its Affiliates is required by (or requested by a Governmental Authority with competent jurisdiction under) applicable Law to disclose any such information, such Person shall, to the extent permitted by applicable Law, promptly notify the Buyer in writing, which notification shall include the nature of the legal requirement or request and the extent of the required disclosure, and shall reasonably cooperate with the Buyer, at the Buyer&#8217;s sole cost and expense, to preserve the confidentiality of such information consistent with applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="37" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Competition and Non-Solicitation</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Each of the Sellers hereby understand, acknowledge and agree that: the Company is engaged in the operation of developing and supplying advanced battery solutions, including battery packs, battery chargers, and electro-magnetic assemblies related thereto (the &#8220;<u>Business</u>&#8221;); (ii) the Company is conducting the Business throughout the United States and Canada (the &#8220;<u>Territory</u>&#8221;); (iii) the Sellers, will receive consideration in connection with the closing of the transactions contemplated by this Agreement; (iv) as a current and/or recent owner of the Company, each of the Sellers has obtained valuable knowledge, technical expertise, and confidential and proprietary information and data concerning the Business; and (v) the Sellers&#8217; entry into the agreements set forth in this <u>Section 6.2</u> is essential to preserve the value of the Company, the Business, and the assets and properties being acquired by the Buyer in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;During the Term, the Sellers shall not, anywhere in the Territory, for themselves, respectively, or through or on behalf of any other Person (other than the Company), whether as an officer, director, employee, seller, partner, consultant, advisor, creditor or otherwise, as applicable, directly or indirectly:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;engage in, participate in, advise, assist, invest, lend money to, guarantee the debts or obligations of, or acquire any financial or beneficial interest in (which, for the avoidance of doubt, will include employment with or engagement as an independent contractor for), any Competitive Business; <i>provided</i>, <i>however</i>, that nothing in this <u>Section 6.2(a)(i)</u> shall prevent the Sellers from owning as a passive investment less than two percent (2%) of the issued and outstanding shares in the capital (or other equity ownership interests) of a publicly-held company, other issuer whose securities are quoted on any stock exchange or inter-dealer quotation system, mutual fund, hedge fund, private equity fund or venture capital fund or;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;encourage, induce, attempt to induce, solicit or attempt to solicit any individual who is an employee of the Company as of the date hereof, or becomes an employee of the Company at any time during the Term (each, a &#8220;<u>Specified Employee</u>&#8221;) to leave his or her employment with the Company, or hire or attempt to hire any Specified Employee; provided that nothing in this <u>Section 6.2(a)(ii)</u> shall prohibit the Sellers from (y) making general solicitation advertisements that are not targeted at any employee of the Company and from hiring any employee that responds to a general solicitation advertisement, and (z) soliciting or hiring any Person whose employment with the Company has been terminated at least six (6) months prior to the commencement of any such solicitation or employment or engagement discussions between such Seller and such Person; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;encourage, induce, attempt to induce, solicit or attempt to solicit, any customer, distributor, vendor, marketer, supplier or sponsor of the Company who was a customer, distributor, vendor, marketer, supplier or sponsor of the Company as at the Closing Date or during the one-year period preceding the Closing Date, and in the event any Seller becomes an employee of the Company, any customers with whom such Seller had contact in the 12-month period prior to the termination of such Seller&#8217;s employment with the Company; to cease or negatively alter its customer, distributor, vendor, marketer, supplier or sponsor relationship with the Company, as the case may be, with respect to the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="38" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Parties acknowledge and agree that the Sellers will not be in breach of this <u>Section 6.2</u> by virtue of the Sellers performing services for or providing services to the Buyer or any of its Subsidiaries (including the Company) pursuant to and in accordance with any employment or consulting agreements or arrangements between such Seller and the Buyer or any of its Subsidiaries (including the Company).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Parties acknowledge that Mark and his Affiliates and affiliated entities including Excell Battery Holdings Ltd., 53 Avenue Properties Ltd., Tasman Helicopters Ltd., Tasman Ventures Ltd. and Tasman Aviation Ltd. have engaged Carmena Gee, a current employee of the Company, as an independent contractor to provide financial and accounting services to Mark and his Affiliates and affiliated entities, provided that Carmena Gee continues to devote her full business time to the affairs of the Company and that such engagement does not create any conflicts of interest. Each of the Buyer and the Company acknowledges and consents to Carmena Gee continuing to provide such services to Mark and his Affiliates and affiliated entities after the Closing and Mark will not be in breach of this <u>Section 6.2</u> by virtue of this arrangement with Carmena Gee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Sellers acknowledge that a breach or threatened breach by the Sellers of any provision of this Agreement will result in the Buyer suffering irreparable harm that cannot be calculated fully or adequately by recovery of damages alone. Accordingly, the Sellers agree that, in addition to any other relief to which the Buyer may become entitled, the Buyer shall be entitled to interim and permanent injunctive relief, specific performance and other equitable remedies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Preservation of Books and Records</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Each Party shall, and shall cause, as applicable, the Sellers, the Buyer and the Company, in accordance with commercially reasonable retention policy practices, to preserve and keep the material records held by them relating to the business of the Company as applicable, for a period of seven (7) years from the Closing Date and shall make such records and personnel available to a requesting Party (including the right to make copies thereof), at such requesting Party&#8217;s own cost and expense and to the extent not unreasonably burdensome to the Sellers and the Company, as applicable, as may be reasonably required by the requesting Party in connection with any insurance claims by, Legal Proceedings (including with respect to the enforcement of this Agreement, including indemnity claims) or Tax audits against or investigations by any Governmental Authority of the Sellers, the Buyer or the Company or any of their respective Affiliates with respect to their ownership of the Company, as applicable, or the transactions contemplated by this Agreement and the other Transaction Documents (including in connection with the final determination of Working Capital). Notwithstanding the foregoing, no Party will be obligated to provide a requesting Party with access to any books or records (including personnel files) where such access would (i) cause the loss of any solicitor-client or other similar privilege; or (ii) contravene any applicable Law, fiduciary duty or binding agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act Notification.</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Within 30 days following Closing, the Buyer shall file notification of the transaction contemplated under this Agreement with Industry Canada, Director of Investments pursuant to and in accordance with the <i>Investment Canada Act</i>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="39" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Privileged Communications</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">From and after Closing, all Privileged Communications will be privileged and confidential and remain the exclusive property of the Sellers, as applicable, and will not belong to the Buyer, the Company or any other Person, notwithstanding that such Privileged Communications may remain at the premises of the Company, in the books and records of the Company or on any servers on the computer network of the Company or any other Person. For certainty, and without limiting the generality of the foregoing, all Privileged Communications are protected by privilege and any inadvertent disclosure of any Privileged Communications does not and will not constitute a waiver of such privilege by the Sellers or any other Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transferred Information. </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Buyer covenants to and with the Sellers that it will do or cause to be done the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;after the completion of the transactions contemplated by this Agreement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;collect, use and disclose the Transferred Information only for those purposes for which the Transferred Information was initially collected from or in respect of the individual to which such Transferred Information relates and which solely relates to the carrying on of the Business, unless:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 36pt; text-align: justify;">(A)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer has first notified such individual of such additional purpose and, where required by Law, obtained the consent of such individual to such additional purpose; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 36pt; text-align: justify;">(B)&nbsp;&nbsp;&nbsp;&nbsp;such use or disclosure is permitted or authorized by Law, without notice to, or consent from, such individual; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;return or destroy the Transferred Information, at the option of the Sellers, should the transactions contemplated by this Agreement not be completed; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;where the disclosure or transfer of Transferred Information to the Buyer requires the consent of, or the provision of notice to, the individual to which such Transferred Information relates, to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;not require or accept the disclosure or transfer of such Transferred Information until the Sellers or the Company have first notified such individual of such disclosure or transfer and the purpose for same and, where required by Law, obtained the individual&#8217;s consent to same; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;only collect, use and disclose such information to the extent necessary to complete the transactions contemplated by this Agreement and as authorized or permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Buyer covenants to cause the Company to, if and to the extent required by Law, not less than thirty (30) days following the completion of the transactions contemplated by this Agreement, provide written notification to all individuals to whom the Transferred Information relates that such transactions have taken place and that the Transferred Information has been disclosed to the Buyer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="40" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Excluded Accounts Receivable. </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Within five Business Days after the date on which the Final Net Purchase Price is finally determined pursuant to <u>Section 2.6</u>, the Buyer will cause the Company to assign to the Sellers, in consideration for the payment by the Sellers to the Company of $1.00 in the aggregate, all Excluded Accounts Receivable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Following the date on which the Final Net Purchase Price is finally determined pursuant to <u>Section 2.6</u>, the Buyer will cause the Company to use commercially reasonable efforts to collect the Excluded Accounts Receivable and remit to the Sellers, in such proportions as the Sellers&#8217; Representative directs, on a monthly basis, all such amounts collected, without set-off or deduction. Any amounts payable to the Sellers pursuant to this <u>Section 6.7</u> shall constitute an upwards adjustment to the Purchase Price.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Responsibility for Filing Tax Returns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer shall engage MNP LLP to prepare all Tax Returns of the Company for Tax periods ending on or before the Closing Date that are due after the Closing Date (collectively, the &#8220;<u>Buyer Prepared Pre-Closing Tax Returns</u>&#8221;). Each Buyer Prepared Pre-Closing Tax Return shall be prepared consistent with the past practices of the Company, as applicable and for greater certainty, no deduction shall be claimed on such Tax Returns in respect of any expenses incurred for the benefit of the Sellers in respect of the Transaction. Notwithstanding the foregoing, in any such Tax Returns, the Company shall not deduct any amount in the nature of a reserve or claim any Tax credit that would require the Company to include in a taxable period ending after the Closing Date any amount of income, unless the Tax liability in respect of such income (determined as though such income were the only income or loss of the Company for the Tax period and without regard for the availability of any loss carryforwards or carrybacks) is taken into account in computing Working Capital. The Buyer shall provide a copy of such Buyer Prepared Pre-Closing Tax Return to the Sellers&#8217; Representative for review and comment at least 30 days (10 days in the case of a non-income Tax Return) prior to the due date for filing such Tax Returns, and Buyer shall consider in good faith any reasonable comments provided by Sellers&#8217; Representative on the Buyer Prepared Pre-Closing Tax Return. The Sellers&#8217; Representative and Buyer shall work in good faith to resolve any disputes with respect to any Buyer Prepared Pre-Closing Tax Returns. If the Parties are unable to resolve a dispute, then such dispute shall be submitted to the Independent Accounting Firm to resolve such dispute in a manner consistent with the procedures for resolving disputed items set forth in <u>Section 2.6(b)</u>. If a Buyer Prepared Pre-Closing Tax Return is required to be filed prior to the resolution of a dispute, the Buyer Prepared Pre-Closing Tax Return shall be filed as determined by the Buyer and such Tax Return shall be promptly amended if and to the extent required to reflect the final resolution of the dispute. The Buyer shall cause the Company to timely file all Buyer Prepared Pre-Closing Tax Returns. The Sellers shall timely pay to the appropriate Tax Authority any Taxes shown as due on the Buyer Prepared Pre-Closing Tax Returns if and only to the extent that a liability for the amount of such Taxes was not included in Working Capital or such Taxes were not pre-paid by the Company or the Sellers prior to the Closing Date. The Company shall, and the Buyer shall cause the Company to, promptly and timely execute a Buyer Prepared Pre-Closing Tax Return to the extent required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="41" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Buyer shall prepare, or cause to be prepared, and timely file, or cause to be timely filed, all Tax Returns of the Company for any Straddle Period (the &#8220;<u>Buyer Prepared Post-Closing Tax Returns</u>&#8221;). Each Buyer Prepared Post-Closing Tax Return shall be prepared consistent with the past practices of the Company, as applicable, except as required by applicable Law. Buyer shall provide a copy of such Buyer Prepared Post-Closing Tax Return to the Sellers&#8217; Representative for review and comment at least thirty (30) days (10 days in the case of a non-income Tax Return) prior to the due date for filing such Buyer Prepared Post-Closing Tax Returns, and Buyer shall consider in good faith any reasonable comments provided by Sellers&#8217; Representative on such Buyer Prepared Post-Closing Tax Return. The Sellers&#8217; Representative and Buyer shall work in good faith to resolve any disputes with respect to any Buyer Prepared Post-Closing Tax Returns. If the Parties are unable to resolve a dispute, then such dispute shall be submitted to the Independent Accounting Firm to resolve such dispute in a manner consistent with the procedures for resolving disputed items set forth in <u>Section 2.6(b)</u>. If a Buyer Prepared Post-Closing Tax Return is required to be filed prior to the resolution of a dispute, the Tax Return shall be filed as determined by the Buyer and it shall be promptly amended if and to the extent required to reflect the final resolution of the dispute. The Sellers shall pay to Buyer all Taxes due and payable with a Buyer Prepared Post-Closing Tax Return for a Straddle Period that are allocated to the Pre-Closing Tax Period in accordance with <u>Section 6.8(c)</u> within two (2) Business Days before payment of Taxes (including estimated Taxes) is due to the applicable Tax Authority if and only to the extent that a liability for such Taxes was not included in Working Capital or such Taxes were not pre-paid by the Company or the Sellers prior to the Closing Date. The Company shall, and the Buyer shall cause the Company to, promptly and timely execute a Buyer Prepared Post-Closing Tax Return to the extent required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Cooperation on Tax Matters</u>. Buyer, the Company, and the Sellers shall, and Buyer shall cause the Company to, reasonably cooperate, as and to the extent reasonably requested by any other Party, in connection with the preparation and filing of Tax Returns pursuant to this Agreement and any audit, litigation or other proceeding with respect to Taxes or Tax Returns of the Company for or that include a Pre-Closing Tax Period (a &#8220;<u>Tax Contest</u>&#8221;). Such cooperation will include the retention and (upon the other Party&#8217;s written request) the provision of records and information that is in the possession of such Party, which is reasonably relevant to any such Tax Contest and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided under this Agreement. Buyer, the Company, and the Sellers agree to retain all books and records with respect to Tax matters pertinent to the Company relating to any taxable period beginning before the Closing Date until the expiration of the statute of limitations (and, to the extent notified by Buyer, the Company or the Sellers any extensions thereof) of the respective taxable periods, and to abide by all record retention agreements entered into with any Tax Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Contests</u>. If, subsequent to the Closing, Buyer or the Company receives notice of a Tax Contest relating to Taxes of the Company that relates to a Pre-Closing Tax Period, then within five days after receipt of such notice, Buyer shall notify the Sellers&#8217; Representative of such notice; <i>provided</i>, <i>however</i>, that any failure on the part of Buyer to so notify the Sellers&#8217; Representative shall not limit any of the obligations of the Sellers under <u>Article VII</u> (except to the extent such failure prejudices the defense of such Tax Contest). Sellers&#8217; Representative shall have the right, but not the obligation, to control the conduct and resolution of any Tax Contest that relates to any taxable period that ends on or before the Closing Date, including any settlement or compromise thereof; provided, that if the Sellers&#8217; Representative exercises its right to control the Tax Contest Sellers&#8217; Representative shall keep the Buyer reasonably informed of all material developments on a timely basis and <i>provided further</i> that the Buyer will be entitled to participate in the defense of such claim if and only to the extent that the resolution of the Tax Contest would reasonably be expect to adversely impact the Taxes or Tax Returns of the Company for a Tax period beginning on or after the Closing Date, and to employ counsel of its choice for such purpose, the fees and expenses of which separate counsel will be borne solely by Buyer. If and only to the extent that a settlement of a Tax Contest controlled by Sellers&#8217; Representative would reasonably be expected to subject the Buyer or the Company to a non-indemnified Tax, Sellers&#8217; Representative shall not settle such Tax Contest without the prior written consent of the Buyer (which consent shall not be unreasonably withheld, conditioned or delayed). Buyer shall have the right and obligation to control the conduct and resolution of any Tax Contest that relates to a Straddle Period or that is not controlled by the Sellers&#8217; Representative, including any settlement or compromise thereof; <i>provided</i>, that Buyer shall keep the Sellers&#8217; Representative reasonably informed of all material developments on a timely basis<i> provided further</i> that the Sellers&#8217; Representative will be entitled to participate in the defense of such Tax Contest and to employ counsel of its choice for such purpose, the fees and expenses of which separate counsel will be borne by Sellers. Neither Buyer nor the Company shall settle a Tax Contest that Buyer controls without the prior written consent of the Sellers&#8217; Representative (which consent shall not be unreasonably withheld, conditioned or delayed if such settlement would impact the Sellers). To the extent any provisions in <u>Section 7.6</u> are inconsistent with this <u>Section 6.8(c)</u> with respect to any Third-Party Claim that relates to Taxes, this <u>Section 6.8(c)</u> shall control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="42" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Straddle Period Allocation</u>. For purposes of <u>Section 6.8(a)(ii)</u> and <u>Article VII</u>, the portion of any Tax that relates to the portion of any Straddle Period ending on the day prior to the Closing Date shall be allocated to the Pre-Closing Tax Period as follows: (A) the amount of any Taxes for the Pre-Closing Tax Period that are (i) based on or measured by income or receipts, (ii) imposed in connection with the sale, transfer or assignment of property, or (iii) required to be withheld, shall be determined based on an interim closing of the books as of the close of business on the day prior to the Closing Date; (B) the amount of all other Taxes that relate to the Pre-Closing Tax Period shall be deemed equal to the amount of such Taxes for the entire period multiplied by a fraction, the numerator of which is the number of days in the period ending on the day prior to the Closing Date and the denominator of which is the number of days in the entire period. Taxes allocated to the Pre-Closing Tax Period shall be borne by the Sellers to the extent set forth in this Agreement. The remainder of the Taxes for the Straddle Period that are not allocated to the Pre-Closing Tax Period shall be allocated to the portion of the Straddle Period beginning on the Closing Date and such Taxes shall be borne by Buyer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If, at any time after the Closing Date, the Company is assessed for Taxes under subsection 185.1(1) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of an "excessive eligible dividend designation" within the meaning of subsection 89(1) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of any dividend paid on or before the Closing (including for greater certainty, any dividends paid, or deemed to have been paid, on the Closing Date and before the Closing), Buyer shall cause the Company to make the election under subsection 185.1(2) of the Tax Act (or equivalent provision under any provincial tax legislation) in prescribed manner and within the time specified in subsection 185.1(2) (or equivalent provision under any provincial tax legislation), in respect of any such "excessive eligible dividend designation" so as to treat such excess amount as a separate taxable dividend and each of the Sellers hereby concurs with the making of the election under subsection 185.1(2) of the Tax Act (or equivalent provision under any provincial tax legislation) to treat such excess amount as a taxable dividend and shall cooperate with the Company and take all steps necessary in order to make such election. Notwithstanding the foregoing, the filing of the election by a Company and the concurrence of the Sellers does not relieve the Sellers from their indemnification obligations to the Buyer to the extent that either the Company or the Buyer is liable to pay any Tax or otherwise suffers any Losses as a result of such excessive eligible dividend election.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;If, at any time after the Closing Date, the Company is assessed for Taxes under subsection 184(2) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of a dividend paid on or before the Closing (including for greater certainty, any dividends paid, or deemed to have been paid, on the Closing Date and before the Closing) in respect of which such Company made a capital dividend election under subsection 83(2) of the Tax Act (or equivalent provision under any provincial tax legislation), Buyer shall cause such Company to make the election under subsection 184(3) of the Tax Act (or equivalent provision under any provincial tax legislation) in prescribed manner and within the time specified in subsection 184(3) (or equivalent provision under any provincial tax legislation) in respect of any such excessive capital dividend election so as to treat such excess amount as a separate taxable dividend and each of the Sellers hereby concurs with the making of an election under subsection 184(3) of the Tax Act (or equivalent provision under any provincial tax legislation) to treat such excess amount as a taxable dividend and shall cooperate with the Company and take all steps necessary in order to make such election. Notwithstanding the foregoing, the filing of the election by a Company and the concurrence of the Sellers does not relieve the Sellers from their indemnification obligations to the Buyer to the extent that either the Company or the Buyer is liable to pay any Tax or otherwise suffers any loss or damage as a result of such capital dividend election.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="43" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer Taxes</u>. All transfer, documentary, sales, use, stamp, registration and other such Taxes (including any penalties and interest) incurred in connection with this Agreement (&#8220;<u>Transfer Taxes</u>&#8221;), if any, shall be borne by the Buyer. All necessary Tax Returns and other documentation with respect to all such Transfer Taxes shall be filed by the Party required to file such Tax Returns under applicable Law (at the cost and expense of the Buyer) and such Party shall provide copies of such Tax Returns to the other Party and, if required by applicable Law, the other Party will join in the execution of any such Tax Returns and other documentation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Post-Closing Tax Matters.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;To the extent not reflected as a positive adjustment to the Final Net Purchase Price or not included in the calculation of Working Capital, promptly upon receipt by the Company or Buyer, the Buyer shall pay (net of any applicable Taxes) to Sellers any refund, rebate, abatement, reduction or other recovery (whether direct or indirect through a right of setoff or credit) of Taxes of the Company and any interest received thereon, attributable to any Pre-Closing Tax Period of the Company. The Parties agree to treat any payment made pursuant to this <u>Section 6.8(h)(i)</u> as an adjustment to the Purchase Price for Tax purposes. Upon request by Sellers&#8217; Representative after the Closing Date, the Buyer shall cause the Company to use commercially reasonable efforts to obtain any refund, rebate, abatement, reduction or other recovery (whether direct or indirect through a right of setoff or credit) of Taxes of the Company and any applicable interest for any Pre-Closing Tax Period that would be payable to the Sellers pursuant to this <u>Section 6.8(h)(i)</u>, including by filing amended Tax Returns. In the event that the Company is subsequently required to repay to any Tax Authority any amount paid to the Sellers pursuant to the provisions of this <u>Section 6.4(h)(i)</u>, any such amount shall be repaid to Buyer, together with any interest and penalties owed in respect of such disallowed refund or credit, within ten (10) Business Days, as an adjustment to the Purchase Price.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing, unless the Sellers&#8217; Representative provides his prior written consent, the Buyer and the Company shall not (i)&nbsp;amend, refile or otherwise modify any Tax election or Tax Return of or related to the Company with respect to any Pre&#8209;Closing Tax Period, (ii)&nbsp;file a Tax Return of the Company for a Pre&#8209;Closing Tax Period in a jurisdiction where the Company has not previously filed a Tax Return, (iii)&nbsp;grant an extension of any applicable statute of limitations with respect to a Tax Return of the Company for a Pre&#8209;Closing Tax Period, or (iv)&nbsp;enter into any voluntary disclosure Tax program, agreement or arrangement with any Governmental Authority or Tax Authority that relates to the Taxes or Tax Returns of the Company for a Pre-Closing Tax Period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="44" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this <u>Section 6.8</u>, all references to the Buyer, the Sellers, Sellers&#8217; Representative and the Company include their respective successors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictive Covenants</u>. The parties agree that no amount of the Purchase Price will be allocated to the granting of any restrictive covenants (as such term is defined in the Tax Act) by the Sellers or any other Person, including those contained in <u>Section 6.2</u> of this Agreement. Notwithstanding that the parties have not allocated any amount of the Purchase Price to such covenants, the Buyer agrees to make, if requested by a Seller, a joint election to have the provisions of section 56.4 of the Tax Act, and any equivalent or corresponding provision under applicable provincial or territorial Tax Laws, apply in respect of any such covenants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">From time to time after the date hereof, and without further consideration, the Parties shall execute and deliver, or arrange for the execution and delivery of, such other instruments of conveyance and transfer and take or arrange for such other actions as may be reasonably requested by the other Party to more effectively complete any of the transactions provided for in this Agreement or any document contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>D&amp;O Policy; Indemnification of Directors and Officers</u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Company shall purchase an extended reporting period endorsement under the Company's existing directors' and officers' liability insurance coverage for the Company&#8217;s directors and officers in a form reasonably acceptable to the Company that shall provide such directors and officers with coverage for six years following the Closing of not less than the existing coverage and have other terms not materially less favorable to, the insured Persons than the directors&#8217; and officers&#8217; liability insurance coverage presently maintained by the Company (the &#8220;<u>D&amp;O Tail Policy</u>&#8221;). The Company shall maintain the D&amp;O Tail Policy in full force and effect, and continue to honor the obligations thereunder. 50% of the cost of the D&amp;O Tail Policy shall be considered a Company Transaction Expense and 50% shall be borne by the Buyer as a Buyer Transaction Expense.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;For a period of six years after the Closing, the Buyer shall not, and shall not permit the Company to, amend, repeal or modify (in a manner adverse to the beneficiary thereof) any provision in the Company&#8217;s constating documents relating to exculpation or indemnification of any current or former officers or directors of the Company, it being the intent of the parties hereto that the officers and directors of the Company continue to be entitled to such exculpation and indemnification to the full extent of the law. In the event the Buyer, the Company or any of their respective successors or assigns (a) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity in such consolidation or merger or (b) transfers all or substantially all of its properties and assets to any Person, then, and in either such case, proper provision shall be made so that the successors and assigns of the Buyer or the Company, as the case may be, shall assume all of the obligations set forth in this <u>Section 6.10</u>. This <u>Section 6.10</u> is intended for the benefit of, and is enforceable by, each current and former officer and director of the Company and his or her heirs, executors and representatives, and are in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Person may have had by contract or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="45" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VII</u></b><b><u>&nbsp;- INDEMNIFICATION</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations, Warranties and Covenants</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">All representations, warranties, covenants, and agreements of the Company, the Sellers, and the Buyer made in this Agreement, all Transaction Documents executed and delivered in connection herewith, and all certificates delivered in connection therewith (a) shall be deemed to have been relied upon by the Party or Parties to whom they are made, and shall survive the Closing in accordance with the terms and conditions of this Agreement, and (b) shall bind the Parties&#8217; successors and assigns (including, without limitation, any successor to the Company by way of acquisition, merger or otherwise), whether so expressed or not, and, except as otherwise provided in this Agreement, all such representations, warranties, covenants and agreements shall inure to the benefit of the Parties (subject to <u>Section 7.2</u> below) and their respective successors and assigns and to their transferees of Shares, whether so expressed or not.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival Period</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Other than with respect to the Fundamental Representations of the Sellers and the Fundamental Representations of the Buyer, and as set forth in this <u>Section 7.2</u>, all of the representations and warranties of the Company, the Sellers, and the Buyer contained in this Agreement shall survive the Closing and continue in full force and effect until the date that is 16 months after the Closing Date, except that any written claim for breach thereof made in good faith with commercially reasonable specificity prior to such expiration date and delivered to the Party against whom indemnification is sought shall survive thereafter until finally resolved and, as to any such claim, such applicable expiration will not affect the rights to indemnification of the Party making such claim; <i>provided</i>, that (a) the Fundamental Representations of the Sellers and the Fundamental Representations of the Buyer shall survive the Closing and continue indefinitely, (b) <u>Section 3.10</u> (Tax Matters) and <u>Section 4.5</u> (Residency) (collectively, the &#8220;<u>Regulatory Representations</u>&#8221;) shall survive until the date that is 60 calendar days from the last date on which an assessment or reassessment for Taxes under the Tax Act or under any other Law imposing Taxes can be made against the Company in respect of the dates or periods covered by the Regulatory Representations and (c) <u>Section 3.20</u> (Environmental Matters) shall survive until the date that is 60 months from the Closing Date. &#8220;Fundamental Representations of the Seller&#8221; shall mean the representations set forth in <u>Section 3.1</u> (Organization and Company Power); <u>Section 3.2(a)</u> (Authorization); <u>Section 3.3</u> (Shares); <u>Section 3.4</u> (Subsidiaries); <u>Section 3.18</u> (No Brokers or Finders); <u>Section 4.1(a)</u> (Authority); <u>Section 4.2</u> (Shares); and <u>Section 4.4</u> (Investment Banking; Brokerage Fees). &#8220;Fundamental Representations of the Buyer&#8221; shall mean the representations set forth in <u>Section 5.1</u> (Organization and Power), <u>Section 5.2</u> (Authority and Non-Contravention), <u>Section 5.3</u> (Consents and Approvals) and <u>Section 5.8</u> (Investment Banking; Brokerage Fees). The covenants contained in this Agreement shall survive the Closing until they are otherwise terminated by their respective term.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification Provisions for Buyer</u></b><u>&#8217;</u><b><u>s Benefit</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Provided that the Buyer makes a written claim for indemnification, describing with commercially reasonable specificity the facts and circumstances with respect to the subject matter of such claim within the applicable survival period set forth in <u>Section 7.2</u>, subject to the limitations set forth in this <u>Article VII</u>, the Sellers, severally (and not jointly and severally), except among the Kroeker Trust Sellers and among the Peters Trust Sellers, which each Kroeker Trust Seller, jointly and severally among the Kroeker Trust Sellers, and each Peters Trust Seller, jointly and severally among the Peters Trust Sellers, shall indemnify Buyer and its successors and permitted assigns (collectively, the &#8220;<u>Buyer Indemnified Parties</u>&#8221;) from and against any Losses incurred by any of the Buyer Indemnified Parties arising out of, or by reason of:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="46" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach by the Company or the Sellers of the Fundamental Representations of the Sellers and/or <u>Section 3.10</u> (Tax Matters), and <u>Section 4.5</u> (Residency);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;any Taxes of the Company with respect to any Pre-Closing Tax Period; <i>provided</i>, <i>however</i>, that the Sellers shall have no liability under this <u>Section 7.3(b)</u> for any Taxes to the extent they were paid to the appropriate Tax Authority or to the Buyer pursuant to <u>Section 6.8(a)</u> or treated as Final Indebtedness or reserved in the Working Capital;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach of any of the representations or warranties of the Company or the Sellers (other than Fundamental Representations of the Sellers or <u>Section 3.10</u> (Tax Matters), <u>Section 3.20</u> (Environmental Matters), or <u>Section 4.5</u> (Residency)) contained in this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach by the Company or the Sellers of the representations and warranties of the Company or the Sellers pursuant to <u>Section 3.20</u> (Environmental Matters); and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;any breach or non-fulfillment of any covenant, agreement or obligation to be performed by the Company or the Sellers pursuant to this Agreement or any Transaction Document.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding the foregoing, for purposes of this Agreement, other than in respect of Losses pursuant to breaches of the Fundamental Representations of the Sellers, <u>Section 3.10</u> (Tax Matters), <u>Section 4.5</u> (Residency) and claims arising out of or related to fraud in which a Seller or the Sellers participated, no indemnification shall be due or payable by the Sellers and no claim will be made against them with respect to Losses, until (i) the amount of Losses arising from any one claim exceeds $14,000.00 (a &#8220;<u>Qualifying Claim</u>&#8221;) and (ii) the aggregate amount of all Qualifying Claims exceeds $100,000.00 (the &#8220;<u>Basket</u>&#8221;), in which case, the Buyer Indemnified Parties shall be entitled to recover all Losses from the first dollar, subject to the limitations hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Section 7.3(c)</u> against such Seller will be limited to 12% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Section 7.3(d)</u> against such Seller will be limited to 50% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Sections 7.3(a), 7.3(b) and 7.3(e)</u> (inclusive of any claims for Losses brought under <u>Sections 7.3(c) and 7.3(d)</u>) against such Seller will be limited to 100% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding the foregoing, any claims arising out of or related to fraud in which a Seller or the Sellers participated shall not be subject to the limitations set forth in this <u>Section 7.3</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding anything provided in this Agreement to the contrary, no indemnification shall be payable by any Seller pursuant to this <u>Section 7.3</u> with respect to any claim asserted by the Buyer Indemnified Party after the expiration of the survival period, if any, prescribed for such representation, warranty or covenant in <u>Section 7.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="47" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification Provisions for the Seller</u></b><u>&#8217;</u><b><u>s Benefit; Limitations </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of this <u>Article VII</u>, from and after Closing, the Buyer agrees to indemnify and hold each of the Sellers and its respective successors, heirs and permitted assigns (the &#8220;<u>Seller Indemnified Parties</u>&#8221;) harmless from and against any Losses sustained or suffered by the Seller Indemnified Parties to the extent caused by or arising from a breach of, or inaccuracy in, any representation or warranty made by the Buyer, the common law fraud of the Buyer, or a failure to perform any covenant or agreement made by the Buyer herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything provided in this Agreement to the contrary, no indemnification shall be payable by the Buyer pursuant to <u>Section 7.4(a)</u> with respect to any claim asserted by a Seller Indemnified Party after the expiration of the survival period, if any, prescribed for such representation, warranty or covenant in <u>Section 7.2</u>. In no event shall the aggregate liability of the Buyer for indemnification payable under this <u>Article VII</u> exceed an amount equal to the Final Net Purchase Price (as finally determined in accordance with <u>Article II</u>). Notwithstanding the foregoing, any claims arising out of or related to fraud in which the Buyer participated shall not be subject to the limitations set forth in this <u>Section 7.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Matters Involving Third Parties </u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;If any third party notifies any Party (the &#8220;<u>Indemnified Party</u>&#8221;) with respect to any matter (a &#8220;<u>Third-Party Claim</u>&#8221;) that gives rise to a claim for indemnification against another Party (the &#8220;<u>Indemnifying Party</u>&#8221;) under this <u>Article VII</u>, then the Indemnified Party shall promptly (and in any event within 15 Business Days after receiving notice of the Third-Party Claim) notify the Indemnifying Party thereof in writing (a &#8220;<u>Notice</u>&#8221;); <i>provided</i>, <i>however</i>, that failure to give such Notice shall not limit the right of an Indemnified Party to recover indemnity or reimbursement from any Indemnifying Party except to the extent that such Indemnifying Party suffers any material prejudice or material harm with respect to such claim as a result of such failure except and to the extent that the Indemnifying Party can demonstrate actual material loss or actual material prejudice (and in any event, solely to the extent of such loss or prejudice) as a result of such failure. For the avoidance of doubt, this <u>Section 7.5</u> shall not apply with respect to any Tax Contests, which shall be governed solely by <u>Section 6.8(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the case of any Third-Party Claims for which indemnification is sought, the Indemnifying Party shall be entitled at its cost and expense to (i)&nbsp;conduct and control any proceedings or negotiations with such third party, (ii) perform and control or direct the performance of any required activities, (iii)&nbsp;take all other steps to settle or defend any such claim (<i>provided</i> that the Indemnifying Party shall not settle any such claim without the consent of the Indemnified Party (which consent shall not be unreasonably withheld, conditioned or delayed) unless the settlement includes a complete release of the Indemnified Party with respect to the claim and no additional obligation, restriction or Losses shall be imposed on the Indemnified Party other than solely the payment of money damages for which the Indemnified Party will be indemnified hereunder) and (iv)&nbsp;employ counsel to contest any such claim or liability; <i>provided</i>, that the Indemnifying Party shall not have the right to assume control of such defense, if the claim for which the Indemnifying Party&nbsp;seeks to assume control: (w) seeks non&#8209;monetary relief (except where non&#8209;monetary relief is merely incidental to a primary claim or claims for monetary damages), (x)&nbsp;involves criminal allegations, (y) is one in which the Indemnifying Party is also a Party and for which joint representation would, in the reasonable opinion of the Indemnified Party&#8217;s or Indemnifying Party&#8217;s respective counsel, be inappropriate or, in the reasonable opinion of the Indemnified Party&#8217;s or Indemnifying Party&#8217;s respective counsel, there may be legal defenses available to the Indemnified Party that are materially different from or materially additional to those available to the Indemnifying Party or (z) involves a claim for which, upon petition by the Indemnified Party, the appropriate court rules that the Indemnifying Party failed or is failing to vigorously prosecute or defend. The Indemnifying Party shall, within 30&nbsp;days after delivery of the Notice to Indemnifying Party (or sooner, if the nature of the Third-Party Claim so requires) (the &#8220;<u>Dispute Period</u>&#8221;), notify the Indemnified Party of its intention as to the conduct and control of the defense of such claim, <i>provided</i> that the Indemnified Party and its counsel shall cooperate with the Indemnifying Party and its counsel. Until the Indemnified Party has received notice of the Indemnifying Party&#8217;s election whether to defend any claim, the Indemnified Party shall take commercially reasonable steps to defend (but may not settle) such claim. If the Indemnifying Party shall decline to assume the defense of any such claim, or the Indemnifying Party shall fail to notify the Indemnified Party within the Dispute Period of the Indemnifying Party&#8217;s election to defend such claim, the Indemnified Party shall defend against such claim (<i>provided</i> that the Indemnified Party shall not settle such claim without the consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed)) and the Indemnifying Party will remain responsible for any Losses the Indemnified Party may suffer as a result of such Third-Party Claim to the extent subject to indemnification under this <u>Article VII</u>.<b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="48" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Direct Claims </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Any indemnification claim by an Indemnified Party which does not result from a Third Party Claim shall be asserted by the Indemnified Party by giving the Indemnifying Party prompt written notice thereof. Such written notice shall summarize the basis for the indemnification claim based on the information reasonably available at that time to the Indemnified Party. The failure to give written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, unless, and then solely to the extent that, the rights of the Parties from whom indemnity is sought are materially prejudiced as a result of such failure; <i>provided</i>, <i>however</i>, that no such notice shall have any effect or be valid if it is given following the end of any applicable survival period provided for in <u>Section 7.2</u>. The Indemnifying Party shall have 30 days after its receipt of such notice to respond in writing to such claim. If the Indemnifying Party does not so respond within such 30 day period, the Indemnifying Party shall be deemed to have accepted such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of this Agreement and the Indemnifying Party shall promptly pay any amounts owed in accordance with the terms of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Limitations and Qualifications </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Right to Recover</u>. The Indemnified Parties shall attempt in good faith to promptly seek to recover or make a claim for insurance proceeds as a result of any matter giving rise to an indemnification claim of the Indemnified Parties against the Indemnifying Party, to the extent available therefor. The failure to promptly seek to recover or make a claim for insurance proceeds shall not, however, relieve the Indemnifying Party of its indemnification obligations, unless, and then solely to the extent that, the rights of the Parties from whom indemnity is sought are materially prejudiced or materially harmed as a result of such failure. In addition, the Indemnifying Party shall, to the extent of any indemnification payment made by it and to the extent consistent with any related indemnification agreement, insurance policy, or applicable Law, be subrogated to all rights of the Indemnified Party against any third party in respect of the claim (or portion of such claim) to which the indemnification payment relates. If the Indemnified Party actually receives any insurance proceeds as a result of the matter giving rise to any indemnification claim of the Indemnified Party, the Indemnifying Party&#8217;s indemnification obligation with respect to such claim shall be reduced by the amount of any such insurance proceeds (net of any expenses incurred in collection thereof) actually received by the Indemnified Party. If the Indemnified Party actually receives any insurance proceeds with respect to any Loss after the Indemnifying Party has provided indemnification for such Loss to the Indemnified Party, then the Indemnified Party shall promptly turn over any such insurance proceeds (net of any expenses incurred in collection thereof) to the Indemnifying Party with respect to such Loss.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="49" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Exclusive Remedies</u>. Subject to (and without limiting the effects of) the terms of <u>Section 8.12</u>, from and after Closing, except with respect to matters covered by <u>Section 2.6</u>, the remedies provided in this <u>Article VII</u> shall constitute the sole and exclusive remedies available to any Party hereto with respect to any claim relating to this Agreement or the transactions contemplated hereby and the facts and circumstances relating and pertaining hereto (whether any such claim shall be made in contract, breach of warranty, tort or otherwise), other than for common law fraud.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Duration of Claim</u>. The indemnification obligations of the Indemnifying Party pursuant to this Agreement with respect to a specific claim for which indemnification is provided under this Agreement shall extend beyond the time period for indemnification set forth herein with respect to such specific claim until it has been fully discharged or resolved or settled so long as a written notice prepared in good faith with reasonable specificity (to the extent known at such time) shall have been given to the Indemnifying Party on or prior to the end of such time period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Calculating Losses</u>. For the purpose of determining the amount of Losses arising from a breach of or inaccuracy in any representation or warranty of the Company or the Sellers, any limitation or qualification as to materiality (or a similar concept) set forth in such representation or warranty shall be disregarded, but for certainty, shall not be disregarded for the purposes of determining whether a breach of any representation or warranty of the Company or the Sellers has occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Limitations</u>. No Party will have any liability to any other Party under this <u>Article VII to the extent</u>:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp; &nbsp; &nbsp; of any related and reasonably determinable Tax benefit available to the Indemnified Party (or, in the case of the Buyer, the Company) as a result of the matters giving rise to the Losses as determined by the Indemnifying Party&#8217;s external accountants, acting reasonably;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp; &nbsp; &nbsp;that any Losses could reasonably have been minimized or avoided had the Indemnified Party exercised reasonable diligence and ordinary care in attempting to minimize or avoid aggravating such Losses;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a reserve or provision for the individual fact, matter or circumstance was made in the Financial Statements, in which case the Indemnified Party will be entitled, subject to the provisions of this Agreement, only to make a claim in respect of such item for the amount which exceed such reserve or provision;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Losses have been accrued as a Current Liability (or netted against a Current Asset) and included in the determination of Working Capital; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp; &nbsp; &nbsp;such liability arises or the amount thereof is increased as a result of a change after the Closing Date in the accounting policies or practices of the Indemnified Party (or, in the case of the Buyer, the Company) or a change in the Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="50" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">50</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Mitigation</u>. Each Party will use commercially reasonable efforts to mitigate any Losses for which an Indemnifying Party is required to indemnify the Indemnified Party hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duplication</u>. Any liability for indemnification hereunder shall be determined without duplication of recovery by reason of the state of facts giving rise to such liability constituting a breach of more than one representation, warranty, covenant or agreement. In this regard, there shall be no duplication of recovery under <u>Article III</u> and/or <u>Article IV</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Set-off</u>. An Indemnified Party will not be entitled to set off the amount of any Losses subject to indemnification under this Agreement against any other amounts payable to an Indemnifying Party, whether under this Agreement or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Recourse to Indemnification Escrow</u>. The indemnification obligations of the Sellers pursuant to this <u>Article VII</u> will be satisfied first by the Buyer claiming against the Indemnification Escrow Fund in accordance with the Escrow Agreement and then, to the extent obligations remain after the Indemnification Escrow Fund has been exhausted, the Buyer may, subject to and in accordance with the provisions of this <u>Article VII</u>, recover its Losses directly from the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;<u>Release of Indemnification Escrow Fund</u>. Within five (5) Business Days after the 1<sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup> anniversary of the Closing Date, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to release to the Sellers&#8217; legal counsel, in trust for the Sellers, an amount equal to the Indemnification Escrow Amount then available and not subject to any prior indemnification claim by the Buyer Indemnified Parties under this <u>Article VII</u> up to an amount equal to 50% of the Indemnification Escrow Amount. Within five (5) Business Days after the date that is 16 months after the Closing Date, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to release to the Sellers&#8217; legal counsel, in trust for the Sellers, an amount equal to (A) the balance of the Indemnification Escrow Fund minus (B) the amount, if any, of any unresolved indemnification claims pending under this <u>Article VII</u>. Upon the resolution of all such unresolved claims referred to in the foregoing clause (B), the Buyer and the Sellers&#8217; Representative shall, within five (5) Business Days following the determination of the amount to be distributed to the Buyer and/or the Sellers in accordance with the resolution of such claims, execute and deliver to the Escrow Agent a joint written instruction directing the Escrow Agent to release the balance of the Indemnification Escrow Fund to the Buyer or the Sellers&#8217; legal counsel, in trust for the Sellers, as the case may be.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Subrogation</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Following the Closing, the Sellers shall not have any right of subrogation against the Company in connection with any of the representations or warranties made by the Company in <u>Article III</u> or in connection with any covenants made by the Company in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Treatment of Indemnification Payments </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">All indemnification payments made under this Agreement shall be treated by the Parties as an adjustment to the Purchase Price for Tax purposes, unless otherwise required by Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="51" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VIII</u></b><b><u>&nbsp;- MISCELLANEOUS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Agreement together with the Transaction Documents constitutes the full and entire understanding and agreement among the Parties hereto with respect to the subject matters hereof and thereof and any and all other written or oral agreements existing prior to are expressly superseded and canceled. Without limiting the generality of the foregoing, the Parties make no representations or warranties of any kind or nature, express or implied, at law or in equity, except as expressly set forth in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>No Third-Party Beneficiaries</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Other than the Indemnified Parties, this Agreement is not intended to, and shall not, confer any rights or remedies upon any Person other than the Parties and their respective successors and permitted assigns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments, Waivers, Consents and Assignability</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Agreement and all agreements, documents and instruments executed pursuant hereto, except as otherwise specifically set forth herein or therein, no course of dealing between the Company or the Sellers on the one hand, and the Buyer on the other, and no delay on the part of any Party hereto in exercising any rights hereunder or thereunder shall operate as a waiver of the rights hereof and thereof. Any term or provision hereof may be amended, terminated or waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the Buyer and the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer may assign its rights to an Affiliate without obtaining the consent of the Sellers, but no such assignment will relieve the Buyer of its obligations under this Agreement. This Agreement may not otherwise be assigned by any Party without the prior written consent of each other Party. This Agreement shall be binding upon and enforceable by, and shall inure to the benefit of, the Parties hereto and their respective successors, heirs, executors, administrators and permitted assigns, and no others. Notwithstanding the foregoing and except as otherwise expressly provided, nothing in this Agreement is intended to give any Person not named herein the benefit of any legal or equitable right, remedy or claim under this Agreement, except as expressly provided herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices and Demands</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Any notice or other communication required or permitted to be given to any Person hereunder shall be in writing and shall be given to such Person at such Person&#8217;s address set forth below, or such other address as such Person may hereafter specify by notice in writing to the other Persons. Any such notice or other communication shall be addressed as aforesaid and given by: (i)&nbsp;certified mail (registered mail), with first class postage prepaid and return receipt requested, (ii)&nbsp;hand delivery, or (iii)&nbsp;reputable overnight express courier. Any notice or other communication will be deemed to have been duly given immediately when actually delivered or upon refusal of delivery:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Sellers&#8217;&nbsp;Representative:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark Kroeker</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="52" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">52</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:33.7%;">With a copy (which shall not constitute notice) to:</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mogan Daniels Slager LLP</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Suite 1700<br>
			1185 West Georgia Street<br>
			Vancouver, British Columbia<br>
			Canada V6E 4E6</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Company or the Buyer:</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1336889 B.C. Unlimited Liability Company</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c/o Ultralife Corporation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2000 Technology Parkway</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Newark, New York 14513</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">With a copy (which shall not constitute notice) to:</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Lippes Mathias LLP<br>
			50 Fountain Plaza, Suite 1700</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Buffalo, New York 14202</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable Law. If any portion of this Agreement is declared invalid for any reason in any jurisdiction, such declaration shall have no effect upon the remaining portions of this Agreement which shall continue in full force and effect as if this Agreement had been executed with the invalid portions thereof deleted; <i>provided</i>, <i>however</i>, if such severability will negate in any material respect the monetary terms of this Agreement, then the Parties shall negotiate in good faith to amend the invalid terms in a manner so that such terms shall not be invalid and will not modify in any material respect the monetary terms of this Agreement unless otherwise agreed to by the Parties. Furthermore, the entirety of this Agreement shall continue in full force and effect in all other jurisdictions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Agreement may be executed in counterparts (including by DocuSign, facsimile or other means of electronic transmission, such as by electronic mail in &#8220;.pdf&#8221; form), all of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by DocuSign, facsimile transmission or other electronic transmission shall be as effective as delivery of a manually executed counterpart of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="53" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">53</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings; Interpretation</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. For purposes of this Agreement: (a) the words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; will be deemed to be followed by the words &#8220;without limitation&#8221;; and (b) the words &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereby,&#8221; &#8220;hereto&#8221; and &#8220;hereunder&#8221; refer to this Agreement as a whole. Unless the context otherwise requires, references in this Agreement: (x) to Articles, Sections, Disclosure Schedule and Exhibits mean the Articles and Sections of, and Disclosure Schedule and Exhibits attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (z) to a statute means such statute as amended, re-enacted, consolidated or replaced from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. Notwithstanding the foregoing, any representation or warranty made with respect to compliance with a statute shall mean such statute as in effect as of the date such representation or warranty is made. This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting an instrument or causing any instrument to be drafted. The Disclosure Schedule and Exhibits referred to in this Agreement will be construed with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim in this Agreement. The words &#8220;dollar&#8221; or &#8220;$&#8221; shall mean, unless otherwise specified, United States dollars. For purposes of calculating any amounts denominated in Canadian dollars, unless otherwise specified, such amounts shall be converted into US dollars based on the Bank of Canada daily exchange rate on the relevant date, or if the calculation is being made on such relevant date, the Bank of Canada daily exchange rate on the date that is one<b> </b>(1) Business Day prior to the relevant date. For the purposes of calculating the Canadian dollar equivalent of the US dollar amounts set out in <u>Sections 3.11, 3.13 and 3.22</u>, such amounts shall be converted into Canadian dollars based on the Bank of Canada daily exchange rate on November 15, 2021.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Exhibits and Schedules</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Exhibits and Schedules to this Agreement are incorporated herein by reference and made a part of this Agreement. The Disclosure Schedule is arranged in sections and paragraphs corresponding to the numbered and lettered sections and paragraphs of <u>Article III</u> and <u>Article IV</u> , as applicable. The disclosure in any section or paragraph of the Disclosure Schedule qualifies other sections and paragraphs in this Agreement to the extent it is reasonably apparent from the face and terms of such disclosure that such disclosure is applicable to such other sections and paragraphs. The Disclosure Schedule shall not be construed as indicating that any matter disclosed therein is required to be disclosed or that such information is material with respect to the Sellers or the Company, as applicable. No reference in the Disclosure Schedule to any agreement or document shall be construed as an admission to any third party that such agreement or document is enforceable or currently in effect or that there are any obligations remaining to be performed or any rights that may be exercised under such agreement or document. No disclosure in the Disclosure Schedule relating to any possible breach or violation of any agreement or Law shall be construed as an admission to any third party that any such breach or violation exists or has already occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law; Venue</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Agreement shall be governed by and construed in accordance with the Laws of the Province of British Columbia without giving effect to any Law that would cause the application of the Laws of any jurisdiction other than the Province of British Columbia. Any action or proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement, except as provided in <u>Section 8.12</u>, must be brought in the courts of the Province of British Columbia.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="54" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">54</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Consent to Jurisdiction</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">THIS SECTION SHALL APPLY EXCEPT WITH RESPECT TO WHICH A PARTY OTHERWISE SEEKS EQUITABLE REMEDIES PURSUANT TO <u>SECTION 8.12</u> (SPECIFIC PERFORMANCE). EACH OF THE PARTIES IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COURTS LOCATED IN THE PROVINCE OF BRITISH COLUMBIA FOR THE PURPOSES OF ANY SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES FURTHER AGREES THAT SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY REGISTERED MAIL TO SUCH PARTY&#8217;S RESPECTIVE ADDRESS SET FORTH ABOVE SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING IN THE PROVINCE OF BRITISH COLUMBIA WITH RESPECT TO ANY MATTERS TO WHICH IT HAS SUBMITTED TO JURISDICTION IN THIS <u>SECTION 8.10</u>. EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY IN THE PROVINCIAL AND FEDERAL COURTS LOCATED IN THE PROVINCE OF BRITISH COLUMBIA AND HEREBY AND THEREBY FURTHER IRREVOCABLY AND UNCONDITIONALLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION, SUIT OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.11<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Incorporation by Reference</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Disclosure Schedule and other schedules and exhibits hereto constitute integral parts of this Agreement and are hereby incorporated by reference herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.12<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Performance</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Parties agree that irreparable damage may occur and that the Parties hereto would not have any adequate remedy at law in the event of any breach or threatened breach of any covenant, obligation or other provision of this Agreement. It is accordingly agreed that the Parties hereto may be entitled to seek (a) a decree or order of specific performance to enforce the observance and performance of such covenant, obligation or other provision, and (b) an injunction restraining such breach or threatened breach, without proof of actual damages (and each Party hereto hereby waives any requirement for the securing or posting of any bond or other security in connection therewith), such remedies being in addition to any other remedy to which the Parties hereto are entitled at law or in equity and that notwithstanding <u>Section 8.9</u>, such remedies sought in accordance with this <u>Section 8.12</u> may be sought in a court of competent jurisdiction within the United States or Canada..</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.13<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>WAIVER OF JURY TRIAL</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">EACH PARTY HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER RELATED DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <u>SECTION 8.13</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="55" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">55</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.14<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Sellers</u></b><u>&#8217;</u><b><u> Representative</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Mark Kroeker (the &#8220;<u>Sellers</u><u>&#8217;</u><u> Representative</u>&#8221;) is hereby irrevocably constituted and appointed as the attorney-in-fact and agent for each Seller in his, her or its name, place and stead to act on behalf of such Seller in connection with this Agreement and any Transaction Documents and the consummation of the Transactions contemplated hereby or thereby, with such power and authority to execute any and all instruments or other documents, and to do any and all other acts or things (or refrain from doing), in the name and on behalf of each such Seller that Sellers&#8217; Representative may deem necessary, appropriate, helpful or advisable, or that may be required of or permitted by such Seller pursuant to this Agreement or any Transaction Documents or in connection with the consummation of the Transactions contemplated hereby or thereby, provided that, for certainty, such appointment shall not extend to acting for any Seller with respect to matters of employment or matters relating thereto. Without limiting the generality of the foregoing, Sellers&#8217; Representative, acting in his capacity as such, shall have the full power and authority, in the name and on behalf of each Seller, (i) to agree with Buyer or the Company with respect to any matter or thing required or deemed necessary by Sellers&#8217; Representative in connection with the provisions of this Agreement or any Transaction Documents calling for the agreement of the Sellers, (ii) to agree to amend, modify or terminate this Agreement or any Transaction Document, (iii) to give and receive notices on behalf of the Sellers, (iv) to act on behalf of the Sellers in connection with any matter as to which the Sellers are or may be obligated to indemnify Buyer under this Agreement, (v) to interpret the terms and provisions of this Agreement or any Transaction Document, (vi) to dispute or decline to dispute any liability claim hereunder and to negotiate and compromise any dispute that may arise under this Agreement and to sign any releases or other documents with respect to any such dispute, (vii) to negotiate, execute and deliver any Transaction Document, certificate, statement, notice, approval, extension, waiver, amendment or other document required or permitted to be delivered, made or given in connection with the consummation of the Transactions contemplated by this Agreement, (viii) to take all action necessary or desirable in connection with the waiver of any condition to the obligations of the Sellers to consummate the Transactions contemplated by this Agreement and (ix) to do all other things and perform all other acts, including executing and delivering all agreements, certificates, receipts, consents, elections, instructions and other instruments or documents contemplated by, or deemed by Sellers&#8217; Representative to be necessary, appropriate, helpful or advisable in connection with, this Agreement or any Transaction Document. By his or its execution of this Agreement, each Seller hereby acknowledges that Sellers&#8217; Representative has full authority to act on his, her or its behalf and to bind him, her or it as and to the fullest extent provided in this <u>Section 8.14</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except in cases of fraud or willful misconduct, Sellers&#8217; Representative will have no liability to Buyer, the Company or any Seller or their respective successors or assigns with respect to actions taken or omitted to be taken in good faith in his capacity as Sellers&#8217; Representative and shall be entitled to indemnification and reimbursement from the Sellers against any loss, liability, fees or expenses arising out of actions taken or omitted to be taken in good faith in his capacity as Sellers&#8217; Representative. Buyer will have no liability to any Seller or their respective successors or assigns with respect to any matters provided for in this <u>Section 8.14</u>, including in respect of any actions taken or omitted to be taken by Sellers&#8217; Representative or any claims between the Sellers in connection therewith, and shall be entitled to indemnification and reimbursement from the Sellers against any loss, liability, fees or expenses arising therefrom.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers&#8217; Representative will be entitled to rely, and will be fully protected in relying, upon any statements furnished to them by any Seller or the Buyer, or any other evidence deemed by the Sellers&#8217; Representative to be reliable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="56" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">56</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Any approval, consent, election, notice, decision, agreement, waiver, delivery, interpretation, amendment or other action of the Sellers required or permitted under, or otherwise provided for in, this Agreement or any Transaction Document (each, a &#8220;<u>Seller Action</u>&#8221;) shall be conclusively deemed given, made or taken (as the case may be) if given, made or taken by Sellers&#8217; Representative in his capacity as such for the Sellers and shall be binding upon each Seller as if expressly ratified and confirmed in writing by such Seller and Buyer shall be entitled to conclusively and absolutely rely, without inquiry, on any Seller Action given, made or taken by Sellers&#8217; Representative in his capacity as such for all such purposes. All Seller Actions by Sellers&#8217; Representative in his capacity as such shall be conclusive and binding upon all Sellers and no Seller shall have any cause of action against Buyer or Sellers&#8217; Representative for any action taken or not taken by Seller Representative in his capacity as such.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The power of attorney created under this Agreement is coupled with an interest and shall be binding and enforceable on and against the heirs, personal representatives, successors and assigns of each of the Sellers, and such power of attorney shall not be revoked or terminated by the death, disability, bankruptcy, incompetency, dissolution or termination of any Seller or any heir, personal representative, successor or assign thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;In the event that Sellers&#8217; Representative resigns or otherwise becomes unable to serve as Sellers&#8217; Representative, all references herein or in any Transaction Document to Sellers&#8217; Representative shall be deemed to refer to each Seller unless and until another Person is appointed by the Sellers to be Sellers&#8217; Representative.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers&#8217; Representative will not have any duties or responsibilities except those set forth in this Agreement and no implied covenants, functions, responsibilities, duties, obligations or liabilities will be read into this Agreement or otherwise exist against the Sellers&#8217; Representative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Signature pages follow)</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="57" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">57</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>IN WITNESS WHEREOF</b>, the undersigned have executed this Share Purchase Agreement as of the day and year first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>COMPANY:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>EXCELL BATTERY CANADA INC.</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Ian Kane</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Ian Kane</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: Chief Executive Officer</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;text-indent:-36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>BUYER:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>1336889 B.C. UNLIMITED LIABILITY COMPANY</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: President</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;"><b>SELLERS:</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Mark Kroeker</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>MARK KROEKER</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Randolph Peters</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>RANDOLPH PETERS</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Brian Larsen</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>BRIAN LARSEN</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Karen Kroeker</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>KAREN KROEKER</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Heather Peterson</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>HEATHER PETERSON</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Michael Kroeker&nbsp;&nbsp;&nbsp;&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>MICHAEL KROEKER</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Nicholas Kroeker</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>NICHOLAS KROEKER</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Brentley Peters&nbsp;&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>BRENTLEY PETERS</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Craig Peters</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>CRAIG PETERS</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Kurtis Peters&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>KURTIS PETERS</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Heather Larsen&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>HEATHER LARSEN</b></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>/s/ Ian Kane&nbsp;</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td><b>IAN KANE</b></td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p>&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="margin-left: 9pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"><br>
&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0px; width: 100%; font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt;">

		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="border-bottom: 1px solid black;" valign="top" width="38%">/s/ Carol Peters&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" valign="top" width="38%"><b>CAROL PETERS</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" valign="top" width="38%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin-top: 0; margin-bottom: 0;"><b>M. &amp;. W. HOLDINGS LTD.</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>William Fast&nbsp;&nbsp;&nbsp;</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: William Fast</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">Title: Director</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" valign="top" width="3%"><b>0835205 B.C. LTD.</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">By:</td>
			<td style="border-bottom: 1px solid black;" valign="top" width="35%">/s/ Brian Larsen</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">Name: Brian Larsen</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">Title: Director</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="35%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" rowspan="1" valign="top" width="3%"><b>SELLERS</b>&#8217;<b> REPRESENTATIVE:</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" valign="top" width="3%">&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" style="border-bottom: 1px solid black;" valign="top" width="3%">/s/ Mark Kroeker&nbsp;</td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>
		<tr>
			<td valign="top" width="50%">&nbsp;</td>
			<td colspan="2" valign="top" width="3%"><b>MARK KROEKER</b></td>
			<td valign="top" width="12%">&nbsp;</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;text-indent:-36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><i>Omitted Exhibits and Schedules Disclosure List</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The following list briefly identifies the contents of the Exhibits and Schedules to the foregoing Share Purchase Agreement which have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The Registrant agrees to furnish to the Securities and Exchange Commission, to supplement and upon request, a copy of any of the following omitted Exhibits and Schedules.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms by the foregoing Share Purchase Agreement.</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>1.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 2.1 </i>&#8211;<i> Contains the allocation of the Purchase Price among the Sellers.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>2.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.2 </i>&#8211;<i> Contains five contracts to which the Company is a party that will result in a default of the Company</i>&#8217;<i>s obligations thereunder due to the Transaction.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>3.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.3 </i>&#8211;<i> Contains the capitalization of the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>4.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.5(a) </i>&#8211;<i> Contains consolidated financial statements of the Company as of January 31st of the years 2019, 2020 and 2021 and October 31, 2021.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>5.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.5(c) </i>&#8211;<i> Contains a statement that the Company has no accounts receivable or loans receivable from Affiliated Persons.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>6.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.7 </i>&#8211;<i> Contains a statement that the Company has no Indebtedness outstanding.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>7.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.8 </i>&#8211;<i> Contains a statement regarding the acceleration of certain vesting options and accrual of certain liabilities.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>8.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.9 </i>&#8211;<i> Contains a statement that there is no pending and threatened Legal Proceeding against the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>9.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.10(f) </i>&#8211;<i> Contains a statement that there are no tax liens against the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>10.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.10(i) </i>&#8211;<i> Contains a statement describing prior joint venture and partnership arrangements.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>11.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.11 </i>&#8211;<i> Contains a list of all personal property of the Company necessary for its operations with a value of at least Fifty Thousand Dollars ($50,000).</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>12.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.12 </i>&#8211;<i> Contains a list of all Company Intellectual Property.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>13.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.13 </i>&#8211;<i> Contains a list of: (i) any contract, lease or agreement involving a potential commitment or payment by the Company in excess of $50,000 annually; (ii) any contract containing covenants directly or explicitly limiting in any material respect the freedom of the Company to compete in any line of business or with any Person (other than confidentiality agreements containing non-competition or non-solicitation covenants on the part of the Company that were entered into by the Company in the ordinary course of business); (iii) any indenture, mortgage, promissory note, loan agreement, guaranty or other agreement or commitment for borrowing or any pledge or security arrangement; (iv) any employment, consulting or other service agreements with present or former officers, directors, employees, consultants, shareholders of the Company or any other service provider of the Company that includes any change of control payments severance, termination, or retention obligations or similar accounts payable by the Company or its Affiliates in connection with the transactions contemplated by this Agreement; (v) any redemption or purchase agreements or other agreements affecting or relating to the shares of the Company, including, without limitation, any agreement with any shareholder of the Company which includes anti-dilution rights, registration rights, voting arrangements, operating covenants or similar provision; (vi) any collective bargaining agreement, (vii) any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any contract or agreement involving fixed price or fixed volume arrangements; (viii) any joint venture, franchise, partnership, manufacturer, development or agreement; (ix) any supply agreement pursuant to which the Company is required to supply materials in excess of $50,000 annually; (x) any acquisition, merger or similar agreement; (xi) any contract with any Governmental Authority; (xii) any contract providing for indemnification of any Person by the Company (excluding confidentiality agreements, customer and vendor contracts and purchase orders including indemnification provisions entered into in the ordinary course of business); (xiii) any material contract that can be terminated, or the provisions of which are altered, as a result of the consummation of the transactions contemplated by this Agreement or any of the other Transaction Documents to which the Company is a party; (xiv) any contract entered into in connection with any settlement or other resolution of any action pursuant to which the Company has any ongoing payment obligation after the Closing; and (xv) any other material contract not executed in the ordinary course of business.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>14.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.14(a) </i>&#8211;<i> Contains a statement that there are government approvals required by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>15.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.15 </i>&#8211;<i> Contains a list of all insurance policies of the Company currently in effect.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>16.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.16 </i>&#8211;<i> Contains a list of all Employee Benefit Plans.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>17.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.17 </i>&#8211;<i> Contains a list of all employees of the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>18.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.19 </i>&#8211;<i> Contains a list of any Affiliate of the Company that is currently a party to a contract with the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>19.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(b) </i>&#8211;<i> Contains a statement that no Environmental Permits are necessary in connection with the Company</i>&#8217;<i>s ownership and operation of its business.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>20.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(d) </i>&#8211;<i> Contains a statement that no Hazardous Materials have been Released.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>21.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(e) </i>&#8211;<i> Contains a list of all off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>22.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.22(a) </i>&#8211;<i> Contains a list of top ten (10) customers from whom the Company makes annual revenue exceeding Fifty Thousand Dollars ($50,000) for the calendar year ended January 31, 2021 or reasonably expected to exceed such amount for the fiscal year ended January 31, 2022.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>23.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.22(a) </i>&#8211;<i> Contains a list of top ten (10) suppliers from whom the Company makes annual purchases exceeding Fifty Thousand Dollars ($50,000) for the calendar year ended January 31, 2021 or reasonably expected to exceed such amount for the fiscal year ended January 31, 2022.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>24.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.23(a) </i>&#8211;<i> Contains a list of Assets used by the Company, but not owned by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>25.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.23(b) </i>&#8211;<i> Contains a statement that all Inventory of the Company is in good, usable and /or salable condition.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>26.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.26 </i>&#8211;<i> Contains a list of all governmental programs the Company has availed itself of related to COVID-19.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>27.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 4.1 </i>&#8211;<i> Contains a statement regarding each Seller</i>&#8217;<i>s full right, authority and power to enter into this Share Purchase Agreement.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">28.<i>&nbsp;&nbsp;&nbsp;&nbsp;Exhibit A </i>&#8211;<i> Contains the calculation of estimated Working Capital used in the determination of the Closing Net Purchase Price.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.2
<SEQUENCE>3
<FILENAME>ex_316643.htm
<DESCRIPTION>EXHIBIT 2.2
<TEXT>
<html><head>
	<title>ex_316643.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 8:00:00 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SHARE PURCHASE AGREEMENT</b><br>
<br>
<b>By and Among</b><br>
<br>
<b>1336902 B.C. UNLIMITED LIABILITY COMPANY,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Buyer</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>M. &amp; W. HOLDINGS LTD.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>SANFORD CAPITAL LTD.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>IAN KANE,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>ARCEE ENTERPRISES INC.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>0835205 B.C. LTD.,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Sellers </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>MARK KROEKER,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Sellers</b>&#8217;<b> Representative</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>And</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>656700 B.C. LTD,</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>as the Company</b></p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="margin: 0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>Dated December 13, 2021</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TABLE OF CONTENTS</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">TABLE OF CONTENTS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">ii</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SHARE PURCHASE AGREEMENT</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article </font>I - DEFINED TERMS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">1.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Defined Terms Used in this Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">1</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article </font>II - PURCHASE AND SALE OF SHARES</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Purchase and Sale of the Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Payments at the Closing</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">11</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing Deliveries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">12</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Closing Net Purchase Price</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Post-Closing Adjustment</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">14</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">2.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Withholding</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article</font> III - REPRESENTATIONS AND WARRANTIES OF<font style="text-transform:uppercase;"> the</font> COMPANY</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Company Power</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">16</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subsidiaries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">17</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial Statements</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Undisclosed Liabilities</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">18</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indebtedness</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">19</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.8</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Developments</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">19</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.9</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">21</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.10</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">21</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.11</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Properties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">25</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.12</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">26</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.13</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Contracts and Arrangements</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">27</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.14</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governmental Approvals; Compliance with Laws</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">29</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.15</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance Coverage</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">29</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.16</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Benefits; ERISA</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">30</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.17</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labour and Employment Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">31</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.18</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Brokers or Finders</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.19</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transactions with Affiliates</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.20</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">33</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.21</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Company Records</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">34</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.22</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Customers and Suppliers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.23</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assets; Solvency</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">35</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.24</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.25</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competition Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">3.26</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COVID-19 Compliance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">36</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article </font>IV - REPRESENTATIONS AND WARRANTIES OF THE<font style="text-transform:uppercase;"> SellerS</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">4.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">4.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">37</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">4.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Legal Proceedings</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">4.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Banking; Brokerage Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">4.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Residency</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article </font>V - REPRESENTATIONS AND WARRANTIES <font style="text-transform:uppercase;">OF the Buyer</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Organization and Power</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">38</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consents and Approvals</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Competition Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transferred Information</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">5.8</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Banking; Brokerage Fees</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">39</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VI </font>- ADDITIONAL AGREEMENTS</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Announcement; Confidentiality</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Non-Competition and Non-Solicitation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">40</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Preservation of Books and Records</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Investment Canada Act Notification.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Privileged Communications</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transferred Information.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">42</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Excluded Accounts Receivable.</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">43</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.8</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Matters</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">43</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.9</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Further Assurances</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">47</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">6.10</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">D&amp;O Policy; Indemnification of Directors and Officers</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" style="vertical-align: middle; width: 15%;">&nbsp;</td>
			<td style="vertical-align: middle; width: 5%;">&nbsp;</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VII</font> - INDEMNIFICATION</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Representations, Warranties and Covenants</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">48</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Survival Period</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnification Provisions for Buyer&#8217;s Benefit</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">49</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indemnification Provisions for the Seller&#8217;s Benefit; Limitations</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">50</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Matters Involving Third Parties</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Direct Claims</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">51</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Further Limitations and Qualifications</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">52</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.8</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Subrogation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">7.9</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tax Treatment of Indemnification Payments</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">ii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr style="background-color: rgb(204, 238, 255);">
			<td colspan="2" rowspan="1" style="vertical-align: middle; width: 15%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="text-transform:uppercase;">Article VIII - MISCELLANEOUS</font></p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.1</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Entire Agreement</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.2</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">No Third-Party Beneficiaries</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.3</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amendments, Waivers, Consents and Assignability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">54</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.4</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Notices and Demands</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">55</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.5</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Severability</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.6</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Counterparts</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.7</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Headings; Interpretation</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.8</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exhibits and Schedules</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">56</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.9</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governing Law; Venue</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.10</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Consent to Jurisdiction</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.11</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Incorporation by Reference</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.12</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Specific Performance</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">57</p>
			</td>
		</tr>
		<tr style="background-color: rgb(255, 255, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.13</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">WAIVER OF JURY TRIAL</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">58</p>
			</td>
		</tr>
		<tr style="background-color: rgb(204, 238, 255);">
			<td style="vertical-align: middle; width: 15%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt;">8.14</p>
			</td>
			<td style="vertical-align: middle; width: 80%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Sellers&#8217;&nbsp;Representative</p>
			</td>
			<td style="vertical-align: middle; width: 5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;">58</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">iii</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>EXHIBITS AND SCHEDULES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">EXHIBIT A&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Calculation of Closing Net Purchase Price and Working Capital</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>DISCLOSURE SCHEDULES</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 2.1</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Allocation of Purchase Price</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.2</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authorization and Non-Contravention</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.3</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Shares</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.5(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Financial Statements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.5(c)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accounts Receivable or Loans Receivable from Affiliated Persons</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.7</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indebtedness</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.8</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Absence of Certain Developments</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.9</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Litigation</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.10(f)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Liens for Taxes</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.10(i)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Joint Venture, Partnership or Other Arrangements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.11</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Title to Properties</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.12</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Intellectual Property</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.13</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certain Contracts and Arrangements</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.14(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Governmental Approvals; Compliance with Laws</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.15</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Insurance Coverage</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.16</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Employee Matters; ERISA</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.17</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Labour and Employment Matters</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.19</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Transaction with Affiliates</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Environmental Permits</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(d)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Release of Hazardous Substances</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.20(e)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Off-Site Hazardous Materials Facilities or Locations</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.22(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Customers</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.22(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Suppliers</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.23(a)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Assets</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.23(b)</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventory</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 3.26</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">COVID-19 Compliance</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">&nbsp;</td>
			<td style="vertical-align: top; width: 82%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 18%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">SCHEDULE 4.1</p>
			</td>
			<td style="vertical-align: top; width: 82%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Authority and Non-Contravention</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">iv</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;text-indent:9pt;"><b>SHARE PURCHASE AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>THIS SHARE PURCHASE AGREEMENT</b> (this &#8220;<u>Agreement</u>&#8221;) is made as of December 13, 2021, by and among 1336902 B.C. UNLIMITED LIABILITY COMPANY, a British Columbia unlimited liability company (the &#8220;<u>Buyer</u>&#8221;), M. &amp;. W. HOLDINGS LTD. (&#8220;<u>M&amp;W</u>&#8221;), IAN KANE (&#8220;<u>Ian</u>&#8221;), SANFORD CAPITAL LTD. (&#8220;Sanford&#8221;), ARCEE ENTERPRISES INC. (&#8220;Arcee&#8221;) and, 0835205 B.C. LTD. (&#8220;<u>LarsenCo</u>&#8221;, and collectively with M&amp;W, Sanford, Arcee, and Ian, the &#8220;<u>Sellers</u>&#8221;, and each individually a &#8220;<u>Seller</u>&#8221;), MARK KROEKER, in his capacity as the Sellers&#8217; Representative, and 656700 B.C. LTD, a British Columbia corporation (the &#8220;<u>Company</u>&#8221; and, together with the Sellers and the Buyer, the &#8220;<u>Parties</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS, </b>as of the date hereof, the Sellers own 100% of the issued and outstanding shares of the Company (the &#8220;<u>Shares</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>WHEREAS</b>, the Buyer desires to purchase from the Sellers, and the Sellers desire to sell to the Buyer, the Shares, subject to the terms and conditions set forth herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>NOW, THEREFORE</b>, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE I</u></b><b><u>&nbsp;- DEFINED TERMS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Defined Terms Used in this Agreement</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">As used in this Agreement, the following terms have the meanings ascribed thereto below:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>656 Historical Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5(a)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Accounting Principles</u>&#8221; means ASPE, consistently applied using the same accounting principles, practices, procedures, policies, assumptions and methods (with consistent classifications, judgments, inclusions, exclusions and valuation and estimation methodologies) used in the preparation of the Historical Financials.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Adjustment Time</u>&#8221; means the close of business on the day immediately prior to the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Affiliate</u>&#8221; means, with respect to any specified Person, a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common control with, the Person specified. For purposes of this definition, &#8220;control&#8221; (including the correlative terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and &#8220;under common control with&#8221;) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting equity interest, by contract or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Agreement</u>&#8221; shall have the meaning ascribed in the Preamble.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>ASPE</u>&#8221; means generally accepted accounting principles in Canada from time to time applying the standards prescribed in Part II of the CPA Canada Handbook &#8211; Accounting (Accounting Standards for Private Enterprises).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 36pt;">&#8220;<u>Balance Sheet Date</u>&#8221; shall have the meaning ascribed in <u>Section 3.5</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Basket</u>&#8221; shall have the meaning ascribed in <u>Section 7.3.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Business</u>&#8221; shall have the meaning ascribed in <u>Section 6.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Business Day</u>&#8221; means a day other than Saturday, Sunday or any day on which banks located in Vancouver, British Columbia, Toronto, Ontario, and Rochester, New York are authorized or obligated to close.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Buyer</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Buyer Indemnified Parties</u>&#8221; shall have the meaning ascribed in <u>Section 7.3</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Buyer Post-Closing Prepared Tax Returns</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(a)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Buyer Pre-Closing Prepared Tax Returns</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(a)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Buyer Transaction Expenses</u>&#8221; shall mean the fees, costs and expenses incurred by the Buyer in connection with the transactions contemplated by this Agreement and the other Transaction Documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>CARES Act</u>&#8221; means the Coronavirus Aid, Relief, and Economic Security Act, as amended, and the statutes, rules and regulations promulgated thereunder and any successor to such statutes, rules or regulations.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>CARES Act Programs</u>&#8221; shall have the meaning ascribed in <u>Section 3.26</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>CARES Act Terms</u>&#8221; means all terms and conditions established by any Governmental Authority for the receipt of any funds under any CARES Act Program.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Cash</u>&#8221; shall mean the aggregate amount of the Companies&#8217; cash and cash equivalents <u>plus</u>, without duplication, security deposits and checks, wire transfers, ACH transactions and credit card payments in transit to the Companies as of the measurement date therefor, and <u>minus</u>, without duplication, outstanding checks, wire transfers, ACH transactions and credit card payments in transit by the Companies to the extent there has been a reduction in accounts payable in the calculation of Working Capital on account thereof, as determined in accordance with the Accounting Principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing</u>&#8221; shall have the meaning ascribed in <u>Section 2.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Balance Sheet</u>&#8221; shall have the meaning ascribed in <u>Section 2.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Cash</u>&#8221; shall mean the aggregate amount of Cash held by the Companies, as of the Adjustment Time, determined in accordance with the Accounting Principles.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Date</u>&#8221; shall have the meaning ascribed in <u>Section 2.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Closing Net Purchase Price</u>&#8221; means an amount equal to the Purchase Price <u>minus</u> (i) the Estimated Indebtedness, the Estimated Company Transaction Expenses, the Estimated Working Capital Deficiency (if any) <u>plus</u> (ii) the Estimated Working Capital Surplus (if any) and the Estimated Closing Cash.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Code</u>&#8221; shall mean the U.S. Internal Revenue Code of 1986, as amended.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Companies</u>&#8221; shall have the meaning ascribed in <u>Section 3.1</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company Data</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company Database</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company Intellectual Property</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Company Transaction Expenses</u>&#8221; shall mean all expenses of the Companies incurred prior to the Closing in connection with the transactions contemplated by this Agreement and the other Transaction Documents that have not been paid as of the Closing and are not included or reflected in the calculation of Working Capital, including without limitation (i) all legal fees, accountants and other service providers payable by or on behalf of the Companies and (ii) the amount of stay bonuses, sales bonuses, transaction or similar bonuses, change of control payments, retention payments or other similar payments that are accelerated, accrue or become payable to, or in respect of any current or former employee, individual independent contractor or other service provider, officer or director of the Companies or any other Person, in each case, pursuant to agreements or plans in place prior to the Closing Date in connection with the consummation of the transactions contemplated hereby and payable by the Companies, including, in each case, the employer portion of any employment, payroll, unemployment, withholding Taxes or similar Taxes paid, payable or incurred by the Companies in connection therewith, but for greater certainty, excludes any such amounts that become due and payable after the Closing as a result of actions of the Companies, the Buyer or any such employee, individual independent contractor or other service provider, officer or director of the Companies or other Person after the Closing;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Competitive Business</u>&#8221; shall mean any business that competes with the Business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Confidential Data</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>COVID-19</u>&#8221; means SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) or COVID-19.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>COVID-19 Measures</u>&#8221; means any quarantine, &#8220;shelter in place&#8221;, &#8220;stay at home&#8221;, workforce reduction, social distancing, shut down, closure, sequester or any other Law, Order, directive, guidelines or recommendations by any Governmental Authority in connection with or in response to COVID-19, including the CARES Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>COVID-19 Government Assistance</u>&#8221; shall mean any Tax amounts related to the Canada Emergency Wage Subsidy, the Temporary Wage Subsidy, the Canada Emergency Rent Subsidy, the Canada Recovery Hiring Program and Canada Emergency Business Account Loan, including any interest, penalties, or additions to Tax attributable thereto (or attributable to excessive amounts received thereto).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Current Assets</u>&#8221; means, as of the Adjustment Time, accounts receivable, inventory, income Taxes receivable or recoverable and prepaid expenses, but excluding (a) the portion of any prepaid expense of which the Buyer will not receive the benefit following the Closing, (b) deferred Tax assets, (c) Cash, (d) receivables from any of the Companies&#8217; Affiliates, directors, employees, officers or shareholders and any of their respective Affiliates, and (e) Excluded Accounts Receivables, determined without duplication and in accordance with <u>Exhibit A</u> and the Accounting Principles (provided that, in the event of any conflict or inconsistency between the Accounting Principles and <u>Exhibit A</u>, <u>Exhibit A</u> shall prevail).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Current Liabilities</u>&#8221; means, as of the Adjustment Time, accounts payable, accrued Taxes and accrued expenses, but excluding (a) payables to any of the Companies&#8217; Affiliates, directors, employees, officers or shareholders and any of their respective Affiliates, (b) deferred Tax liabilities, (c) Company Transaction Expenses, and (d) any Indebtedness of the Companies, determined without duplication and in accordance with <u>Exhibit A</u> and the Accounting Principles. (provided that, in the event of any conflict or inconsistency between the Accounting Principles and <u>Exhibit A</u>, <u>Exhibit A</u> shall prevail).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Customers</u>&#8221; shall have the meaning ascribed in <u>Section 3.22(a).</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Disclosure Schedule</u>&#8221; shall have the meaning ascribed in <u>Article III</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Dispute Period</u>&#8221; has the meaning ascribed in <u>Section 7.5(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Employee Benefit Plan</u>&#8221; shall have the meanings ascribed in <u>Section 3.16</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Encumbrances</u>&#8221; shall mean any charge, claim, community property interest, pledge, condition, equitable interest, lien (statutory or other), option, security interest, mortgage, easement, encroachment, right of way, right of first refusal, or restriction of any kind, including any restriction on use, voting, transfer, receipt of income or exercise of any other attribute of ownership.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Claim</u>&#8221; shall mean any legal claim, legal demand or Legal Proceeding arising under Environmental Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Laws</u>&#8221; shall mean any applicable law, including without limitation, federal, provincial and municipal laws, regulations and by-laws and any order or binding agreement with any Governmental Authority: (a) relating to pollution (or the cleanup thereof) or the protection of natural resources, endangered or threatened species, human health and safety, or the environment (including ambient air, soil, surface water or groundwater, or subsurface strata); or (b) concerning the presence of, exposure to, or the management, manufacture, use, containment, storage, recycling, reclamation, reuse, treatment, generation, discharge, Release, transportation, processing, manufacturing, labeling, warning, testing, production, disposal, risk management, control, clean up or remediation of any Hazardous Materials; or (c) any product responsibility, extended producer responsibility or stewardship requirements, in each case, concerning the recycling or disposal of batteries or waste batteries.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Notice</u>&#8221;&nbsp;shall mean any written directive, notice of violation, infraction, investigation, remediation, corrective obligation, complaint, penalty or notice respecting any Environmental Claim relating to actual or alleged non-compliance with any Environmental Laws or any term or condition of any Environmental Permit.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Environmental Permit</u>&#8221;&nbsp;shall mean any Permit, license, sublicense, approval, certification, registration, exemption, variance, permissive use, letter, clearance, consent, waiver, closure, exemption, decision, approval, other authorization of any nature or other action required under or issued, granted, given, authorized by or made pursuant to Environmental Laws.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>ERISA</u>&#8221; shall have the meaning ascribed in <u>Section 3.16.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Escrow Agent</u>&#8221; means Cassels Brock &amp; Blackwell LLP.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Escrow Agreement</u>&#8221; means the escrow agreement by and among the Buyer, the Sellers&#8217; Representative and the Escrow Agent to be entered into as of the Closing Date, in a form acceptable to the parties thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Escrow Amount</u>&#8221; means the Indemnification Escrow Amount <u>plus</u> the Working Capital Escrow Amount.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Estimated Closing Cash</u>&#8221; shall mean the estimated Closing Cash as of the Adjustment Time, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Estimated Company Transaction Expenses</u>&#8221; shall mean the estimated Company Transaction Expenses that are unpaid as of the Closing, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Estimated Indebtedness</u>&#8221; shall mean the estimated Indebtedness of the Companies as of the Adjustment Time, as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Estimated Working Capital Deficiency</u>&#8221; shall mean the estimated Working Capital Deficiency of the Companies as of the Adjustment Time (determined in accordance with <u>Exhibit A</u> and the Accounting Principles), as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Estimated Working Capital Surplus</u>&#8221; shall mean the estimated Working Capital Surplus of the Companies as of the Adjustment Time (determined in accordance with <u>Exhibit A</u> and the Accounting Principles), as set forth in <u>Exhibit A</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Excell USA</u>&#8221; means Excell Battery Corporation USA, a Texas corporation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Excell USA Historical Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5(a)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Excluded Accounts Receivable</u>&#8221; means without duplication, any accounts receivable of the Companies as of the Adjustment Time and that are not included or reflected in the calculation of Working Capital.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Closing Cash</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Company Transaction Expenses</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Indebtedness</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Net Purchase Price</u>&#8221; shall mean an amount equal to the Purchase Price <i><u>minus</u></i> (i)&nbsp;the Final Indebtedness, the Final Company Transaction Expenses and the Final Working Capital Deficiency (if any), <i><u>plus</u></i> (ii) the Final Working Capital Surplus (if any) and<i> </i>the Final Closing Cash.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Working Capital Deficiency</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Final Working Capital Surplus</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Financial Statements</u>&#8221; shall have the meaning ascribed in <u>Section 3.5(a)(iii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Fundamental Representations of the Buyer</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Fundamental Representations of the Seller</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>General Release</u>&#8221; shall have the meaning ascribed in <u>Section 2.4(a)(xi)</u>.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Governmental Authority</u>&#8221; means any federal, state, provincial, territorial, local, municipal or foreign government (including any political subdivision thereof, court, administrative agency, regulatory body, board, organization, authority), or any agency or instrumentality of such government or political subdivision, or any self-regulated organization or other non-governmental regulatory authority or quasi-governmental authority (to the extent that the rules, regulations or orders of such organization or authority have the force of law), or any arbitrator, court or tribunal of competent jurisdiction.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>GST</u>&#8221; shall have the meaning ascribed in <u>Section 3.10(p)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Hazardous Material</u>&#8221; means any substance or material meeting any one or more of the following criteria: (i) it is or contains a substance designated as a hazardous waste, hazardous substance, hazardous material, pollutant, contaminant or toxic substance under any Environmental Laws; (ii) it is toxic, explosive, corrosive, reactive, ignitable, infectious, radioactive, mutagenic, dangerous or otherwise hazardous; (iii) its presence at some quantity requires investigation, notification or remediation under any Environmental Law; or (iv) it is or contains, without limiting the foregoing clauses (i)-(iii), asbestos, polychlorinated biphenyls, petroleum hydrocarbons, petroleum derived substances or waste, crude oil or any fraction thereof, nuclear fuel or waste, natural gas or synthetic gas.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Historical Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5(a)(ii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indebtedness</u>&#8221; shall mean with respect to any Person, without duplication: (i) any indebtedness for borrowed money (including credit card liabilities or obligations) or issued in substitution for or exchange of indebtedness for borrowed money, whether current, short-term or long-term, secured or unsecured, including principal, premium (if any) and accrued interest; (ii) any indebtedness or obligation evidenced by any bond, debenture, note, debt security, unfunded letter of credit or other similar instrument, including principal, premium (if any) and accrued interest; (iii) any obligations for earn-outs or other similar payments owed in connection with any acquisitions; (iv) obligations for the deferred purchase price of property or services (other than Current Liabilities taken into account in the calculation of Working Capital); (v) capital lease obligations; (vi) any guaranty of any other Person for the obligations and indebtedness set forth in subsections (i) through (v) herein; and (vii) any accrued and unpaid interest on, and any prepayment premiums, penalties or similar contractual charges in respect of, any of the foregoing obligations computed as though payment is being made in respect thereof at the Adjustment Time. Notwithstanding the foregoing, &#8220;Indebtedness&#8221; shall not include (x) any amounts included as Company Transaction Expenses (y) any Current Liabilities and (z) the PPP Loan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indemnification Escrow Amount</u>&#8221; means $846,000.00.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indemnification Escrow Fund</u>&#8221; means the Indemnification Escrow Amount (such amount, including any interest or other amounts earned thereon and less any disbursements therefrom in accordance with the Escrow Agreement).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indemnified Party</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Indemnifying Party</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Independent Accounting Firm</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Inventory</u>&#8221; shall have the meaning ascribed in <u>Section 3.23(b).</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Item of Dispute</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Interim Financials</u>&#8221; shall have the meaning ascribed in <u>Section 3.5(a)(iii)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Knowledge</u>&#8221; shall have the meaning ascribed in <u>Article III</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Law</u>&#8221; means any applicable (a) international, multinational, foreign, federal, provincial, state, territorial, local or municipal law, rule, statute, constitution, treaty, regulation, judgment, injunction, common law, order, directive, ordinance, code, decree, other requirements having the force of law, and any legally-binding requirements in a Permit or restriction of any Governmental Authority or (b) governmental order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Leases</u>&#8221; shall have the meaning ascribed in <u>Section 3.11</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Legal Proceeding</u>&#8221;<b><i> </i></b>shall mean any action, suit, litigation, arbitration, proceeding (including any civil, criminal, administrative or appellate proceeding), hearing or formal inquiry or audit commenced, brought, conducted or heard by or before, or otherwise involving, any court or other Governmental Authority or any arbitrator or arbitration panel.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Loss</u>&#8221; or &#8220;<u>Losses</u>&#8221; shall mean any losses, Taxes, liabilities, costs, fines, penalties, interests, expenses (including the reasonable fees of lawyers, accountants, consultants, experts, and other professionals) and damages, but excluding any and all aggravated or punitive losses, claims for loss profits, diminution in value, &#8220;multiple of profits&#8221;, &#8220;multiple of cash flow&#8221; or similar losses (in each case, except arising out of Third Party Claims) as well as any consequential or indirect damages, except to the extent such consequential or indirect damages were reasonably foreseeable, incurred by any Party entitled to indemnification under this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Material Adverse Effect</u>&#8221; means any event, circumstance, change, occurrence or effect (collectively, &#8220;<u>Events</u>&#8221;) that, individually, has had a continuing material and adverse effect upon the assets, liabilities, financial condition or operating results of the Companies; <i>provided</i>, <i>however</i>, that none of the following shall be deemed to constitute, and no adverse Event arising from or relating to the following shall be taken into account in determining whether there has been, a Material Adverse Effect: (a) general economic or political conditions, including capital, credit and financial markets and such conditions related to the business thereof, (b) general changes in the industries or lines of business in which the Companies operate, except such general changes that have a disproportionate impact on the Companies compared to other participants in such industries or lines of business, (c) changes in the Law or in ASPE or generally accepted accounting principles outside of Canada, or the interpretation, application or non-application thereof, (d) the taking of or failure to take any action permitted by this Agreement and the other agreements contemplated hereby, (e) failures to meet financial projections, estimates or forecasts of revenues, earnings or other measures of financial or operating performance of any period, except that the underlying causes of such failures shall not be excluded when determining whether there has been a Material Adverse Effect, (f) any &#8220;act of God,&#8221; including, but not limited to, weather, fires, natural disasters, earthquakes, pandemics (including the COVID-19 coronavirus pandemic), acts of war, terrorism, civil unrest or sabotage, or (g) changes resulting from the announcement of the execution of this Agreement or the transactions contemplated hereunder or the consummation of such transactions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Negative Adjustment Amount</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Notice</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Notice of Disagreement</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Party</u>&#8221; or &#8220;<u>Parties</u>&#8221; shall mean those entities or individuals identified in the first paragraph of the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Permits</u>&#8221; shall have the meaning ascribed in <u>Section 3.14</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Permitted Encumbrances</u>&#8221; means each of the following: (a) Encumbrances incurred or deposits made in the ordinary course of business in connection with workers&#8217; compensation, unemployment insurance and other types of social security or to secure the performance of tenders, statutory obligations, surety and appeal bonds, bids, leases, government contracts, performance and return of money bonds and similar obligations; (b) mechanics&#8217;, carriers&#8217;, workers&#8217;, repairers&#8217;, materialmen&#8217;s, warehousemen&#8217;s, landlords&#8217; and other similar Encumbrances which (1) purely arise due to statutory provisions, (2) arise in the ordinary course of business and (3) relate to charges that are not overdue, delinquent or disputed, or if overdue or delinquent, the validity of which the Company or Excell USA, as applicable, is contesting in good faith by proper Legal Proceedings; (c) permits, licenses, agreements, easements, servitudes, restrictive covenants, rights-of-way, requirements and restrictions of zoning, building and other Laws, rules and regulations which do not arise as a result of a violation of Law or which do not materially impair the current use or marketability of the applicable property; (d) Encumbrances related to Taxes which are not due or delinquent or, if due or delinquent, the validity of which the Company or Excell USA, as applicable, is or will be contesting in good faith by proper Legal Proceedings; (e) undetermined or inchoate Encumbrances arising in the ordinary course of or incidental to the Business which have not been filed pursuant to Law against the Companies or in respect of which no steps or proceedings to enforce such Encumbrances have been initiated or which relate to obligations which are not due or delinquent or, if due or delinquent, which the Company or Excell USA, as applicable, is contesting in good faith by appropriate proceedings; (f) all instruments registered against the title to any real property prior to Closing; and (g) any Encumbrances arranged by or on behalf of Buyer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Person</u>&#8221; shall mean an individual, corporation, partnership, joint venture, limited liability company, Governmental Authority, unincorporated organization, trust, association or other entity.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Personal Information</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Positive Adjustment Amount</u>&#8221; shall have the meaning ascribed in <u>Section 2.6(d)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>PPP Lender</u>&#8221; means City National Bank, or any subsequent holder of the PPP Loan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>PPP Loan</u>&#8221; means the loan made to Excell USA by the PPP Lender on March 31, 2021, in the original principal amount of $315,230.00 as evidenced by a U.S. small business administration note dated March 31, 2021 from Excell USA to the PPP Lender.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>PPP Loan Obligations</u>&#8221; means Excell USA&#8217;s obligations for the repayment in full of the PPP Loan, including the payment, performance, discharge and satisfaction of all liabilities and obligations of Excell USA to the PPP Lender in connection with any documents entered into in connection with the PPP Loan and all costs, expenses, legal fees and liabilities incurred by the PPP Lender in connection with enforcement of its rights or remedies in connection with the PPP Loan.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Pre-Closing Tax Period</u>&#8221; shall mean any Tax period ending on or prior to the Closing Date and that portion of any Straddle Period ending on the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Privacy Commitments</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Privacy Laws</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Privacy Policy</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Privileged Communications</u>&#8221; means all privileged communications prior to and after Closing and arising out of or relating to the negotiation, documentation and consummation of this Agreement and the other documents and instruments contemplated hereby (including the Transaction Documents), and the completion of the transactions contemplated hereby and thereby, between or among the Sellers and their agents and representatives, on the one hand, and the Sellers&#8217; legal counsel, on the other hand.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Process</u>&#8221; or &#8220;<u>Processing</u>&#8221; shall have the meaning ascribed in <u>Section 3.12(c)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>PST</u>&#8221; shall have the meaning ascribed in <u>Section 3.10(p)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Purchase Price</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Qualifying Claim</u>&#8221; shall have the meaning ascribed in <u>Section 7.3.</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Regulatory Representations</u>&#8221; shall have the meaning ascribed in <u>Section 7.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Release</u>&#8221; means any release, spill, emission, discharge, leaking, pumping, injection, deposit, disposal, dispersal, leaching or migration into the indoor or outdoor environment (including, without limitation, ambient air, surface water, groundwater and surface or subsurface strata) or into or out of any property, including the movement of Hazardous Materials through or in the air, soil, surface water, groundwater or property.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Seller Indemnified Parties</u>&#8221; shall have the meaning ascribed in <u>Section 7.4</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Sellers</u>&#8221; shall have the meaning ascribed in the Preamble.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Sellers</u><u>&#8217;</u><u> Representative</u>&#8221; shall have the meaning ascribed in <u>Section 8.14(a)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Share Purchase</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Shares</u>&#8221; shall have the meaning ascribed in the Recitals.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Specified Employee</u>&#8221; shall have the meaning ascribed in <u>Section 6.2(a)(i)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Straddle Period</u>&#8221; shall mean any Tax period beginning before the Closing Date and ending on or after the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Subsidiary</u>&#8221; means, with respect to a specified Person, any corporation or other Person of which securities or other interests having the power to elect a majority of that corporation&#8217;s or other Person&#8217;s board of directors or similar governing body, or otherwise having the power to direct the business and policies of that corporation or other Person (other than securities or other interests having such power only upon the happening of a contingency that has not occurred) are held by the specified Person or one or more of its Subsidiaries. When used in this Agreement without reference to a particular Person, &#8220;Subsidiary&#8221; means a Subsidiary of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Suppliers</u>&#8221; shall have the meaning ascribed in <u>Section 3.22(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Target Working Capital</u>&#8221; shall mean $1,772,816.00.<b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax</u>&#8221; or &#8220;<u>Taxes</u>&#8221; shall mean any federal, provincial, local or foreign income, gross receipts, branch profits, license, payroll, employment, excise, severance, stamp, occupation, premium, windfall profits, environmental, customs duties, capital stock, franchise, profits, withholding, social security, unemployment, disability, real property, personal property, sales, use, transfer, registration, ad valorem, value added, alternative or add-on minimum or estimated tax or other tax of any kind whatsoever, including any interest, penalty or addition thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Act</u>&#8221; means the <i>Income Tax Act</i> (Canada), and the regulations thereunder, as amended from time to time.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Authority</u>&#8221; shall mean any Governmental Authority, board, bureau, body, department or authority of any Canadian federal, provincial, territorial or local jurisdiction or any foreign jurisdiction (including the U.S.), having or purporting to exercise jurisdiction with respect to any Tax.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Contest</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(b)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Tax Return</u>&#8221; shall mean any return, declaration, report, election, claim for refund or information return or statement of any kind relating to Taxes, including any schedule or attachment thereto, and including any amendment thereof, filed or required to be filed with any Tax Authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Term</u>&#8221; means the period beginning on the Closing Date and ending on the later of (A) in the case of Ian, the one (1) year anniversary of the Closing Date, (B) in the case of the other Sellers (other than Ian), the five (5) year anniversary of the Closing Date, and (C) to the extent any Seller becomes an employee of the Company, the one (1) year anniversary of the termination of such employment with the Company, for any reason.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Territory</u>&#8221; shall have the meaning ascribed in <u>Section 6.2</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Third-Party Claim</u>&#8221; shall have the meaning ascribed in <u>Section 7.6</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Transaction</u>&#8221; shall have the meaning ascribed in <u>Section 2.1</u>.<u> </u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Transaction Documents</u>&#8221; shall mean this Agreement, the Escrow Agreement and the General Releases.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Transfer Taxes</u>&#8221; shall have the meaning ascribed in <u>Section 6.8(g)</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Transferred Information</u>&#8221; means the Personal Information to be disclosed or transferred to the Buyer or any of its representatives or agents by or on behalf of the Sellers or the Companies as a result of, or in conjunction with, the transactions contemplated by this Agreement, and includes all such Personal Information disclosed to the Buyer or any of its representatives or agents prior to the execution of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Working Capital</u>&#8221; means as of the Adjustment Time, the Current Assets of the Companies <u>minus</u> the Current Liabilities of the Companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Working Capital Deficiency</u>&#8221; means the amount, if any, by which the Target Working Capital exceeds the Working Capital.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Working Capital Escrow Amount</u>&#8221; means $88,641.00.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Working Capital Escrow Fund</u>&#8221; means the Working Capital Escrow Amount (such amount, including any interest or other amounts earned thereon and less any disbursements therefrom in accordance with the Escrow Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">&#8220;<u>Working Capital Surplus</u>&#8221; means the amount, if any, by which the Working Capital exceeds the Target Working Capital.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE II</u></b><b><u>&nbsp;- PURCHASE AND SALE OF SHARES</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Purchase and Sale of the Shares </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">At the Closing, on the terms and subject to the conditions set forth in this Agreement, the Sellers shall sell the Shares and the Buyer shall purchase the Sellers&#8217; right, title and interest in and to such Shares, free and clear of all Encumbrances (other than Permitted Encumbrances and transfer restrictions imposed by applicable securities Laws and those put in place by the Buyer at Closing) (the &#8220;<u>Share Purchase</u>&#8221;), in exchange for an aggregate cash payment of $7,050,000.00 (the &#8220;<u>Purchase Price</u>&#8221;), as further adjusted pursuant to <u>Article II</u> (collectively, the &#8220;<u>Transaction</u>&#8221;). The Purchase Price shall be allocated among the Shares as set forth in <u>Schedule 2.1</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Transaction shall occur at a closing (the &#8220;<u>Closing</u>&#8221;) to take place on the date hereof remotely via electronic exchange of documents and signatures, or at such other time or such other place as the Parties hereto may mutually determine (the &#8220;<u>Closing Date</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Payments at the Closing</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">At the Closing:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver or shall cause to be delivered to the Sellers&#8217; legal counsel, in trust for the Sellers, in accordance with <u>Section 2.1</u>, by wire transfer of immediately available funds to a bank account designated in writing by the Sellers&#8217; legal counsel, the Closing Net Purchase Price less the Escrow Amount;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid to each holder of Indebtedness of the Companies from which the Buyer shall have received a payoff letter in accordance with the second to the last sentence of this <u>Section 2.3</u>, the amount of Indebtedness to be repaid as of the Adjustment Time pursuant to such payoff letters;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid the Company Transaction Expenses for which the Buyer shall have received an invoice in accordance with the second to last sentence of this <u>Section 2.3</u>, the amount to be paid at the Closing pursuant to such invoices;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deposit the Escrow Amount by wire transfer of immediately available funds into an escrow account to be established pursuant to the Escrow Agreement, to satisfy (or partially satisfy) (i) the Sellers&#8217; payment obligations under <u>Section 2.6</u> and (ii) the Sellers&#8217; payment obligations under <u>Article VII</u>; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall cause to be paid at the Buyer&#8217;s sole cost (and not as a portion of the Purchase Price) the Buyer Transaction Expenses to the appropriate party to which such payments are due.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">With respect to Company Transaction Expenses and Indebtedness of the Companies, the Buyer shall contribute to the Company funds as a non-interest-bearing loan that are sufficient to enable the Company to pay such Company Transaction Expenses and Indebtedness of the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">In order to facilitate the payments pursuant to <u>Section 2.3(b)</u> and <u>Section 2.3(c)</u>, the Company shall on or prior to the Closing Date, deliver to the Buyer (x)&nbsp;payoff letters, each on terms and in a form reasonably acceptable to the Buyer, from each holder of Indebtedness of the Companies that is to be repaid on the Closing Date pursuant to <u>Section 2.3(b)</u> and shall have made arrangements reasonably satisfactory to the Buyer for such holders of such Indebtedness to deliver all related lien releases to the Buyer as soon as practicable after the Closing and (y) invoices for each of the Company Transaction Expenses that is to be paid at Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing Deliveries</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Sellers shall deliver, or shall cause to be delivered (unless previously delivered), the following to the Buyer, in each case in form and substance reasonably acceptable to the Buyer:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the original share certificates representing the Shares and duly executed copies of instruments of transfer and any other documents necessary to transfer to the Buyer good and valid title to the Shares, free and clear of all Encumbrances (other than Permitted Encumbrances);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of the Company, certifying as to the resolutions of the board of directors of the Company approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of each non-individual Seller, certifying as to the resolutions of the board of directors or trustees of such Seller approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a copy of the certificate of incorporation of the Company and a copy of the notice of articles of the Company, each together with all amendments thereto and certified by an officer of the Company;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the original minute books of the Companies to the extent not in the possession of the Companies at the Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;certificates of good standing (or in the case of Excell USA, a Texas franchise tax account status report) with respect to each of the corporate Sellers and the Companies, in each case issued in their respective jurisdictions of existence;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vii)&nbsp;&nbsp;&nbsp;&nbsp;written resignations, effective as of the Closing, from each Person who serves as a director or officer of the Companies as of immediately prior to the Closing;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(viii)&nbsp;&nbsp;&nbsp;&nbsp;any and all consents or waivers required from third parties relating to this Agreement or the other Transaction Documents or any of the other transactions contemplated hereby or thereby, including, but not limited to, any consents related to any &#8220;change of control&#8221; of the Companies, provided that, if and to the extent that any such consents or waivers are not obtained or delivered prior to Closing and the Buyer consummates the transactions contemplated by this Agreement notwithstanding same, the Buyer shall be deemed to have waived the requirement for such consents or waivers and the Sellers shall be forever released and discharged from the obligation to obtain or deliver such consents or waivers, provided that this shall not limit any continuing obligations of the Sellers under <u>Section 6.9</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ix)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, executed by the Sellers&#8217; Representative;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;evidence of the termination of any shareholder agreements in respect of the Companies;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(xi)&nbsp;&nbsp;&nbsp;&nbsp;a general release in a form acceptable to the parties thereto (the &#8220;<u>General Release</u>&#8221;) executed by the Sellers in favour of the Company; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(xii)&nbsp;&nbsp;&nbsp;&nbsp;a certificate from each Seller stating that such Seller is not a non-resident of Canada within the meaning of the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Buyer shall deliver, or cause to be delivered (unless previously delivered), the following to the Sellers&#8217; Representative, in each case in form and substance reasonably acceptable to the Sellers:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;a certificate signed by an officer of the Buyer, certifying as to the resolutions of the board of directors of the Buyer approving this Agreement and the transactions contemplated hereby;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Escrow Agreement, executed by the Buyer and the Escrow Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the General Release, executed by the Buyer, the Company and Excell USA in favour of the Sellers; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;a certificate of good standing issued by the British Columbia Registrar of Companies, certifying that the Buyer is in active status or good standing in British Columbia.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the following shall occur:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall purchase the Shares by paying, or causing to be paid, (x) to the Sellers the Closing Net Purchase Price less the Escrow Amount by wire transfer of immediately available funds to the Sellers&#8217; legal counsel, in trust for the Sellers, to the bank account designated by the Sellers&#8217; legal counsel prior to the Closing and (y) to the Escrow Agent the Escrow Amount by wire transfer of immediately available funds;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall make each other payment as set forth in <u>Section 2.3</u>;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;the Sellers shall sell, assign, transfer, convey and deliver, and effective at Closing hereby does sell, assign, transfer, convey and deliver, the Shares owned by the Sellers to the Buyer, and the books and records of Companies shall be updated to reflect such transfer;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Company and the Sellers shall deliver to the Buyer such other supporting documents and certificates as the Buyer may reasonably request;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver to the Sellers&#8217; Representative such other supporting documents and certificates as the Sellers may reasonably request; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer shall deliver, or cause to be delivered, the Escrow Amount to the Escrow Agent.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Closing Net Purchase Price </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 9pt; text-align: justify;">The Sellers and the Buyer have estimated, in good faith, the Closing Net Purchase Price, based on the calculations set out in <u>Exhibit A</u>. <u>Exhibit A</u> sets out the Sellers&#8217; and the Buyer&#8217;s good faith estimates of (i) the Estimated Company Transaction Expenses, (ii) the Estimated Working Capital Deficiency, if any, (iii) the Estimated Working Capital Surplus, if any, (iv) the Estimated Indebtedness<b>,</b> (v) the Estimated Closing Cash, and (v) the Closing Net Purchase Price, in each case as of the Adjustment Time and, if applicable, determined in accordance with the Accounting Principles.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Post-Closing Adjustment</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Promptly, but in any event within 60 days after the Closing Date, the Buyer shall (X) prepare and deliver to the Sellers&#8217; Representative a consolidated balance sheet of the Companies (the &#8220;<u>Closing Balance Sheet</u>&#8221;) (prepared in accordance with <u>Exhibit A</u> and the Accounting Principles, <i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail), which will reflect in reasonable detail the Buyer&#8217;s determination of the Final Net Purchase Price and (i) the unpaid Company Transaction Expenses (which shall be included as a liability of the Company on the Closing Balance Sheet), (ii) the Working Capital Deficiency, if any, (iii) the Working Capital Surplus, if any, (iv) the Indebtedness of the Companies, and (v) the Closing Cash, in each case as of the Adjustment Time, and (Y) deliver to the Sellers&#8217; Representative the Closing Balance Sheet, together with a certificate of the Buyer executed on its behalf by its Chief Financial Officer confirming that the Closing Balance Sheet was properly prepared in good faith and in accordance with <u>Exhibit A</u> and the Accounting Principles, <i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail. For the avoidance of doubt, the provisions of <u>Exhibit A</u> shall be interpreted so as to avoid double counting (whether positive or negative), of any item to be included in the Closing Balance Sheet, including Working Capital, Company Transaction Expenses, Closing Cash and Indebtedness.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;If the Sellers&#8217; Representative in good faith disagrees with the Buyer&#8217;s determination of the Final Net Purchase Price, the Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and/or Closing Cash in each case as reflected on the Closing Balance Sheet, the Sellers&#8217; Representative may, within 30 days after receipt of the Closing Balance Sheet, deliver a written notice (the &#8220;<u>Notice of Disagreement</u>&#8221;) to the Buyer setting forth each item of dispute (each an &#8220;<u>Item of Dispute</u>&#8221;), the reasonable basis for such dispute and the Sellers&#8217; Representative&#8217;s calculation of such Item of Dispute. If the Buyer does not receive a Notice of Disagreement within 30 days after delivery by the Buyer of the Closing Balance Sheet, the Closing Balance Sheet shall be conclusive and binding upon each of the Parties. If the Buyer receives a Notice of Disagreement from the Sellers&#8217; Representative within 30 days after delivery by the Buyer of the Closing Balance Sheet, the Buyer and the Sellers&#8217; Representative shall attempt in good faith to resolve each Item of Dispute, and, if any Item of Dispute is so resolved, the Closing Balance Sheet shall be modified to the extent necessary to reflect such resolution. During the period between the Buyer&#8217;s delivery of the Closing Balance Sheet pursuant to <u>Section 2.6(a)</u> and the final determination of the same pursuant to <u>Section 2.6(b)</u>, the Buyer shall provide the Sellers&#8217; Representative and its representatives with reasonable access to the books, records, personnel and representatives of the Companies, and such other information related to the Companies as the Sellers&#8217; Representative or its representatives may reasonably request, so as to enable the Sellers&#8217; Representative and its representatives to analyze the Closing Balance Sheet and the underlying calculations and documents related thereto. If any Item of Dispute remains unresolved as of the 30<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup> day after timely delivery by the Seller of the Notice of Disagreement, the Buyer and the Sellers&#8217; Representative shall jointly retain an impartial, nationally recognized firm of chartered professional accountants agreeable to both the Buyer and Sellers&#8217; Representative (the &#8220;<u>Independent Accounting Firm</u>&#8221;) to resolve such remaining disagreement, it being understood that any item not included as an Item of Dispute on the Notice of Disagreement shall be conclusive and binding upon each of the Parties as set forth on the Closing Balance Sheet. The Buyer and the Sellers&#8217; Representative shall request that the Independent Accounting Firm render a determination as to each unresolved Item of Dispute as soon as practicable after its retention and in no event greater than 30 days after the engagement of the Independent Accounting Firm, and each of the Buyer, the Sellers&#8217; Representative and each of their respective agents and representatives shall cooperate with the Independent Accounting Firm, and shall provide the Independent Accounting Firm with reasonable access to their respective books, records, personnel and representatives and such other information as the Independent Accounting Firm may reasonably request, so as to enable it to make such determination as quickly and accurately as practicable. The Independent Accounting Firm shall consider only those Items of Dispute and amounts related thereto that were set forth in the Closing Balance Sheet and the Notice of Disagreement and that remain unresolved by the Buyer and the Sellers&#8217; Representative, and in resolving any Item of Dispute, the Independent Accounting Firm may not assign a value to any item greater than the greatest value for such item claimed by either Party nor less than the smallest value for such item claimed by either Party. The Independent Accounting Firm&#8217;s determination(s) shall be based upon the definitions of Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and Closing Cash (as applicable) included herein and in accordance with <u>Exhibit A</u> and the Accounting Principles (<i>provided</i> that in the event of a conflict between <u>Exhibit A</u> and the Accounting Principles, <u>Exhibit A</u> shall prevail). The Independent Accounting Firm&#8217;s determination of each Item of Dispute submitted to it shall be in writing, shall conform with this <u>Section 2.6</u> and, absent manifest error, shall be conclusive and binding upon each of the Parties, and the Closing Balance Sheet shall be modified to the extent necessary to reflect such determination(s). The Independent Accounting Firm shall allocate its fees, costs and expenses between the Buyer on the one hand, and the Sellers on the other hand, based upon the percentage which the portion of the contested amount not awarded to each such Person bears to the amount actually contested by such Person. The Company Transaction Expenses, Working Capital Deficiency, Working Capital Surplus, Indebtedness and Closing Cash, in each case as of the Adjustment Time and as finally determined pursuant to this <u>Section 2.6</u>, are referred to herein as the &#8220;<u>Final Company Transaction Expenses</u>,&#8221; &#8220;<u>Final Working Capital Deficiency</u>,&#8221; &#8220;<u>Final Working Capital Surplus</u>,&#8221; &#8220;<u>Final Indebtedness</u>,&#8221; and &#8220;<u>Final Closing Cash</u>,&#8221; respectively.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Negative Adjustment</u>. If the Closing Net Purchase Price exceeds the Final Net Purchase Price as finally determined in accordance with this <u>Section 2.6</u> (such excess amount, the &#8220;<u>Negative Adjustment Amount</u>&#8221;), then the Sellers&#8217; Representative shall promptly (but in any event within five (5) Business Days following the final determination of the Final Net Purchase Price) pay an amount equal to such insufficiency to the Buyer (i) from the Working Capital Escrow Fund; and (ii) to the extent the amount of the Negative Adjustment Amount exceeds the amount available in the Working Capital Escrow Fund, from the Indemnification Escrow Fund or from Sellers, at the discretion of Buyer; in accordance with the Escrow Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Positive Adjustment</u>. If the Final Net Purchase Price exceeds the Closing Net Purchase Price as finally determined in accordance with this <u>Section 2.6</u> (such excess amount, the &#8220;<u>Positive Adjustment Amount</u>&#8221;), then the Buyer shall promptly (but in any event within five (5) Business Days following the final determination of the Final Net Purchase Price) pay the Positive Adjustment Amount to the Sellers&#8217; legal counsel, in trust for the Sellers, by wire transfer of immediately available funds to the account designated by the Sellers&#8217; legal counsel.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Release of Working Capital Escrow Fund</u>. Within five (5) Business Days after the date on which the Final Net Purchase Price is finally determined pursuant to this <u>Section 2.6</u>, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to deliver any portion of the Working Capital Escrow Fund not distributed to the Buyer pursuant to <u>Section 2.6(c)</u> (if any) to the Sellers&#8217; legal counsel, in trust for the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Any payments made to any Party pursuant to this <u>Section 2.6</u> shall be treated as an adjustment of the Purchase Price for all Tax purposes to the greatest extent permitted by law and shall be reported as such by the Parties on their Tax Returns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Withholding</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding anything to the contrary in this Agreement, Buyer and its agents shall be entitled to deduct and withhold from any consideration otherwise payable or deliverable to Sellers or any other Person pursuant to this Agreement or the Transaction Documents such amounts that are required to be deducted or withheld pursuant to the Tax Act or any Tax Law. To the extent such amounts are so deducted or withheld, such amounts shall be treated for all purposes as having been paid to the Person to whom such amounts would otherwise have been paid absent such deduction or withholding.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE III</u></b><b><u>&nbsp;- REPRESENTATIONS AND WARRANTIES OF THE COMPANY</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In order to induce the Buyer to enter into this Agreement and consummate the transactions contemplated hereby, the Company hereby represents and warrants to the Buyer that, except as and to the extent disclosed in a written Disclosure Schedule delivered by the Sellers&#8217; Representative to the Buyer simultaneously with the execution and delivery of this Agreement (the &#8220;<u>Disclosure Schedule</u>&#8221;), the statements contained in this <u>Article III</u> are true and correct as of the Closing. The Disclosure Schedule (a)&nbsp;shall be arranged in sections corresponding to the applicable sections of this Agreement, and (b) shall not be construed as indicating that any matter disclosed therein is required to be disclosed, nor shall such disclosure be construed as an admission that such information is material to the Companies. References to the &#8220;Knowledge&#8221; of the Company or the Sellers are deemed to mean the actual knowledge of Mark Kroeker, Ian Kane and Carmena Gee after making reasonable inquiry into the subject matter in question. For the purposes hereof, &#8220;reasonable inquiry into the subject matter in question&#8221; will be satisfied by such individual via a question and answer period conducted by any such individual with senior management personnel of the Companies who would reasonably be expected to have knowledge of the relevant subject matter and reasonable subsequent inquiry based on the content of such question and answer period. For the avoidance of doubt, to the extent that a representation or warranty refers to a prior time period, all references to the &#8220;Company&#8221; as used in such representation or warranty shall include the Company as in existence during that time period, including prior names and corporate and limited liability company or entity forms.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Company Power</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Company is a corporation duly organized, validly existing and in good standing under the laws of the Province of British Columbia. The Company has all requisite corporate power and authority to own its properties, to carry on its business as presently conducted, to enter into and perform this Agreement and the Transaction Documents to which it is a party and to carry out the transactions contemplated hereby and thereby. Excell USA is a corporation duly organized, validly existing and in good standing under the laws of the State of Texas. Excell USA has all requisite corporate power and authority to own its properties, to carry on its business as presently conducted. The Company and Excell USA (collectively, the &#8220;<u>Companies</u>&#8221;) are duly licensed or qualified to do business in each jurisdiction wherein the character of its property, or the nature of the activities presently conducted by it, makes such qualification necessary. The Companies are not in violation of any term or provision of their respective organizational documents, each as in effect as of this date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authorization and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Transaction Documents to which the Company is a party (when executed by the Company and the other parties thereto) are valid and binding obligations of the Company, enforceable in accordance with their terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws, from time to time in effect, which affect enforcement of creditors&#8217; rights generally. The execution, delivery and performance of the Transaction Documents to which the Company is a party and the sale and delivery of the Shares in accordance with this Agreement, have been duly authorized by all necessary corporate or other action of the Company.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.2</u>, the execution, delivery and performance of the Transaction Documents to which the Company is a party by the Company, including, without limitation, the sale and delivery of the Shares in accordance with this Agreement and the performance by the Company of any transactions contemplated by the Transaction Documents to which the Company is a party will not: (i) violate or result in a default (whether after the giving of notice, lapse of time or both) under any contract or obligation to which the Companies are a party or by which they or the assets of the Companies are bound, or any provision of the organizational documents of the Companies, or cause the creation of any Encumbrance (other than Permitted Encumbrances) upon any of the assets of the Companies; (ii) violate, conflict with or result in a default (whether after the giving of notice, lapse of time or both) under, any provision of any material Law, or any order of, or any restriction imposed by any court or other Governmental Authority applicable to the Companies; (iii) require from the Companies any notice to, declaration or filing with, or consent or approval of any Governmental Authority or other third party; or (iv) accelerate any obligation under, or give rise to a right of termination of, any material agreement, permit, license or authorization to which the Companies are a party or by which each is bound.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Shares</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The authorized capital of the Company is set out in <u>Schedule 3.3</u>. All Shares of the Company are held beneficially and of record by the Sellers as disclosed on <u>Schedule 3.3</u>. Except as disclosed in <u>Schedule 3.3</u> and in the Transaction Documents, there are no outstanding subscriptions, options, warrants, phantom rights, commitments, agreements, arrangements or commitments of any kind for or relating to the issuance, or sale of, or outstanding securities convertible into or exchangeable for, any shares of any class or other equity interests of the Company. Except as set forth in <u>Schedule 3.3</u> or as expressly provided for in this Agreement, the Company does not have any obligation to purchase, redeem, or otherwise acquire any of its equity interests or any interests therein. All of the outstanding equity interests of the Company are duly authorized, validly issued, fully paid and non-assessable and were issued in compliance with all applicable securities Laws. There are no preemptive rights, rights of first refusal, put or call rights or obligations or anti-dilution rights with respect to the issuance, sale or redemption of the Company&#8217;s equity interests, other than rights set forth herein. Other than the rights set forth in <u>Schedule 3.3</u>, there are no rights to have the Company&#8217;s equity interests registered for sale to the public pursuant to the Laws of any jurisdiction, and there are no agreements relating to the voting of the Company&#8217;s voting securities or restrictions on the transfer of the Company&#8217;s equity interests.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsidiaries</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Excell USA is the sole Subsidiary of the Company, and the Company owns, directly or indirectly, all of the issued and outstanding capital stock of Excell USA, free and clear of all Liens. Except for its ownership of Excell USA, the Company does not own or control, directly or indirectly, any interest in any other corporation, partnership, limited liability company, association or other business entity. All issued and outstanding shares of capital stock of Excell USA have been duly authorized and are validly issued, fully paid and nonassessable, and were not issued in violation of any preemptive rights. There are no authorized or outstanding options, warrants, calls, subscriptions or other rights relating to Excell USA with respect to which Excell USA may be obligated to issue or sell any shares of capital stock of Exell USA or other securities convertible into, exchangeable for or evidencing the right to subscribe for or purchase shares of capital stock of Excell USA. At the Closing, the Company will not have any Subsidiaries other than Excell USA.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Financial Statements</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered to the Buyer the following financial statements, copies of which are attached as <u>Schedule 3.5(a)</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;notice to reader financial statements of the Company consisting of the balance sheets of the Company as of January 31, 2021, 2020 and 2019 and the related statement of loss and deficit for the years then ended (the &#8220;<u>656 Historical Financials</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;reviewed financial statements of Excell USA consisting of the balance sheets of Excell USA as of January 31, 2021, 2020 and 2019 and the related statements of earnings and retained earnings and cash flows for the years then ended (the &#8220;<u>Excell USA Historical Financials</u>&#8221; and together with the 656 Historical Financials, the &#8220;<u>Historical Financials</u>&#8221;); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;internally prepared financial statements of Excell USA consisting of the balance sheet of Excell USA as of October 31, 2021 and the related income statement for the nine and 12 months, respectively, then ended (the &#8220;<u>Interim Financials</u>&#8221; and together with the Historical Financials, the &#8220;<u>Financial Statements</u>&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.5(a)</u> and except for the 656 Historical Financials which have been prepared on a notice to reader basis, the Financial Statements have been prepared in accordance with ASPE, applied on a consistent basis throughout the period involved, except as may be indicated in the notes thereto and subject, in the case of the Interim Financials, to year-end adjustments and the absence of notes (if any). The Financial Statements fairly present, in all material respects, in accordance with ASPE, (except as provided above), the financial condition of the Companies as of the respective dates they were prepared and the results of the operations of the Companies for the periods indicated.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the reserve for bad debts set forth in the Interim Financials or that would, consistent with ASPE, be included in the next year-end financial statements of the Companies, all of the accounts receivable of the Companies are valid and, to the Sellers&#8217; and Company&#8217;s Knowledge, payable claims in accordance with their terms at their recorded amounts and subject to no known set off or counterclaim. Since January 31, 2021 (the &#8220;<u>Balance Sheet Date</u>&#8221;), the Companies have collected their accounts receivable in the ordinary course of its business and in a manner which is consistent with past practices. Except as disclosed in <u>Schedule 3.5(c)</u>, the Companies do not have any accounts receivable or loans receivable from any Person which is affiliated with it or any of its directors, officers, employees or shareholders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Undisclosed Liabilities</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as stated or adequately reserved against in the Financial Statements, incurred as a result of or arising out of the transactions contemplated under the Transaction Documents, or which have been incurred in the ordinary course of business since the Balance Sheet Date or are not, individually or in the aggregate, material in amount, the Companies do not have any material liability or obligation of any nature, whether accrued, absolute, contingent or otherwise, or known or unknown that is required by ASPE, to be reflected on a balance sheet of the Companies or disclosed in the notes thereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indebtedness</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except for Indebtedness set forth on <u>Schedule 3.7</u>, the Companies have no Indebtedness outstanding. The Companies have not assumed, guaranteed, endorsed or otherwise become directly or contingently liable on or for any Indebtedness of any other Person. The Companies are not in default with respect to any outstanding Indebtedness or any instrument relating thereto, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, is there any event which, with the passage of time or giving of notice, or both, would result in a default, and no such Indebtedness or any instrument or agreement relating thereto purports to limit the issuance of any securities by the Companies or the operation of the Companies&#8217; business. Complete and correct copies of all instruments (including all amendments, supplements, waivers and consents) relating to any outstanding Indebtedness of the Companies have been furnished to or made available to the Buyer.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Absence of Certain Developments</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 3.8</u>, since the Balance Sheet Date, the Companies have conducted its business only in the ordinary course consistent with past practice in all material respects and except for general industry and economic conditions and transactions expressly contemplated by this Agreement, there has been:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;no occurrence or event which, in the aggregate, has or would be reasonably expected to have a Material Adverse Effect on the Companies;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;no declaration, setting aside or payment of any non-cash dividend or other non-cash distribution with respect to, or any direct or indirect redemption or acquisition of, any of the shares of the Companies;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;no waiver of any material right of the Companies or cancellation of any material debt or claim held by the Companies;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;no increase in the compensation paid or payable or employee benefits provided to any officer, employee or agent of the Companies other than in the ordinary course of business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;no material loss, destruction or damage to any property of the Companies, whether or not insured;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;no entry into or agreement to enter into a collective bargaining agreement or similar labour contract, no labour dispute involving the Companies and no material change in the personnel of the Companies or the terms and conditions of their employment, other than in the ordinary course of business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;no adoption, amendment or modification of any Employee Benefit Plan, except as required by Law or the terms of such Employee Benefit Plan, and no action to accelerate the vesting of, or payment of, any compensation or benefit under any Employee Benefit Plan or to fund or in any other way secure the payment of compensation or benefits under any Employee Benefit Plan;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(h)&nbsp;&nbsp;&nbsp;&nbsp;no material acquisition or disposition or abandonment of any assets (or any contract or arrangement therefor) except in the ordinary course of business nor any other transaction by the Companies otherwise than for fair value in the ordinary course of business, except between Affiliates of the Companies;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(i)&nbsp;&nbsp;&nbsp;&nbsp; no change in accounting methods or practices of the Companies, except as required by Law or as disclosed in the notes to the Historical Financials;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(j)&nbsp;&nbsp;&nbsp;&nbsp;no loss, or any material development that would reasonably be expected by the Companies to result in a loss, of any significant supplier, customer, distributor or account of the Companies (other than the completion in the ordinary course of business of specific projects for customers);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(k)&nbsp;&nbsp;&nbsp;&nbsp;no termination of any material contract or agreement to which the Companies are a party or by which it is bound;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(l)&nbsp;&nbsp;&nbsp;&nbsp;no Encumbrance placed on any of the properties of the Companies other than Permitted Encumbrances or in the ordinary course of business for equipment leased, consistent with past practices;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(m)&nbsp;&nbsp;&nbsp;&nbsp;no payment or discharge of a material lien or material liability of the Companies, other than in the ordinary course of business consistent with past practices, purchase money liens and liens for taxes not yet due and payable;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(n)&nbsp;&nbsp;&nbsp;&nbsp;no contingent liability incurred by the Companies as guarantor or otherwise with respect to the obligations of others;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(o)&nbsp;&nbsp;&nbsp;&nbsp;no obligation or liability incurred by the Companies to any of its officers, directors, shareholders or employees, or any loans or advances made by the Companies to any of its respective officers, directors, shareholders or employees, except compensation and expense allowances payable to officers, directors or employees in the ordinary course of business;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(p)&nbsp;&nbsp;&nbsp;&nbsp;no new arrangements relating to any royalty or similar payment based on the revenues, profits or sales volume of the Companies, whether as part of the terms of the shares in the Companies&#8217; capital or by any separate agreement (other than variable incentive compensation provided to new employees of the Companies);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(q)&nbsp;&nbsp;&nbsp;&nbsp;no amendment to the Companies&#8217; organizational documents other than as expressly contemplated by this Agreement;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(r)&nbsp;&nbsp;&nbsp;&nbsp;no settlement or compromise of any material claim, written notice, audit report or assessment in respect of Taxes; no change in any annual Tax accounting period; no change of any method of Tax accounting; no entrance into any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement or closing agreement, in each case, the primary subject matter of which is Tax; no surrender of any right to claim a material Tax refund; nor consent to any extension or waiver of the statute of limitations period applicable to any Tax claim or assessment (excluding extensions pursuant to normal course extensions of time to file Tax Returns); and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(s)&nbsp;&nbsp;&nbsp;&nbsp;no commitment to do any of the foregoing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 3.9</u>, there is no litigation or Legal Proceeding pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened, by or against the Companies or affecting any of the Companies&#8217; properties or assets, or against any director, officer, or shareholder of the Companies in his or her capacity as such, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, has there occurred any event nor does there exist any condition on the basis of which any litigation, Legal Proceeding or investigation might properly be instituted with any substantial chance of recovery. To the Sellers&#8217; and the Company&#8217;s Knowledge, no event has occurred and no claim, dispute or other condition or circumstance exists, that would reasonably be expected to, give rise to or serve as a basis for the commencement of any such Legal Proceeding. Neither the Companies nor any director, officer, or shareholder of the Companies in his or her capacity as such is a party to or in default with respect to any order, writ, injunction, decree, ruling or decision of any court, commission, board or other Governmental Authority. <u>Schedule 3.9</u> includes a description of all litigation, claims or Legal Proceedings involving the Companies occurring, arising or existing during the two years prior to the Closing Date.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Company and Excell USA have duly and timely filed with the appropriate Tax Authorities all Tax Returns required to be filed. All such Tax Returns are complete and accurate in all respects. All Taxes due and owing by the Company or Excell USA (whether or not shown on any Tax Returns) have been paid. Neither the Company nor Excell USA is currently the beneficiary of any extension of time to file any Tax Return (excluding extensions of time to file Tax Returns that are requested by the Company or Excell USA in the ordinary course). The amounts provided as current liability on the Financial Statements for all Taxes are, and the amount taken into account in calculating the Working Capital for all Taxes will be, adequate to cover all unpaid liabilities for all Taxes, whether or not disputed, that have accrued with respect to or are applicable to the period ended on and included the date thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company and Excell USA have complied in all material respects with all applicable Laws relating to the reporting, payment, and withholding of Taxes and all Taxes which the Company and Excell USA are required by Law to withhold or collect, including sales and use taxes, goods and services taxes, harmonized sales and all amounts required to be withheld for Taxes of any employee, independent contractor, non-resident of Canada, creditor, customer, shareholder, or other Person have been duly withheld or collected and, to the extent required, have been paid over to the proper Tax Authorities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No deficiencies for Taxes with respect to the Company or Excell USA have been claimed, proposed or assessed in writing by any Tax Authority, which remain outstanding. Neither the Company nor Excell USA (or any predecessor of the Company or Excell USA) has waived any statute of limitations in respect of Taxes or agreed to any extension of time with respect to a Tax assessment or deficiency (excluding extensions as a result of normal course extensions of time to file Tax Returns), nor has any request been made in writing for any such extension or waiver, where the applicable statute of limitations remains outstanding.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;None of the Tax Returns of the Company or Excell USA have ever been audited or investigated by any Tax Authority, and no facts exist which would constitute grounds for the assessment of any additional Taxes by any Tax Authority with respect to the taxable years covered in such Tax Returns and any filings. No proceeding by any Tax Authority is pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened with respect to Taxes of the Company or Excell USA. No material issues have been raised in any examination by any Tax Authority of the Company or Excell USA which, by application of similar principles, would reasonably be expected to result in a proposed adjustment to the liability for Taxes for any other period not so examined, and no position has been taken on any Tax Return of the Company or Excell USA for a taxable year for which the statute of limitations for the assessment of any Tax with respect thereto has not expired that is contrary to any publicly announced position of a Tax Authority or that is substantially similar to any position which a Tax Authority has successfully challenged in the course of an examination of a Tax Return of the Company or Excell USA.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="21" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">21</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;No claim has ever been made in writing by a Tax Authority in a jurisdiction where the Company or Excell USA does not file Tax Returns that the Company or Excell USA is or may be subject to taxation by that jurisdiction.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;There are no liens encumbering any of the assets of the Company or Excell USA for Taxes (other than Encumbrances related to Taxes which are not due or delinquent or if due or delinquent, the validity of which the Company or Excell USA is contesting in good faith by proper Legal Proceedings) and which is set forth on <u>Schedule 3.10(f)</u>).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor Excell USA is, and has ever been, a party to or bound by any Tax allocation agreement, Tax sharing agreement, Tax indemnity agreement or similar agreement in each case, excluding agreements entered into in the ordinary course of business the primary subject matter of which is not Taxes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor Excell USA is a party to or otherwise subject to any arrangement having the effect of or giving rise to the recognition of a deduction or loss in a taxable period ending on or before the Closing Date, and a corresponding recognition of taxable income or gain in a taxable period ending after the Closing Date, or any other arrangement that would have the effect of or give rise to the recognition of taxable income or gain in a taxable period ending after the Closing Date without the receipt of or entitlement to a corresponding amount of cash. Neither the Company nor Excell USA has used any improper Tax accounting method.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <u>Schedule 3.10(i)</u>, neither the Company nor Excell USA has been a party in the last three (3) calendar years to any joint venture, partnership or other arrangement which is treated as a partnership for federal income Tax purposes.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;All provincial and federal income Tax Returns of the Company have been provided to the Buyer prior to the date hereof for the taxable periods ended within the last two calendar years, and all such provincial and federal income Tax Returns of the Company are correct and complete in all material respects.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;The Company or Excell USA have provided or made available to Buyer (i) true, correct and complete copies of all Tax Returns relating to U.S. income Taxes and other material U.S. or local Tax Returns filed by the Company, Excell USA or any predecessor entity and (ii) true, correct and complete copies of all notices of deficiencies, notices of proposed adjustments, notices of assessments, revenue agent reports, closing agreements, settlement agreements, information document requests, protests, and any other similar document, notice or correspondence, in each case, that the Company or Excell USA (or their representative) has received from, sent to, or entered into with the U.S. Internal Revenue Service or other Taxing Authority or that relates to any Taxes or Tax Return which is not closed by the applicable statute of limitations. Neither the Company nor Excell USA has commenced a voluntary disclosure proceeding in any U.S. state or local jurisdiction that has not been fully resolved or settled.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="22" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">22</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Company nor Excell USA has requested or received a ruling from any Tax Authority or signed a closing or other agreement with any Tax Authority which would affect any taxable period after the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, no facts, circumstances or events exist or have existed that have resulted in or may result in the application of any of sections 67,17, 78, 79, 80 to 80.04 of the Tax Act or any similar applicable provincial or territorial provision to the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;In the last three calendar years, neither the Company nor Excell USA has acquired property from any Person in circumstances where the Company or Excell USA did or would reasonably be expected to be liable for any Taxes of such Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;The value of the consideration paid or received by the Company or Excell USA for any acquisition, sale, transfer or provision of property (including intangibles) or any provision of services (including financial transactions) from or to a Person with whom the Company or Excell USA was not dealing at arm&#8217;s length (within the meaning of the Tax Act) was equal to the estimated fair market value of such property acquired, provided or sold or services purchased or provided.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;The Company is not registered with the Canada Revenue Agency under the <i>Excise Tax Act</i> (Canada) for purposes of the goods and services and harmonized sales tax (&#8220;<u>GST</u>&#8221;) or under the <i>Provincial Sales Tax Act</i> (British Columbia) for purposes of provincial sales tax (&#8220;<u>PST</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(q)&nbsp;&nbsp;&nbsp;&nbsp;Records or documents that meet the requirements of paragraphs 247(4)(a) to (c) of the Tax Act or any similar applicable provincial or territorial provision have been made and obtained by the Company with respect to all material transactions between such Company and any non-resident Person with whom the Company was not dealing at arm&#8217;s length (within the meaning of the Tax Act) during a taxation year commencing after 1998 and ending on or before the date of Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(r)&nbsp;&nbsp;&nbsp;&nbsp;The Company is a Canadian controlled private corporation for the purposes of the Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(s)&nbsp;&nbsp;&nbsp;&nbsp;A trust that is not resident in Canada has never been a registered shareholder of the Company.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(t)&nbsp;&nbsp;&nbsp;&nbsp;The Shares are not &#8220;taxable Canadian property&#8221;, as that term is defined in the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(u)&nbsp;&nbsp;&nbsp;&nbsp;All Tax credits and refunds, including refundable and non-refundable investment Tax credits in respect of scientific research and experimental development claimed by the Company, if any, were claimed and calculated in accordance with applicable Law and accepted practices of the applicable Tax Authority.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="23" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">23</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not received any requirement from any Tax Authority pursuant to section 224 of the Tax Act or any similar applicable provincial or territorial provision which remains unsatisfied in any respect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(w)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not made an &#8220;excessive eligible dividend designation&#8221; as defined in the Tax Act.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(x)&nbsp;&nbsp;&nbsp;&nbsp;With respect to the declaration and payment of all dividends on or prior to the Closing Date that were designated to be capital dividends (as provided pursuant to subsection 83(2) of the Tax Act), then (i) all such dividends so designated were recorded on Form T2054 (as prescribed under the regulations to the Tax Act) and which Form T2054 was filed with the Canada Revenue Agency (and any applicable provincial Tax Authority) in the prescribed manner on or before the particular time on which any part of the dividend was paid, and (ii) as a consequence of the declaration of such capital dividends and the filing of the Form T2054, the Company was not subject to any Tax pursuant to the provisions of Part III of the Tax Act (and applicable provisions of a provincial Tax statute).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(y)&nbsp;&nbsp;&nbsp;&nbsp;The Company will not be required to include in any taxable period ending after the Closing Date any taxable income attributable to income that accrued (or cash that was received), but was not recognized, in any taxable period ending on or before the Closing Date as a result of a reserve, deduction, election, prepaid amount, an agreement with Tax Authorities, any subsidy or deemed overpayment of Tax related to COVID-19, or for any other reason.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(z)&nbsp;&nbsp;&nbsp;&nbsp;Any amounts claimed by the Company under the Canada Emergency Wage Subsidy or the Canada Emergency Rent Subsidy under section 125.7 of the Tax Act or any similar provincial provision and any other amounts claimed by the Company under a subsidy or deferral in respect of COVID-19 in respect of any period (or portion thereof) ending on or before the Closing Date were claimed by the Company in accordance with the Tax Act and all other applicable Laws</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(aa)&nbsp;&nbsp;&nbsp;&nbsp;The Company has not claimed any reserve under any one or more of subparagraph 40(1)(a)(iii), or paragraph 20(1)(m) or 20(1)(n) of the Tax Act or any similar provincial or territorial provision, if any such amount would reasonably be expected to be included in the income of the Company for any period ending after the Closing Date</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(bb)&nbsp;&nbsp;&nbsp;&nbsp;Excell USA is not required to include an item of income, or exclude an item of deduction for any period after the Closing Date as a result of (i) an installment sale transaction occurring on or before the Closing governed by Code Section 453 (or any similar provision of foreign, state, or local Law); (ii) a transaction occurring on or before the Closing reported as an open transaction for U.S. federal income Tax purposes (or any similar doctrine for foreign, state or local Tax purposes); (iii) prepaid amounts or advance payments received on or prior to the Closing Date; (iv) a change in method of accounting requested or occurring on or prior to the Closing Date; (v) a Contract entered into with any Taxing Authority (including a "closing agreement" under Code Section 7121) on or prior to the Closing Date; (vi) the application of Code Section 263A (or any similar provision of foreign, state or local Law) applied consistently; or (vii) any election under Code Section 108(i) made effective on or prior to the Closing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(cc)&nbsp;&nbsp;&nbsp;&nbsp;Excell USA has not engaged in any transaction that could affect the income Tax liability for any taxable year not closed by the statute of limitations (i) which is a "reportable transaction", (ii) which is a "listed transaction" or (iii) "a significant purpose of which is the avoidance or evasion of United States federal income tax" within the meanings of Code Sections 6662, 6662A, 6011, 6012, 6111, or 6707A or U.S. Treasury Regulations promulgated thereunder or pursuant to notices or other guidance published by the U.S. Internal Revenue Service (irrespective of the effective date).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="24" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">24</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(dd)&nbsp;&nbsp;&nbsp;&nbsp;Excell USA has (i) properly complied with all provisions of any COVID-19 Measure pursuant to which it reduced its obligation to pay any Tax, deferred its obligation to pay any Tax, or delayed its obligation to file any Tax Return, (ii) not deferred the withholding of any Taxes under any COVID-19 Measure, and (iii) not sought a covered loan under paragraph (36) of Section 7(a) of the U.S. Small Business Act (15 U.S.C. 636(a)), as added by Section 1102 of the CARES Act. Excell USA has not deferred any payroll tax obligations pursuant to any U.S. Payroll Tax Executive Order.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(ee)&nbsp;&nbsp;&nbsp;&nbsp;Excell USA does not sponsor or maintain any "nonqualified deferred compensation plans" within the meaning of Code Section 409A. Excell USA does not have any obligation to pay, gross up or otherwise indemnify any employee or contractor for any Taxes including potential Taxes imposed under Code Section 409A or Code Section 4999.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.11<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Title to Properties</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><u>Schedule 3.11</u> lists all personal property with a value of at least $50,000.00 necessary to the conduct of the Companies&#8217; business and all personal property leased to the Companies which is necessary to conduct the Companies&#8217; business. All leases relating to leased real property, including the identification of the lessor thereunder, are identified on <u>Schedule 3.11</u> (the &#8220;<u>Leases</u>&#8221;) and true and complete copies thereof have been delivered or made available to the Buyer. Except as set forth on <u>Schedule 3.11</u>, assuming good title in the lessor, each Company has a valid and enforceable leasehold interest in all of its leased real property, free and clear of all Encumbrances other than Permitted Encumbrances or as set forth in the applicable Lease, except to the extent that enforceability may be subject to, and limited by applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles. Each Company has good title to or a valid and enforceable leasehold interest (except to the extent that enforceability may be subject to, and limited by applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles) in all material personal property used in or necessary to the Business and the same is in good condition and repair in all material respects given its age and usage (ordinary wear and tear excepted). The Companies are not in material violation of any zoning, building or safety ordinance, regulation or requirement or other Law applicable to the operation of its leased properties, or any restrictive covenant or deed restriction applicable thereto, nor have the Companies received written notice of any violation with which it has not complied in all material respects. The Companies have not received any written notice of condemnation or taking of any of its leased properties. With respect to each of the Leases: (i) such Lease has been duly authorized and executed by Excell USA and, assuming good title of the applicable landlord, is in full force and effect; (ii) Excell USA is not in material default under such Lease, nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, has any event occurred which would reasonably be expected to give rise to such a default by Excell USA; (iii) to the Sellers&#8217; and the Company&#8217;s Knowledge, no lessor is in material default under such Lease and such lease is the only agreement in effect under which the lessor has leased the premises described therein; (iv) there is no outstanding material dispute between the lessor and Excell USA under any Lease; and (v) the rent and other sums due and payable by Excell USA to the lessor under such Lease are current in all material respects.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="25" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">25</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.12<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Intellectual Property</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.12</u> lists all patents, patent applications, trademarks, trademark applications, trade names, service marks, service names, domain names, custom software, copyrights, and applications and registrations therefor owned by the Companies or used by the Companies in the Business (other than intellectual property used by the Companies which comes as a result of a shrink-wrap or off-the-shelf software license) (collectively, the &#8220;<u>Company Intellectual Property</u>&#8221;). Other than as described on <u>Schedule 3.12</u>, Excell USA owns all of the Company Intellectual Property and the Company Intellectual Property is not subject to the payment of any continuing fees, royalties, or other compensation in consideration to any third party, and was developed, created, and designed by employees of Excell USA acting within the scope of their employment or by consultants or contractors who have assigned all of their right, title, and interest in and to such Company Intellectual Property to Excell USA and have waived their moral rights in any Company Intellectual Property. Upon the consummation of the transactions contemplated hereby, Excell USA will continue to own and have the right to use the Company Intellectual Property. No claims have been asserted in writing and no claims are pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened by any Person, as to the use of any such Company Intellectual Property or challenging or questioning the validity or effectiveness of any state or federal registration of the Company Intellectual Property. Other than as described on <u>Schedule 3.12</u>, the Companies&#8217; use of the Company Intellectual Property does not, to the Sellers&#8217; and the Company&#8217;s Knowledge, infringe the rights of any Person. The Companies&#8217; operation of its Business prior to Closing, to the Sellers&#8217; and the Company&#8217;s Knowledge, has not infringed on the intellectual property of any other Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Privacy Commitments.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;No material breach or violation of any security policy of the Companies has occurred or, to the Sellers&#8217; and the Company&#8217;s Knowledge, is threatened. To the Sellers&#8217; and the Company&#8217;s Knowledge, there has been no unauthorized or illegal use of or access to any of the data or information in any Company Database. Since December 31, 2016, the Companies have complied in all material respects with all Privacy Laws, privacy rights of third parties, contractual obligations and Privacy Policies pertaining to privacy and Personal Information, and the collection, use storage, registration and transfer thereof (collectively, &#8220;<u>Privacy Commitments</u>&#8221;). Since December 31, 2016, the Companies have also complied in all material respects with all privacy policies of third parties with which the Companies are obligated to comply. The execution, delivery and performance of this Agreement complies with all Privacy Commitments applicable to the Companies. &nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have at all times since December 31, 2016 made all material disclosures to third persons required by applicable Privacy Laws, obtained all consents of data subjects as required under Privacy Laws and none of such disclosures made or contained in any Privacy Policy or in any such materials has been inaccurate, misleading, or deceptive or in violation of any Privacy Laws in any material respects. No action is pending and, to the Sellers&#8217; and the Company&#8217;s Knowledge, no Person has threatened to commence any action against the Company concerning any claim that the Companies have violated any law, rule or regulation in connection with or relating to the Company Databases or Personal Information.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have maintained complete records concerning its compliance with Privacy Laws, including mandatory disclosures in requests for consent, records of consent received, withdrawals of consent, electronic message disclosures, electronic message unsubscribe requests, and records of dates of implementation of electronic message unsubscribe requests.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Agreement,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp; &nbsp; &nbsp; &nbsp;&#8220;<u>Company Data</u>&#8221; means all data collected, generated, or received by or on behalf of the Companies in connection with the services rendered by the Companies including Confidential Data, collected, held, or otherwise managed by or on behalf of the Companies.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="26" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">26</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp; &nbsp; &nbsp; &#8220;<u>Company Database</u>&#8221; mean the distinct electronic or other databases containing (in whole or in part) Personal Information maintained by or for the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp; &nbsp; &nbsp;&#8220;<u>Confidential Data</u>&#8221; means information, including Personal Information, in whatever form that the Companies are obligated, by law or contract, to protect from unauthorized access, use, disclosure, modification or destruction together with any data owned or licensed by the Companies that is not intentionally shared with the general public or that is classified by the Companies with a designation that precludes sharing with the general public.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp; &#8220;<u>Personal Information</u>&#8221; has the meaning ascribed thereto in the <i>Personal Information Protection Act</i> (British Columbia&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp; &nbsp; &nbsp; &#8220;<u>Privacy Laws</u>&#8221; means each applicable law, rule and regulation applicable to the protection or Processing or both of Personal Information including without limitation, to the extent applicable: <i>Personal Information Protection and Electronic Documents Act</i> (Canada), the <i>Personal Information Protection Act</i> (British Columbia), <i>An Act to promote the efficiency and adaptability of the Canadian economy by regulating certain activities that discourage reliance on electronic means of carrying out commercial activities, and to amend the Canadian Radio-television and Telecommunications Commission Act, the Competition Act, the Personal Information Protection and Electronic Documents Act and the Telecommunications Act </i>(Canada), the European Union Data Protection Directive and all implementing regulations, the Children&#8217;s Online Privacy Protection Act (COPPA), the Computer Fraud and Abuse Act (CFAA), Fair Credit Reporting Act (FCRA), Gramm-Leach- Bliley Act (GLBA), Dodd-Frank Wall Street Reform and Consumer Protection Act, and the Telephone Consumer Protection Act (TCPA).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vi)&nbsp; &nbsp; &nbsp;&#8220;<u>Privacy Policy</u>&#8221; means a policy of the Companies (or a third party that supplies Personal Information to the Companies where the Companies are obligated by law or contract to apply the terms of such policy of such third party data supplier) made available in connection with the collection of information provided by or on behalf of individuals that is labeled as a &#8220;Privacy Policy,&#8221; is reached on a website by a link that includes the label &#8220;Privacy&#8221; or that is a written policy or disclosure that describes the purposes for which and how information provided by or on behalf of individuals will be collected, held, used, processed and disclosed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(vii)&nbsp; &nbsp; &#8220;<u>Process</u>&#8221; or &#8220;<u>Processing</u>&#8221; means, with respect to Company Data, the use, collection, processing, storage, recording, organization, adaption, alteration, transfer, retrieval, consultation, disclosure, dissemination or combination of such Company Data.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.13<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Contracts and Arrangements</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except as set forth in the Transaction Documents or in <u>Schedule 3.13</u> (true and correct copies of which have previously been provided or made available to the Buyer), the Companies are not a party or subject to or bound by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="27" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">27</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;any contract, lease or agreement involving a potential commitment or payment by the Companies in excess of $50,000 annually;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;any contract containing covenants directly or explicitly limiting in any material respect the freedom of the Companies to compete in any line of business or with any Person (other than confidentiality agreements containing non-competition or non-solicitation covenants on the part of the Companies that were entered into by the Companies in the ordinary course of business);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;any indenture, mortgage, promissory note, loan agreement, guaranty or other agreement or commitment for borrowing or any pledge or security arrangement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;any employment, consulting or other service agreements with present or former officers, directors, employees, consultants, shareholders of the Companies or any other service provider of the Companies that includes any change of control payments severance, termination, or retention obligations or similar accounts payable by the Companies or its Affiliates in connection with the transactions contemplated by this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;any redemption or purchase agreements or other agreements affecting or relating to the shares of the Companies, including, without limitation, any agreement with any shareholder of the Companies which includes anti-dilution rights, registration rights, voting arrangements, operating covenants or similar provisions;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;any collective bargaining agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;any royalty, dividend or similar arrangement based on the revenues or profits of the Companies or any contract or agreement involving fixed price or fixed volume arrangements;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;any joint venture, franchise, partnership, manufacturer, development or agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;any supply agreement pursuant to which the Companies are required to supply materials in excess of $50,000 annually;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;any acquisition, merger or similar agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;any contract with any Governmental Authority;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;any contract providing for indemnification of any Person by the Companies (excluding confidentiality agreements, customer and vendor contracts and purchase orders including indemnification provisions entered into in the ordinary course of business);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;any material contract that can be terminated, or the provisions of which are altered, as a result of the consummation of the transactions contemplated by this Agreement or any of the other Transaction Documents to which the Companies are a party;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;any contract entered into in connection with any settlement or other resolution of any action pursuant to which the Companies has any ongoing payment obligation after the Closing; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;any other material contract not executed in the ordinary course of business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="28" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">28</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">All contracts, agreements, leases and instruments set forth on <u>Schedule 3.13</u> are valid and are in full force and effect and constitute legal, valid and binding obligations of the Company or Excell USA who is party thereto and, to the Knowledge of the Sellers and the Company, the other parties, and are enforceable in accordance with their respective terms, except as enforceability may be limited by applicable bankruptcy, insolvency, moratorium, reorganization or similar laws, from time to time in effect, which affect enforcement of creditors&#8217; rights generally. Except as set forth on <u>Schedule 3.13</u>, there has not been any written notice or, to the Sellers&#8217; and the Company&#8217;s Knowledge, oral notice or threat to terminate any material contracts, agreements, leases or instruments. Neither the Companies nor, to the Sellers&#8217; and the Company&#8217;s Knowledge, any other party to such contract is in material default in complying with any provisions of any such contract, agreement, lease or instrument, and, to the Sellers&#8217; and the Company&#8217;s Knowledge, no condition or event or fact exists which, with notice, lapse of time or both, would constitute a material default thereunder.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.14<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governmental Approvals; Compliance with Laws</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Companies are in compliance in all material respects with all applicable Laws. The Companies have all of the material permits, licenses, orders, franchises and other rights and privileges of all federal, provincial, territorial, local or foreign Governmental Authority or regulatory bodies necessary for the Companies to conduct its business as presently conducted (&#8220;<u>Permits</u>&#8221;). All such Permits are in full force and effect in all material respects, and no suspension or cancellation of any of them is, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened. Except as set forth on <u>Schedule 3.14(a)</u>, the operation of the Business as currently conducted is not, and has not been, in material default or violation of, nor are the Companies in material default or violation under, any Permit, and, to the Knowledge of the Sellers and the Company, no event has occurred which, with notice or the lapse of time or both, would constitute a default or violation of any terms, condition or provision of any Permit. Except as set forth on <u>Schedule 3.14(a),</u> the Companies have not entered into or been subject to any judgment, consent decree, compliance order or administrative order with respect to any Permit or any material aspect of the business, affairs, properties or assets of the Companies or received any request for information, written notice, demand letter, administrative inquiry or formal or informal complaint or claim from any regulatory agency with respect to any Permit or any material aspect of the business, affairs, properties or assets of the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies, nor any director, officer, agent, employee or other Person acting on behalf of the Companies (in their capacity as director, officer, agent, or employee), has: (i) used any corporate funds of the Companies for unlawful contributions, gifts, entertainment or other unlawful expenses relating to political activity in respect of the business, or failed to disclose fully any such contribution in violation of applicable Laws; (ii) directly or indirectly, paid or delivered any fee, commission or other sum of money or item of property, however characterized, to any finder, agent or other party acting on behalf of or under the auspices of a governmental official or Governmental Authority, in Canada or any other country, which is in any manner illegal under any Law of Canada or any other country having jurisdiction; (iii) made any unlawful payment or given any other unlawful consideration to any customer, agent, distributor or supplier of the Companies or any director, officer, agent, or employee of such customer or supplier; (iv) violated or taken any act that would violate any provision of the <i>Corruption of Foreign Public Officials Act</i> (Canada), <i>the Special Economic Measures Act</i> (Canada), the <i>Freezing Assets of Corrupt Foreign Public Officials Act</i> (Canada) or other similar Laws of other jurisdictions.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.15<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Insurance Coverage</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;"><u>Schedule 3.15</u> hereto contains (i) a list of all insurance policies currently in effect that insure the physical properties, business, operations and assets of the Companies, (ii) a description of all material claims of the Companies that are currently pending or that have been made with an insurance carrier since January 1, 2018, and (iii) a description of any self-insurance, co-insurance or retention arrangement by or affecting the Companies, including any reserves established thereunder. Each policy set forth in <u>Schedule 3.15</u> is valid and binding and in full force and effect (subject to bankruptcy, insolvency, reorganization, moratorium or similar laws now or hereinafter in effect relating to creditors&#8217; rights generally and to the application of equitable principles (regardless of whether enforcement is sought in a proceeding at law or in equity)) and there is no claim pending under any such policies as to which coverage has been denied or disputed. No written notice of cancellation or termination has been received by the Companies within the preceding five years<b> </b>with respect to any policy which has not been replaced on substantially similar terms prior to the date of such cancellation or termination.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="29" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">29</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">3.16<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Employee Benefits; ERISA</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.16(a)</u> contains a complete and accurate list of each plan, program, policy, contract, agreement or arrangement relating to retirement, employment, consulting, compensation, bonus, incentive, equity or equity-based compensation, change in control, severance, termination, retention, deferred compensation, profit-sharing, vacation or sick pay, medical, retiree medical, paid time off, fringe-benefits, and any other &#8220;employee benefit plan&#8221; as defined in Section&nbsp;3(3) of the Employee Retirement Income Security Act of 1974, as amended (&#8220;<u>ERISA</u>&#8221;) (whether or not subject to ERISA), and any other agreement, plan, policy or program pertaining to compensation or benefits, whether or not reduced to writing, that is in effect and covering or otherwise providing compensation or benefits to or for the benefit of one or more employees, former employees, or current or former directors or other service providers of the Companies, or the beneficiaries or dependents of any such Persons (hereinafter collectively referred to as the &#8220;<u>Employee Benefit Plans</u>&#8221; and individually as an &#8220;<u>Employee Benefit Plan</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have heretofore delivered or made available to the Buyer true and correct copies of each Employee Benefit Plan that has been reduced to writing, and with respect to each such Employee Benefit Plan true, and correct copies of, where applicable, (i) the most recently filed or circulated annual report and summary plan descriptions, if any (and any summary of material modifications thereof), (ii) the most recently received IRS determination letters, if any (iii) for the three most recently filed years, the Form 5500 and attached schedules, (iv) each trust, insurance, annuity or other funding contract related thereto and (v) the most recent financial statements and actuarial or other valuation reports prepared with respect thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Each Employee Benefit Plan is funded, maintained and administered in material compliance with the terms of such Employee Benefit Plan and all applicable Laws (including ERISA, the Code and the regulations promulgated thereunder).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;With respect to each Employee Benefit Plan:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp; There are no actions pending (other than routine claims for benefits) or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened against such Employee Benefit Plan, the Companies, or against any fiduciary of such Employee Benefit Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Full payment has been timely made, or otherwise properly accrued on the books and records of the Companies, of all amounts that the Companies are required, under the terms of the Employee Benefit Plans or applicable Law, to have paid as contributions to such Employee Benefit Plans on or prior to the date hereof (excluding any amounts not yet due);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;Each Employee Benefit Plan that is intended to be qualified under Section 401(a) of the Code (A) has received a favorable determination or opinion letter as to its qualification, (B) has been established under a standardized master and prototype or volume submitter plan for which a current favorable Internal Revenue Service advisory letter or opinion letter has been obtained by the plan sponsor and is valid as to the adopting employer, or (C) has time remaining under applicable Laws and related guidance to apply for a determination or opinion letter or to make any amendments necessary to obtain a favorable determination or opinion letter within the remedial amendment period, and, in each case, nothing has occurred that would reasonably be expected to affect such qualification;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="30" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">30</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;Neither the Companies, nor to the Sellers&#8217; and the Company&#8217;s Knowledge, any other Person, has taken any action, or failed to take any action, which action or failure would reasonably be expected to subject the Companies, or any of its employees, to any material liability for breach of any fiduciary duty, or for any prohibited transaction (as defined in Section 4975 of the Code), with respect to or in connection with such Employee Benefit Plan;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;No Employee Benefit Plan is a &#8220;multiemployer plan&#8221; as defined in Section 3(37) of ERISA or Section 414(f) of the Code, a &#8220;multiple employer plan&#8221; within the meaning of Section 413(c) of the Code or a &#8220;multiple employer welfare arrangement&#8221; within the meaning of Section 3(40) of ERISA. No Employee Benefit Plan is subject to Title IV of ERISA or the minimum funding requirements of Section 302 of ERISA or Section 412 of the Code and the Companies have not sponsored, maintained, contributed to, been required to maintain or contribute to or has had any actual or contingent liability with respect to any multiemployer plan or other benefit plan subject to Section 302 or Title IV of ERISA or Section 412 or 430 of the Code or any plan that is otherwise a defined benefit pension plan; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(vi)&nbsp;&nbsp;&nbsp;&nbsp;Except as disclosed in <u>Schedule 3.16</u>, the Companies are not required to provide any benefits for any Person upon or following retirement or termination of employment except pursuant to Part 6 of Subtitle B of Title I of ERISA or Section 4980B of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each Employee Benefit Plan that constitutes in any part a nonqualified deferred compensation plan within the meaning of Section&nbsp;409A of the Code has been operated and maintained in all material respects in operational and documentary compliance with Section&nbsp;409A of the Code and all IRS guidance promulgated thereunder, to the extent such section and such guidance have been applicable to such Employee Benefit Plan. There is no agreement, plan or other arrangement to which the Company or any of the Subsidiaries is a party or by which any of them is otherwise bound to compensate any Person in respect of Taxes pursuant to Section&nbsp;409A or 4999 of the Code.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except as set forth on <u>Schedule 3.16</u>, there are no: (i)&nbsp;bonus, golden parachute, retirement, retention, change of control, termination, severance, unemployment compensation, or other compensation or benefit or enhanced benefit arrangements with respect to any current or former director, employee or consultant or other service provider of the Companies, (ii)&nbsp;material increases in compensation or benefits otherwise payable under any Employee Benefit Plan, (iii)&nbsp;entitlements of any employee of the Companies to any job security or similar benefit or enhanced benefits, (iv)&nbsp;acceleration of the time of payment or vesting of any compensation or benefits otherwise payable under any Employee Benefit Plan, or termination of such Employee Benefit Plan other than at the sole and unfettered discretion of the Companies, (v) funding of any compensation or benefits, (vi) breach or violation of or default under or any limit on the Companies&#8217; right to amend, modify or terminate any Employee Benefit Plan or (vii) payment of any &#8220;excess parachute payment&#8221; (as defined in Section 280G(b)(1) of the Code), in each case, resulting from the execution and delivery of this Agreement, the performance of the Companies&#8217; obligations under this Agreement or the consummation of any of the transactions contemplated in this Agreement or the other Transaction Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.17<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Labour and Employment Matters</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.17</u> sets forth a complete and correct list of all employees, consultants, and independent contractors by unique identifier that identifies their work location; whether they are full-time or part-time; their position or title; their number of years of service; their current base salary, wage rate, commission, incentives, consulting fees, profit-sharing, deferred compensation, variable remuneration and any other compensation as well as any bonus or commission paid to them for the prior calendar year; whether they are on leave of absence and, if so, the type of leave and expected return to work date (if known); any perquisites; any accrued vacation, overtime or sick day entitlement and whether such employee, consultant or independent contractor is subject to a written employee/consultant/contractor agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="31" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">31</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set out in <u>Schedule 3.17</u>, no employee, consultant, or contractor has any agreement as to length of notice or severance, retention bonus, change of control, or golden parachute.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Except as set out in <u>Schedule 3.17</u>, the negotiation and execution of this Agreement, or the consummation of the Transactions will not entitle any current or former employee to severance, retention, bonus, or other similar payment or right, or accelerate the time of payment or vesting or increase the amount of compensation due to any such employee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;All accruals for unpaid vacation pay, sick pay and overtime, premiums for employment insurance, Employee Benefit Plan premiums, Canada Pension Plan premiums, accrued wages, salaries and incentive payments have been reflected in the Companies&#8217; books and records;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;There are no unionized employees. The Companies are not bound by or subject to or negotiating any collective bargaining agreement, application for certification, notice to bargain, voluntary recognition, or any other labour agreement. The Companies have not made any commitments to voluntarily recognize or negotiate with any union or employee association. There is no union organization activity or any application for certification of a collective bargaining agent involving any of the employees of the Companies pending or, and, during the three (3) year period ending on the date hereof, to the Knowledge of the Sellers and the Company, no such organizing activity has been threatened. The Companies have not engaged in and, to the Sellers and the Company&#8217;s Knowledge, has not been alleged to have engaged in any unfair labour practices for the past three years.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;The Companies and the conduct of the Business are in compliance, in all material respects, with all Laws relating to the employment of labour, including all such Laws relating to employment standards such as, wages, hours, overtime, vacation, public holidays, leaves of absence, human rights and harassment and discrimination prevention, immigration, occupational safety and health, accessibility, privacy, mass termination, pay equity, workers&#8217; compensation and the collection and payment of deductions, withholdings and premiums associated with Canada Pension Plan, Employment Insurance, income tax, Employer Health Tax, and workers&#8217; compensation insurance.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have, for each of its employees, completed documentation which verifies the identity and work authorization status of each of its employees in compliance with applicable immigration Laws and related regulations thereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;During the three year period ending on the date hereof, there has been no &#8220;mass layoff&#8221; or &#8220;plant closing&#8221; with respect to the Companies. The Business has not, during the last three (3) years, experienced any and, to the Sellers&#8217; and the Company&#8217;s Knowledge, there are no currently threatened, strikes, slowdowns, picketing or work stoppages. There is no material charge, grievance proceeding or other claim pending, or to the Knowledge of the Sellers and the Company threatened, against or affecting the Companies relating to the alleged violation of any Law pertaining to labour relations or employment, discrimination or harassment or termination of employment, including any charge or complaint filed by an employee with the provincial Ministry of Labour or any comparable Governmental Authority. The Companies have delivered or otherwise made available to the Buyer, true, correct and complete copies of all current employee manuals and handbooks relating to the employment of employees, including all amendments thereof and modifications thereto. There are no outstanding orders against the Companies under applicable employment standards or health and safety legislation.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="32" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">32</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, those individuals who have been classified as consultants or independent contractors have been properly classified and the Companies have not received any written notice from any Governmental Authority disputing that classification. No consultant or independent contractor has raised any type of claim regarding classification or asserted that he or she should be classified and treated as an employee. No consultant or independent contractor has been promised employment, contingent or otherwise, with the Companies now or in the future.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;There are no outstanding assessments or other amounts due and owing by the Companies under any workplace safety and insurance or workers&#8217; compensation insurance requirements. To the Sellers&#8217; and the Company&#8217;s knowledge, there are no facts or circumstances (including claims and potential claims) that would reasonably be expected to result in a material increase in the Companies&#8217; accident cost experience. There are no charges against the Companies pending, or to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened or anticipated under applicable health and safety legislation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.18<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>No Brokers or Finders</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except for Legacy Business Advisory Services Inc., no Person has, as a result of the transactions contemplated by this Agreement, any right, interest or claim against or upon the Companies for any commission, fee or other compensation as a finder or broker because of any act or omission by the Company or its shareholders or Affiliates.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.19<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transactions with Affiliates</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Except as set forth on <u>Schedule 3.19</u>, and except for the Transaction Documents, no present officer, director or shareholder of the Companies, nor any Affiliate of the Companies, is currently a party to any transaction or contract with the Companies, other than (i)&nbsp;payment of compensation for employment or as an independent contractor or reimbursement of expenses to employees, independent contractors or directors consistent with past practice or as is required by law, and other matters incidental to employment with or board membership with the Companies, and (ii) contracts which will be terminated at or prior to the Closing without penalty.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.20<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Environmental Matters</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The Companies are currently and have been in material compliance with all Environmental Laws and have not, and the Companies have not received from any Person or Governmental Authority in relation to the Companies or any property currently or formerly owned, operated or leased by the Companies, any actual, pending or, to the Sellers&#8217; and the Company&#8217;s Knowledge, threatened: (i) Environmental Notice or Environmental Claim; and (ii) written request for information pursuant to Environmental Laws, which, in each case, either remains pending or unresolved, or is the source of ongoing obligations or requirements as of the Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have obtained and is in material compliance with all Environmental Permits (of which there are none, except for those disclosed in <u>Schedule 3.20(b)</u>) necessary for the ownership, lease, operation or use of the business or assets of the Companies and all such Environmental Permits are in full force and effect, and there is no condition, event or circumstance that would reasonably be anticipated to prevent or impede the ownership, lease, operation or use of the business or assets of the Companies as currently carried out.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="33" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">33</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;No real property currently or formerly owned, operated or leased by the Companies is listed on, or to the Sellers&#8217; and the Company&#8217;s Knowledge, has been proposed for listing on, any list of known or suspected contaminated sites under any Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.20(d)</u>, there has been no Release of Hazardous Materials in contravention of Environmental Laws with respect to the business or assets of the Companies or any real property currently or formerly owned, operated or leased by the Companies, and the Companies have not received an Environmental Notice that any real property currently or formerly owned, operated or leased in connection with the business of the Companies (including soils, groundwater, surface water, buildings and other structure located on any such real property) has been contaminated with any Hazardous Material which, in each case, would reasonably be expected to result in an Environmental Claim against, or a violation of Environmental Laws or term of any Environmental Permits by, the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.20(e)</u> contains a complete and accurate list of all off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Companies and any predecessors as to which the Companies may retain liability, and to the Sellers&#8217; and the Company&#8217;s Knowledge, none of these facilities or locations has been placed or proposed for placement on any list of known or suspected contaminated sites under any Environmental Laws, and the Companies have not received any Environmental Notice regarding potential liabilities with respect to such off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Companies in respect of the transportation of Hazardous Materials.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, the Company has not retained or assumed, by contract or operation of law, any liabilities or obligations of third parties under Environmental Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers and the Companies have provided or otherwise made available to the Buyer: (i) any and all material environmental reports, studies, audits, investigations, records, sampling data, site assessments, risk assessments, economic models and other similar documents and reports with respect to the business or assets of the Companies or any currently or formerly owned, operated or leased real property which are in the possession or control of the Companies or the Sellers related to compliance with Environmental Laws, Environmental Claims or an Environmental Notice or the presence of, exposure to or Release of Hazardous Materials; and (ii) any and all material documents concerning planned or anticipated capital expenditures required to reduce, offset, limit or otherwise control pollution and/or emissions, manage waste or otherwise ensure compliance with current or future Environmental Laws (including, without limitation, costs of remediation, pollution control equipment, transportation of Hazardous Materials and dangerous goods, producer responsibility or stewardship requirements and operational changes).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Sellers&#8217; and the Company&#8217;s Knowledge, there is no condition, event or circumstance concerning the release or regulation of Hazardous Materials that would reasonably be anticipated, as of the Closing Date, to prevent, impede or materially increase the costs associated with the ownership, lease, operation, performance or use of the business or assets of the Companies as currently carried out.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.21<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Company Records</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The minute books of the Companies accurately reflect in all material respects all corporate or other action taken by its shareholders and board of directors and committees. The copies of the minutes of the Companies, as made available to the Buyer for review, are true and complete copies of the originals of such documents.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="34" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">34</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.22<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Customers and Suppliers</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.22(a)</u> sets forth a list of top 10 customers from whom Excell USA made annual sales exceeding $50,000 during the fiscal year ended January 31, 2021 and reasonably expected to exceed $50,000 during the fiscal year ended January 31, 2022 and the dollar amount of sales to such customers for such fiscal year (the &#8220;<u>Customers</u>&#8221;). The Companies&#8217; relationships with the Customers are, to the Knowledge of the Sellers and the Company, good commercial working relationships, and, within the last 12 months, no Customer has canceled, materially modified, or otherwise terminated its relationship with Excell USA, or materially decreased its orders from the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.22(b)</u> sets forth a list of top 10 suppliers from whom Excell USA made annual purchases exceeding $50,000 during the fiscal year ended January 31, 2021 and reasonably expected to exceed $50,000 during the fiscal year ended January 31, 2022 and the dollar amount of purchases from such suppliers for such fiscal year (the &#8220;<u>Suppliers</u>&#8221;). The Companies&#8217; relationships with the Suppliers are, to the Knowledge of the Sellers and the Company, good commercial working relationships, and, within the last 12 months, no Supplier has canceled, materially modified, or otherwise terminated its relationship with Excell USA, or materially decreased its services, supplies or materials to the Companies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.23<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Assets; Solvency</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.23(a)</u>, the assets owned by the Companies, or to which the Companies have access, include all rights and property necessary to enable the Companies to conduct the business of the Companies, as conducted on the date hereof, in all material respects. The Companies own (with good title, except for Permitted Encumbrances) all of the properties and assets (whether real, personal or mixed and whether tangible or intangible) that it purports to own in accordance with <u>Schedule 3.23(a)</u>, including all the properties and assets reflected as being owned by the Companies in its financial books and records. Except with respect to liens associated with the Indebtedness set forth on <u>Schedule 3.7</u>, the Companies have legal and beneficial ownership of such assets free and clear of all liens other than Permitted Encumbrances.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.23(b)</u>, the inventory of the Companies, wherever located, including the supplies inventory (collectively, the &#8220;<u>Inventory</u>&#8221;), is in all material respects in good, useable and/or salable condition and consists of items of a quality and quantity previously used and/or sold by the Companies in the ordinary course of business determined and expensed consistent with the Companies&#8217; past practice and contains no significant amount of excess, dated or obsolete inventory except for Inventory that has been appropriately written off, written down to net realizable value or otherwise adequately reserved for in the Interims. The Companies have not had any material liability arising out of any injury to individuals or property as a result of the ownership, possession, distribution, sale, use or consumption of any product formulated, designed, manufactured, delivered or sold, or services rendered by or on behalf of the Companies, and, to the Knowledge of the Sellers and the Company, there are no facts and/or circumstances that could give rise to any such liability. In the past three (3) years, the Companies have not had any material liability to replace or recall any Inventory or other damages in connection therewith, and, to the Knowledge of the Sellers and the Company, there are no facts and/or circumstances that could give rise to any such liability.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Companies have not: (i) made a general assignment for the benefit of creditors; (ii) filed any voluntary petition in bankruptcy or suffered the filing of any involuntary petition by its creditors; (iii) suffered the appointment of a receiver to take possession of all, or substantially all, of its assets; (iv) suffered the attachment or other judicial seizure of all, or substantially all, of its assets; (v) admitted its inability to pay its debts as they come due; or (vi) made an offer of settlement, extension or composition to its creditors generally.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="35" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">35</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.24<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Companies are not engaged in the activities of a &#8220;cultural business&#8221; as defined in the <i>Investment Canada Act</i>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.25<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Competition Act</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">For the purposes of the threshold set out at Section 110(3) of the <i>Competition Act</i> (Canada), the Company and its affiliates (as such term is used in the <i>Competition Act</i> (Canada)) do not have aggregate assets in Canada that exceed Cdn$93,000,000, nor do they have aggregate gross revenues from sales in or from Canada generated from their assets in Canada that exceed Cdn$93,000,000, all as determined in accordance with Part IX of the <i>Competition Act</i> (Canada).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.26<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>COVID-19 Compliance</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.26(a)</u> sets forth all governmental programs that the Company has availed itself of that provide financial or other relief in connection with the COVID-19 pandemic. <u>Schedule 3.26(a)</u> sets forth the status of the Company under each program, including acceptance or rejection of its application, amount of funds received, and any other relief received. In respect of the government programs disclosed on <u>Schedule 3.26(a)</u>, the Company has (i) not made a claim for, nor received, any such government sponsored financial aid that it is not entitled to receive, and (ii) not received any written notice, claims or written correspondence indicating, or has any reason to believe, that the Company would be denied any such government sponsored financial aid.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Company has implemented all applicable workplace, operational and other guidelines, directives, recommendations, precautions and measures regarding the COVID-19 pandemic required of the Company by applicable Laws, including social distancing measures, increased sanitization measures, measures to protect employee and partner health, measures to prevent crowds, and measures to prevent unnecessary contact, and the Company has at all times complied and is in compliance, in all material respects, with all applicable Laws regarding the COVID-19 pandemic. The Company has not experienced any occurrence of (i) to the Knowledge of the Sellers and the Company, any diagnosis of COVID-19 with respect to any employee or independent contractor of the Company that was subject to exposure on any of the Company&#8217;s locations or premises, or (ii) during the course of the COVID-19 pandemic, other than mandatory shutdowns pursuant to applicable Law, any shutdown of or ceasing of operations at any of the Company&#8217;s locations or premises.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Company has delivered or made available to the Buyer correct and complete copies of all written policies of the Company relating to the COVID-19 pandemic and compliance with the applicable Laws referred to in <u>Section 3.26(b).</u></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Except as set forth on <u>Schedule 3.26(d),</u> Excell USA has not experienced, and to Seller&#8217;s and the Company&#8217;s Knowledge, there are not any facts that would give rise to, any business interruptions arising out of, resulting from or related to COVID-19 or COVID-19 Measures. Except as set forth on <u>Schedule 3.26(d)</u> and except for COVID-19 Measures that generally apply to all businesses operating in Texas, USA, Excell USA is not subject to (or has received an exclusion from the applicable Governmental Authority) any COVID-19 Measure that, individually or in the aggregate, prevents, or would reasonably be expected to prevent, Excell USA from operating in the ordinary course of business.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="36" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">36</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Schedule 3.26(e)</u> sets forth a true, correct and complete list of the CARES Act stimulus or relief programs (the &#8220;<u>CARES Act Programs</u>&#8221;) in which Excell USA is participating, or in which it has participated, and the amount of funds requested or received by Excell USA under each such program. The Companies have made available to Buyer true, correct and complete copies of all applications, forms and other documents filed or submitted by Excell USA relating to any CARES Act Program, and all statements and information contained in such applications, forms and other documents are true, correct, and complete. The proceeds received from any CARES Act Program, including the PPP Loan, were not used by the Companies in violation of the CARES Act or any CARES Act Terms. An application for forgiveness of 100% of the PPP Loan has been submitted to the PPP Lender, which application has been received by the PPP Lender.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE IV</u></b><b><u>&nbsp;- REPRESENTATIONS AND WARRANTIES OF THE SELLERS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">In order to induce the Buyer to enter into this Agreement and consummate the transactions contemplated hereby, each of the Sellers, severally (and not jointly and severally), hereby represent and warrant to the Buyer that, except as and to the extent disclosed in the Disclosure Schedule, the statements contained in this <u>Article IV</u> are complete and accurate as of the Closing.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as set forth on <u>Schedule 4.1</u>:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Such Seller has full right, authority and power to enter into this Agreement, the Transaction Documents to which Such Seller is a party and all agreements, documents and instruments executed by such Seller pursuant hereto and to carry out the transactions contemplated hereby and thereby. This Agreement, the Transaction Documents to which such Seller is a party and all agreements, documents and instruments executed by such Seller pursuant hereto are valid and binding obligations of such Seller enforceable in accordance with their respective terms, except to the extent that enforceability may be subject to, and limited by, applicable bankruptcy, insolvency, reorganization, moratorium, receivership and similar Laws affecting the enforcement of creditors&#8217; rights generally, and general equitable principles.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The execution, delivery and performance by such Seller of this Agreement, the Transaction Documents to which such Seller is a party and all agreements, documents and instruments to be executed and delivered by such Seller pursuant hereto do not and will not: (a) violate or result in a violation of, or constitute or result in a default (whether after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any material contract, agreement, obligation, permit, license or authorization to which such Seller is a party or by which such Seller or its assets are bound; (b) violate or result in a violation of, or constitute a default (whether after the giving of notice, lapse of time or both) under, any provision of any material Law, or any order of, or any restriction imposed by, any court or governmental agency applicable to such Seller; or (c) require from such Seller any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third party (that has not already been obtained).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Shares</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">As of the date hereof, such Seller is the only record and beneficial owner of the Shares to be sold, conveyed, assigned and transferred to the Buyer pursuant to the terms and conditions of this Agreement. Such Seller has good and valid title to such Shares, free and clear of all Encumbrances (except for Permitted Encumbrances). Such Seller is not a party to (a) any option, warrant, purchase right, or other contract or commitment that could require such Seller to sell, transfer or otherwise dispose of any Shares (other than this Agreement) or (b) any voting trust, proxy or other contract with respect to the voting of any Shares.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="37" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">37</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Legal Proceedings</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There are no Legal Proceedings pending, threatened by or, to the Knowledge of such Seller, threatened against such Seller or any Affiliate of such Seller that challenge or seek to prevent, enjoin or otherwise delay the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Banking; Brokerage Fees</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except to Legacy Business Advisory Services Inc., such Seller has not incurred nor become liable for any investment banking fees, brokerage commissions, broker&#8217;s or finder&#8217;s fees or similar compensation (exclusive of professional fees to lawyers and accountants) in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">4.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Residency </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Such Seller is not a non-resident of Canada within the meaning of the Tax Act.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE V</u></b><b><u>&nbsp;- REPRESENTATIONS AND WARRANTIES OF THE BUYER </u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer hereby represents, warrants and covenants on behalf of itself only that, the statements contained in this <u>Article V</u> are complete and accurate as of the Closing:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Organization and Power</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer is validly existing and in good standing under the Laws of the Province of British Columbia, and has the requisite corporate power and authority to own, lease and operate its properties and assets, to carry on its business as now being conducted and to enter into and perform this Agreement and the Transaction Documents to which it is a party and to carry out the transactions contemplated hereby and thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Authority and Non-Contravention</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has full right, authority and power to enter into this Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto and to carry out the transactions contemplated hereby and thereby. This Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto are valid and binding obligations of the Buyer enforceable in accordance with their respective terms. The execution, delivery and performance of this Agreement, the Transaction Documents and all agreements, documents and instruments executed by the Buyer pursuant hereto have been duly authorized by all necessary action under the Buyer&#8217;s organizational documents. The execution, delivery and performance by the Buyer of this Agreement, the Transaction Documents and all agreements, documents and instruments to be executed and delivered by the Buyer pursuant hereto do not and will not: (a) violate or result in a violation of, or constitute or result in a default (whether after the giving of notice, lapse of time or both) under, accelerate any obligation under, or give rise to a right of termination of, any material contract, agreement, obligation, permit, license or authorization to which the Buyer is a party or by which the Buyer or its assets are bound, or any provision of the Buyer&#8217;s organizational documents; (b) violate or result in a violation of, or constitute a default (whether after the giving of notice, lapse of time or both) under, any provision of any Law, or any order of, or any restriction imposed by, any court or governmental agency applicable to the Buyer; or (c) other than a post-Closing notification under the Investment Canada Act, require from the Buyer any notice to, declaration or filing with, or consent or approval of, any Governmental Authority or other third party (that has not already been obtained).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="38" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">38</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Consents and Approvals</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No consent, approval, waiver, exception, authorization, notice or filing is required to be obtained by the Buyer from, or to be given by the Buyer to, or be made by the Buyer with, any Governmental Authority in connection with the execution, delivery and performance by the Buyer of this Agreement and the Transaction Documents to which it is a party.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">No consent, approval, waiver, authorization, notice, exemption or filing is required to be obtained by the Buyer from, or to be given by the Buyer to, or made by the Buyer with, any Person which is not a Governmental Authority in connection with the execution, delivery and performance by the Buyer of this Agreement and the Transaction Documents to which it is a party</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Litigation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">There is no action pending or, to the knowledge of the Buyer, threatened against the Buyer and the Buyer is not subject to any outstanding order with respect to execution of this Agreement and the other Transaction Documents to which it is a party or the consummation by the Buyer of the transactions contemplated hereby and thereby.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Competition Act</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The assets and gross revenues of the Buyer and its affiliates (as such term is used in the <i>Competition Act</i> (Canada)) are such that, after taking into account the assets and gross revenues of the Company, do not exceed the monetary threshold set forth in section 110(3) of the <i>Competition Act</i> (Canada).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer is a &#8220;non-Canadian&#8221; and is a &#8220;WTO investor&#8221; for the purposes of and within the meaning of the <i>Investment Canada Act</i>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transferred Information</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has collected, used and disclosed the Transferred Information solely for the purpose of reviewing and completing the transactions contemplated by this Agreement, including for the purpose of determining to complete such transactions, or as otherwise authorized or permitted by applicable Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">5.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Banking; Brokerage Fees</u></b><b> </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Buyer has not incurred or become liable for any investment banking fees, brokerage commissions, broker&#8217;s or finder&#8217;s fees or similar compensation (exclusive of professional fees to lawyers and accountants) in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="39" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">39</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VI</u></b><b><u>&nbsp;- ADDITIONAL AGREEMENTS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Announcement; Confidentiality</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;None of the Companies, the Sellers, or the Buyer will issue any press release or otherwise make any public statement with respect to this Agreement and the transactions contemplated hereby without the prior consent of the other parties hereto (which consent will not be unreasonably withheld), except as may be required by applicable Law, including, without limitation, any securities filings which are to be made by a Party. Notwithstanding anything in this <u>Section 6.1</u> to the contrary, the Sellers&#8217; Representative and the Buyer will, to the extent practicable, consult with each other before issuing, and provide each other a reasonable prior opportunity to review and comment upon, any such press release or other public statements with respect to this Agreement and the transactions contemplated hereby, whether or not required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Until the fifth anniversary of the Closing Date, the Sellers each respectively agrees that, without the prior written consent of the Buyer, (i) it shall, and shall cause each of its Affiliates to, keep confidential all confidential, non-public or proprietary information and materials regarding the Buyer, the Company and their respective Affiliates (except to the extent (a) disclosure of such information is required by applicable Law, (b) such information becomes available to such Person after the Closing Date from a source (which is not known by such Person to have made the disclosure in violation of any confidentiality obligations), or (c) such information becomes publicly known except through the actions or inactions of any such Person in violation of this <u>Section 6.1(b)</u>), (ii) it shall take reasonable and appropriate steps (and cause each of its Affiliates to take reasonable and appropriate steps) to safeguard such information and to protect it against disclosure, misuse, espionage, loss and theft, in each case at the Buyer&#8217;s or the Company&#8217;s expense, and (iii) in the event such Person or any of its Affiliates is required by (or requested by a Governmental Authority with competent jurisdiction under) applicable Law to disclose any such information, such Person shall, to the extent permitted by applicable Law, promptly notify the Buyer in writing, which notification shall include the nature of the legal requirement or request and the extent of the required disclosure, and shall reasonably cooperate with the Buyer, at the Buyer&#8217;s sole cost and expense, to preserve the confidentiality of such information consistent with applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Non-Competition and Non-Solicitation</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Each of the Sellers hereby understand, acknowledge and agree that: the Companies are engaged in the operation of developing and supplying advanced battery solutions, including battery packs, battery chargers, and electro-magnetic assemblies related thereto (the &#8220;<u>Business</u>&#8221;); (ii) the Companies are conducting the Business throughout the United States (the &#8220;<u>Territory</u>&#8221;); (iii) the Sellers, will receive consideration in connection with the closing of the transactions contemplated by this Agreement; (iv) as a current and/or recent owner of the Company, each of the Sellers has obtained valuable knowledge, technical expertise, and confidential and proprietary information and data concerning the Business; and (v) the Sellers&#8217; entry into the agreements set forth in this <u>Section 6.2</u> is essential to preserve the value of the Company, the Business, and the assets and properties being acquired by the Buyer in connection with the transactions contemplated by this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;During the Term, the Sellers shall not, anywhere in the Territory, for themselves, respectively, or through or on behalf of any other Person (other than the Companies), whether as an officer, director, employee, seller, partner, consultant, advisor, creditor or otherwise, as applicable, directly or indirectly:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;engage in, participate in, advise, assist, invest, lend money to, guarantee the debts or obligations of, or acquire any financial or beneficial interest in (which, for the avoidance of doubt, will include employment with or engagement as an independent contractor for), any Competitive Business; <i>provided</i>, <i>however</i>, that nothing in this <u>Section 6.2(a)(i)</u> shall prevent the Sellers from owning as a passive investment less than two percent (2%) of the issued and outstanding shares in the capital (or other equity ownership interests) of a publicly-held company, other issuer whose securities are quoted on any stock exchange or inter-dealer quotation system, mutual fund, hedge fund, private equity fund or venture capital fund or;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="40" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">40</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;encourage, induce, attempt to induce, solicit or attempt to solicit any individual who is an employee of the Companies as of the date hereof, or becomes an employee of the Company at any time during the Term (each, a &#8220;<u>Specified Employee</u>&#8221;) to leave his or her employment with the Company, or hire or attempt to hire any Specified Employee; provided that nothing in this <u>Section 6.2(a)(ii)</u> shall prohibit the Sellers from (y) making general solicitation advertisements that are not targeted at any employee of the Companies and from hiring any employee that responds to a general solicitation advertisement, and (z) soliciting or hiring any Person whose employment with the Companies has been terminated at least six (6) months prior to the commencement of any such solicitation or employment or engagement discussions between such Seller and such Person; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;encourage, induce, attempt to induce, solicit or attempt to solicit, any customer, distributor, vendor, marketer, supplier or sponsor of the Companies who was a customer, distributor, vendor, marketer, supplier or sponsor of the Companies as at the Closing Date or during the one-year period preceding the Closing Date, and in the event any Seller becomes an employee of the Companies, any customers with whom such Seller had contact in the 12-month period prior to the termination of such Seller&#8217;s employment with the Companies; to cease or negatively alter its customer, distributor, vendor, marketer, supplier or sponsor relationship with the Companies, as the case may be, with respect to the Business.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Parties acknowledge and agree that the Sellers will not be in breach of this <u>Section 6.2</u> by virtue of the Sellers performing services for or providing services to the Buyer or any of its Subsidiaries (including the Companies) pursuant to and in accordance with any employment or consulting agreements or arrangements between such Seller and the Buyer or any of its Subsidiaries (including the Companies).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Parties acknowledge that Mark and his Affiliates and affiliated entities including Excell Battery Holdings Ltd., 53 Avenue Properties Ltd., Tasman Helicopters Ltd., Tasman Ventures Ltd. and Tasman Aviation Ltd. have engaged Carmena Gee, a current employee of Excell Battery Canada Inc., as an independent contractor to provide financial and accounting services to Mark and his Affiliates and affiliated entities, provided that Carmena Gee continues to devote her full business time to the affairs of Excell Battery Canada Inc. and that such engagement does not create any conflicts of interest. Each of the Buyer and the Company acknowledges and consents to Carmena Gee continuing to provide such services to Mark and his Affiliates and affiliated entities after the Closing and Mark will not be in breach of this <u>Section 6.2</u> by virtue of this arrangement with Carmena Gee.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Each of the Sellers acknowledge that a breach or threatened breach by the Sellers of any provision of this Agreement will result in the Buyer suffering irreparable harm that cannot be calculated fully or adequately by recovery of damages alone. Accordingly, the Sellers agree that, in addition to any other relief to which the Buyer may become entitled, the Buyer shall be entitled to interim and permanent injunctive relief, specific performance and other equitable remedies.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="41" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">41</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Preservation of Books and Records</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Each Party shall, and shall cause, as applicable, the Sellers, the Buyer and the Companies, in accordance with commercially reasonable retention policy practices, to preserve and keep the material records held by them relating to the business of the Companies as applicable, for a period of seven (7) years from the Closing Date and shall make such records and personnel available to a requesting Party (including the right to make copies thereof), at such requesting Party&#8217;s own cost and expense and to the extent not unreasonably burdensome to the Sellers and the Company, as applicable, as may be reasonably required by the requesting Party in connection with any insurance claims by, Legal Proceedings (including with respect to the enforcement of this Agreement, including indemnity claims) or Tax audits against or investigations by any Governmental Authority of the Sellers, the Buyer or the Company or any of their respective Affiliates with respect to their ownership of the Company, as applicable, or the transactions contemplated by this Agreement and the other Transaction Documents (including in connection with the final determination of Working Capital). Notwithstanding the foregoing, no Party will be obligated to provide a requesting Party with access to any books or records (including personnel files) where such access would (i) cause the loss of any solicitor-client or other similar privilege; or (ii) contravene any applicable Law, fiduciary duty or binding agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Investment Canada Act Notification.</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Within 30 days following Closing, the Buyer shall file notification of the transaction contemplated under this Agreement with Industry Canada, Director of Investments pursuant to and in accordance with the <i>Investment Canada Act</i>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Privileged Communications</u></b><b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">From and after Closing, all Privileged Communications will be privileged and confidential and remain the exclusive property of the Sellers, as applicable, and will not belong to the Buyer, the Companies or any other Person, notwithstanding that such Privileged Communications may remain at the premises of the Companies, in the books and records of the Companies or on any servers on the computer network of the Companies or any other Person. For certainty, and without limiting the generality of the foregoing, all Privileged Communications are protected by privilege and any inadvertent disclosure of any Privileged Communications does not and will not constitute a waiver of such privilege by the Sellers or any other Person.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Transferred Information. </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Buyer covenants to and with the Sellers that it will do or cause to be done the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;after the completion of the transactions contemplated by this Agreement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;collect, use and disclose the Transferred Information only for those purposes for which the Transferred Information was initially collected from or in respect of the individual to which such Transferred Information relates and which solely relates to the carrying on of the Business, unless:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="42" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">42</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 36pt; text-align: justify;">(A)&nbsp;&nbsp;&nbsp;&nbsp;the Buyer has first notified such individual of such additional purpose and, where required by Law, obtained the consent of such individual to such additional purpose; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 36pt; text-align: justify;">(B)&nbsp;&nbsp;&nbsp;&nbsp;such use or disclosure is permitted or authorized by Law, without notice to, or consent from, such individual; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;return or destroy the Transferred Information, at the option of the Sellers, should the transactions contemplated by this Agreement not be completed; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;where the disclosure or transfer of Transferred Information to the Buyer requires the consent of, or the provision of notice to, the individual to which such Transferred Information relates, to:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;not require or accept the disclosure or transfer of such Transferred Information until the Sellers or the Companies have first notified such individual of such disclosure or transfer and the purpose for same and, where required by Law, obtained the individual&#8217;s consent to same; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 108pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;only collect, use and disclose such information to the extent necessary to complete the transactions contemplated by this Agreement and as authorized or permitted by Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The Buyer covenants to cause the Companies to, if and to the extent required by Law, not less than thirty (30) days following the completion of the transactions contemplated by this Agreement, provide written notification to all individuals to whom the Transferred Information relates that such transactions have taken place and that the Transferred Information has been disclosed to the Buyer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Excluded Accounts Receivable. </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Within five Business Days after the date on which the Final Net Purchase Price is finally determined pursuant to <u>Section 2.6</u>, the Buyer will cause the Companies to assign to the Sellers, in consideration for the payment by the Sellers to the Companies of $1.00 in the aggregate, all Excluded Accounts Receivable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Following the date on which the Final Net Purchase Price is finally determined pursuant to <u>Section 2.6</u>, the Buyer will cause the Companies to use commercially reasonable efforts to collect the Excluded Accounts Receivable and remit to the Sellers, in such proportions as the Sellers&#8217; Representative directs, on a monthly basis, all such amounts collected, without set-off or deduction. Any amounts payable to the Sellers pursuant to this <u>Section 6.7</u> shall constitute an upwards adjustment to the Purchase Price.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Matters</u></b>&#8220;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Responsibility for Filing Tax Returns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer shall engage MNP LLP to prepare all Tax Returns of the Company or Excell USA for Tax periods ending on or before the Closing Date that are due after the Closing Date (collectively, the &#8220;<u>Buyer Prepared Pre-Closing Tax Returns</u>&#8221;). Each Buyer Prepared Pre-Closing Tax Return shall be prepared consistent with the past practices of the Company or Excell USA, as applicable and for greater certainty, no deduction shall be claimed on such Tax Returns in respect of any expenses incurred for the benefit of the Sellers in respect of the Transaction. Notwithstanding the foregoing, in any such Tax Returns, neither the Company nor Excell USA shall deduct any amount in the nature of a reserve or claim any Tax credit that would require the Company or Excell USA to include in a taxable period ending after the Closing Date any amount of income, unless the Tax liability in respect of such income (determined as though such income were the only income or loss of the Company or Excell USA for the Tax period and without regard for the availability of any loss carryforwards or carrybacks) is taken into account in computing Working Capital. The Buyer shall provide a copy of such Buyer Prepared Pre-Closing Tax Return to the Sellers&#8217; Representative for review and comment at least 30 days (10 days in the case of a non-income Tax Return) prior to the due date for filing such Tax Returns, and Buyer shall consider in good faith any reasonable comments provided by Sellers&#8217; Representative on the Buyer Prepared Pre-Closing Tax Return. The Sellers&#8217; Representative and Buyer shall work in good faith to resolve any disputes with respect to any Buyer Prepared Pre-Closing Tax Returns. If the Parties are unable to resolve a dispute, then such dispute shall be submitted to the Independent Accounting Firm to resolve such dispute in a manner consistent with the procedures for resolving disputed items set forth in <u>Section 2.6(b)</u>. If a Buyer Prepared Pre-Closing Tax Return is required to be filed prior to the resolution of a dispute, the Buyer Prepared Pre-Closing Tax Return shall be filed as determined by the Buyer and such Tax Return shall be promptly amended if and to the extent required to reflect the final resolution of the dispute. The Buyer shall cause the Company or Excell USA to timely file all Buyer Prepared Pre-Closing Tax Returns. The Sellers shall timely pay to the appropriate Tax Authority any Taxes shown as due on the Buyer Prepared Pre-Closing Tax Returns if and only to the extent that a liability for the amount of such Taxes was not included in Working Capital or such Taxes were not pre-paid by the Company, Excell USA or the Sellers prior to the Closing Date. The Company or Excell USA shall, and the Buyer shall cause the Company or Excell USA to, promptly and timely execute a Buyer Prepared Pre-Closing Tax Return to the extent required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="43" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">43</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Buyer shall prepare, or cause to be prepared, and timely file, or cause to be timely filed, all Tax Returns of the Company or Excell USA for any Straddle Period (the &#8220;<u>Buyer Prepared Post-Closing Tax Returns</u>&#8221;). Each Buyer Prepared Post-Closing Tax Return shall be prepared consistent with the past practices of the Company or Excell USA, as applicable, except as required by applicable Law. Buyer shall provide a copy of such Buyer Prepared Post-Closing Tax Return to the Sellers&#8217; Representative for review and comment at least thirty (30) days (10 days in the case of a non-income Tax Return) prior to the due date for filing such Buyer Prepared Post-Closing Tax Returns, and Buyer shall consider in good faith any reasonable comments provided by Sellers&#8217; Representative on such Buyer Prepared Post-Closing Tax Return. The Sellers&#8217; Representative and Buyer shall work in good faith to resolve any disputes with respect to any Buyer Prepared Post-Closing Tax Returns. If the Parties are unable to resolve a dispute, then such dispute shall be submitted to the Independent Accounting Firm to resolve such dispute in a manner consistent with the procedures for resolving disputed items set forth in <u>Section 2.6(b)</u>. If a Buyer Prepared Post-Closing Tax Return is required to be filed prior to the resolution of a dispute, the Tax Return shall be filed as determined by the Buyer and it shall be promptly amended if and to the extent required to reflect the final resolution of the dispute. The Sellers shall pay to Buyer all Taxes due and payable with a Buyer Prepared Post-Closing Tax Return for a Straddle Period that are allocated to the Pre-Closing Tax Period in accordance with <u>Section 6.8(c)</u> within two (2) Business Days before payment of Taxes (including estimated Taxes) is due to the applicable Tax Authority if and only to the extent that a liability for such Taxes was not included in Working Capital or such Taxes were not pre-paid by the Company, Excell USA or the Sellers prior to the Closing Date. The Company or Excell USA shall, and the Buyer shall cause the Company or Excell USA to, promptly and timely execute a Buyer Prepared Post-Closing Tax Return to the extent required by applicable Law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="44" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">44</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Cooperation on Tax Matters</u>. Buyer, the Company, Excell USA and the Sellers shall, and Buyer shall cause the Company and Excell USA to, reasonably cooperate, as and to the extent reasonably requested by any other Party, in connection with the preparation and filing of Tax Returns pursuant to this Agreement and any audit, litigation or other proceeding with respect to Taxes or Tax Returns of the Company or Excell USA for or that include a Pre-Closing Tax Period (a &#8220;<u>Tax Contest</u>&#8221;). Such cooperation will include the retention and (upon the other Party&#8217;s written request) the provision of records and information that is in the possession of such Party, which is reasonably relevant to any such Tax Contest and making employees available on a mutually convenient basis to provide additional information and explanation of any material provided under this Agreement. Buyer, the Company, Excell USA and the Sellers agree to retain all books and records with respect to Tax matters pertinent to the Company or Excell USA relating to any taxable period beginning before the Closing Date until the expiration of the statute of limitations (and, to the extent notified by Buyer, the Company, Excell USA or the Sellers any extensions thereof) of the respective taxable periods, and to abide by all record retention agreements entered into with any Tax Authority.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Contests</u>. If, subsequent to the Closing, Buyer, the Company or Excell USA receives notice of a Tax Contest relating to Taxes of the Company or Excell USA that relate to a Pre-Closing Tax Period, then within five days after receipt of such notice, Buyer shall notify the Sellers&#8217; Representative of such notice; <i>provided</i>, <i>however</i>, that any failure on the part of Buyer to so notify the Sellers&#8217; Representative shall not limit any of the obligations of the Sellers under <u>Article VII</u> (except to the extent such failure prejudices the defense of such Tax Contest). Sellers&#8217; Representative shall have the right, but not the obligation, to control the conduct and resolution of any Tax Contest that relates to any taxable period that ends on or before the Closing Date, including any settlement or compromise thereof; provided, that if the Sellers&#8217; Representative exercises its right to control the Tax Contest Sellers&#8217; Representative shall keep the Buyer reasonably informed of all material developments on a timely basis and <i>provided further</i> that the Buyer will be entitled to participate in the defense of such claim if and only to the extent that the resolution of the Tax Contest would reasonably be expect to adversely impact the Taxes or Tax Returns of the Company or Excell USA for a Tax period beginning on or after the Closing Date, and to employ counsel of its choice for such purpose, the fees and expenses of which separate counsel will be borne solely by Buyer. If and only to the extent that a settlement of a Tax Contest controlled by Sellers&#8217; Representative would reasonably be expected to subject the Buyer, the Company or Excell USA to a non-indemnified Tax, Sellers&#8217; Representative shall not settle such Tax Contest without the prior written consent of the Buyer (which consent shall not be unreasonably withheld, conditioned or delayed). Buyer shall have the right and obligation to control the conduct and resolution of any Tax Contest that relates to a Straddle Period or that is not controlled by the Sellers&#8217; Representative, including any settlement or compromise thereof; <i>provided</i>, that Buyer shall keep the Sellers&#8217; Representative reasonably informed of all material developments on a timely basis<i> provided further</i> that the Sellers&#8217; Representative will be entitled to participate in the defense of such Tax Contest and to employ counsel of its choice for such purpose, the fees and expenses of which separate counsel will be borne by Sellers. Neither Buyer, the Company nor Excell USA shall settle a Tax Contest that Buyer controls without the prior written consent of the Sellers&#8217; Representative (which consent shall not be unreasonably withheld, conditioned or delayed if such settlement would impact the Sellers). To the extent any provisions in <u>Section 7.6</u> are inconsistent with this <u>Section 6.8(c)</u> with respect to any Third-Party Claim that relates to Taxes, this <u>Section 6.8(c)</u> shall control.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="45" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">45</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Straddle Period Allocation</u>. For purposes of <u>Section 6.8(a)(ii)</u> and <u>Article VII</u>, the portion of any Tax that relates to the portion of any Straddle Period ending on the day prior to the Closing Date shall be allocated to the Pre-Closing Tax Period as follows: (A) the amount of any Taxes for the Pre-Closing Tax Period that are (i) based on or measured by income or receipts, (ii) imposed in connection with the sale, transfer or assignment of property, or (iii) required to be withheld, shall be determined based on an interim closing of the books as of the close of business on the day prior to the Closing Date; (B) the amount of all other Taxes that relate to the Pre-Closing Tax Period shall be deemed equal to the amount of such Taxes for the entire period multiplied by a fraction, the numerator of which is the number of days in the period ending on the day prior to the Closing Date and the denominator of which is the number of days in the entire period. Taxes allocated to the Pre-Closing Tax Period shall be borne by the Sellers to the extent set forth in this Agreement. The remainder of the Taxes for the Straddle Period that are not allocated to the Pre-Closing Tax Period shall be allocated to the portion of the Straddle Period beginning on the Closing Date and such Taxes shall be borne by Buyer.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;If, at any time after the Closing Date, the Company is assessed for Taxes under subsection 185.1(1) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of an "excessive eligible dividend designation" within the meaning of subsection 89(1) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of any dividend paid on or before the Closing (including for greater certainty, any dividends paid, or deemed to have been paid, on the Closing Date and before the Closing), Buyer shall cause the Company to make the election under subsection 185.1(2) of the Tax Act (or equivalent provision under any provincial tax legislation) in prescribed manner and within the time specified in subsection 185.1(2) (or equivalent provision under any provincial tax legislation), in respect of any such "excessive eligible dividend designation" so as to treat such excess amount as a separate taxable dividend and each of the Sellers hereby concurs with the making of the election under subsection 185.1(2) of the Tax Act (or equivalent provision under any provincial tax legislation) to treat such excess amount as a taxable dividend and shall cooperate with the Company and take all steps necessary in order to make such election. Notwithstanding the foregoing, the filing of the election by a Company and the concurrence of the Sellers does not relieve the Sellers from their indemnification obligations to the Buyer to the extent that either the Company or the Buyer is liable to pay any Tax or otherwise suffers any Losses as a result of such excessive eligible dividend election.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;If, at any time after the Closing Date, the Company is assessed for Taxes under subsection 184(2) of the Tax Act (or equivalent provision under any provincial tax legislation) in respect of a dividend paid on or before the Closing (including for greater certainty, any dividends paid, or deemed to have been paid, on the Closing Date and before the Closing) in respect of which such Company made a capital dividend election under subsection 83(2) of the Tax Act (or equivalent provision under any provincial tax legislation), Buyer shall cause such Company to make the election under subsection 184(3) of the Tax Act (or equivalent provision under any provincial tax legislation) in prescribed manner and within the time specified in subsection 184(3) (or equivalent provision under any provincial tax legislation) in respect of any such excessive capital dividend election so as to treat such excess amount as a separate taxable dividend and each of the Sellers hereby concurs with the making of an election under subsection 184(3) of the Tax Act (or equivalent provision under any provincial tax legislation) to treat such excess amount as a taxable dividend and shall cooperate with the Company and take all steps necessary in order to make such election. Notwithstanding the foregoing, the filing of the election by a Company and the concurrence of the Sellers does not relieve the Sellers from their indemnification obligations to the Buyer to the extent that either the Company or the Buyer is liable to pay any Tax or otherwise suffers any loss or damage as a result of such capital dividend election.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>Transfer Taxes</u>. All transfer, documentary, sales, use, stamp, registration and other such Taxes (including any penalties and interest) incurred in connection with this Agreement (&#8220;<u>Transfer Taxes</u>&#8221;), if any, shall be borne by the Buyer. All necessary Tax Returns and other documentation with respect to all such Transfer Taxes shall be filed by the Party required to file such Tax Returns under applicable Law (at the cost and expense of the Buyer) and such Party shall provide copies of such Tax Returns to the other Party and, if required by applicable Law, the other Party will join in the execution of any such Tax Returns and other documentation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="46" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">46</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Post-Closing Tax Matters.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;To the extent not reflected as a positive adjustment to the Final Net Purchase Price or not included in the calculation of Working Capital, promptly upon receipt by the Company, Excell USA or Buyer, the Buyer shall pay (net of any applicable Taxes) to Sellers any refund, rebate, abatement, reduction or other recovery (whether direct or indirect through a right of setoff or credit) of Taxes of the Company or Excell USA and any interest received thereon, attributable to any Pre-Closing Tax Period of the Company or Excell USA. The Parties agree to treat any payment made pursuant to this <u>Section 6.8(h)(i)</u> as an adjustment to the Purchase Price for Tax purposes. Upon request by Sellers&#8217; Representative after the Closing Date, the Buyer shall cause the Company or Excell USA to use commercially reasonable efforts to obtain any refund, rebate, abatement, reduction or other recovery (whether direct or indirect through a right of setoff or credit) of Taxes of the Company or Excell USA and any applicable interest for any Pre-Closing Tax Period that would be payable to the Sellers pursuant to this <u>Section 6.8(h)(i)</u>, including by filing amended Tax Returns. In the event that the Company or Excell USA is subsequently required to repay to any Tax Authority any amount paid to the Sellers pursuant to the provisions of this <u>Section 6.4(h)(i)</u>, any such amount shall be repaid to Buyer, together with any interest and penalties owed in respect of such disallowed refund or credit, within ten (10) Business Days, as an adjustment to the Purchase Price.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;Following the Closing, unless the Sellers&#8217; Representative provides his prior written consent, the Buyer, the Company and Excell USA shall not (i)&nbsp;amend, refile or otherwise modify any Tax election or Tax Return of or related to the Company or Excell USA with respect to any Pre&#8209;Closing Tax Period, (ii)&nbsp;file a Tax Return of the Company or Excell USA for a Pre&#8209;Closing Tax Period in a jurisdiction where the Company or Excell USA has not previously filed a Tax Return, (iii)&nbsp;grant an extension of any applicable statute of limitations with respect to a Tax Return of the Company or Excell USA for a Pre&#8209;Closing Tax Period, or (iv)&nbsp;enter into any voluntary disclosure Tax program, agreement or arrangement with any Governmental Authority or Tax Authority that relates to the Taxes or Tax Returns of the Company or Excell USA for a Pre-Closing Tax Period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this <u>Section 6.8</u>, all references to the Buyer, the Sellers, Sellers&#8217; Representative, the Company and Excell USA include their respective successors.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Restrictive Covenants</u>. The parties agree that no amount of the Purchase Price will be allocated to the granting of any restrictive covenants (as such term is defined in the Tax Act) by the Sellers or any other Person, including those contained in <u>Section 6.2</u>. Notwithstanding that the parties have not allocated any amount of the Purchase Price to such covenants, the Buyer agrees to make, if requested by a Seller, a joint election to have the provisions of section 56.4 of the Tax Act, and any equivalent or corresponding provision under applicable provincial or territorial Tax Laws, apply in respect of any such covenants.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Assurances</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">From time to time after the date hereof, and without further consideration, the Parties shall execute and deliver, or arrange for the execution and delivery of, such other instruments of conveyance and transfer and take or arrange for such other actions as may be reasonably requested by the other Party to more effectively complete any of the transactions provided for in this Agreement or any document contemplated hereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="47" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">47</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>D&amp;O Policy; Indemnification of Directors and Officers</u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;At the Closing, the Company shall purchase an extended reporting period endorsement under the Companies&#8217; existing directors' and officers' liability insurance coverage for the Companies&#8217; directors and officers in a form reasonably acceptable to the Company that shall provide such directors and officers with coverage for six years following the Closing of not less than the existing coverage and have other terms not materially less favorable to, the insured Persons than the directors&#8217; and officers&#8217; liability insurance coverage presently maintained by the Companies (the &#8220;<u>D&amp;O Tail Policy</u>&#8221;). The Company shall maintain the D&amp;O Tail Policy in full force and effect, and continue to honor the obligations thereunder. 50% of the cost of the D&amp;O Tail Policy shall be considered a Company Transaction Expense and 50% shall be borne by the Buyer as a Buyer Transaction Expense.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;For a period of six years after the Closing, the Buyer shall not, and shall not permit the Companies to, amend, repeal or modify (in a manner adverse to the beneficiary thereof) any provision in the Companies&#8217; constating documents relating to exculpation or indemnification of any current or former officers or directors of the Companies, it being the intent of the parties hereto that the officers and directors of the Companies continue to be entitled to such exculpation and indemnification to the full extent of the law. In the event the Buyer, the Companies or any of their respective successors or assigns (a) consolidates with or merges into any other Person and shall not be the continuing or surviving corporation or entity in such consolidation or merger or (b) transfers all or substantially all of its properties and assets to any Person, then, and in either such case, proper provision shall be made so that the successors and assigns of the Buyer or the Companies, as the case may be, shall assume all of the obligations set forth in this <u>Section 6.10</u>. This <u>Section 6.10</u> is intended for the benefit of, and is enforceable by, each current and former officer and director of the Companies and his or her heirs, executors and representatives, and are in addition to, and not in substitution for, any other rights to indemnification or contribution that any such Person may have had by contract or otherwise.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VII</u></b><b><u>&nbsp;- INDEMNIFICATION</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations, Warranties and Covenants</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">All representations, warranties, covenants, and agreements of the Company, the Sellers, and the Buyer made in this Agreement, all Transaction Documents executed and delivered in connection herewith, and all certificates delivered in connection therewith (a) shall be deemed to have been relied upon by the Party or Parties to whom they are made, and shall survive the Closing in accordance with the terms and conditions of this Agreement, and (b) shall bind the Parties&#8217; successors and assigns (including, without limitation, any successor to the Company by way of acquisition, merger or otherwise), whether so expressed or not, and, except as otherwise provided in this Agreement, all such representations, warranties, covenants and agreements shall inure to the benefit of the Parties (subject to <u>Section 7.2</u> below) and their respective successors and assigns and to their transferees of Shares, whether so expressed or not.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="48" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">48</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Survival Period</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Other than with respect to the Fundamental Representations of the Sellers and the Fundamental Representations of the Buyer, and as set forth in this <u>Section 7.2</u>, all of the representations and warranties of the Company, the Sellers, and the Buyer contained in this Agreement shall survive the Closing and continue in full force and effect until the date that is 16 months after the Closing Date, except that any written claim for breach thereof made in good faith with commercially reasonable specificity prior to such expiration date and delivered to the Party against whom indemnification is sought shall survive thereafter until finally resolved and, as to any such claim, such applicable expiration will not affect the rights to indemnification of the Party making such claim; <i>provided</i>, that (a) the Fundamental Representations of the Sellers and the Fundamental Representations of the Buyer shall survive the Closing and continue indefinitely, (b) <u>Section 3.10</u> (Tax Matters) and <u>Section 4.5</u> (Residency) (collectively, the &#8220;<u>Regulatory Representations</u>&#8221;) shall survive until the date that is 60 calendar days from the last date on which an assessment or reassessment for Taxes under the Tax Act or under any other Law imposing Taxes can be made against the Company in respect of the dates or periods covered by the Regulatory Representations and (c) <u>Section 3.20</u> (Environmental Matters) shall survive until the date that is 60 months from the Closing Date. &#8220;Fundamental Representations of the Seller&#8221; shall mean the representations set forth in <u>Section 3.1</u> (Organization and Company Power); <u>Section 3.2(a)</u> (Authorization); <u>Section 3.3</u> (Shares); <u>Section 3.4</u> (Subsidiaries); <u>Section 3.18</u> (No Brokers or Finders); <u>Section 4.1(a)</u> (Authority); <u>Section 4.2</u> (Shares); and <u>Section 4.4</u> (Investment Banking; Brokerage Fees). &#8220;Fundamental Representations of the Buyer&#8221; shall mean the representations set forth in <u>Section 5.1</u> (Organization and Power), <u>Section 5.2</u> (Authority and Non-Contravention), <u>Section 5.3</u> (Consents and Approvals) and <u>Section 5.8</u> (Investment Banking; Brokerage Fees). The covenants contained in this Agreement shall survive the Closing until they are otherwise terminated by their respective term.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification Provisions for Buyer</u></b><u>&#8217;</u><b><u>s Benefit</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Provided that the Buyer makes a written claim for indemnification, describing with commercially reasonable specificity the facts and circumstances with respect to the subject matter of such claim within the applicable survival period set forth in <u>Section 7.2</u>, subject to the limitations set forth in this <u>Article VII</u>, the Sellers, severally (and not jointly and severally), shall indemnify Buyer and its successors and permitted assigns (collectively, the &#8220;<u>Buyer Indemnified Parties</u>&#8221;) from and against any Losses incurred by any of the Buyer Indemnified Parties arising out of, or by reason of:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach by the Company or the Sellers of the Fundamental Representations of the Sellers and/or <u>Section 3.10</u> (Tax Matters), and <u>Section 4.5</u> (Residency);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;any Taxes of the Company or Excell USA with respect to any Pre-Closing Tax Period; <i>provided</i>, <i>however</i>, that the Sellers shall have no liability under this <u>Section 7.3(b)</u> for any Taxes to the extent they were paid to the appropriate Tax Authority or to the Buyer pursuant to <u>Section 6.8(a)</u> or treated as Final Indebtedness or reserved in the Working Capital;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach of any of the representations or warranties of the Company or the Sellers (other than Fundamental Representations of the Sellers or <u>Section 3.10</u> (Tax Matters), <u>Section 3.20</u> (Environmental Matters), or <u>Section 4.5</u> (Residency)) contained in this Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;any inaccuracy in or breach by the Company or the Sellers of the representations and warranties of the Company or the Sellers pursuant to <u>Section 3.20</u> (Environmental Matters);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;any breach or non-fulfillment of any covenant, agreement or obligation to be performed by the Company or the Sellers pursuant to this Agreement or any Transaction Document; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;the PPP Loan Obligations.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding the foregoing, for purposes of this Agreement, other than in respect of Losses pursuant to breaches of the Fundamental Representations of the Sellers, <u>Section 3.10</u> (Tax Matters), <u>Section 4.5</u> (Residency) and claims arising out of or related to fraud in which a Seller or the Sellers participated, no indemnification shall be due or payable by the Sellers and no claim will be made against them with respect to Losses, until (i) the amount of Losses arising from any one claim exceeds $14,000.00 (a &#8220;<u>Qualifying Claim</u>&#8221;) and (ii) the aggregate amount of all Qualifying Claims exceeds $100,000.00 (the &#8220;<u>Basket</u>&#8221;), in which case, the Buyer Indemnified Parties shall be entitled to recover all Losses from the first dollar, subject to the limitations hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="49" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">49</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Section 7.3(c)</u> against such Seller will be limited to 12% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Section 7.3(d)</u> against such Seller will be limited to 50% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">The maximum, aggregate liability of each Seller to the Buyer Indemnified Parties under or in connection with this Agreement with respect to claims for Losses that may properly be brought under <u>Sections 7.3(a), 7.3(b), 7.3(e) and 7.3(f) </u>(inclusive of any claims for Losses brought under <u>Sections 7.3(c)</u> and<u> 7.3(d)</u> against such Seller will be limited to 100% of the amount of the Purchase Price received by such Seller.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding the foregoing, any claims arising out of or related to fraud in which a Seller or the Sellers participated shall not be subject to the limitations set forth in this <u>Section 7.3</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Notwithstanding anything provided in this Agreement to the contrary, no indemnification shall be payable by any Seller pursuant to this <u>Section 7.3</u> with respect to any claim asserted by the Buyer Indemnified Party after the expiration of the survival period, if any, prescribed for such representation, warranty or covenant in <u>Section 7.2</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Indemnification Provisions for the Seller</u></b><u>&#8217;</u><b><u>s Benefit; Limitations </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of this <u>Article VII</u>, from and after Closing, the Buyer agrees to indemnify and hold each of the Sellers and its respective successors, heirs and permitted assigns (the &#8220;<u>Seller Indemnified Parties</u>&#8221;) harmless from and against any Losses sustained or suffered by the Seller Indemnified Parties to the extent caused by or arising from a breach of, or inaccuracy in, any representation or warranty made by the Buyer, the common law fraud of the Buyer, or a failure to perform any covenant or agreement made by the Buyer herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything provided in this Agreement to the contrary, no indemnification shall be payable by the Buyer pursuant to <u>Section 7.4(a)</u> with respect to any claim asserted by a Seller Indemnified Party after the expiration of the survival period, if any, prescribed for such representation, warranty or covenant in <u>Section 7.2</u>. In no event shall the aggregate liability of the Buyer for indemnification payable under this <u>Article VII</u> exceed an amount equal to the Final Net Purchase Price (as finally determined in accordance with <u>Article II</u>). Notwithstanding the foregoing, any claims arising out of or related to fraud in which the Buyer participated shall not be subject to the limitations set forth in this <u>Section 7.4</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="50" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">50</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Matters Involving Third Parties </u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;If any third party notifies any Party (the &#8220;<u>Indemnified Party</u>&#8221;) with respect to any matter (a &#8220;<u>Third-Party Claim</u>&#8221;) that gives rise to a claim for indemnification against another Party (the &#8220;<u>Indemnifying Party</u>&#8221;) under this <u>Article VII</u>, then the Indemnified Party shall promptly (and in any event within 15 Business Days after receiving notice of the Third-Party Claim) notify the Indemnifying Party thereof in writing (a &#8220;<u>Notice</u>&#8221;); <i>provided</i>, <i>however</i>, that failure to give such Notice shall not limit the right of an Indemnified Party to recover indemnity or reimbursement from any Indemnifying Party except to the extent that such Indemnifying Party suffers any material prejudice or material harm with respect to such claim as a result of such failure except and to the extent that the Indemnifying Party can demonstrate actual material loss or actual material prejudice (and in any event, solely to the extent of such loss or prejudice) as a result of such failure. For the avoidance of doubt, this <u>Section 7.5</u> shall not apply with respect to any Tax Contests, which shall be governed solely by <u>Section 6.8(c)</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;In the case of any Third-Party Claims for which indemnification is sought, the Indemnifying Party shall be entitled at its cost and expense to (i)&nbsp;conduct and control any proceedings or negotiations with such third party, (ii) perform and control or direct the performance of any required activities, (iii)&nbsp;take all other steps to settle or defend any such claim (<i>provided</i> that the Indemnifying Party shall not settle any such claim without the consent of the Indemnified Party (which consent shall not be unreasonably withheld, conditioned or delayed) unless the settlement includes a complete release of the Indemnified Party with respect to the claim and no additional obligation, restriction or Losses shall be imposed on the Indemnified Party other than solely the payment of money damages for which the Indemnified Party will be indemnified hereunder) and (iv)&nbsp;employ counsel to contest any such claim or liability; <i>provided</i>, that the Indemnifying Party shall not have the right to assume control of such defense, if the claim for which the Indemnifying Party&nbsp;seeks to assume control: (w) seeks non&#8209;monetary relief (except where non&#8209;monetary relief is merely incidental to a primary claim or claims for monetary damages), (x)&nbsp;involves criminal allegations, (y) is one in which the Indemnifying Party is also a Party and for which joint representation would, in the reasonable opinion of the Indemnified Party&#8217;s or Indemnifying Party&#8217;s respective counsel, be inappropriate or, in the reasonable opinion of the Indemnified Party&#8217;s or Indemnifying Party&#8217;s respective counsel, there may be legal defenses available to the Indemnified Party that are materially different from or materially additional to those available to the Indemnifying Party or (z) involves a claim for which, upon petition by the Indemnified Party, the appropriate court rules that the Indemnifying Party failed or is failing to vigorously prosecute or defend. The Indemnifying Party shall, within 30&nbsp;days after delivery of the Notice to Indemnifying Party (or sooner, if the nature of the Third-Party Claim so requires) (the &#8220;<u>Dispute Period</u>&#8221;), notify the Indemnified Party of its intention as to the conduct and control of the defense of such claim, <i>provided</i> that the Indemnified Party and its counsel shall cooperate with the Indemnifying Party and its counsel. Until the Indemnified Party has received notice of the Indemnifying Party&#8217;s election whether to defend any claim, the Indemnified Party shall take commercially reasonable steps to defend (but may not settle) such claim. If the Indemnifying Party shall decline to assume the defense of any such claim, or the Indemnifying Party shall fail to notify the Indemnified Party within the Dispute Period of the Indemnifying Party&#8217;s election to defend such claim, the Indemnified Party shall defend against such claim (<i>provided</i> that the Indemnified Party shall not settle such claim without the consent of the Indemnifying Party (which consent shall not be unreasonably withheld, conditioned or delayed)) and the Indemnifying Party will remain responsible for any Losses the Indemnified Party may suffer as a result of such Third-Party Claim to the extent subject to indemnification under this <u>Article VII</u>.<b> </b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Direct Claims </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Any indemnification claim by an Indemnified Party which does not result from a Third Party Claim shall be asserted by the Indemnified Party by giving the Indemnifying Party prompt written notice thereof. Such written notice shall summarize the basis for the indemnification claim based on the information reasonably available at that time to the Indemnified Party. The failure to give written notice shall not, however, relieve the Indemnifying Party of its indemnification obligations, unless, and then solely to the extent that, the rights of the Parties from whom indemnity is sought are materially prejudiced as a result of such failure; <i>provided</i>, <i>however</i>, that no such notice shall have any effect or be valid if it is given following the end of any applicable survival period provided for in <u>Section 7.2</u>. The Indemnifying Party shall have 30 days after its receipt of such notice to respond in writing to such claim. If the Indemnifying Party does not so respond within such 30 day period, the Indemnifying Party shall be deemed to have accepted such claim, in which case the Indemnified Party shall be free to pursue such remedies as may be available to the Indemnified Party on the terms and subject to the provisions of this Agreement and the Indemnifying Party shall promptly pay any amounts owed in accordance with the terms of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="51" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">51</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Further Limitations and Qualifications </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Right to Recover</u>. The Indemnified Parties shall attempt in good faith to promptly seek to recover or make a claim for insurance proceeds as a result of any matter giving rise to an indemnification claim of the Indemnified Parties against the Indemnifying Party, to the extent available therefor. The failure to promptly seek to recover or make a claim for insurance proceeds shall not, however, relieve the Indemnifying Party of its indemnification obligations, unless, and then solely to the extent that, the rights of the Parties from whom indemnity is sought are materially prejudiced or materially harmed as a result of such failure. In addition, the Indemnifying Party shall, to the extent of any indemnification payment made by it and to the extent consistent with any related indemnification agreement, insurance policy, or applicable Law, be subrogated to all rights of the Indemnified Party against any third party in respect of the claim (or portion of such claim) to which the indemnification payment relates. If the Indemnified Party actually receives any insurance proceeds as a result of the matter giving rise to any indemnification claim of the Indemnified Party, the Indemnifying Party&#8217;s indemnification obligation with respect to such claim shall be reduced by the amount of any such insurance proceeds (net of any expenses incurred in collection thereof) actually received by the Indemnified Party. If the Indemnified Party actually receives any insurance proceeds with respect to any Loss after the Indemnifying Party has provided indemnification for such Loss to the Indemnified Party, then the Indemnified Party shall promptly turn over any such insurance proceeds (net of any expenses incurred in collection thereof) to the Indemnifying Party with respect to such Loss.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Exclusive Remedies</u>. Subject to (and without limiting the effects of) the terms of <u>Section 8.12</u>, from and after Closing, except with respect to matters covered by <u>Section 2.6</u>, the remedies provided in this <u>Article VII</u> shall constitute the sole and exclusive remedies available to any Party hereto with respect to any claim relating to this Agreement or the transactions contemplated hereby and the facts and circumstances relating and pertaining hereto (whether any such claim shall be made in contract, breach of warranty, tort or otherwise), other than for common law fraud.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Duration of Claim</u>. The indemnification obligations of the Indemnifying Party pursuant to this Agreement with respect to a specific claim for which indemnification is provided under this Agreement shall extend beyond the time period for indemnification set forth herein with respect to such specific claim until it has been fully discharged or resolved or settled so long as a written notice prepared in good faith with reasonable specificity (to the extent known at such time) shall have been given to the Indemnifying Party on or prior to the end of such time period.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Calculating Losses</u>. For the purpose of determining the amount of Losses arising from a breach of or inaccuracy in any representation or warranty of the Company or the Sellers, any limitation or qualification as to materiality (or a similar concept) set forth in such representation or warranty shall be disregarded, but for certainty, shall not be disregarded for the purposes of determining whether a breach of any representation or warranty of the Company or the Sellers has occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="52" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">52</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Other Limitations</u>. No Party will have any liability to any other Party under this <u>Article VII to the extent</u>:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;of any related and reasonably determinable Tax benefit available to the Indemnified Party (or, in the case of the Buyer, the Companies) as a result of the matters giving rise to the Losses as determined by the Indemnifying Party&#8217;s external accountants, acting reasonably;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;that any Losses could reasonably have been minimized or avoided had the Indemnified Party exercised reasonable diligence and ordinary care in attempting to minimize or avoid aggravating such Losses;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;a reserve or provision for the individual fact, matter or circumstance was made in the Financial Statements, in which case the Indemnified Party will be entitled, subject to the provisions of this Agreement, only to make a claim in respect of such item for the amount which exceed such reserve or provision;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;the Losses have been accrued as a Current Liability (or netted against a Current Asset) and included in the determination of Working Capital; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(v)&nbsp;&nbsp;&nbsp;&nbsp;such liability arises or the amount thereof is increased as a result of a change after the Closing Date in the accounting policies or practices of the Indemnified Party (or, in the case of the Buyer, the Companies) or a change in the Laws.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;<u>Mitigation</u>. Each Party will use commercially reasonable efforts to mitigate any Losses for which an Indemnifying Party is required to indemnify the Indemnified Party hereunder.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Duplication</u>. Any liability for indemnification hereunder shall be determined without duplication of recovery by reason of the state of facts giving rise to such liability constituting a breach of more than one representation, warranty, covenant or agreement. In this regard, there shall be no duplication of recovery under <u>Article III</u> and/or <u>Article IV</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;<u>No Set-off</u>. An Indemnified Party will not be entitled to set off the amount of any Losses subject to indemnification under this Agreement against any other amounts payable to an Indemnifying Party, whether under this Agreement or otherwise.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;<u>Recourse to Indemnification Escrow</u>. The indemnification obligations of the Sellers pursuant to this <u>Article VII</u> will be satisfied first by the Buyer claiming against the Indemnification Escrow Fund in accordance with the Escrow Agreement and then, to the extent obligations remain after the Indemnification Escrow Fund has been exhausted, the Buyer may, subject to and in accordance with the provisions of this <u>Article VII</u>, recover its Losses directly from the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;<u>Release of Indemnification Escrow Fund</u>. Within five (5) Business Days after the 1<sup style="vertical-align:top;line-height:120%;font-size:pt">st</sup> anniversary of the Closing Date, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to release to the Sellers&#8217; legal counsel, in trust for the Sellers, an amount equal to the Indemnification Escrow Amount then available and not subject to any prior indemnification claim by the Buyer Indemnified Parties under this <u>Article VII</u> up to an amount equal to 50% of the Indemnification Escrow Amount. Within five (5) Business Days after the date that is 16 months after the Closing Date, the Buyer and the Sellers&#8217; Representative shall deliver joint written instructions to the Escrow Agent instructing the Escrow Agent to release to the Sellers&#8217; legal counsel, in trust for the Sellers, an amount equal to (A) the balance of the Indemnification Escrow Fund minus (B) the amount, if any, of any unresolved indemnification claims pending under this <u>Article VII</u>. Upon the resolution of all such unresolved claims referred to in the foregoing clause (B), the Buyer and the Sellers&#8217; Representative shall, within five (5) Business Days following the determination of the amount to be distributed to the Buyer and/or the Sellers in accordance with the resolution of such claims, execute and deliver to the Escrow Agent a joint written instruction directing the Escrow Agent to release the balance of the Indemnification Escrow Fund to the Buyer or the Sellers&#8217; legal counsel, in trust for the Sellers, as the case may be.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="53" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">53</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Subrogation</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Following the Closing, the Sellers shall not have any right of subrogation against the Company in connection with any of the representations or warranties made by the Company in <u>Article III</u> or in connection with any covenants made by the Company in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Tax Treatment of Indemnification Payments </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">All indemnification payments made under this Agreement shall be treated by the Parties as an adjustment to the Purchase Price for Tax purposes, unless otherwise required by Law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>ARTICLE VIII</u></b><b><u>&nbsp;- MISCELLANEOUS</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.1<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Entire Agreement</u></b> <b><u> </u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Agreement together with the Transaction Documents constitutes the full and entire understanding and agreement among the Parties hereto with respect to the subject matters hereof and thereof and any and all other written or oral agreements existing prior to are expressly superseded and canceled. Without limiting the generality of the foregoing, the Parties make no representations or warranties of any kind or nature, express or implied, at law or in equity, except as expressly set forth in this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.2<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>No Third-Party Beneficiaries</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Other than the Indemnified Parties, this Agreement is not intended to, and shall not, confer any rights or remedies upon any Person other than the Parties and their respective successors and permitted assigns.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.3<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Amendments, Waivers, Consents and Assignability</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;For the purposes of this Agreement and all agreements, documents and instruments executed pursuant hereto, except as otherwise specifically set forth herein or therein, no course of dealing between the Company or the Sellers on the one hand, and the Buyer on the other, and no delay on the part of any Party hereto in exercising any rights hereunder or thereunder shall operate as a waiver of the rights hereof and thereof. Any term or provision hereof may be amended, terminated or waived (either generally or in a particular instance and either retroactively or prospectively) with the written consent of the Buyer and the Sellers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;The Buyer may assign its rights to an Affiliate without obtaining the consent of the Sellers, but no such assignment will relieve the Buyer of its obligations under this Agreement. This Agreement may not otherwise be assigned by any Party without the prior written consent of each other Party. This Agreement shall be binding upon and enforceable by, and shall inure to the benefit of, the Parties hereto and their respective successors, heirs, executors, administrators and permitted assigns, and no others. Notwithstanding the foregoing and except as otherwise expressly provided, nothing in this Agreement is intended to give any Person not named herein the benefit of any legal or equitable right, remedy or claim under this Agreement, except as expressly provided herein.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="54" data-prefix="" data-suffix="" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-align: center;">54</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink" style="text-align: justify;">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;, Times, serif; font-size: 10pt; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.4<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices and Demands</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">Any notice or other communication required or permitted to be given to any Person hereunder shall be in writing and shall be given to such Person at such Person&#8217;s address set forth below, or such other address as such Person may hereafter specify by notice in writing to the other Persons. Any such notice or other communication shall be addressed as aforesaid and given by: (i)&nbsp;certified mail (registered mail), with first class postage prepaid and return receipt requested, (ii)&nbsp;hand delivery, or (iii)&nbsp;reputable overnight express courier. Any notice or other communication will be deemed to have been duly given immediately when actually delivered or upon refusal of delivery:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Sellers&#8217;&nbsp;Representative:</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mark Kroeker</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333;">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">With a copy (which shall not constitute notice) to:</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Mogan Daniels Slager LLP</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Suite 1700<br>
			1185 West Georgia Street<br>
			Vancouver, British Columbia<br>
			Canada V6E 4E6</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="margin: 0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;margin-left:auto;margin-right:auto;">

		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">To the Company or the Buyer:</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">1336902 B.C. Unlimited Liability Company</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">c/o Ultralife Corporation</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2000 Technology Parkway</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Newark, New York 14513</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">&nbsp;</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:33.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">With a copy (which shall not constitute notice) to:</p>
			</td>
			<td style="vertical-align:top;width:5.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:62%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Lippes Mathias LLP<br>
			50 Fountain Plaza, Suite 1700</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Buffalo, New York 14202</p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><font style="background-color:#333333">&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="55" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">55</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.5<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Severability</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Whenever possible, each provision of this Agreement shall be interpreted in such a manner as to be effective and valid under applicable Law. If any portion of this Agreement is declared invalid for any reason in any jurisdiction, such declaration shall have no effect upon the remaining portions of this Agreement which shall continue in full force and effect as if this Agreement had been executed with the invalid portions thereof deleted; <i>provided</i>, <i>however</i>, if such severability will negate in any material respect the monetary terms of this Agreement, then the Parties shall negotiate in good faith to amend the invalid terms in a manner so that such terms shall not be invalid and will not modify in any material respect the monetary terms of this Agreement unless otherwise agreed to by the Parties. Furthermore, the entirety of this Agreement shall continue in full force and effect in all other jurisdictions.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.6<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Agreement may be executed in counterparts (including by DocuSign, facsimile or other means of electronic transmission, such as by electronic mail in &#8220;.pdf&#8221; form), all of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. Delivery of an executed counterpart of a signature page to this Agreement by DocuSign, facsimile transmission or other electronic transmission shall be as effective as delivery of a manually executed counterpart of this Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.7<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings; Interpretation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The section headings contained in this Agreement are inserted for convenience only and shall not affect in any way the meaning or interpretation of this Agreement. For purposes of this Agreement: (a) the words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; will be deemed to be followed by the words &#8220;without limitation&#8221;; and (b) the words &#8220;herein,&#8221; &#8220;hereof,&#8221; &#8220;hereby,&#8221; &#8220;hereto&#8221; and &#8220;hereunder&#8221; refer to this Agreement as a whole. Unless the context otherwise requires, references in this Agreement: (x) to Articles, Sections, Disclosure Schedule and Exhibits mean the Articles and Sections of, and Disclosure Schedule and Exhibits attached to, this Agreement; (y) to an agreement, instrument or other document means such agreement, instrument or other document as amended, supplemented and modified from time to time to the extent permitted by the provisions thereof; and (z) to a statute means such statute as amended, re-enacted, consolidated or replaced from time to time and includes any successor legislation thereto and any regulations promulgated thereunder. Notwithstanding the foregoing, any representation or warranty made with respect to compliance with a statute shall mean such statute as in effect as of the date such representation or warranty is made. This Agreement will be construed without regard to any presumption or rule requiring construction or interpretation against the Party drafting an instrument or causing any instrument to be drafted. The Disclosure Schedule and Exhibits referred to in this Agreement will be construed with, and as an integral part of, this Agreement to the same extent as if they were set forth verbatim in this Agreement. The words &#8220;dollar&#8221; or &#8220;$&#8221; shall mean, unless otherwise specified, United States dollars. For purposes of calculating any amounts denominated in Canadian dollars, unless otherwise specified, such amounts shall be converted into US dollars based on the Bank of Canada daily exchange rate on the relevant date, or if the calculation is being made on such relevant date, the Bank of Canada daily exchange rate on the date that is one<b> </b>(1) Business Day prior to the relevant date. For the purposes of calculating the Canadian dollar equivalent of the US dollar amounts set out in <u>Sections 3.11, 3.13 and 3.22</u>, such amounts shall be converted into Canadian dollars based on the Bank of Canada daily exchange rate on November 15, 2021.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.8<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Exhibits and Schedules</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Exhibits and Schedules to this Agreement are incorporated herein by reference and made a part of this Agreement. The Disclosure Schedule is arranged in sections and paragraphs corresponding to the numbered and lettered sections and paragraphs of <u>Article III</u> and <u>Article IV</u> , as applicable. The disclosure in any section or paragraph of the Disclosure Schedule qualifies other sections and paragraphs in this Agreement to the extent it is reasonably apparent from the face and terms of such disclosure that such disclosure is applicable to such other sections and paragraphs. The Disclosure Schedule shall not be construed as indicating that any matter disclosed therein is required to be disclosed or that such information is material with respect to the Sellers or the Company, as applicable. No reference in the Disclosure Schedule to any agreement or document shall be construed as an admission to any third party that such agreement or document is enforceable or currently in effect or that there are any obligations remaining to be performed or any rights that may be exercised under such agreement or document. No disclosure in the Disclosure Schedule relating to any possible breach or violation of any agreement or Law shall be construed as an admission to any third party that any such breach or violation exists or has already occurred.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="56" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">56</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.9<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law; Venue</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Agreement shall be governed by and construed in accordance with the Laws of the Province of British Columbia without giving effect to any Law that would cause the application of the Laws of any jurisdiction other than the Province of British Columbia. Any action or proceeding arising out of or relating to this Agreement or the transactions contemplated by this Agreement, except as provided in <u>Section 8.12</u>, must be brought in the courts of the Province of British Columbia.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.10<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Consent to Jurisdiction</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">THIS SECTION SHALL APPLY EXCEPT WITH RESPECT TO WHICH A PARTY OTHERWISE SEEKS EQUITABLE REMEDIES PURSUANT TO <u>SECTION 8.12</u> (SPECIFIC PERFORMANCE). EACH OF THE PARTIES IRREVOCABLY SUBMITS TO THE EXCLUSIVE JURISDICTION OF THE COURTS LOCATED IN THE PROVINCE OF BRITISH COLUMBIA FOR THE PURPOSES OF ANY SUIT, ACTION OR OTHER PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY. EACH OF THE PARTIES FURTHER AGREES THAT SERVICE OF ANY PROCESS, SUMMONS, NOTICE OR DOCUMENT BY REGISTERED MAIL TO SUCH PARTY&#8217;S RESPECTIVE ADDRESS SET FORTH ABOVE SHALL BE EFFECTIVE SERVICE OF PROCESS FOR ANY ACTION, SUIT OR PROCEEDING IN THE PROVINCE OF BRITISH COLUMBIA WITH RESPECT TO ANY MATTERS TO WHICH IT HAS SUBMITTED TO JURISDICTION IN THIS <u>SECTION 8.10</u>. EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY OBJECTION TO THE LAYING OF VENUE OF ANY ACTION, SUIT OR PROCEEDING ARISING OUT OF THIS AGREEMENT, ANY RELATED DOCUMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY AND THEREBY IN THE PROVINCIAL AND FEDERAL COURTS LOCATED IN THE PROVINCE OF BRITISH COLUMBIA AND HEREBY AND THEREBY FURTHER IRREVOCABLY AND UNCONDITIONALLY WAIVES AND AGREES NOT TO PLEAD OR CLAIM IN ANY SUCH COURT THAT ANY SUCH ACTION, SUIT OR PROCEEDING BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.11<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Incorporation by Reference</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Disclosure Schedule and other schedules and exhibits hereto constitute integral parts of this Agreement and are hereby incorporated by reference herein.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.12<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Specific Performance</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The Parties agree that irreparable damage may occur and that the Parties hereto would not have any adequate remedy at law in the event of any breach or threatened breach of any covenant, obligation or other provision of this Agreement. It is accordingly agreed that the Parties hereto may be entitled to seek (a) a decree or order of specific performance to enforce the observance and performance of such covenant, obligation or other provision, and (b) an injunction restraining such breach or threatened breach, without proof of actual damages (and each Party hereto hereby waives any requirement for the securing or posting of any bond or other security in connection therewith), such remedies being in addition to any other remedy to which the Parties hereto are entitled at law or in equity and that notwithstanding <u>Section 8.9</u>, such remedies sought in accordance with this <u>Section 8.12</u> may be sought in a court of competent jurisdiction within the United States or Canada.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="57" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">57</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.13<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>WAIVER OF JURY TRIAL</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">EACH PARTY HERETO IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW, ANY RIGHT IT MAY HAVE TO A TRIAL BY JURY IN ANY LEGAL PROCEEDING DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS AGREEMENT OR ANY OTHER TRANSACTION DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED HEREBY OR THEREBY (WHETHER BASED ON CONTRACT, TORT OR ANY OTHER THEORY). EACH PARTY HERETO (A) CERTIFIES THAT NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PERSON HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PERSON WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER AND (B) ACKNOWLEDGES THAT IT AND THE OTHER PARTIES HERETO HAVE BEEN INDUCED TO ENTER INTO THIS AGREEMENT AND THE OTHER RELATED DOCUMENTS BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <u>SECTION 8.13</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">8.14<b>&nbsp;&nbsp;&nbsp;&nbsp;<u>Sellers</u></b><u>&#8217;</u><b><u> Representative</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Mark Kroeker (the &#8220;<u>Sellers</u><u>&#8217;</u><u> Representative</u>&#8221;) is hereby irrevocably constituted and appointed as the attorney-in-fact and agent for each Seller in his, her or its name, place and stead to act on behalf of such Seller in connection with this Agreement and any Transaction Documents and the consummation of the Transactions contemplated hereby or thereby, with such power and authority to execute any and all instruments or other documents, and to do any and all other acts or things (or refrain from doing), in the name and on behalf of each such Seller that Sellers&#8217; Representative may deem necessary, appropriate, helpful or advisable, or that may be required of or permitted by such Seller pursuant to this Agreement or any Transaction Documents or in connection with the consummation of the Transactions contemplated hereby or thereby, provided that, for certainty, such appointment shall not extend to acting for any Seller with respect to matters of employment or matters relating thereto. Without limiting the generality of the foregoing, Sellers&#8217; Representative, acting in his capacity as such, shall have the full power and authority, in the name and on behalf of each Seller, (i) to agree with Buyer or the Company with respect to any matter or thing required or deemed necessary by Sellers&#8217; Representative in connection with the provisions of this Agreement or any Transaction Documents calling for the agreement of the Sellers, (ii) to agree to amend, modify or terminate this Agreement or any Transaction Document, (iii) to give and receive notices on behalf of the Sellers, (iv) to act on behalf of the Sellers in connection with any matter as to which the Sellers are or may be obligated to indemnify Buyer under this Agreement, (v) to interpret the terms and provisions of this Agreement or any Transaction Document, (vi) to dispute or decline to dispute any liability claim hereunder and to negotiate and compromise any dispute that may arise under this Agreement and to sign any releases or other documents with respect to any such dispute, (vii) to negotiate, execute and deliver any Transaction Document, certificate, statement, notice, approval, extension, waiver, amendment or other document required or permitted to be delivered, made or given in connection with the consummation of the Transactions contemplated by this Agreement, (viii) to take all action necessary or desirable in connection with the waiver of any condition to the obligations of the Sellers to consummate the Transactions contemplated by this Agreement and (ix) to do all other things and perform all other acts, including executing and delivering all agreements, certificates, receipts, consents, elections, instructions and other instruments or documents contemplated by, or deemed by Sellers&#8217; Representative to be necessary, appropriate, helpful or advisable in connection with, this Agreement or any Transaction Document. By his or its execution of this Agreement, each Seller hereby acknowledges that Sellers&#8217; Representative has full authority to act on his, her or its behalf and to bind him, her or it as and to the fullest extent provided in this <u>Section 8.14</u>.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="58" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">58</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Except in cases of fraud or willful misconduct, Sellers&#8217; Representative will have no liability to Buyer, the Companies or any Seller or their respective successors or assigns with respect to actions taken or omitted to be taken in good faith in his capacity as Sellers&#8217; Representative and shall be entitled to indemnification and reimbursement from the Sellers against any loss, liability, fees or expenses arising out of actions taken or omitted to be taken in good faith in his capacity as Sellers&#8217; Representative. Buyer will have no liability to any Seller or their respective successors or assigns with respect to any matters provided for in this <u>Section 8.14</u>, including in respect of any actions taken or omitted to be taken by Sellers&#8217; Representative or any claims between the Sellers in connection therewith, and shall be entitled to indemnification and reimbursement from the Sellers against any loss, liability, fees or expenses arising therefrom.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(c)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers&#8217; Representative will be entitled to rely, and will be fully protected in relying, upon any statements furnished to them by any Seller or the Buyer, or any other evidence deemed by the Sellers&#8217; Representative to be reliable.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(d)&nbsp;&nbsp;&nbsp;&nbsp;Any approval, consent, election, notice, decision, agreement, waiver, delivery, interpretation, amendment or other action of the Sellers required or permitted under, or otherwise provided for in, this Agreement or any Transaction Document (each, a &#8220;<u>Seller Action</u>&#8221;) shall be conclusively deemed given, made or taken (as the case may be) if given, made or taken by Sellers&#8217; Representative in his capacity as such for the Sellers and shall be binding upon each Seller as if expressly ratified and confirmed in writing by such Seller and Buyer shall be entitled to conclusively and absolutely rely, without inquiry, on any Seller Action given, made or taken by Sellers&#8217; Representative in his capacity as such for all such purposes. All Seller Actions by Sellers&#8217; Representative in his capacity as such shall be conclusive and binding upon all Sellers and no Seller shall have any cause of action against Buyer or Sellers&#8217; Representative for any action taken or not taken by Seller Representative in his capacity as such.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(e)&nbsp;&nbsp;&nbsp;&nbsp;The power of attorney created under this Agreement is coupled with an interest and shall be binding and enforceable on and against the heirs, personal representatives, successors and assigns of each of the Sellers, and such power of attorney shall not be revoked or terminated by the death, disability, bankruptcy, incompetency, dissolution or termination of any Seller or any heir, personal representative, successor or assign thereof.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(f)&nbsp;&nbsp;&nbsp;&nbsp;In the event that Sellers&#8217; Representative resigns or otherwise becomes unable to serve as Sellers&#8217; Representative, all references herein or in any Transaction Document to Sellers&#8217; Representative shall be deemed to refer to each Seller unless and until another Person is appointed by the Sellers to be Sellers&#8217; Representative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:72pt;">(g)&nbsp;&nbsp;&nbsp;&nbsp;The Sellers&#8217; Representative will not have any duties or responsibilities except those set forth in this Agreement and no implied covenants, functions, responsibilities, duties, obligations or liabilities will be read into this Agreement or otherwise exist against the Sellers&#8217; Representative.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">(Signature pages follow)</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="59" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">59</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>IN WITNESS WHEREOF</b>, the undersigned have executed this Share Purchase Agreement as of the day and year first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>COMPANY:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>656700 B.C. LTD.</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Ian Kane</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Ian Kane</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: Chief Executive Officer</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;text-indent:-36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>BUYER:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>1336902 B.C. UNLIMITED LIABILITY COMPANY</b></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: President</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;text-indent:-36pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>SELLERS:</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="border-bottom: 1px solid black; width: 6%;">/s/ Ian Kane</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>IAN KANE</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>M. &amp;. W. HOLDINGS LTD.</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">By:</td>
			<td style="width: 44%; border-bottom: 1px solid black;">/s/ William Fast&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 44%;">Name: William Fast</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 44%;">Title: Director</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>SANFORD CAPITAL LTD.</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">By:</td>
			<td style="width: 6%; border-bottom: 1px solid black;">/s/ Mark Kroeker&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Name: Mark Kroeker</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Title: Director</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>ARCEE ENTERPRISES INC.</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">By:</td>
			<td style="width: 6%; border-bottom: 1px solid black;">/s/ Randolph Peters</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Name: Randolph Peters</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Title: Director</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>0835205 B.C. LTD.</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">By:&nbsp;</td>
			<td style="width: 6%; border-bottom: 1px solid black;">/s/ Brian Larsen</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Name: Brian Larsen</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">Title: Director</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
			<td style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>SELLERS</b>&#8217;<b> REPRESENTATIVE:</b></td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%; border-bottom: 1px solid black;">/s/ Mark Kroeker</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td colspan="2" style="width: 6%;"><b>MARK KROEKER</b></td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 216pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Signature Page to Share Purchase Agreement</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 252pt;text-indent:-36pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><i>Omitted Exhibits and Schedules Disclosure List</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The following list briefly identifies the contents of the Exhibits and Schedules to the foregoing Share Purchase Agreement which have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>The Registrant agrees to furnish to the Securities and Exchange Commission, to supplement and upon request, a copy of any of the following omitted Exhibits and Schedules.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms by the foregoing Share Purchase Agreement.</i></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>1.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 2.1 </i>&#8211;<i> Contains the allocation of the Purchase Price among the Sellers.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>2.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.2 </i>&#8211;<i> Contains three contracts to which the Company is a party that will result in a default of the Company</i>&#8217;<i>s obligations thereunder due to the Transaction.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>3.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.3 </i>&#8211;<i> Contains the capitalization of the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>4.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.5(a) </i>&#8211;<i> Contains consolidated financial statements of the Company as of January 31st of the years 2019, 2020 and 2021 and October 31, 2021.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>5.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.5(c) </i>&#8211;<i> Contains a statement that the Company has no accounts receivable or loans receivable from Affiliated Persons.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>6.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.7 </i>&#8211;<i> Contains a statement that the Company has no Indebtedness outstanding.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>7.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.8 </i>&#8211;<i> Contains a statement regarding the acceleration of certain vesting options and accrual of certain liabilities.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>8.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.9 </i>&#8211;<i> Contains a statement that there is no pending and threatened Legal Proceeding against the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>9.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.10(f) </i>&#8211;<i> Contains a statement that there are no tax liens against the Company.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>10.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.10(i) </i>&#8211;<i> Contains a statement that there are no joint venture or partnership arrangements.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>11.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.11 </i>&#8211;<i> Contains a list of all personal property of the Company necessary for its operations with a value of at least Fifty Thousand Dollars ($50,000).</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;"><i>12.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.12 </i>&#8211;<i> Contains a list of all Company Intellectual Property.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>13.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.13 </i>&#8211;<i> Contains a list of: (i) any contract, lease or agreement involving a potential commitment or payment by the Company in excess of $50,000 annually; (ii) any contract containing covenants directly or explicitly limiting in any material respect the freedom of the Company to compete in any line of business or with any Person (other than confidentiality agreements containing non-competition or non-solicitation covenants on the part of the Company that were entered into by the Company in the ordinary course of business); (iii) any indenture, mortgage, promissory note, loan agreement, guaranty or other agreement or commitment for borrowing or any pledge or security arrangement; (iv) any employment, consulting or other service agreements with present or former officers, directors, employees, consultants, shareholders of the Company or any other service provider of the Company that includes any change of control payments severance, termination, or retention obligations or similar accounts payable by the Company or its Affiliates in connection with the transactions contemplated by this Agreement; (v) any redemption or purchase agreements or other agreements affecting or relating to the shares of the Company, including, without limitation, any agreement with any shareholder of the Company which includes anti-dilution rights, registration rights, voting arrangements, operating covenants or similar provision; (vi) any collective bargaining agreement, (vii) any royalty, dividend or similar arrangement based on the revenues or profits of the Company or any contract or agreement involving fixed price or fixed volume arrangements; (viii) any joint venture, franchise, partnership, manufacturer, development or agreement; (ix) any supply agreement pursuant to which the Company is required to supply materials in excess of $50,000 annually; (x) any acquisition, merger or similar agreement; (xi) any contract with any Governmental Authority; (xii) any contract providing for indemnification of any Person by the Company (excluding confidentiality agreements, customer and vendor contracts and purchase orders including indemnification provisions entered into in the ordinary course of business); (xiii) any material contract that can be terminated, or the provisions of which are altered, as a result of the consummation of the transactions contemplated by this Agreement or any of the other Transaction Documents to which the Company is a party; (xiv) any contract entered into in connection with any settlement or other resolution of any action pursuant to which the Company has any ongoing payment obligation after the Closing; and (xv) any other material contract not executed in the ordinary course of business.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>14.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.14(a) </i>&#8211;<i> Contains a statement that there are government approvals required by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>15.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.15 </i>&#8211;<i> Contains a list of all insurance policies of the Company currently in effect.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>16.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.16 </i>&#8211;<i> Contains a list of all Employee Benefit Plans.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>17.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.17 </i>&#8211;<i> Contains a list of all employees of the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>18.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.19 </i>&#8211;<i> Contains a statement that no Affiliate of the Company that is currently a party to a contract with the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>19.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(b) </i>&#8211;<i> Contains a statement that no Environmental Permits are necessary in connection with the Company</i>&#8217;<i>s ownership and operation of its business.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>20.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(d) </i>&#8211;<i> Contains a statement that no Hazardous Materials have been Released.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>21.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.20(e) </i>&#8211;<i> Contains a list of all off-site Hazardous Materials treatment, storage, or disposal facilities or locations used by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>22.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.22(a) </i>&#8211;<i> Contains a list of top ten (10) customers from whom the Company makes annual revenue exceeding Fifty Thousand Dollars ($50,000) for the calendar year ended January 31, 2021 or reasonably expected to exceed such amount for the fiscal year ended January 31, 2022.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>23.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.22(a) </i>&#8211;<i> Contains a list of top ten (10) suppliers from whom the Company makes annual purchases exceeding Fifty Thousand Dollars ($50,000) for the calendar year ended January 31, 2021 or reasonably expected to exceed such amount for the fiscal year ended January 31, 2022.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>24.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.23(a) </i>&#8211;<i> Contains a statement that no Assets used by the Company are not owned by the Company.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>25.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.23(b) </i>&#8211;<i> Contains a statement that all Inventory of the Company is in good, usable and /or salable condition.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>26.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 3.26 </i>&#8211;<i> Contains a list of all governmental programs the Company has availed itself of related to COVID-19 and any business interruptions experienced as a result of COVID-19.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>27.</i><i>&nbsp;&nbsp;&nbsp;&nbsp;Schedule 4.1 </i>&#8211;<i> Contains a statement regarding each Seller</i>&#8217;<i>s full right, authority and power to enter into this Share Purchase Agreement.</i></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">28.<i>&nbsp;&nbsp;&nbsp;&nbsp;Exhibit A </i>&#8211;<i> Contains the calculation of estimated Working Capital used in the determination of the Closing Net Purchase Price.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>4
<FILENAME>ex_316662.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
	<title>ex_316662.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 8:08:41 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><u>SECOND AMENDMENT AGREEMENT</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">This Second Amendment Agreement (this &#8220;<u>Agreement</u>&#8221;) is made and entered into as of this 13th day of December, 2021, by and among ULTRALIFE CORPORATION, a Delaware corporation (&#8220;<u>Ultralife</u>&#8221;), SOUTHWEST ELECTRONIC ENERGY CORPORATION, a Texas corporation (&#8220;<u>Southwest</u>&#8221;), CLB, INC., a Texas corporation (&#8220;<u>CLB</u>&#8221;, and together with Ultralife and Southwest, collectively, the &#8220;<u>Existing Borrowers</u>&#8221;, and each individually an &#8220;<u>Existing</u><u>&nbsp;</u><u>Borrower</u>&#8221;), ULTRALIFE EXCELL HOLDING CORP., a Delaware corporation (&#8220;<u>UEHC</u><u>&#8221;</u>), ULTRALIFE CANADA HOLDING CORP., a Delaware corporation (&#8220;<u>UCHC</u><u>&#8221;</u>), EXCELL BATTERY CORPORATION USA, a Texas corporation (&#8220;<u>Excell USA</u>&#8221;, and together with UEHC and UCHC, collectively, the &#8220;<u>New Borrowers</u>&#8221;, and each individually a &#8220;<u>New</u><u>&nbsp;</u><u>Borrower</u>&#8221;, and together with the Existing Borrowers, collectively, the &#8220;<u>Borrowers</u>&#8221;, and each individually a &#8220;<u>Borrower</u>&#8221;), the lending institutions currently a party to the Credit Agreement (as hereinafter defined) (each, a &#8220;<u>Lender</u>&#8221; and collectively, the &#8220;<u>Lenders</u>&#8221;), and KEYBANK NATIONAL ASSOCIATION (&#8220;<u>KeyBank</u>&#8221;, and in its capacity as agent for the Lenders under the Credit Agreement, &#8220;<u>Agent</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, Lenders, Agent and Existing Borrowers are parties to a certain Credit and Security Agreement dated as of May 31, 2017 (as amended by that certain First Amendment Agreement dated as of May 1, 2019, and as it may from time to time be further amended, restated or otherwise modified or supplemented from time to time, the &#8220;<u>Credit Agreement</u>&#8221;).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, Lenders, Agent and Existing Borrowers desire to amend the Credit Agreement by modifying certain provisions thereof, including, among other things, joining each of the New Borrowers as a Borrower under the Credit Agreement and other Loan Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">WHEREAS, unless defined herein, each term used herein shall be defined in accordance with the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">NOW, THEREFORE, in consideration of the premises and of the mutual covenants herein and for other valuable consideration Lenders, Agent, and Borrowers agree as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;Borrowers, Agent and the Lenders agree and acknowledge that all references in the Credit Agreement and each other Loan Document to the term &#8220;Borrowers&#8221; shall be deemed to include each of the New Borrowers as a co-borrower with the other Borrowers. The obligations, duties, undertakings and liabilities of the New Borrowers and the Existing Borrowers as &#8220;Borrowers&#8221; under the Credit Agreement and each other Loan Document shall be joint and several and, without limiting the generality of the foregoing, (a) each Borrower, including each New Borrower, hereby specifically and expressly ratifies and reaffirms the provisions of Section 11.20 of the Credit Agreement and agrees that each of them shall be jointly and severally liable for the payment and performance of all Secured Debt, and (b) each Borrower hereby specifically and expressly ratifies and reaffirms all of the provisions of Article XII of the Credit Agreement and its guaranty of the full and prompt payment and performance when due of the Secured Debt provided for thereunder, and agrees that its obligations, duties, undertakings and liabilities under such Article XII and such guaranty are unaffected by the joinder of each of the New Borrowers as a co-borrower with the other Borrowers under the Credit Agreement and the other Loan Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;Article I of the Credit Agreement is hereby amended to delete the definitions of &#8220;Aggregate Commitment Percentage&#8221;, &#8220;Applicable Commitment Percentage&#8221;, &#8220;Applicable Debt&#8221;, &#8220;Change in Control&#8221;, &#8220;Commitment&#8221;, &#8220;Commitment Period&#8221;, &#8220;Excluded Accounts&#8221;, &#8220;Note&#8221; or &#8220;Notes&#8221;, &#8220;Required Lenders&#8221; and &#8220;Total Commitment Amount&#8221; therefrom in their entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Aggregate Commitment Percentage&#8221; shall mean, for any Lender, as of any date, the percentage calculated by dividing (a) the aggregate, on such date, of (i)&nbsp;the Revolving Credit Commitments of such Lender, or if the Revolving Credit Commitments have expired or have been terminated or otherwise reduced to $0, then the amount outstanding under the Revolving Credit Notes of such Lender, plus (ii) the amount outstanding for such Lender under the Term Notes, plus (iii) the amount outstanding for such Lender under the Term Notes B, by (b) the aggregate, on such date, of (i) the Revolving Credit Commitments of all Lenders, or if the Revolving Credit Commitments have expired or have been terminated or otherwise reduced to $0, then the amount outstanding under the Revolving Credit Notes of all Lenders, plus (ii) the amount outstanding for all Lenders under the Term Notes, plus (iii) the amount outstanding for all Lenders under the Term Notes B.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Applicable Commitment Percentage&#8221; shall mean, for each Lender, (a) with respect to the Revolving Credit Commitment, the percentage set forth opposite such Lender&#8217;s name under the column headed &#8220;Revolving Credit Commitment Percentage&#8221; as described in <u>Schedule 1</u> hereto, and (b) with respect to the Term Loan Commitment, the percentage set forth opposite such Lender&#8217;s name under the column headed &#8220;Term Loan Commitment Percentage&#8221; as described in <u>Schedule 1</u> hereto, and (c) with respect to the Term Loan B Commitment, the percentage set forth opposite such Lender&#8217;s name under the column headed &#8220;Term Loan B Commitment Percentage&#8221; as described in <u>Schedule 1</u> hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Applicable Debt&#8221; at any time shall mean:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with respect to the Revolving Credit Commitment, collectively, (i) all Debt incurred by Borrowers to Agent or the Lenders pursuant to this Agreement and includes the principal of and accrued and unpaid interest on all Notes at such time, and (ii) each extension, renewal or refinancing thereof in whole or in part;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with respect to the Term Loan Commitment, collectively, (i) all Debt incurred by Borrowers to Agent or the Lenders pursuant to the Term Loan Commitment and includes the principal of, and accrued and unpaid interest on, the Term Notes at such time, and (ii) each extension, renewal or refinancing thereof in whole or in part hereunder, and (iii) any prepayment fees payable in connection with the Term Loan Commitment; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;with respect to the Term Loan B Commitment, collectively, (i)&nbsp;all Debt incurred by Borrowers to Agent or the Lenders pursuant to the Term Loan B Commitment and includes the principal of, and accrued and unpaid interest on, the Term Notes B at such time, and (ii) each extension, renewal or refinancing thereof in whole or in part hereunder, and (iii) any prepayment fees payable in connection with the Term Loan B Commitment</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Change in Control&#8221; shall mean: (a) with respect to any Person or group (within the meaning of the Exchange Act and the rules of the SEC thereunder as in effect on the Closing Date) holding in excess of ten percent (10%) of the voting Capital Stock of Ultralife as of the Closing Date (based upon Exchange Act filings of beneficial ownership with the SEC), the acquisition of ownership, directly or indirectly, beneficially or of record, by such Person or group, of Capital Stock of Ultralife representing more than 49% of the aggregate ordinary voting power represented by the issued and outstanding voting Capital Stock of Ultralife; (b) the acquisition of ownership, directly or indirectly, beneficially or of record, by any other Person or group (within the meaning of the Exchange Act and the rules of the Securities and Exchange Commission thereunder as in effect on the date hereof), of Capital Stock of Ultralife representing more than 25% of the aggregate ordinary voting power represented by the issued and outstanding voting Capital Stock of Ultralife; (c) occupation of a majority of the seats (other than vacant seats) on the board of directors of Borrower or any of its Subsidiaries by Persons who were neither (i) nominated by the board of directors of Ultralife or any of its Subsidiaries nor (ii) appointed by directors so nominated; (d) any merger, consolidation or sale of substantially all of the property or assets of Borrowers; (e) Ultralife ceasing to directly own and control 100% of each class of the outstanding Capital Stock of Southwest or UEHC; (f) Southwest ceasing to directly own and control 100% of each class of the outstanding Capital Stock of CLB; or (g) UEHC ceasing to directly or indirectly own and control 100% of each class of the outstanding Capital Stock of its Subsidiaries as of the Second Amendment Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Commitment&#8221; shall mean the obligation hereunder of each Lender as set forth on <u>Schedule 1</u>, to make Loans pursuant to the Revolving Credit Commitment, the Term Loan Commitment and the Term Loan B Commitment, and to participate in the issuance of Letters of Credit up to the Maximum Amount for such Lender, as such amounts may be reduced or adjusted pursuant to the terms hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Commitment Period&#8221; shall mean the period from the Closing Date until May 30, 2025, or such earlier date on which the Commitment shall have been terminated pursuant to Article IX hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excluded Accounts&#8221; shall mean (a) up to three (3) Deposit Accounts which are not maintained with KeyBank so long as (i) the maximum amount at any time in any such account is not more than $5,000, and (ii) the maximum aggregate amount at any time in all such accounts is not more than $25,000, (b) any other Deposit Accounts used exclusively to fund payroll obligations (including payroll taxes and other employee wage and benefit payments) so long as the Credit Parties shall not maintain funds on deposit therein or credited thereto at any time in excess of 105% of the amounts necessary to fund such payroll obligations and any related payroll processing expenses routinely paid from such accounts on a current basis, (c) Deposit accounts used for segregating 401(k) contributions, and (d) Deposit Accounts in foreign jurisdictions in which KeyBank does not maintain a branch so long as the aggregate maximum amount at any time in all such accounts is not more than $2,000,000.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Note&#8221; or &#8220;Notes&#8221; shall mean any Revolving Credit Note, any Term Note, any Term Note B or any other note delivered pursuant to this Agreement, together with any replacement or substitution thereof, any addition or allonge thereto and any amendment, restatement or other modification thereto from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Required Lenders&#8221; shall mean the holders of at least 51% of the Total Commitment Amount, or, if there is any borrowing hereunder, the holders of at least 51% of the aggregate of (a) the Revolving Credit Commitments, (b) the amount outstanding under the Term Notes, and (c) the amount outstanding under the Term Notes B; <u>provided</u>, <u>however</u>, that the unused Revolving Credit Commitment of, and the portion of the total outstandings held or deemed held by, any Defaulting Lender shall be excluded for purposes of making a determination of Required Lenders; <u>provided</u> <u>further</u>, <u>however</u>, that at any time there are fewer than three (3) Lenders hereunder, &#8220;Required Lenders&#8221; shall mean both such Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Total Commitment Amount&#8221; shall mean the Maximum Revolving Amount, plus the aggregate Term Loan Commitment, plus the aggregate Term Loan B Commitment of the Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;Article I of the Credit Agreement is hereby amended to insert the following new definitions thereto in the appropriate alphabetical order:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Aggregate Term Loan B Commitment Percentage&#8221; shall mean, for any Term Loan B Lender, as of any date, the percentage calculated by dividing (a) the aggregate, on such date, of the amount outstanding for such Lender under the Term Notes B, by (b) the aggregate, on such date, of the amount outstanding for all Lenders under the Term Notes B.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell Acquisition&#8221; shall mean the acquisition by UCHC of all of the Capital Stock of Excell Canada, Excell USA and Excell USA Holdco from the Excell Sellers pursuant to the terms of the Excell Acquisition Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell Acquisition Agreements&#8221; shall mean (a) that certain Share Purchase Agreement dated as of December 13, 2021, by and among 1336889 B.C. Unlimited Liability Company, the Excell Sellers, Mark Kroeker, in his capacity as the Sellers&#8217; Representative, and Excell Canada, together with all exhibits and schedules thereto, as the same may be amended, modified, supplemented or restated from time to time, and (b) that certain Share Purchase Agreement dated as of December 13, 2021, by and among 1336902 B.C. Unlimited Liability Company, the Excell Sellers, Mark Kroeker, in his capacity as the Sellers&#8217; Representative and Excell USA Holdco, together with all exhibits and schedules thereto, as the same may be amended, modified, supplemented or restated from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell Acquisition Documents&#8221; shall mean the Excell Acquisition Agreements and all other agreements, documents and writings heretofore, now or hereafter executed, delivered, or otherwise authenticated in connection with or related to the Excell Acquisition Agreements, in each case as any of the foregoing may be amended, restated or otherwise modified from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell Canada&#8221; shall mean Excell Battery Canada Inc., a British Columbia corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell Sellers&#8221; shall mean (a) with respect to clause (a) of the definition of Excell Acquisition Agreements, Mark Kroeker, Randolph Peters, Brian Larsen, M.&nbsp;&amp;. W. Holdings Ltd., Karen Kroeker, Heather Peterson, Michael Kroeker, Nicholas Kroeker, Brentley Peters, Craig Peters, Kurtis Peters, Heather Larsen, Ian Kane, Carol Peters and 0835205 B.C. Ltd., and (b) with respect to clause (b) of the definition of Excell Acquisition Agreements, M. &amp; W. Holdings Ltd., Sanford Capital Ltd., Ian Kane, Arcee Enterprises Inc. and 0835205 B.C. Ltd.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell USA&#8221; shall mean Excell Battery Corporation USA, a Texas corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Excell USA Holdco&#8221; shall mean 656700 B.C. Ltd., a British Columbia corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Second Amendment Closing Date&#8221; shall mean December 13, 2021.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Term Loan B&#8221; shall mean the Loan granted to Borrowers by the Term Loan B Lenders in accordance with Section 2.1C hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Term Loan B Commitment&#8221; shall mean the obligation hereunder of the Term Loan B Lenders to make a Term Loan B in the original principal amount of $10,000,000, with each Term Loan B Lender&#8217;s obligation to participate therein being in the amount set forth opposite such Term Loan B Lender&#8217;s name under the column headed &#8220;Term Loan B Commitment&#8221; as set forth on <u>Schedule 1</u> hereto (as such amounts may be reduced by the amounts of any payments applied thereto).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Term Loan B Lenders&#8221; shall mean, collectively, each Lender which has a Term Loan B Commitment.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;Term Note B&#8221; shall mean the Term Notes B executed and delivered pursuant to Section 2.1C hereof, together with any replacement or substitution thereof, any addition or allonge thereto and any amendment, restatement or other modification thereto from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;UCHC&#8221; shall mean Ultralife Canada Holding Corp., a Delaware corporation</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">&#8220;UEHC&#8221; shall mean Ultralife Excell Holding Corp., a Delaware corporation.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;The definition of &#8220;Applicable Margin&#8221; contained in Section 1.1 of the Credit Agreement is hereby amended to delete the pricing table therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto; border: 1px solid black;">

		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 35.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Consolidated Senior Leverage</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Ratio</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 23.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Applicable Basis</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Points for Overnight</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">LIBOR Loans</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 19.8%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Applicable Basis</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Points for</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Base Rate Loans</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 20.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Applicable Basis</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Points for Unused</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">Fee</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:35.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Less than 1.50 to 1.00</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 23.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">185</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.8%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(50)</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">25</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:35.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Greater than or equal to 1.50 to 1.00 but less than 2.50 to 1.00</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 23.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">200</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 19.8%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">(25)</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:20.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">20</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 35.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Greater than or equal to 2.50 to 1.00</p>
			</td>
			<td style="vertical-align: top; width: 23.6%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">215</p>
			</td>
			<td style="vertical-align: top; width: 19.8%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">0</p>
			</td>
			<td style="vertical-align: top; width: 20.8%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">15</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;Article I of the Credit Agreement is hereby amended to insert a new Section 1.6 thereto immediately following Section 1.5 as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 1.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BENCHMARK NOTIFICATION. The Agent does not warrant or accept any responsibility for, and shall not have any liability with respect to, the administration, submission or any other matter related to USD LIBOR or with respect to any alternative or successor benchmark thereto, or replacement rate therefor or thereof, including, without limitation, whether the composition or characteristics of any such alternative, successor or replacement reference rate, as it may or may not be adjusted pursuant to Section 3.6, will be similar to, or produce the same value or economic equivalence of, USD LIBOR or any other benchmark or have the same volume or liquidity as did USD LIBOR or any other benchmark rate prior to its discontinuance or unavailability.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.&nbsp;&nbsp;&nbsp;&nbsp;Section 2.1 of the Credit Agreement is hereby amended to delete the second and third full paragraphs therefrom in their entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">Each Lender, for itself and not for any other Lender, agrees to make Loans and to participate in Letters of Credit issued hereunder during the Commitment Period on such basis that (a) immediately after the completion of any borrowing by Borrowers or issuance of a Letter of Credit hereunder, the aggregate principal amount then outstanding on the Loans held by such Lender, when combined with such Lender&#8217;s Pro Rata Share of the Letter of Credit Exposure, shall not be in excess of the Maximum Amount for such Lender; (b) the aggregate principal amount outstanding of all outstanding Revolving Loans held such Lender shall represent that percentage of the aggregate principal amount then outstanding on all Revolving Loans (including the Revolving Loans held by such Lender) which is not in excess of such Lender&#8217;s Applicable Commitment Percentage with respect thereto; (c) the aggregate principal amount of all outstanding Term Loans held by such Lender shall represent that percentage of the aggregate principal amount then outstanding on all Term Loans (including the Term Loans held by such Lender) which is not in excess of such Lender&#8217;s Applicable Commitment Percentage with respect thereto; (d) the aggregate principal amount of all outstanding Term Loans B held by such Lender shall represent that percentage of the aggregate principal amount then outstanding on all Term Loans B (including the Term Loans B held by such Lender) which is not in excess of such Lender&#8217;s Applicable Commitment Percentage with respect thereto; and (e) such aggregate principal amount outstanding on the Loans held by such Lender shall represent that percentage of the aggregate principal amount then outstanding on all Loans (including the Loans held by such Lender) that is not in excess of such Lender&#8217;s Aggregate Commitment Percentage.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">Each borrowing from the Lenders hereunder shall be made on a Pro Rata Basis according to the Lenders&#8217; respective Applicable Commitment Percentages. The Loans may be made as Revolving Loans, as a Term Loan, as a Term Loan B and Letters of Credit may be issued, as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;Section 2.1 of the Credit Agreement is hereby amended to insert the following new Subpart C at the end thereof:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Term Loan B.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the terms and conditions of this Agreement, the Term Loan B Lenders shall make a Term Loan B to Borrowers on the Second Amendment Closing Date, in the amount for each Term Loan B Lender equal to its respective Term Loan B Commitment. To evidence the Term Loan B, Borrowers shall execute and deliver to each Term Loan B Lender a Term Note B, substantially in the form of <u>Exhibit F</u> hereto, with appropriate insertions. Borrowers shall pay principal on the Term Loan B in equal consecutive monthly installments of $166,667.00 commencing February 1, 2022, and continuing on the first day of each succeeding month thereafter, with a final payment in the amount of the then remaining balance thereof payable in full on January 1, 2027. The Term Loan B may not be reborrowed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall notify Agent from time to time, in accordance with the notice provisions of Section 2.2 hereof, whether the Term Loan B will be a Base Rate Loan or an Overnight LIBOR Loan. The Term Loan B may be a mixture of Base Rate Loans and Overnight LIBOR Loans. The Term Loan B Lenders, at the request of Borrowers to Agent, provided that no Event of Default exists hereunder and subject to the applicable notice and other provisions of Section 2.2 hereof, shall convert a Base Rate Loan to an Overnight LIBOR Loan at any time and shall convert an Overnight LIBOR Loan to a Base Rate Loan at any time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall pay interest on the unpaid principal amount of Base Rate Loans outstanding from time to time from the date thereof until paid, commencing February 1, 2022, and continuing on the first day of each succeeding month thereafter and at the maturity thereof, at the Derived Base Rate from time to time in effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall pay interest on the unpaid principal amount of each Overnight LIBOR Loan outstanding from time to time from the date thereof until paid, fixed in advance for each Overnight LIBOR Interest Period as herein provided for each such Overnight LIBOR Interest Period. Interest on such Overnight LIBOR Loans shall be payable, commencing February 1, 2022, and on the first day of each succeeding month thereafter and at the maturity thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.&nbsp;&nbsp;&nbsp;&nbsp;Section 2.3(b) of the Credit Agreement is hereby amended to delete subpart (i) therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>No Default</u>. Subject to Section 2.7 hereof, if at the time any such funds are received hereunder (A) the Secured Debt has not been accelerated pursuant to Article IX, and (B) no Event of Default has occurred and be continuing (or if an Event of Default has occurred and is continuing, Agent, at the direction of the Required Lenders, shall not have provided notice to a Borrower of its intention to apply the provisions of Section 2.3(b)(ii)), in the following manner: (a) first, to the following items (i), (ii) and (iii) below in such manner as Borrowers shall direct (except that Borrowers may not alter the division as between Lenders as set forth in subparts (ii) and (iii) below), or in the absence of such direction in the following order: (i) to the payment of all fees, charges and reimbursable expenses due and payable to Agent or a Lender under the Secured Debt, this Agreement or the other Loan Documents at such time; (ii) to the payment of all of the interest which shall be due and payable on the principal of the Secured Debt at the time of such payment in accordance with each Lender&#8217;s Applicable Commitment Percentage; (iii) pro rata to (A) the payment of scheduled principal payments of the Term Loan that are then due in accordance with each Term Loan Lender&#8217;s Aggregate Term Loan Commitment Percentage, (B) the payment of scheduled principal payments of the Term Loan B that are then due in accordance with each Term Loan B Lender&#8217;s Aggregate Term Loan B Commitment Percentage, and (C) the payment of all obligations and liabilities of Borrowers under any Hedge Agreement entered into by Borrowers with the Secured Creditors to the extent then due and payable; (b)&nbsp;second, subject to the provisions of Section 2.4 hereof and the fees set forth in Section 2.4, if applicable, to the payment of the principal amount of any Revolving Loans then outstanding in accordance with each Revolving Loan Lender&#8217;s Applicable Commitment Percentage; and (c) third, to Borrowers.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.&nbsp;&nbsp;&nbsp;&nbsp;Section 2.7 of the Credit Agreement is hereby amended to delete subpart (g) therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each prepayment of the Loans pursuant to this Section 2.7 (other than subpart (a)) (unless subject to the provisions of Section 2.3(b)(ii) hereof) shall be applied in the following order: (A) prepayment of the Term Loan, together with all accrued and unpaid interest on the principal amount prepaid, until such Term Loan is paid in full, in the inverse order of maturity, based on each Term Loan Lender&#8217;s Applicable Commitment Percentage, (B) prepayment of the Term Loan B, together with all accrued and unpaid interest on the principal amount prepaid, until such Term Loan B is paid in full, in the inverse order of maturity, based on each Term Loan B Lender&#8217;s Applicable Commitment Percentage and (C)&nbsp;prepayment in full of all outstanding Revolving Loans, which such prepayment shall not constitute a permanent reduction to the Revolving Credit Commitment. Any prepayment required to be made under this Section 2.7 shall be subject to any fee or other charge in connection with any Hedge Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="8" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">8</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.&nbsp;&nbsp;&nbsp;&nbsp;Article III of the Credit Agreement is hereby amended to insert a new Section 3.6 thereto immediately following Section 3.5 as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 3.6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BENCHMARK REPLACEMENT SETTING. Notwithstanding anything to the contrary herein or in any other Loan Document (and any Hedge Agreement shall be deemed not to be a &#8220;Loan Document&#8221; for purposes of this Section):</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Replacing USD LIBOR</u>. On March 5, 2021, the Financial Conduct Authority (&#8220;FCA&#8221;), the regulatory supervisor of USD LIBOR&#8217;s administrator (&#8220;IBA&#8221;), announced in a public statement the future cessation or loss of representativeness of overnight/Spot Next, 1-month, 3-month, 6-month and 12-month USD LIBOR tenor settings. On the earliest of (i) July 1, 2023, (ii) the date that all Available Tenors of USD LIBOR have either permanently or indefinitely ceased to be provided by IBA or have been announced by the FCA pursuant to public statement or publication of information to be no longer representative and (iii) the Early Opt-in Effective Date, if the then-current Benchmark is USD LIBOR, the Benchmark Replacement will replace such Benchmark for all purposes hereunder and under any Loan Document in respect of any setting of such Benchmark on such day and all subsequent settings without any amendment to, or further action by or consent of any other party to, this Agreement or any other Loan Document. If the Benchmark Replacement is Daily Simple SOFR, all interest payments will be payable on a monthly basis.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Replacing Future Benchmarks</u>. If any Benchmark Transition Event occurs after the date hereof (other than as described above with respect to USD LIBOR), the then-current Benchmark will be replaced with the Benchmark Replacement for all purposes hereunder and under any Loan Document in respect of any Benchmark setting on the later of (i) as of 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Benchmark Replacement is provided to the Lenders and the Borrowers (together, if applicable, with an amendment to this Agreement implementing such Benchmark Replacement and any applicable Benchmark Replacement Conforming Changes) or (ii) such other date as may be determined by the Agent, in each case, without any further action or consent of any other party to this Agreement or any other Loan Document, so long as the Agent has not received, by such time (or, in the case of clause (ii) above, such time as may be specified by the Agent as a deadline to receive objections, but in any case, no less than five (5) Business Days after the date such notice is provided to the Lenders and the Borrowers), written notice of objection to such Benchmark Replacement from Lenders comprising the Required Lenders; <u>provided</u>, <u>however</u>, that in the event that the then-current Benchmark is not a SOFR-based rate, then the Benchmark Replacement shall be determined in accordance with clause (1) of the definition of &#8220;Benchmark Replacement&#8221; unless the Agent has determined that neither of such alternative rates is available. At any time that the administrator of the then-current Benchmark has permanently or indefinitely ceased to provide such Benchmark or such Benchmark has been announced by the regulatory supervisor for the administrator of such Benchmark pursuant to public statement or publication of information to be no longer representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored, the Borrowers may revoke any request for a borrowing of, conversion to or continuation of Loans to be made, converted or continued that would bear interest by reference to such Benchmark until the Borrowers&#8217; receipt of notice from the Agent that a Benchmark Replacement has replaced such Benchmark, and, failing that, the Borrowers will be deemed to have converted any such request into a request for a borrowing of or conversion to Base Rate Loans. During the period referenced in the foregoing sentence, the component of the Base Rate based upon the Benchmark will not be used in any determination of the Base Rate.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="9" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">9</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Benchmark Replacement Conforming Changes</u>. In connection with the implementation and administration of a Benchmark Replacement (whether in connection with the replacement of USD LIBOR or any future Benchmark), the Agent will have the right to make Benchmark Replacement Conforming Changes from time to time and, notwithstanding anything to the contrary herein or in any other Loan Document, any amendments implementing such Benchmark Replacement Conforming Changes will become effective without any further action or consent of any other party to this Agreement or any other Loan Document.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Notices; Standards for Decisions and Determinations</u>. The Agent will promptly notify the Borrowers and the Lenders of (i) the implementation of any Benchmark Replacement and (ii) the effectiveness of any Benchmark Replacement Conforming Changes. Any determination, decision or election that may be made by the Agent pursuant to this Section including, without limitation, any determination with respect to a tenor, rate or adjustment, or implementation of any Benchmark Replacement Conforming Changes, the timing of implementation of any Benchmark Replacement or of the occurrence or non-occurrence of an event, circumstance or date and any decision to take or refrain from taking any action, will be conclusive and binding on all parties hereto absent manifest error and may be made in its sole discretion and without consent from any other party to this Agreement or any other Loan Document, except, in each case, as expressly required pursuant to this Section, and shall not be a basis of any claim of liability of any kind or nature by any party hereto, all such claims being hereby waived individually by each party hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Unavailability of Tenor of Benchmark</u>. At any time (including in connection with the implementation of a Benchmark Replacement), (i) if the then-current Benchmark is a term rate (including Term SOFR or USD LIBOR or any alternate rate selected in an Early Opt-in Election), then the Agent may remove any tenor of such Benchmark that is unavailable or non-representative for such Benchmark (including any Benchmark Replacement) settings and (ii) if such tenor becomes available or representative, the Agent may reinstate any previously removed tenor for such Benchmark (including any Benchmark Replacement) settings.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="10" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">10</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Certain Defined Terms</u>. As used in this Section:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Available Tenor</i></b>&#8221; means, as of any date of determination and with respect to the then-current Benchmark, as applicable, (x) if the then-current Benchmark is a term rate, any tenor for such Benchmark that is or may be used for determining the length of an Interest Period or (y) otherwise, any payment period for interest calculated with reference to such Benchmark, as applicable, pursuant to this Agreement as of such date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Benchmark</i></b>&#8221; means, initially, USD LIBOR; <u>provided</u> that if a replacement for the Benchmark has occurred pursuant to this Section, then &#8220;Benchmark&#8221; means the applicable Benchmark Replacement to the extent that such Benchmark Replacement has replaced such prior benchmark rate. Any reference to &#8220;Benchmark&#8221; shall include, as applicable, the published component used in the calculation thereof.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Benchmark Replacement</i></b>&#8221; means, for any Available Tenor:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -36pt; text-align: justify;">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for purposes of clause (a) of this Section, the first alternative set forth below that can be determined by the Agent:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -18pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the sum of: (i) Term SOFR and (ii) 0.11448% (11.448 basis points) for an Available Tenor of one-month&#8217;s duration, 0.26161% (26.161 basis points) for an Available Tenor of three-months&#8217; duration, and 0.42826% (42.826 basis points) for an Available Tenor of six-months&#8217; duration; <u>provided</u>, that, if the Borrowers have provided a notification to the Agent in writing on or prior to the date on which the Benchmark Replacement will become effective that the Borrowers have a Hedge Agreement in place with respect to any of the Loans as of the date of such notice (which such notification the Agent shall be entitled to rely upon and shall have no duty or obligation to ascertain the correctness or completeness of), then the Agent, in its sole discretion, may decide not to determine the Benchmark Replacement pursuant to this clause (1)(a) for such Benchmark Transition Event or Early Opt-in Election, as applicable; or</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the sum of: (i) Daily Simple SOFR and (ii) the spread adjustment for an Available Tenor of one-month&#8217;s duration (0.11448% (11.448 basis points));</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -27pt; text-align: justify;"><u>provided</u>, <u>however</u>, that if an Early Opt-in Election has been made, the Benchmark Replacement will be the benchmark selected in connection with such Early Opt-in Election; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -36pt; text-align: justify;">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for purposes of clause (b) of this Section, the sum of: (a) the alternate benchmark rate and (b) an adjustment (which may be a positive or negative value, or zero), in each case, that has been selected pursuant to this clause (2) by the Agent and the Borrowers as the replacement for such Available Tenor of such Benchmark giving due consideration to any evolving or then-prevailing market convention, including any applicable recommendations made by the Relevant Governmental Body, for U.S. dollar-denominated syndicated credit facilities at such time;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="11" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">11</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify;"><u>provided</u> that, if the Benchmark Replacement as determined pursuant to clause (1) or (2) above would be less than the Floor, the Benchmark Replacement will be deemed to be the Floor for all purposes of this Agreement and the other Loan Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Benchmark Replacement Conforming Changes</i></b>&#8221; means, with respect to any Benchmark Replacement, any technical, administrative or operational changes (including changes to the definition of &#8220;Base Rate,&#8221; the definition of &#8220;Business Day,&#8221; the definition of &#8220;Interest Period,&#8221; timing and frequency of determining rates and making payments of interest, timing of borrowing requests or prepayment, conversion or continuation notices, the applicability and length of lookback periods, the applicability of breakage provisions, and other technical, administrative or operational matters) that the Agent decides may be appropriate to reflect the adoption and implementation of such Benchmark Replacement and to permit the administration thereof by the Agent in a manner substantially consistent with market practice (or, if the Agent decides that adoption of any portion of such market practice is not administratively feasible or if the Agent determines that no market practice for the administration of such Benchmark Replacement exists, in such other manner of administration as the Agent decides is reasonably necessary in connection with the administration of this Agreement and the other Loan Documents).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Benchmark Transition Event</i></b>&#8221; means, with respect to any then-current Benchmark (other than USD LIBOR), the occurrence of a public statement or publication of information by or on behalf of the administrator of the then-current Benchmark, the regulatory supervisor for the administrator of such Benchmark, the Board of Governors of the Federal Reserve System, the Federal Reserve Bank of New York, an insolvency official with jurisdiction over the administrator for such Benchmark, a resolution authority with jurisdiction over the administrator for such Benchmark or a court or an entity with similar insolvency or resolution authority over the administrator for such Benchmark, announcing or stating that (a) such administrator has ceased or will cease on a specified date to provide all Available Tenors of such Benchmark, permanently or indefinitely, <u>provided</u> that, at the time of such statement or publication, there is no successor administrator that will continue to provide any Available Tenor of such Benchmark or (b) all Available Tenors of such Benchmark are or will no longer be representative of the underlying market and economic reality that such Benchmark is intended to measure and that representativeness will not be restored.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Daily Simple SOFR</i></b>&#8221; means, for any day, SOFR, with the conventions for this rate (which will include a lookback) being established by the Agent in accordance with the conventions for this rate recommended by the Relevant Governmental Body for determining &#8220;Daily Simple SOFR&#8221; for syndicated business loans; <u>provided</u>, that if the Agent decides that any such convention is not administratively feasible for the Agent, then the Agent may establish another convention in its reasonable discretion.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="12" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">12</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Early Opt-in Effective Date</i></b>&#8221; means, with respect to any Early Opt-in Election, the sixth (6<sup style="vertical-align:top;line-height:120%;font-size:pt">th</sup>) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, so long as the Agent has not received, by 5:00 p.m. (New York City time) on the fifth (5th) Business Day after the date notice of such Early Opt-in Election is provided to the Lenders, written notice of objection to such Early Opt-in Election from Lenders comprising the Required Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Early Opt-in Election</i></b>&#8221; means the occurrence of:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -36pt; text-align: justify;">(1)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a notification by the Agent to each of the other parties hereto that at least five currently outstanding U.S. dollar-denominated syndicated credit facilities at such time incorporate or adopt (as a result of amendment or as originally executed) either a SOFR-based rate (including SOFR or Term SOFR or any other rate based upon SOFR) as a benchmark rate or an alternate benchmark interest rate to replace USD LIBOR (and such syndicated credit facilities are identified in such notice and are publicly available for review), and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 108pt; text-indent: -36pt; text-align: justify;">(2)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;the joint election by the Agent and the Borrowers to trigger a fallback from USD LIBOR and the provision by the Agent of written notice of such election to the Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Floor</i></b>&#8221; means the benchmark rate floor, if any, provided in this Agreement initially (as of the execution of this Agreement, the modification, amendment or renewal of this Agreement or otherwise) with respect to USD LIBOR.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Relevant Governmental Body</i></b>&#8221; means the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or a committee officially endorsed or convened by the Board of Governors of the Federal Reserve System or the Federal Reserve Bank of New York, or any successor thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;SOFR</i></b>&#8221; means, for any Business Day, a rate per annum equal to the secured overnight financing rate for such Business Day published by the Federal Reserve Bank of New York (or a successor administrator of the secured overnight financing rate) on the website of the Federal Reserve Bank of New York, currently at http://www.newyorkfed.org. (or any successor source for the secured overnight financing rate identified as such by the administrator of the secured overnight financing rate from time to time), on the immediately succeeding Business Day.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;Term SOFR</i></b>&#8221; means, for the applicable corresponding tenor, the forward-looking term rate based on SOFR that has been selected or recommended by the Relevant Governmental Body.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="13" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">13</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;"><b><i>&#8220;USD LIBOR</i></b>&#8221; means the London interbank offered rate for U.S. dollars.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">11.&nbsp;&nbsp;&nbsp;&nbsp;Section 5.7 of the Credit Agreement is hereby amended to delete clause (b) therefrom in its entirety and to insert in place thereof the following</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CONSOLIDATED SENIOR LEVERAGE RATIO. The Companies shall not suffer or permit the Consolidated Senior Leverage Ratio to exceed (i) 3.50 to 1.00 for the Fiscal Quarters ending December 31, 2022 and March 31, 2023, and (ii) 3.00 to 1.00 for the Fiscal Quarter ending June 30, 2023 and on the last day of each Fiscal Quarter thereafter.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.&nbsp;&nbsp;&nbsp;&nbsp;Article V of the Credit Agreement is hereby amended to delete Section 5.13 therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 5.13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ACQUISITIONS. Except for the Southwest Acquisition, the Excell Acquisition, Permitted Acquisitions or as expressly permitted under Section 5.11 or 5.12 hereof, without the prior written consent of the Required Lenders, no Company shall acquire or permit any Subsidiary to acquire the assets or stock of any other Person; <u>provided</u>, <u>however</u>, that in the event Borrowers ask Agent and the Lenders to consider consenting to any Acquisition (other than a Permitted Acquisition) then Agent and the Lenders agree (i) to give such request all due consideration in good faith, as determined by Agent and the Lenders in their Permitted Discretion, and (ii) not to unreasonably delay its decision with respect to such request.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.&nbsp;&nbsp;&nbsp;&nbsp;Section 5.14 of the Credit Agreement is hereby amended to delete clause (b) therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify;">(b) any default has occurred under any Material Contract, the Southwest Acquisition Documents, or the Excell Acquisition Documents which such default is continuing beyond any period of grace provided with respect thereto,</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.&nbsp;&nbsp;&nbsp;&nbsp;Article V of the Credit Agreement is hereby amended to delete Section 5.20 therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 5.20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;RESTRICTED PAYMENTS. The Companies shall not pay or commit themselves to pay any Restricted Payments at any time, <i>except</i>:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any Company may declare and pay or make Capital Distributions that are payable solely in additional shares of its common stock (or warrants, options or other rights to acquire additional shares of its common stock);</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) any Subsidiary may declare and pay or make Capital Distributions to any Credit Party; and (ii) any non-Credit Party may declare and pay or make Capital Distributions to any other non-Credit Party, or to the Borrower or any other Subsidiary;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="14" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">14</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ultralife may declare and pay or make Capital Distributions in cash, so long as (i) no Default or Event of Default shall then exist or, after giving pro forma effect to such payment, thereafter shall begin to exist, (ii)&nbsp;the Consolidated Senior Leverage Ratio, as measured pursuant to Section 5.7, hereof is less than or equal to 3.00 to 1.00 both prior to and after giving pro form effect to such Capital Distribution, and (iii) Borrowers Consolidated Fixed Charge Coverage Ratio, as measured pursuant to Section 5.7 hereof, is greater than or equal to 1.15 to 1.00 both prior to and after giving pro form effect to such Capital Distribution; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 72pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Ultralife may repurchase its capital stock as required by Ultralife&#8217;s executive compensation program, so long as (i) no Default or Event of Default shall then exist or, after giving pro forma effect to such payment, thereafter shall begin to exist, (ii) the proceeds of such repurchase are used solely for the purpose of paying withholding tax incurred pursuant to the issuance of stock (as compensation) under such executive compensation program, and (iii) the amount of stock (as compensation) issued under such executive compensation program is consistent with past business practices of Ultralife.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.&nbsp;&nbsp;&nbsp;&nbsp;Article V of the Credit Agreement is hereby amended to delete Section 5.35 therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 5.35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MODIFICATIONS TO CERTAIN MATERIAL DOCUMENTS. Without the prior written consent of the Required Lenders, the Companies shall not permit any amendment, restatement, waiver or other modification of any of the Southwest Acquisition Documents or any of the Excell Acquisition Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">16.&nbsp;&nbsp;&nbsp;&nbsp;Section 7.22 of the Credit Agreement is hereby amended to delete the last sentence therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-align: justify;">The representations and warranties made by the Credit Parties in the Southwest Acquisition Documents, the Excell Acquisition Documents and in any other agreements, instruments or certificates delivered pursuant thereto, are true and correct in all material respects (except where any such representation and warranty is stated as being true only as of a specific date, in which case such representation and warranty was true and correct in all material respects on such date).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">17.&nbsp;&nbsp;&nbsp;&nbsp;The Credit Agreement is hereby amended to delete Section 8.5 therefrom in its entirety and to insert in place thereof the following:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">SECTION 8.5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;CROSS DEFAULT. If (a) any Company or any Obligor shall default in the payment of principal or interest due and owing upon any other obligation for borrowed money in excess of the aggregate, for all such obligations for all such Companies and Obligors, of $500,000 beyond any period of grace provided with respect thereto or in the performance or observance of any other agreement, term or condition contained in any agreement under which such obligation is created, if the effect of such default is to allow the acceleration of the maturity of such Indebtedness or to permit the holder thereof to cause such Indebtedness to become due prior to its stated maturity, (b) any default by any Company shall have occurred under the Southwest Acquisition Documents, which such default shall be continuing beyond any period of grace provided with respect thereto; or (c) any default by any Company shall have occurred under the Excell Acquisition Documents, which such default shall be continuing beyond any period of grace provided with respect thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="15" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">15</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">18.&nbsp;&nbsp;&nbsp;&nbsp;The Credit Agreement is hereby amended by deleting <u>Schedule 1</u> therefrom in its entirety and by substituting in place thereof a new <u>Schedule 1</u>, in the form of <u>Exhibit 1</u> attached hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">19.&nbsp;&nbsp;&nbsp;&nbsp;The Credit Agreement is hereby amended to insert a new <u>Exhibit F</u> thereto, in the form of <u>Exhibit 2</u> attached hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">20.&nbsp;&nbsp;&nbsp;&nbsp;As a condition precedent to the effectiveness of this Agreement:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have executed and delivered to each Term Loan B Lender a Term Note B, dated as of even date herewith, and each such Term Note B shall otherwise be in substantially the form and substance of <u>Exhibit F</u> of the Credit Agreement;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have executed and delivered to Agent an Assumption and Joinder Agreement (the &#8220;<u>Joinder Agreement</u>&#8221;) and such Joinder Agreement shall be in form and substance satisfactory to Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Pledge Agreement executed by Ultralife on the Closing Date and in connection with the Excell Acquisition, Ultralife has pledged all Equity Interests of UEHC. In connection therewith, Ultralife shall have executed and delivered to Agent share certificates (or control agreements), appropriate stock powers (or equivalent), and such other documents in connection therewith as Agent shall reasonably request, each in form and substance satisfactory to Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;UEHC shall have executed and delivered to Agent a Pledge Agreement (the &#8220;<u>New Pledge Agreement</u>&#8221;), in form and substance satisfactory to Agent, together with the delivery of share certificates (or control agreements), appropriate stock powers (or equivalent), and such other documents in connection therewith as Agent shall reasonably request, each in form and substance satisfactory to Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;Each Borrower shall have delivered to Agent an officer&#8217;s certificate (or equivalent) certifying the names of the officers of such Borrower authorized to sign this Agreement, the Term Note B, the Joinder Agreement, the New Pledge Agreement, the Disbursement Direction Letter (as defined below) and each other document, agreement, writing or instrument executed in connection with this Agreement (collectively, the &#8220;<u>Amendment Documents</u>&#8221;) by such Borrower, together with the true signatures of such officers, and certified copies of (i) the resolutions of the board of directors (or equivalent governing body) of such Borrower evidencing approval of the execution and delivery of such documents, (ii) the articles of incorporation (or equivalent organizational document) of such Borrower, having been certified, not more than ten (10) days prior to this Agreement, by the Secretary of State of the jurisdiction under which such Borrower is organized; <u>provided</u> that Southwest and CLB may deliver their certified articles of incorporation (or equivalent organizational document) no later than five (5) days following the Second Amendment Closing Date, and (iii) the bylaws (or equivalent governance documents) of such Borrower. Notwithstanding the foregoing, each of the Existing Borrowers may, in lieu of providing copies of such Existing Borrower&#8217;s articles of incorporation (or equivalent organizational document) and bylaws (or equivalent governance documents), certify that there has been no change since the Closing Date (or, with respect to Southwest and CLB, the First Amendment Closing Date), to such Existing Borrower&#8217;s formation and governance documents and that such documents are in full force and effect on and as of the date hereof and no action for any amendment to such documents has been taken or is pending;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="16" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">16</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(f)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received a good standing certificate (or equivalent) for each Borrower issued by the Secretary of State in the state where such Borrower is organized; <u>provided</u> that Southwest and CLB may deliver their good standing certificates (or equivalent) no later than one (1) day following the Second Amendment Closing Date;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(g)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received the executed legal opinion of each Borrower&#8217;s counsel, in form and substance satisfactory to Agent, which shall cover such matters incident to the transactions contemplated by this Agreement and the Amendment Documents being executed in connection herewith, and each Borrower hereby authorizes and directs such counsel to deliver such opinions to Agent and Lenders;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(h)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received (i) final executed copies of the Excell Acquisition Documents (including all exhibits, schedules and disclosure letters referred to therein or delivered pursuant thereto, if any) and all material amendments thereto, waivers relating thereto and other side letters or agreements affecting the terms thereof, in each case having been certified by a Financial Officer of Borrowers as true and correct, and (ii) any other evidence that Agent reasonably requests, in form and substance reasonably satisfactory to Agent, that the Excell Acquisition has been completed for an aggregate consideration not in excess of $23,500,000 substantially contemporaneously with this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have delivered to Agent revised schedules to the Credit Agreement, in form and substance satisfactory to Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(j)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received (i) for each Borrower, the results of UCC lien searches reasonably satisfactory to Agent; (ii) for the Existing Borrowers, the results of federal and state tax lien and judicial lien searches reasonably satisfactory to Agent; and (iii) UCC termination statements and payoff letters reflecting termination of all financing statements (other than financing statements related to Permitted Liens) previously filed by any party having a security interest in any part of the Collateral or any other property securing the Secured Debt;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(k)&nbsp;&nbsp;&nbsp;&nbsp;New Borrowers shall deliver to Agent appropriate UCC financing statements;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="17" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">17</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(l)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received in form and substance satisfactory to Agent, one or more insurance certificates and copies of New Borrowers&#8217; casualty insurance policies, and copies of New Borrowers&#8217; liability insurance policies;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(m)&nbsp;&nbsp;&nbsp;&nbsp;Agent shall have received a solvency certificate, in form and substance reasonably satisfactory to Agent, with respect to New Borrowers;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(n)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have delivered to Agent a disbursement direction letter (the &#8220;<u>Disbursement Direction Letter</u>&#8221;), in form and substance satisfactory to Agent;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(o)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have paid to Agent for the pro rata benefit of the Lenders (i) a revolver renewal fee in the amount of $35,000 and (ii) an upfront fee in the amount of $25,000; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(p)&nbsp;&nbsp;&nbsp;&nbsp;Borrowers shall have paid all reasonable and documented out of pocket legal fees and expenses of Agent incurred in connection with this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">21.&nbsp;&nbsp;&nbsp;&nbsp;As a conditions subsequent to the effectiveness of this Agreement, the Borrowers shall have:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;Within one (1) day of the Second Amendment Closing Date, delivered to Agent good standing certificates (or equivalent) of Southwest and CLB;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;within five (5) Business Days of the Second Amendment Closing Date, delivered to Agent the articles of incorporation (or equivalent organizational document) of New Borrowers, having been certified, not more than ten (10) days prior to such date by the Secretary of State of the jurisdiction under which each such New Borrower is organized;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;within five (5) Business Days of the Second Amendment Closing Date, delivered to Agent the certificates or instruments representing the Capital Stock of UEHC and UCHC, and the appropriate transfer powers to each certificate or instrument;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;within ten (10) days of the Second Amendment Closing Date, delivered to Agent loss payable endorsements reasonably satisfactory to Agent naming Agent as Lender loss payee with respect to the insurance policies referenced in Section 20(l) above;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 36pt; text-indent: 36pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;within ninety days (90) days of the Second Amendment Closing Date:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 44pt; text-indent: 74pt; text-align: justify;">(i)&nbsp;&nbsp;&nbsp;&nbsp;delivered to Agent evidence, satisfactory to Agent, that New Borrowers have closed or moved to Agent all Deposit Accounts (other than any Excluded Accounts) and lockboxes;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 44pt; text-indent: 74pt; text-align: justify;">(ii)&nbsp;&nbsp;&nbsp;&nbsp;delivered to Agent a landlord&#8217;s waiver and/or a bailee&#8217;s waiver, if applicable, each in form and substance satisfactory to Agent and the Lenders, for each location where either (i) New Borrowers&#8217; books and records are located, or (ii) any Collateral of a New Borrower with a fair market value in excess of $50,000 in the aggregate is located; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="18" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">18</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 44pt; text-indent: 74pt; text-align: justify;">(iii)&nbsp;&nbsp;&nbsp;&nbsp;delivered to Agent such documents, instruments, legal opinions or other deliveries reasonably required by Agent to (i) join Excell Canada and any other Canadian Subsidiary subject to the Excell Acquisition as a Credit Party to the Credit Agreement and the other Loan Documents, (ii) evidence and perfect Agent&#8217;s security interest in the assets and Equity Interests of such Subsidiaries, and (iii) evidence and perfect Agent&#8217;s security interest in the Equity Interests of Excell USA.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">22.&nbsp;&nbsp;&nbsp;&nbsp;Each Borrower hereby represents and warrants to Agent and the Lenders that as of the date hereof: (a) such Borrower has the legal power and authority to execute and deliver the Amendment Documents executed by such Borrower in connection with this Agreement; (b) the officers (or other authorized Persons) of such Borrower executing the Amendment Documents have been duly authorized to execute and deliver the same and bind such Borrower with respect to the provisions thereof; (c) the execution and delivery by such Borrower of the Amendment Documents to which it is a party and the performance and observance by such Loan Party of the provisions thereof do not violate or conflict with the Organizational Documents of such Borrower or any law applicable to such Borrower or result in a breach of any provision of or constitute a default under any other material agreement, instrument or document binding upon or enforceable against such Loan Party; (d) after giving effect to this Agreement, no Default or Event of Default exists under the Loan Documents, nor will any occur upon giving effect to the execution and delivery of the Amendment Documents or by the performance or observance of any provision thereof; (e) such Borrower does not have any claim or offset against, or defense or counterclaim to, any of such Borrower&#8217;s obligations or liabilities under the Credit Agreement or the other Loan Documents; (f) the representations and warranties set forth in Article VII of the Credit Agreement are true and correct in all material respects (without duplication of materiality qualifiers) on and as of the date hereof, except to the extent such representation or warranty relates to an earlier specified date, in which case such representation and warranty is reaffirmed true and correct in all material respects as of such date; and (g) the Amendment Documents to which such Borrower is a party constitute a valid and binding obligation of such Borrower in every respect, enforceable in accordance with their respective terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency, moratorium or similar laws affecting creditors&#8217; rights generally.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">23.&nbsp;&nbsp;&nbsp;&nbsp;In consideration of this Agreement, each Borrower hereby waives and releases Agent and the Lenders and their respective affiliates, officers, directors, equity holders, agents, attorneys, employees and representatives from any and all such claims, offsets, defenses and counterclaims of which such Borrower is aware or unaware in connection with the Credit Agreement to the extent arising on or prior to the date hereof, such waiver and release being with full knowledge and understanding of the circumstances and effect thereof and after having consulted legal counsel with respect thereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">24.&nbsp;&nbsp;&nbsp;&nbsp;Each reference that is made in the Credit Agreement or any other writing shall hereafter be construed as a reference to the Credit Agreement as amended hereby. Except as herein otherwise specifically provided, all provisions of the Credit Agreement shall remain in full force and effect and be unaffected hereby. Each Amendment Document is a Loan Document as defined in the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">25.&nbsp;&nbsp;&nbsp;&nbsp;Each Borrower hereby reaffirms its obligations, as applicable, under the Credit Agreement and all other Loan Documents to which such Borrower is a party, as any of them may from time to time be amended, restated or otherwise modified (the &#8220;<u>Reaffirmed Documents</u>&#8221;). Each Borrower agrees (i) that each Reaffirmed Document shall remain in full force and effect following the execution and delivery of this Agreement and any other Amendment Document, and (ii) that all references in any of the Reaffirmed Documents to the &#8220;Credit Agreement&#8221; or &#8220;Loan Agreement&#8221; shall be deemed to refer to the Credit Agreement, as amended by this Agreement or as it may be further amended, restated or otherwise modified from time to time.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="19" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">19</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">26.&nbsp;&nbsp;&nbsp;&nbsp;This Agreement may be executed in any number of counterparts and by different parties hereto in separate counterparts and may be delivered by facsimile or pdf electronic transmission, each of which when so executed and delivered shall be deemed to be an original and effective as a manually signed counterpart and all of which when taken together shall constitute but one and the same agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">27.&nbsp;&nbsp;&nbsp;&nbsp;The rights and obligations of all parties hereto shall be governed by the laws of the State of New York, without regard to principles of conflicts of laws (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">28.&nbsp;&nbsp;&nbsp;&nbsp;EACH PARTY TO THIS AGREEMENT HEREBY EXPRESSLY WAIVES ANY RIGHT TO TRIAL BY JURY OF ANY CLAIM, DEMAND, ACTION OR CAUSE OF ACTION (A) ARISING UNDER THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR (B) IN ANY WAY CONNECTED WITH OR RELATED OR INCIDENTAL TO THE DEALINGS OF THE PARTIES HERETO OR ANY OF THEM WITH RESPECT TO THIS AGREEMENT OR ANY OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH, OR THE TRANSACTIONS RELATED HERETO OR THERETO IN EACH CASE WHETHER NOW EXISTING OR HEREAFTER ARISING, AND WHETHER SOUNDING IN CONTRACT OR TORT OR OTHERWISE AND EACH PARTY HEREBY CONSENTS THAT ANY SUCH CLAIM, DEMAND, ACTION OR CAUSE OF ACTION SHALL BE DECIDED BY COURT TRIAL WITHOUT A JURY, AND THAT ANY PARTY TO THIS AGREEMENT MAY FILE AN ORIGINAL COUNTERPART OR A COPY OF THIS SECTION WITH ANY COURT AS WRITTEN EVIDENCE OF THE CONSENTS OF THE PARTIES HERETO TO THE WAIVER OF THEIR RIGHT TO TRIAL BY JURY.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[The remainder of this page is intentionally left blank.]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="20" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">20</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">IN WITNESS WHEREOF, the duly authorized officers of the parties to this Agreement have executed this Agreement as of the date first written above.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><u>BORROWERS</u></b><b>:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ULTRALIFE CORPORATION</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael D. Popielec</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael D. Popielec</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President and Chief Executive Officer</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">SOUTHWEST ELECTRONIC ENERGY</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">CORPORATION</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">CLB, INC.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ULTRALIFE EXCELL HOLDING CORP.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">ULTRALIFE CANADA HOLDING CORP.</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">EXCELL BATTERY CORPORATION USA</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: President</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 216pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 216pt; text-align: justify;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[Signature Page to Second Amendment Agreement &#8211; Key/Ultralife]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 216pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="width: 100%; text-align: justify;">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="width: 100%; text-align: justify;">&nbsp;</div>
</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><b><u>AGENT AND THE LENDERS</u></b><b>:</b></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">KEYBANK NATIONAL ASSOCIATION,</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">as Agent and as a Lender</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">By: <u>/s/ Peter F. Leonard</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Name: Peter F. Leonard</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Title: Senior Vice President</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt 0pt 0pt 180pt; text-indent: 36pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[Signature Page to Second Amendment Agreement &#8211; Key/Ultralife]</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><b><u>EXHIBIT 1</u></b></p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">SCHEDULE 1</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%; margin-left: auto; margin-right: auto; border: 1px solid black;">

		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>LENDING </u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>INSTITUTIONS</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 13.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>REVOLVING CREDIT</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>PERCENTAGE</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>REVOLVING</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>CREDIT</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>TERM LOAN</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>PERCENTAGE</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 13.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>TERM LOAN</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 13%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>TERM LOAN B</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>PERCENTAGE</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12.5%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>TERM LOAN B</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>COMMITMENT</u></p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: bottom; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>MAXIMUM </u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;"><u>AMOUNT</u></p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">KeyBank National Association</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$30,000,000</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:13.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$8,000,000*</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$10,000,000</p>
			</td>
			<td style="border-bottom:solid 1px #000000;vertical-align:top;width:12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$48,000,000</p>
			</td>
		</tr>
		<tr>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; text-align: justify;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13.9%; text-align: justify; border-left: 1px solid black; border-right: 1px solid black;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; text-align: justify;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; text-align: justify; border-left: 1px solid black; border-right: 1px solid black;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13.2%; text-align: justify;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 13%; text-align: justify; border-left: 1px solid black; border-right: 1px solid black;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; text-align: justify; border-right: 1px solid black;">&nbsp;</td>
			<td style="border-bottom: 1px solid rgb(0, 0, 0); vertical-align: top; width: 12.5%; text-align: justify;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Total Commitment Amount</p>
			</td>
			<td style="vertical-align: top; width: 13.9%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$30,000,000</p>
			</td>
			<td style="vertical-align: top; width: 12.5%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="vertical-align: top; width: 13.2%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$8,000,000*</p>
			</td>
			<td style="vertical-align: top; width: 13%; border-left: 1px solid black; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">100%</p>
			</td>
			<td style="vertical-align: top; width: 12.5%; border-right: 1px solid black;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$10,000,000</p>
			</td>
			<td style="vertical-align: top; width: 12.5%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">$48,000,000</p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">*Principal balance is $22,255.52 as of the Second Amendment Closing Date.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>EXHIBIT 2</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">EXHIBIT F</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">TERM NOTE B</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">$<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></td>
			<td style="width: 50%; text-align: right;">Newark, New York</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 324pt;text-indent:36pt;">December [__], 2021</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FOR VALUE RECEIVED, the undersigned, ULTRALIFE CORPORATION, a Delaware corporation (&#8220;<u>Ultralife</u>&#8221;), SOUTHWEST ELECTRONIC ENERGY CORPORATION, a Texas corporation (&#8220;<u>Southwest</u>&#8221;), CLB, INC., a Texas corporation (&#8220;<u>CLB</u>&#8221;), ULTRALIFE EXCELL HOLDING CORP., a Delaware corporation (&#8220;<u>UEHC</u><u>&#8221;</u>), ULTRALIFE CANADA HOLDING CORP., a Delaware corporation (&#8220;<u>UCHC</u><u>&#8221;</u>), EXCELL BATTERY CORPORATION USA, a Texas corporation (&#8220;<u>Excell USA</u>&#8221;), each other Person which may be added as a &#8220;Borrower&#8221; hereto, subsequent to the date hereof (collectively, together with Ultralife, Southwest, CLB, UEHC, UCHC and Excell USA, the &#8220;<u>Borrowers</u>&#8221;, and each individually, a &#8220;<u>Borrower</u>&#8221;), jointly and severally promise to pay to the order of ___________ (&#8220;Lender&#8221;) at the office of KEYBANK NATIONAL ASSOCIATION, as Agent, 726 Exchange Street, Suite 900, Buffalo, NY 14210, the principal sum of</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">______________________AND 00/100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DOLLARS</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">in lawful money of the United States of America at such times, in such amounts and in such manner as provided in Section 2.1C of the Credit Agreement or such earlier time as a prepayment is required pursuant to the Credit Agreement. As used herein, &#8220;Credit Agreement&#8221; means the Credit and Security Agreement dated as of May 31, 2017, among Borrowers, certain other Credit Parties from time to time party thereto, the lenders named therein and KeyBank National Association, as Agent, as the same may from time to time be amended, restated or otherwise modified. Capitalized terms used herein shall have the meanings ascribed to them in the Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Borrowers also promise to pay interest on the unpaid principal amount of the Term Loan B from time to time outstanding, from the date of the Term Loan B until the payment in full thereof, at the rates per annum which shall be determined in accordance with the provisions of Section 2.1C of the Credit Agreement. Such interest shall be payable on each date provided for in such Section 2.1C; <u>provided</u>, <u>however</u>, that interest on any principal portion which is not paid when due shall be payable on demand.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The portions of the principal sum hereof from time to time representing the Term Loan B, and payments of principal of either thereof, shall be shown on the records of Lender by such method as Lender may generally employ; <u>provided</u>, <u>however</u>, that failure to make any such entry shall in no way detract from Borrowers&#8217; obligations under this Note.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">F-1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If this Note shall not be paid at maturity, whether such maturity occurs by reason of lapse of time or by operation of any provision for acceleration of maturity contained in the Credit Agreement, the principal hereof and the unpaid interest thereon shall bear interest, until paid, at a rate per annum equal to the Default Rate. All payments of principal of and interest on this Note shall be made in immediately available funds. In the event of a failure to pay interest or principal, when the same becomes due after giving effect to any applicable grace or cure period, Lender may collect and Borrowers agree to pay a late charge of an amount equal to the greater of $50 or 5% of the amount of such late payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Note is one of the Term Notes B referred to in the Credit Agreement. Reference is made to the Credit Agreement for a description of the right of the undersigned to anticipate payments hereof, the right of the holder hereof to declare this Note due prior to its stated maturity, and other terms and conditions upon which this Note is issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as expressly provided in the Credit Agreement, each Borrower expressly waives presentment, demand, protest and notice of any kind.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">EACH OF THE UNDERSIGNED WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG BORROWERS, AGENT AND THE LENDERS, OR ANY THEREOF, ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED AMONG THEM IN CONNECTION WITH THIS NOTE, THE CREDIT AND SECURITY AGREEMENT OR ANY OTHER NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY WAY AFFECT, WAIVE, LIMIT, AMEND OR MODIFY AGENT&#8217;S OR ANY LENDER&#8217;S ABILITY TO PURSUE REMEDIES PURSUANT TO ANY PROVISION CONTAINED IN ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT AMONG BORROWERS, AGENT AND THE LENDERS, OR ANY THEREOF.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[The remainder of this page is intentionally left blank.]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">F-2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned have executed this Term Note B as of the date and year first written above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><u>BORROWERS</u></b><b>:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Philip A. Fain</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: Chief Financial Officer and Treasurer</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">SOUTHWEST ELECTRONIC ENERGY</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Linda S. Saunders</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: Vice President of Finance</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CLB, INC.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Linda S. Saunders</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: Vice President of Finance</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE EXCELL HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: [__________]</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: [__________]</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CANADA HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: [__________]</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: [__________]</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">EXCELL BATTERY CORPORATION USA</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: [__________]</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Title: [__________]</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">F-3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>SECOND AMENDMENT AGREEMENT</i></b>&#8211;<b><i> KEY/</i></b> <b><i>ULTRALIFE</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">F-4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;"><b><i><u>Omitted Exhibits and Schedule Disclosure List</u></i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>The following list briefly identifies the contents of the Exhibits and Schedules to the foregoing Second Amendment Agreement which have been omitted pursuant to Item 601(b)(2) of Regulation S-K. </i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>The Registrant agrees to furnish to the Securities and Exchange Commission, to supplement and upon request, a copy of any of the following omitted Exhibits and Schedules.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;"><i>Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms by the foregoing Second Amendment Agreement.</i></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: Times New Roman;font-size: 10pt;font-variant:normal;margin:0pt;">1.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 5.8 </i>&#8211;<i>&nbsp;Contains a list of the permitted Indebtedness existing as of the Closing Date comprised of third-party financing for annual insurance premiums.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">2.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 5.9 </i>&#8211;<i>&nbsp;Contains a statement that there are no permitted encumbrances. </i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">3.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 5.11 </i>&#8211;<i>&nbsp;Contains a statement regarding investments made into Subsidiaries.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">4.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 5.33 </i>&#8211;<i>&nbsp;Contains a list of the amount of all Subsidiary Payables as of the Closing Date.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">5.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.1 </i>&#8211;<i>&nbsp;Contains a list stating the existences, good standings, foreign qualifications, and capitalizations of the companies.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">6.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.4 </i>&#8211;<i>&nbsp;Contains descriptions of all Commercial Tort Claims which, if determined adversely, could not reasonably be expected to result in a Material Adverse Effect.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; margin: 0pt; text-align: justify;">7.</p>
			</td>
			<td style="width: auto;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.5 </i>&#8211;<i>&nbsp;Contains a list of each company</i>&#8217;<i>s: (i) location of its chief executive offices during the four (4) months prior to the date of the Agreement; (ii) location of its place of business during the past five (5) years; (iii) location of inventory held by third-parties during the past five (5) years; and, (iv) location of inventory currently held by third-parties.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">8.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.8 </i>&#8211;<i>&nbsp;Contains a list of any of each company</i>&#8217;<i>s Commodity Account, Deposit Account, or Securities Account in which such company has rights or power to transfer title.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">9.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.9 </i>&#8211;<i>&nbsp;Contains a list of real property owned or leased by any of the companies.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">10.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.14 </i>&#8211;<i>&nbsp;Contains a list of all employee benefit plans sponsored or maintained by a company.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; margin: 0pt; text-align: justify;">11.</p>
			</td>
			<td style="width: auto;">
			<p style="font-size: 10pt; font-variant-numeric: normal; font-variant-east-asian: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.19 </i>&#8211;<i>&nbsp;Contains a list of any contract or agreement to which a company is a party that, if violated or breached, would reasonably be expected to have a Material Adverse Effect.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">12.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.20 </i>&#8211;<i>&nbsp;Contains a statement as to all of the registered Intellectual Property owned by the companies.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">13.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Schedule 7.21 </i>&#8211;<i>&nbsp;Contains a list of all insurance policies maintained by the companies as of the Closing Date.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">14.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Exhibit A </i>&#8211;<i>&nbsp;Contains a list of all registered patents of the companies.</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt; text-align: justify;">&nbsp;</td>
			<td style="width: 18pt;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">15.</p>
			</td>
			<td style="width: auto;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Exhibit B </i>&#8211;<i>&nbsp;Contains a list of all registered trademarks of the companies</i></p>
			</td>
		</tr>

</table>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM" style="text-align: center;">F-5</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.2
<SEQUENCE>5
<FILENAME>ex_316663.htm
<DESCRIPTION>EXHIBIT 10.2
<TEXT>
<html><head>
	<title>ex_316663.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 2:32:05 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.2</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>PLEDGE AGREEMENT</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Pledge Agreement, as it may be amended, restated or otherwise modified from time to time (this &#8220;Agreement&#8221;), is executed and delivered as of the 13th day of December, 2021, by ULTRALIFE EXCELL HOLDING CORP., a Delaware corporation (&#8220;Pledgor&#8221;), to KEYBANK NATIONAL ASSOCIATION (together with its successors and assigns in its capacity as agent, &#8220;Agent&#8221;), as agent for the financial institutions which are now or which hereafter become a party to the Credit Agreement, as hereinafter defined (collectively, &#8220;Lenders&#8221;).</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">RECITALS.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">ULTRALIFE CORPORATION, a Delaware corporation (&#8220;Ultralife&#8221;), SOUTHWEST ELECTRONIC ENERGY CORPORATION, a Texas corporation (&#8220;Southwest&#8221;), CLB, INC., a Texas corporation (&#8220;CLB&#8221;), ULTRALIFE CANADA HOLDING CORP., a Delaware corporation (&#8220;UCHC&#8221;), EXCELL BATTERY CORPORATION USA, a Texas corporation (&#8220;Excell USA&#8221;), Pledgor (together with Ultralife, Southwest, CLB, UCHC and Excell USA, collectively, the &#8220;Borrowers&#8221;, and each individually a &#8220;Borrower&#8221;), Agent and Lenders are entering into that certain Second Amendment Agreement, dated as of the date hereof (the &#8220;Amendment&#8221;), which such Amendment amends that certain Credit and Security Agreement, dated as of May 31, 2017 (as amended by that certain First Amendment Agreement dated as of May 1, 2019, and as it may from time to time be further amended, restated or otherwise modified or supplemented, the &#8220;Credit Agreement&#8221;), by and among Borrowers, certain other Credit Parties (as defined in the Credit Agreement) which from time to time become party to the Credit Agreement, Agent and Lenders. Pledgor desires that Lenders continue to grant to Borrowers the financial accommodations as described in the Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pledgor deems it to be in Borrowers&#8217; direct pecuniary and business interests that Borrowers continue to obtain from Lenders the Loans (as defined in the Credit Agreement), and the other financial accommodations provided for in the Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Pledgor understands that Agent and Lenders are willing to enter into the Amendment and to continue to grant to Borrowers the Loans and Letters of Credit and such financial accommodations only upon certain terms and conditions, one of which is that Pledgor grants to Agent, for the benefit of Lenders, a security interest in, and an assignment of, the Pledged Collateral (as hereinafter defined) and this Agreement is being executed and delivered in consideration of Agent and Lenders entering into the Amendment, continuing to grant to Borrowers the Loans and Letters of Credit and such other financial accommodations and for other valuable consideration.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW, THEREFORE, in consideration of the foregoing premises and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">1.&nbsp;&nbsp;&nbsp;&nbsp;DEFINITIONS. As used in this Agreement, the following terms shall have the following meanings:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-applyto="t" data-auto-pgnum="start" data-displaynum="2" data-fontname="Times New Roman" data-fontsize="10pt" data-numstyle="a" data-prefix="" data-startnum="2" data-suffix="" data-textalign="center">&nbsp;</div>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">1.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;Debt&#8221; shall mean the Secured Debt as such term is defined in the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">1.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;Distributable Proceeds&#8221; shall mean all proceeds, income, fees, profits, surplus, dividends, distributions, cash, instruments and other property, from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of the Pledged Collateral.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">1.3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;Pledged Collateral&#8221; shall mean, collectively, (a) the Pledged Securities and each addition, if any, thereto and each substitution, if any, therefor, in whole or in part, including, without limitation, by reason of splits, dividends and similar transactions with respect to the Pledged Securities, (b) any certificates representing the Pledged Securities, and (c) all Distributable Proceeds.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">1.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;Pledged Entities&#8221; shall mean UCHC and any Subsidiary of which Pledgor owns the Equity Interests of after the date hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">1.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#8220;Pledged Securities&#8221; shall mean (a) all of the Equity Interests of the Pledged Entities listed on <u>Exhibit</u><u>&nbsp;</u><u>A</u> hereto; (b) all of the Equity Interests of any other Credit Party which is not a Foreign Subsidiary (as defined in the Credit Agreement) owned by Pledgor from time to time or acquired by Pledgor in any manner and (c) 65% of the Equity Interests of any other Credit Party which is a Foreign Subsidiary (as defined in the Credit Agreement) owned by Pledgor from time to time or acquired by Pledgor in any manner.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Except as specifically defined in this Agreement, capitalized terms used in this Agreement that are defined in the Credit Agreement shall have their respective meanings ascribed to such terms in the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;SECURITY INTEREST. Pledgor hereby grants to Agent, for its benefit and for the ratable benefit of each Lender, a security interest in the Pledged Collateral as security for the Debt. For the better protection of Lenders hereunder, Pledgor has executed appropriate transfer powers, in the form of <u>Exhibit</u><u>&nbsp;</u><u>B</u> attached hereto, and is, concurrently herewith, depositing certificates representing such Pledged Securities and the aforesaid transfer powers with Agent for the benefit of Lenders. Pledgor authorizes Agent, at any time after the occurrence and during the continuance of an Event of Default, to transfer the Pledged Securities into the name of Agent or Agent&#8217;s nominee, for the benefit of Lenders, but Agent shall be under no duty to do so. Notwithstanding any provision in this Agreement to the contrary, Agent shall have no right to vote the Pledged Securities at any time unless and until Agent shall have given Pledgor written notice that an Event of Default has occurred.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;PLEDGOR&#8217;S REPRESENTATIONS AND WARRANTIES. Pledgor represents and warrants to Agent and Lenders, in the case of the Pledged Securities set forth on <u>Exhibit A</u> to this Agreement as of the date hereof, and in the case of Pledged Securities pledged pursuant to this Agreement after the date hereof, as of the date of such pledge, as follows:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor is the legal record and beneficial owner of, and has good title to, the Pledged Securities, and the Pledged Securities are not subject to any Lien, nor to any other agreement purporting to grant to any third party a security interest in the property or assets of Pledgor that would include the Pledged Collateral, except (a) as otherwise permitted pursuant to the Credit Agreement and (b) for the security interest created by this Agreement or otherwise securing only Agent and Lenders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="2" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of the Pledged Securities have been duly authorized and validly issued, and are fully paid and non-assessable.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor has the legal power to pledge all of the Pledged Securities pursuant to the terms of this Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;No consent, license, permit, approval or authorization, filing or declaration with any Governmental Authority, and no consent of any other party, is required to be obtained by Pledgor in connection with the pledge of the Pledged Securities hereunder, in each case that has not been obtained or made, and is not in full force and effect.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The pledge, assignment and delivery of the Pledged Securities hereunder create a valid first lien on, and a first perfected security interest in, the Pledged Securities and the proceeds thereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor fully anticipates that the Debt will be repaid without the necessity of selling the Pledged Securities.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor has received consideration that is the reasonable equivalent value of the obligations and liabilities that Pledgor has incurred to Agent and Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of the Pledged Securities are represented by a certificate or instrument, which such certificate or instrument has been deposited with Agent for the benefit of Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Pledged Securities are &#8220;securities&#8221; as such term is defined in Article 8 of the UCC.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 54pt; text-align: justify;">3.10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the Pledged Securities are subject to any right of first refusal or other restriction that could restrict the transfer of any such interest to Agent or any Lender or any nominee thereof or the ability of any purchaser of any such interest to transfer such interest, except for restrictions on transfer under applicable law.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;REMEDIES. If an Event of Default shall occur and be continuing, Agent, in Agent&#8217;s discretion and upon such terms and in such manner as Agent shall deem advisable, sell, assign, transfer and deliver the Pledged Collateral, or any part thereof, and, in each case, Agent shall apply the net proceeds of the sale thereof to the Debt, as provided in the Credit Agreement. Agent shall give Pledgor not fewer than ten (10) days prior notice of the date after which any intended private sale may be made or the time and place of any intended public sale. Pledgor waives advertisement of sale and, except to the extent required by the preceding sentence, waives notice of any kind in respect of any sale. At any public sale, Agent or any Lender may purchase the Pledged Collateral, or any part thereof, free from any rights of redemption, which rights are hereby waived and released. In addition to other rights and remedies provided for herein or otherwise available to Agent following the occurrence and during the continuance of an Event of Default, Agent shall have all rights and remedies of a secured party under UCC.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="3" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;TERMINATION. At such time as the Debt has been paid in full, the commitment of Lenders under the Credit Agreement terminated, and the Credit Agreement terminated and not replaced by any other credit facility with Lenders, this Agreement shall terminate and Agent shall, upon Pledgor&#8217;s written request, execute and deliver to Pledgor the certificates representing the Pledged Securities, the stock power and any other Pledged Collateral held by Agent, and, at Pledgor&#8217;s expense, appropriate termination statements; provided, however, that the provisions of Sections 8 through 18, all inclusive, shall survive the payment in full of the Debt.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin: 0pt 0pt 0pt 0pt;text-indent:36pt;">6.&nbsp;&nbsp;&nbsp;&nbsp;ADDITIONAL COVENANTS OF PLEDGOR.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:54pt;">6.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor covenants and agrees to defend the right, title and security interest of Agent in and to the Pledged Collateral and the proceeds thereof, and to maintain and preserve the Lien and security interest provided for by this Agreement against the claim and demands of all Persons, so long as this Agreement shall remain in effect.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:54pt;">6.2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor covenants and agrees not to sell, assign, transfer, exchange, or otherwise dispose of, or grant any option with respect to, or create, incur or permit to exist, any Lien with respect to any of the Pledged Collateral, or any interest therein, or any proceeds thereof, except as otherwise permitted by the Credit Agreement and except for the Lien provided for by this Agreement and any security agreement securing Lenders.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:54pt;">6.3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pledgor covenants and agrees (a) to cooperate, in good faith, with Agent and Lenders and to do or cause to be done all such other acts as may be reasonably necessary to enforce the rights of Agent and Lenders under this Agreement, (b) not to take any action, nor fail to take any action that would be adverse to the interest of Agent or Lenders in the Pledged Collateral or under this Agreement or both, and (c) to make any sale or sales of any portion or all of the Pledged Securities valid and binding and in compliance with any and all applicable laws, regulations, orders, writs, injunctions, decrees or awards of any and all courts, arbitrators or governmental instrumentalities, domestic or foreign, having jurisdiction over any such sale or sales at Pledgor&#8217;s expense.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;ATTORNEY-IN-FACT; INSTRUCTIONS TO ISSUERS. Pledgor hereby authorizes and empowers Agent, on behalf of Lenders, to make, constitute and appoint any officer or agent of Agent as Agent may select, in its exclusive discretion, as Pledgor&#8217;s true and lawful attorney-in-fact, with the power to endorse Pledgor&#8217;s name on all applications, documents, papers and instruments necessary for Agent, on behalf of Lenders, to take actions with respect to the Pledged Collateral during the existence of an Event of Default, including, without limitation, actions reasonably necessary for Agent to assign, pledge, convey or otherwise transfer title in or dispose of the Pledged Collateral to any Person. Pledgor ratifies all that such attorney shall lawfully do or cause to be done by virtue hereof. This power of attorney shall be irrevocable for the life of this Agreement. Pledgor hereby authorizes and instructs each issuer of the Pledged Collateral to comply with any instruction received by it from Agent or any officer or agent thereof that states that an Event of Default has occurred and without any other or further instructions from Pledgor, and Pledgor agrees that each such issuer shall be fully protected in so complying.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="4" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">8.&nbsp;&nbsp;&nbsp;&nbsp;COSTS AND EXPENSES. If Pledgor fails to comply with any of its obligations under this Agreement, Agent may do so in Pledgor&#8217;s name or in Agent&#8217;s name, but at Pledgor&#8217;s expense, and Pledgor hereby agrees to reimburse Agent and Lenders in full for all expenses, including reasonable attorney fees, incurred by Agent and Lenders in protecting, defending and maintaining the Pledged Collateral to the extent provided in the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">9.&nbsp;&nbsp;&nbsp;&nbsp;NOTICE. All notices, requests, demands and other communications provided for hereunder shall be in writing and mailed to the applicable party in accordance with the terms of Section 11.4 of the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">10.&nbsp;&nbsp;&nbsp;&nbsp;INTERPRETATION. Each right, power or privilege specified or referred to in this Agreement is in addition to any other rights, powers and privileges that Agent or Lenders may have or acquire by operation of law, by other contract or otherwise. No course of dealing in respect of, nor any omission or delay in the exercise of, any right, power or privilege by Agent or Lenders shall operate as a waiver thereof, nor shall any single or partial exercise thereof preclude any further or other exercise thereof or of any other, as each right, power or privilege may be exercised by Agent or Lenders either independently or concurrently with other rights, powers and privileges and as often and in such order as Agent or Lenders may deem expedient. No waiver or consent granted by Agent or Lenders in respect of this Agreement shall be binding upon Agent or Lenders unless specifically granted in writing, which writing shall be strictly construed.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">11.&nbsp;&nbsp;&nbsp;&nbsp;ASSIGNMENT AND SUCCESSORS. This Agreement shall not be assigned by Pledgor without the prior written consent of Agent. This Agreement shall bind the permitted successors and permitted assigns of Pledgor and shall benefit the respective successors and assigns of Agent and Lenders.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">12.&nbsp;&nbsp;&nbsp;&nbsp;SEVERABILITY. If, at any time, one or more provisions of this Agreement is or becomes invalid, illegal or unenforceable in whole or in part, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">13.&nbsp;&nbsp;&nbsp;&nbsp;GOVERNING LAW; SUBMISSION TO JURISDICTION. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applied to contracts to be performed wholly within the State of New York. Any judicial proceeding brought by or against Pledgor with respect to this Agreement shall be brought as provided in the Credit Agreement. Pledgor hereby waives personal service of any and all process upon Pledgor and consents that all such service of process may be made by registered mail (return receipt requested) directed to Pledgor at Pledgor&#8217;s address set forth in the signature pages of the Credit Agreement and service so made shall be deemed completed as provided in the Credit Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">14.&nbsp;&nbsp;&nbsp;&nbsp;INDEMNITY; ADMINISTRATION AND ENFORCEMENT. Pledgor shall reimburse each Lender, on that Lender&#8217;s demand from time to time, and Agent, on Agent&#8217;s demand from time to time, for any and all reasonable fees, costs, and reasonable expenses (including, without limitation, the reasonable fees and disbursements of legal counsel) incurred by that Lender or Agent, as the case may be, as the case may be, in administering this Agreement and in protecting, enforcing, or attempting to protect or enforce its rights under this Agreement, to the extent provided in the Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="5" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">5</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">15.&nbsp;&nbsp;&nbsp;&nbsp;UNCONDITIONAL AND CONTINUING SECURITY INTEREST. Pledgor&#8217;s obligations under this Agreement and the granting of a security interest to Agent, for the benefit of Lenders, pursuant to this Agreement are unconditional and effective immediately, and (except for obligations surviving indefinitely pursuant to Section 5) those obligations and the security interest so granted shall continue in full effect until the Debt shall have been paid in full, regardless of the lapse of time, regardless of the fact that there may be a time or times when no Debt is outstanding, regardless of any act, omission, or course of dealing whatever on the part of Agent and Lenders, and regardless of any other event, condition, or thing. Without limiting the generality of the foregoing, neither the amount of the Debt for purposes of this Agreement, nor Pledgor&#8217;s obligations under this Agreement, nor the security interest granted pursuant to this Agreement shall be diminished or impaired by:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(a)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">the granting by Agent or any Lender of any credit to any Person, whether or not liability therefor constitutes Debt, or any failure or refusal of Agent or any Lender to grant any other credit to any Person even if Agent or such Lender thereby breaches any duty or commitment to Pledgor or any other Person;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(b)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">the application by Agent or any Lender of credits, payments, or proceeds to any portion of the Debt;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(c)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any extension, renewal, or refinancing of the Debt in whole or in part;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(d)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any amendment, restatement, or other modification of any kind in, to, or of any Related Writing, or any consent or other indulgence granted to any Person, or any waiver of any Event of Default (under this Agreement, the Credit Agreement or any other agreement, document or writing);</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(e)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any acceptance of security for or any other Person on the Debt or any part thereof, or any release of any security or other Person, whether or not Agent or any Lender receives consideration for the release;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(f)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any discharge of the Debt in whole or in part under any bankruptcy or insolvency law or otherwise;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(g)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">the failure of Agent or any Lender to make any presentment or demand for payment, to assert or perfect any claim, demand, or interest, or to enforce any right or remedy, or any delay or neglect by Agent or any Lender in respect of the Debt or any part thereof or any security therefor;</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(h)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any failure to give Pledgor notice of (i) the making of any loan or other credit extension or the terms, conditions, and other provisions applicable thereto, (ii) any dishonor by Pledgor or any other Person, or (iii) the inaccuracy or incompleteness of any representation, warranty, or other statement made by any Person; or</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;">

		<tr style="vertical-align: top;">
			<td style="width: 36pt;">&nbsp;</td>
			<td style="width: 27pt;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">(i)</p>
			</td>
			<td style="width: auto;">
			<p style="margin: 0pt; text-align: justify; font-family: Times New Roman;Times New Roman&quot;; font-size: 10pt;">any defense that may now or hereafter be available to any Person, whether based on suretyship, impairment of Pledged Collateral, accord and satisfaction, breach of warranty, breach of contract, failure of consideration, tort, lack of capacity, usury or otherwise, or any illegality, invalidity, or unenforceability of the Debt or any part thereof or of any Related Writing.</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="6" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">6</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">16.&nbsp;&nbsp;&nbsp;&nbsp;NO SETOFF; RIGHTS AGAINST OTHER OBLIGORS. Pledgor hereby (a) waives all now existing or hereafter arising rights to recoup or offset any obligation of Pledgor under this Agreement against any claim or right of Pledgor against Agent or any Lender, (b)&nbsp;waives all rights of exoneration now or hereafter arising out of or in connection with this Agreement, and (c) agrees that unless and until all of the Debt shall have been paid in full, Pledgor will not assert against any other Person obligated on the Debt or against any such Person&#8217;s property any rights (including, without limitation, contribution, indemnification, reimbursement and subrogation) now or hereafter arising (whether by contract, operation of law or otherwise) out of or in connection with this Agreement or any Related Writing.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">17.&nbsp;&nbsp;&nbsp;&nbsp;MAXIMUM LIABILITY OF PLEDGOR. Anything in this Agreement to the contrary notwithstanding, the security interest and lien granted pursuant to this Agreement shall secure payment of the Debt only to the extent that the granting of such security interest and lien would not be void, voidable or avoidable under any applicable fraudulent transfer law.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[The remainder of this page intentionally left blank.]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM" data-number="7" data-prefix="" data-suffix="" style="text-align: center; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">7</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<div contenteditable="false" data-auto-pgnum="end">&nbsp;</div>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">18.&nbsp;&nbsp;&nbsp;&nbsp;<u>JURY TRIAL WAIVER</u>. PLEDGOR WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG PLEDGOR ON THE ONE HAND AND AGENT AND/OR LENDERS ON THE OTHER HAND, ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED AMONG THEM IN CONNECTION WITH THIS AGREEMENT OR ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION THEREWITH OR THE TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY WAY AFFECT, LIMIT, AMEND OR MODIFY THE ABILITY OF AGENT AND/OR LENDERS TO PURSUE REMEDIES PURSUANT TO ANY CONFESSION OF JUDGMENT OR COGNOVIT PROVISION, OR ANY OTHER PROVISION CONTAINED IN ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT AMONG PLEDGOR ON THE ONE HAND AND AGENT AND/OR LENDERS ON THE OTHER HAND.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="text-indent: 0; width: 100%;font-family: 'Times New Roman', Times, serif; font-size: 10pt">

		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" valign="top" width="38%">
			<p style="margin-top: 0; margin-bottom: 0;">ULTRALIFE EXCELL HOLDING CORP.</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td align="left" nowrap="nowrap" valign="bottom" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td align="left" style="text-align: left;" valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td style="text-align: left" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">By: </font></p>
			</td>
			<td align="left" nowrap="nowrap" style="BORDER-BOTTOM: #000000 1px solid" valign="top" width="35%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">/s/&nbsp;</font>Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;">Name: Michael E. Manna</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>
		<tr>
			<td valign="top" width="50%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
			<td colspan="2" rowspan="1" valign="top" width="3%">
			<p style="margin-top: 0; margin-bottom: 0;">Title: President</p>
			</td>
			<td valign="top" width="12%">
			<p style="margin-top: 0; margin-bottom: 0;"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: center; margin: 0pt;">[Signature Page to Pledge Agreement (UEHC) &#8211; KeyBank/Ultralife]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">EXHIBIT A</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">PLEDGED SECURITIES</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Name of Entity</u></p>
			</td>
			<td style="vertical-align:top;width:22.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Ownership Percentage</u></p>
			</td>
			<td style="vertical-align:top;width:19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Certificate Number</u></p>
			</td>
			<td style="vertical-align:top;width:17.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><u>Class of Equity</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:44%;">&nbsp;</td>
			<td style="vertical-align:top;width:22.4%;">&nbsp;</td>
			<td style="vertical-align:top;width:19.5%;">&nbsp;</td>
			<td style="vertical-align:top;width:17.7%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:44%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">ULTRALIFE CANADA HOLDING CORP., a Delaware corporation</p>
			</td>
			<td style="vertical-align:top;width:22.4%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">100%</p>
			</td>
			<td style="vertical-align:top;width:19.5%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">1</p>
			</td>
			<td style="vertical-align:top;width:17.7%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">Common Stock</p>
			</td>
		</tr>

</table>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">EXHIBIT B</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">IRREVOCABLE POWER TO TRANSFER SECURITY</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FOR VALUE RECEIVED, the undersigned, ULTRALIFE EXCELL HOLDING CORP., A DELAWARE CORPORATION, does hereby sell, assign and transfer unto ________________________________________________________ all interest(s) in ___________________________________, a/n ________________________, standing in the name of the undersigned on the books of said entity and does hereby irrevocably constitute and appoint ___________________________________________ attorney to transfer said interest(s) on the books of the within named entity with full power of substitution in the premises.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt 0pt 0pt 252pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="margin: 0pt;">ULTRALIFE EXCELL HOLDING CORP.,</p>

			<p style="margin: 0pt;">A DELAWARE CORPORATION</p>
			</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">&nbsp;</td>
		</tr>
		<tr>
			<td style="width: 50%;">Date: ______________________&nbsp;&nbsp;</td>
			<td style="width: 50%;">By:<u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</u></td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Print Name: _________________________</td>
		</tr>
		<tr>
			<td>&nbsp;</td>
			<td>Title: _______________________________</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGNUM" style="text-align: center; width: 100%">&nbsp;</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">&nbsp;</div>
</div>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>PLEDGE AGREEMENT (UEHC) </i></b>&#8211;<b><i> KEYBANK/ULTRALIFE </i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.3
<SEQUENCE>6
<FILENAME>ex_316664.htm
<DESCRIPTION>EXHIBIT 10.3
<TEXT>
<html><head>
	<title>ex_316664.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 2:32:22 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size: 10pt; font-family: &quot;Times New Roman&quot;; padding: 0in 0.1in; cursor: auto;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.3</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;"><b>ASSUMPTION AND JOINDER AGREEMENT</b>, dated as of December [___], 2021 (this &#8220;<u>Joinder</u>&#8221;), is executed in connection with that certain SECOND AMENDMENT AGREEMENT dated as of the date hereof (the &#8220;<u>Second Amendment</u>&#8221;) among ULTRALIFE CORPORATION, a Delaware corporation (&#8220;<u>Ultralife</u>&#8221;), SOUTHWEST ELECTRONIC ENERGY CORPORATION, a Texas corporation (&#8220;<u>Southwest</u>&#8221;), CLB, INC., a Texas corporation (&#8220;<u>CLB</u>&#8221;, and together with Ultralife and Southwest, collectively, the &#8220;<u>Existing Borrowers</u>&#8221;, and each individually an &#8220;<u>Existing Borrower</u>&#8221;), ULTRALIFE EXCELL HOLDING CORP., a Delaware corporation (&#8220;<u>UEHC</u>&#8221;), ULTRALIFE CANADA HOLDING CORP., a Delaware corporation (&#8220;<u>UCHC</u>&#8221;), EXCELL BATTERY CORPORATION USA, a Texas corporation (&#8220;<u>Excell USA</u>&#8221;, and together with UEHC and UCHC, collectively, the &#8220;<u>Joining Borrowers</u>&#8221;, and each individually, a &#8220;<u>Joining Borrower</u>&#8221;), each other Person which may be added as a &#8220;Borrower&#8221; thereto, subsequent to the date hereof (collectively, together with the Existing Borrowers and the Joining Borrowers, the &#8220;<u>Borrowers</u>&#8221;, and each individually, a &#8220;<u>Borrower</u>&#8221;), the lending institutions currently a party to the Credit Agreement (as hereinafter defined) (each, a &#8220;<u>Lender</u>&#8221; and collectively, the &#8220;<u>Lenders</u>&#8221;), and KEYBANK NATIONAL ASSOCIATION (&#8220;<u>KeyBank</u>&#8221;, and in its capacity as agent for the Lenders under the Credit Agreement, &#8220;<u>Agent</u>&#8221;), and is executed by and among (i) the Existing Borrowers, (ii) the Joining Borrowers, (iii) Agent and (iv) Lenders. All capitalized terms used herein and not otherwise defined herein shall have the same meanings assigned to such terms in the Second Amendment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><u>BACKGROUND</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">A.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Existing Borrowers, Lenders and Agent are parties to a certain Credit and Security Agreement dated as of May 31, 2017 (as amended by that certain First Amendment Agreement dated as of May 1, 2019, and as it may from time to time be further amended, restated or otherwise modified or supplemented from time to time, the &#8220;<u>Credit Agreement</u>&#8221;);</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">B.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, on the date hereof, Ultralife shall acquire and purchase from Excell Sellers, directly or indirectly, one hundred percent (100%) of all of the issued and outstanding Capital Stock of various Persons, including, without limitation, Excell USA and Excell Canada, pursuant to the Excell Acquisition Agreements;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">C.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Ultralife is forming various Subsidiaries in connection with the Excell Acquisition, including, without limitation, UEHC and UCHC;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">D.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Existing Borrowers, Lenders and Agent have agreed to make certain amendments and modifications to the Credit Agreement, including, without limitation, making certain new loans available in connection therewith in order to enable the Existing Borrowers to complete the Excell Acquisition and the joining of the Joining Borrowers immediately thereafter;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify; text-indent: 36pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">E.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, Existing Borrowers, Lenders and Agent desire to evidence the amendments and modifications described above by entering into the Second Amendment;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">F.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, it is a condition to the execution and delivery of the Second Amendment that each of the Joining Borrowers assumes the obligations and undertakings as a Borrower under the Credit Agreement and the other Loan Documents, as applicable; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">G.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;WHEREAS, the Joining Borrowers have determined that the execution, delivery and performance of this Joinder directly benefits, and is within the corporate purpose and in the best interest of, the Joining Borrowers.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">NOW THEREFORE, with the foregoing background hereinafter deemed incorporated by reference herein and made part hereof, the parties hereto, intending to be legally bound, promise and agree as follows:</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">1.&nbsp;&nbsp;&nbsp;&nbsp;<u>Joinder; Amendment</u>. Upon the effectiveness of this Joinder, each of the Joining Borrowers joins in as, assumes the duties, obligations, indebtedness, liabilities, covenants and undertakings of, adopts the obligations, liabilities and role of and becomes a Borrower under the Credit Agreement and the other Loan Documents. All references to &#8220;Borrower&#8221; or &#8220;Borrowers&#8221; contained in the Credit Agreement and the other Loan Documents are hereby deemed for all purposes to also refer to and include each of the Joining Borrowers as a Borrower, as the case may be, and each of the Joining Borrowers hereby agrees to be bound by and to comply with all terms and conditions of the Credit Agreement and the other Loan Documents as if it were an original signatory to the Credit Agreement and the other Loan Documents in such capacities, and the Credit Agreement and the other Loan Documents are hereby deemed amended, as appropriate, to so provide. Without limiting the generality of the provisions of this paragraph, each of the Joining Borrowers hereby agrees that it is, and will be, jointly and severally liable as a Borrower for all Loans and other Secured Debt incurred prior to the date hereof by Existing Borrowers in Existing Borrowers&#8217; capacity a Borrowers under the Credit Agreement and the other Loan Documents.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">2.&nbsp;&nbsp;&nbsp;&nbsp;<u>Security Interest</u>. Without limiting the generality of Section 1 of this Joinder, to secure the prompt payment and performance of the Secured Debt to Agent, each of the Joining Borrowers (in its capacity as a Borrower under the Credit Agreement) hereby pledges and grants to Agent, for its benefit and the benefit of the other Lenders, a continuing security interest in and to and Lien on all of its Collateral, whether now owned or existing or hereafter acquired or arising and wheresoever located.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">3.&nbsp;&nbsp;&nbsp;&nbsp;<u>Representations and Warranties of the Joining Borrower</u>. Each of the Joining Borrowers hereby:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;reaffirms and restates as of the date hereof all representations and warranties made by any Borrower under the Credit Agreement and the other Loan Documents;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;reaffirms all of the covenants applicable to any Borrower contained in the Credit Agreement and the other Loan Documents, in each case as amended by this Joinder, and covenants to abide thereby until the satisfaction in full of the Secured Debt and the termination of the commitments of Agent and Lenders to extend credit under the Credit Agreement or any other Loan Document; and</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;represents and warrants that (i) it has full power, authority and legal right to enter into this Joinder and to perform all its respective duties, obligations, indebtedness, liabilities, covenants and undertakings hereunder, (ii) this Joinder has been duly executed and delivered by such Joining Borrower, and this Joinder constitutes the legal, valid and binding obligation of such Joining Borrower enforceable in accordance with its terms, except as such enforceability may be limited by any applicable bankruptcy, insolvency, moratorium or similar laws affecting creditors&#8217; rights generally and the principle that equitable remedies may be granted or refused at the discretion of a court and the limitation of enforcement by laws relating to insolvency, reorganization and other laws generally affecting the rights of creditors; (iii) the execution, delivery and performance of this Joinder (1) are within such Joining Borrower&#8217;s corporate or company powers, as applicable, have been duly authorized by all necessary corporate or company action, as applicable, are not in contravention of the terms of such Joining Borrower&#8217;s Organizational Documents or of any material agreement or undertaking to which such Joining Borrower is a party or by which it is bound, (2) will not conflict with or violate any applicable law, or any applicable judgment, order or decree of any Governmental Authority, (3)&nbsp;will not require the consent, authorization or approval of any Governmental Authority, or any other Person, except those consents, authorizations or approvals the failure of which to obtain would not be reasonably likely to have a Material Adverse Effect, all of which will have been duly obtained, made or compiled prior to the Second Amendment Closing Date and which are in full force and effect and (4) will not conflict with, nor result in any breach in any of the provisions of or constitute a default under or result in the creation of any Lien except Permitted Liens upon any asset of such Joining Borrower under the provisions of any agreement, contract, document, undertaking or other instrument to which such Joining Borrower is a party or by which it or its property is a party or by which it may be bound.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">4.&nbsp;&nbsp;&nbsp;&nbsp;<u>Ultralife</u><u>&#8217;</u><u>s Pledge Agreement</u>. Pursuant to Ultralife&#8217;s Pledge Agreement dated as of dated as of May 31, 2017 (as amended, and as it may from time to time be further amended, restated or otherwise modified or supplemented, the &#8220;<u>Ultralife Pledge Agreement</u>&#8221;), Ultralife hereby confirms its grant of a security interest in the Capital Stock of UEHC as security for the Debt (as defined in the Ultralife Pledge Agreement), and confirms that such Capital Stock of UEHC shall be considered Pledged Collateral (as defined in the Pledge Agreement) thereunder. As of the date hereof, Ultralife hereby reaffirms the representations and warranties contained in the Ultralife Pledge Agreement.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">5.&nbsp;&nbsp;&nbsp;&nbsp;<u>Conditions Precedent/Effectiveness Conditions</u>. This Joinder shall be effective upon:</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;The satisfaction of all of the conditions precedent set forth in the Second Amendment; and</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;Execution and delivery of this Joinder by all parties hereto.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">6.&nbsp;&nbsp;&nbsp;&nbsp;<u>Reaffirmation of Credit Agreement and the Other Loan Documents</u>. Except as modified by the terms hereof, all of the terms and conditions of the Credit Agreement and the other Loan Documents are hereby reaffirmed and shall continue in full force and effect as therein written.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 36pt; text-align: justify;">7.&nbsp;&nbsp;&nbsp;&nbsp;<u>Miscellaneous</u>.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(a)&nbsp;&nbsp;&nbsp;&nbsp;<u>Successors and Assigns</u>. This Joinder shall be binding upon and inure to the benefit of each of the Joining Borrowers, each other Borrower, Agent, each Lender and all future holders of the Secured Debt (or any portion thereof) and their respective successors and assigns, except that the Joining Borrowers may not assign or transfer any of their rights or obligations under this Joinder without the prior written consent of Agent and each Lender.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">3</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(b)&nbsp;&nbsp;&nbsp;&nbsp;<u>Third Party Rights</u>. No rights are intended to be created hereunder for the benefit of any third party donee, creditor, or incidental beneficiary.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(c)&nbsp;&nbsp;&nbsp;&nbsp;<u>Headings</u>. The headings of any paragraph of this Joinder are for convenience only and shall not be used to interpret any provision hereof.</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(d)&nbsp;&nbsp;&nbsp;&nbsp;<u>Governing Law</u>. This Joinder shall be governed by and construed in accordance with the laws of the State of New York, without regard to principles of conflicts of laws (other than Sections 5-1401 and 5-1402 of the New York General Obligations Law).</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-indent: 72pt; text-align: justify;">(e)&nbsp;&nbsp;&nbsp;&nbsp;<u>Counterparts</u>. This Joinder may be executed in any number of and by different parties hereto on separate counterparts, all of which, when so executed, shall be deemed an original, but all such counterparts shall constitute one and the same agreement. Any signature delivered by a party by facsimile or electronic transmission (including email transmission of a PDF copy) shall be deemed to be an original signature hereto.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[The remainder of this page is intentionally left blank.]</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">4</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">IN WITNESS WHEREOF, the parties have caused this Joinder to be executed and delivered by their duly authorized officers as of the date first above written.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>JOINING BORROWERS:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:333pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE EXCELL HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CANADA HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">EXCELL BATTERY CORPORATION USA</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:333pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:54pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[Signature Page to Assumption and Joinder Agreement (Second Amendment) &#8211; KeyBank/Ultralife]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>EXISTING BORROWERS:</b></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael D. Popielec</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael D. Popielec</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President and Chief Executive Officer</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">SOUTHWEST ELECTRONIC ENERGY</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CLB, INC.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Title: President</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:333pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt 0pt 0pt 8pt;">[Signature Page to Assumption and Joinder Agreement (Second Amendment) &#8211; KeyBank/Ultralife]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%; vertical-align: top;"><b>AGENT AND LENDERS:</b></td>
			<td style="width: 50%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">KEYBANK NATIONAL ASSOCIATION,</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">as Agent and as a Lender</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">By: <u>/s/ Peter F. Leonard</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Name: Peter F. Leonard</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Title: Senior Vice President</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">[Signature Page to Assumption and Joinder Agreement (Second Amendment) &#8211; KeyBank/Ultralife]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><i>ASSUMPTION AND JOINDER AGREEMENT (SECOND AMENDMENT) </i></b>&#8211;<b><i> KEYBANK/ULTRALIFE</i></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.4
<SEQUENCE>7
<FILENAME>ex_316665.htm
<DESCRIPTION>EXHIBIT 10.4
<TEXT>
<html><head>
	<title>ex_316665.htm</title>

	<!-- Generated by ThunderDome Portal - 12/15/2021 2:15:27 AM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 10.4</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b>TERM NOTE B</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">$10,000,000.00</td>
			<td style="width: 50%; text-align: right;">Newark, New York</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 324pt;text-indent:36pt;">December __, 2021</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">FOR VALUE RECEIVED, the undersigned, ULTRALIFE CORPORATION, a Delaware corporation (&#8220;<u>Ultralife</u>&#8221;), SOUTHWEST ELECTRONIC ENERGY CORPORATION, a Texas corporation (&#8220;<u>Southwest</u>&#8221;), CLB, INC., a Texas corporation (&#8220;<u>CLB</u>&#8221;), ULTRALIFE EXCELL HOLDING CORP., a Delaware corporation (&#8220;<u>UEHC</u><u>&#8221;</u>), ULTRALIFE CANADA HOLDING CORP., a Delaware corporation (&#8220;<u>UCHC</u><u>&#8221;</u>), EXCELL BATTERY CORPORATION USA, a Texas corporation (&#8220;<u>Excell USA</u>&#8221;), each other Person which may be added as a &#8220;Borrower&#8221; hereto, subsequent to the date hereof (collectively, together with Ultralife, Southwest, CLB, UEHC, UCHC and Excell USA, the &#8220;<u>Borrowers</u>&#8221;, and each individually, a &#8220;<u>Borrower</u>&#8221;), jointly and severally promise to pay to the order of KEYBANK NATIONAL ASSOCIATION (&#8220;Lender&#8221;) at the office of KEYBANK NATIONAL ASSOCIATION, as Agent, 726 Exchange Street, Suite 900, Buffalo, NY 14210, the principal sum of</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">TEN MILLION AND 00/100&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;DOLLARS</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">in lawful money of the United States of America at such times, in such amounts and in such manner as provided in Section 2.1C of the Credit Agreement or such earlier time as a prepayment is required pursuant to the Credit Agreement. As used herein, &#8220;Credit Agreement&#8221; means the Credit and Security Agreement dated as of May 31, 2017, among Borrowers, certain other Credit Parties from time to time party thereto, the lenders named therein and KeyBank National Association, as Agent, as the same may from time to time be amended, restated or otherwise modified. Capitalized terms used herein shall have the meanings ascribed to them in the Credit Agreement.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Borrowers also promise to pay interest on the unpaid principal amount of the Term Loan B from time to time outstanding, from the date of the Term Loan B until the payment in full thereof, at the rates per annum which shall be determined in accordance with the provisions of Section 2.1C of the Credit Agreement. Such interest shall be payable on each date provided for in such Section 2.1C; <u>provided</u>, <u>however</u>, that interest on any principal portion which is not paid when due shall be payable on demand.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">The portions of the principal sum hereof from time to time representing the Term Loan B, and payments of principal of either thereof, shall be shown on the records of Lender by such method as Lender may generally employ; <u>provided</u>, <u>however</u>, that failure to make any such entry shall in no way detract from Borrowers&#8217; obligations under this Note.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">If this Note shall not be paid at maturity, whether such maturity occurs by reason of lapse of time or by operation of any provision for acceleration of maturity contained in the Credit Agreement, the principal hereof and the unpaid interest thereon shall bear interest, until paid, at a rate per annum equal to the Default Rate. All payments of principal of and interest on this Note shall be made in immediately available funds. In the event of a failure to pay interest or principal, when the same becomes due after giving effect to any applicable grace or cure period, Lender may collect and Borrowers agree to pay a late charge of an amount equal to the greater of $50 or 5% of the amount of such late payment.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">1</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">This Note is one of the Term Notes B referred to in the Credit Agreement. Reference is made to the Credit Agreement for a description of the right of the undersigned to anticipate payments hereof, the right of the holder hereof to declare this Note due prior to its stated maturity, and other terms and conditions upon which this Note is issued.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">Except as expressly provided in the Credit Agreement, each Borrower expressly waives presentment, demand, protest and notice of any kind.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:36pt;">EACH OF THE UNDERSIGNED WAIVES ANY RIGHT TO HAVE A JURY PARTICIPATE IN RESOLVING ANY DISPUTE, WHETHER SOUNDING IN CONTRACT, TORT OR OTHERWISE, AMONG BORROWERS, AGENT AND THE LENDERS, OR ANY THEREOF, ARISING OUT OF, IN CONNECTION WITH, RELATED TO, OR INCIDENTAL TO THE RELATIONSHIP ESTABLISHED AMONG THEM IN CONNECTION WITH THIS NOTE, THE CREDIT AND SECURITY AGREEMENT OR ANY OTHER NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT EXECUTED OR DELIVERED IN CONNECTION HEREWITH OR THE TRANSACTIONS RELATED THERETO. THIS WAIVER SHALL NOT IN ANY WAY AFFECT, WAIVE, LIMIT, AMEND OR MODIFY AGENT&#8217;S OR ANY LENDER&#8217;S ABILITY TO PURSUE REMEDIES PURSUANT TO ANY PROVISION CONTAINED IN ANY NOTE OR OTHER INSTRUMENT, DOCUMENT OR AGREEMENT AMONG BORROWERS, AGENT AND THE LENDERS, OR ANY THEREOF.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;">[The remainder of this page is intentionally left blank.]</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">2</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt; text-indent: 36pt;">IN WITNESS WHEREOF, the undersigned have executed this Term Note B as of the date and year first written above.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; width: 100%;">

		<tr>
			<td style="width: 50%;">&nbsp;</td>
			<td style="width: 50%;">
			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><b><u>BORROWERS</u></b><b>:</b></p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael D. Popielec</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael D. Popielec</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President and Chief Executive Officer</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">SOUTHWEST ELECTRONIC ENERGY</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CORPORATION</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">CLB, INC.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE EXCELL HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">ULTRALIFE CANADA HOLDING CORP.</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">EXCELL BATTERY CORPORATION USA</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">By: <u>/s/ Michael E. Manna</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</u></p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Name: Michael E. Manna</p>

			<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">Title: President</p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;text-indent:216pt;">&nbsp;</p>

<p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: center;">3</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>8
<FILENAME>ex_316038.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
	<title>ex_316038.htm</title>

	<!-- Generated by ThunderDome Portal - 12/14/2021 5:57:23 PM --><meta charset="utf-8"><meta name="format-detection" content="telephone=no">
</head>
<body style="font-size:10pt;font-family:'Times New Roman';padding:0in .1in;">
<p style="margin-bottom: 0px; text-align: right; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt"><b>Exhibit 99.1</b></font></p>

<p style="margin-bottom: 0px; text-align: left; margin-top: 0px"><font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt">&nbsp;</font></p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Ultralife Corporation Acquires Excell Battery Group </b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:12pt;font-variant:normal;text-align:center;margin:0pt;"><b>Advances Ultralife</b>&#8217;<b>s Commercial Revenue Diversification Strategy</b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;text-indent:18pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">NEWARK, N.Y. &#8211; December 14, 2021 -- Ultralife Corporation (NASDAQ: ULBI)<b> </b>has acquired all of the outstanding shares of Excell Battery Group (&#8220;Excell&#8221;) for $23.5 million in cash, subject to customary working capital and net cash adjustments.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Based in Canada with U.S. operations, Excell is a leading independent designer and manufacturer of high-performance smart battery systems, battery packs and monitoring systems to customer specifications. Excell serves a variety of industrial markets including downhole drilling, OEM industrial and medical devices, automated meter reading, and mining, marine and other mission critical applications which demand uncompromised safety, service, reliability and quality. For the trailing twelve-month period ended November 30, 2021, Excell generated revenues of $21.2 million. The transaction is expected to be accretive on an EPS basis within twelve months.</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Acquisitions have been and remain an important component of our strategy to diversify commercial revenue and expand the end markets we serve. With this transaction, we are advancing that strategy while adhering to our disciplined approach,&#8221; said Michael D. Popielec, President and Chief Executive Officer. &#8220;Acquiring Excell offers us opportunities to further scale our Battery &amp; Energy Products business and drive the proven operating leverage of our business model, expand into OEM device verticals that we do not presently serve, enhance our contributed value to both our customers and realize cost synergies. Importantly, Excell possesses experienced technical resources which we plan to utilize in progressing our global new product initiatives while adding a complementary line of highly engineered products that are costly to switch out. Finally, with an organizational culture and business model similar to our own, we look forward to a seamless integration process and welcome the Excell Team to Ultralife.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">&#8220;Excell Battery is well known among its long-standing customer base for its innovative team, exceptional customer service and quality battery solutions,&#8221; said Ian Kane, President and Chief Executive Officer of Excell Battery Group. &#8220;In joining Ultralife Corporation, we can both provide our existing customers with a wider range of services and improved resiliency for their supply chains. We are thrilled to have found a partner that shares our operating philosophy and commitment to customer collaboration.&#8221;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b><u>About Ultralife Corporation</u></b></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Ultralife Corporation serves its markets with products and services ranging from portable power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government, defense and commercial customers across the globe. Headquartered in Newark, New York, the Company's business segments include: Battery &amp; Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorp.com.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="PGBK" style="width: 100%; margin-left: 0pt; margin-right: 0pt">
<div class="PGFTR" style="text-align: center; width: 100%">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>

<hr style="PAGE-BREAK-AFTER: always; border: none; width: 100%; height: 2px; color: #000000; background-color: #000000">
<div class="PGHDR" style="text-align: left; width: 100%">
<div class="hf-row">
<div class="hf-cell TOCLink">&nbsp;</div>
</div>
</div>
</div>

<p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include the impact of COVID-19, potential reductions in revenues from key customers, acceptance of our new products on a global basis and uncertain global economic conditions. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife&#8217;s financial results is included in Ultralife&#8217;s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<table border="0" cellpadding="0" cellspacing="0" style="font-family: Times New Roman; font-size: 10pt; width: 100%;">

		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Company Contact:</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>Ultralife Corporation</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Philip A. Fain</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(315) 210-6110</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:100%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>pfain@ulbi.com</u></p>

			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:77.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Investor Relations Contact:</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:77.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>LHA</u></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:77.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>Jody Burfening</b></p>
			</td>
		</tr>
		<tr>
			<td style="vertical-align:top;width:77.8%;">
			<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>(212) 838-3777</b></p>
			</td>
		</tr>

</table>

<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><u>jburfening@lhai.com</u></p>

<p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">&nbsp;</p>

<div class="LAST-PAGE-BREAK">
<div class="PGFTR">
<div class="hf-row">
<div class="hf-cell PGNUM">&nbsp;</div>
</div>
</div>
</div>


</body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>9
<FILENAME>ulbi-20211213.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/16/2021 1:11:23 PM-->
<xsd:schema xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:ulbi="http://www.ulbi.com/20211213" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ulbi.com/20211213">
<xsd:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
<xsd:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"/>
<xsd:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
<xsd:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd"/>
<xsd:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd"/>

<xsd:annotation>
<xsd:appinfo>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ulbi-20211213_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ulbi-20211213_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
<link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ulbi-20211213_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
<link:roleType id="statement-document-and-entity-information" roleURI="http://www.ulbi.com/20211213/role/statement-document-and-entity-information">
<link:definition xmlns="http://www.xbrl.org/2003/linkbase">000 - Document - Document And Entity Information</link:definition>
<link:usedOn>link:calculationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:presentationLink</link:usedOn>
</link:roleType>
</xsd:appinfo>
</xsd:annotation>
<xsd:element abstract="true" id="ulbi_DocumentAndEntityInformation" name="DocumentAndEntityInformation" nillable="true" substitutionGroup="xbrli:item" type="xbrli:stringItemType" xbrli:periodType="duration"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>10
<FILENAME>ulbi-20211213_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/16/2021 1:11:23 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
<link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
<link:roleRef roleURI="http://www.ulbi.com/20211213/role/statement-document-and-entity-information" xlink:href="ulbi-20211213.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:definitionLink xlink:role="http://www.ulbi.com/20211213/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain-default" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain-default" xlink:type="arc"/>

<link:definitionArc order="0" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>


<link:definitionArc order="0" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" xlink:type="arc"/>
<link:definitionArc order="1" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:definitionArc order="2" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:definitionArc order="3" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:definitionArc order="4" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:definitionArc order="5" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:definitionArc order="6" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:definitionArc order="7" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:definitionArc order="8" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:definitionArc order="9" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:definitionArc order="10" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:definitionArc order="11" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:definitionArc order="12" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:definitionArc order="13" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:definitionArc order="14" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:definitionArc order="15" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:definitionArc order="16" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:definitionArc order="17" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:definitionArc order="18" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:definitionArc order="19" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:definitionArc order="20" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:definitionArc order="21" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:definitionArc order="22" xbrldt:closed="true" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>11
<FILENAME>ulbi-20211213_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/16/2021 1:11:23 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple"/>
<link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple"/>
<link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:label xlink:label="dei_EntityDomain-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity [Domain]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityDomain" xlink:to="dei_EntityDomain-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:label xlink:label="dei_LegalEntityAxis-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Entity [Axis]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationLineItems-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationLineItems-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentInformationTable-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationTable-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentType-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Type</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:label xlink:label="dei_DocumentPeriodEndDate-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document, Period End Date</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:label xlink:label="dei_EntityRegistrantName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Registrant Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityIncorporationStateCountryCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Incorporation, State or Country Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityFileNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, File Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:label xlink:label="dei_EntityTaxIdentificationNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Tax Identification Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressAddressLine1-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Address Line One</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressCityOrTown-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, City or Town</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressStateOrProvince-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, State or Province</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:label xlink:label="dei_EntityAddressPostalZipCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Address, Postal Zip Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:label xlink:label="dei_CityAreaCode-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:label xlink:label="dei_LocalPhoneNumber-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:label xlink:label="dei_Security12bTitle-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:label xlink:label="dei_TradingSymbol-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:label xlink:label="dei_SecurityExchangeName-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:label xlink:label="dei_WrittenCommunications-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:label xlink:label="dei_SolicitingMaterial-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:label xlink:label="dei_PreCommencementIssuerTenderOffer-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:label xlink:label="dei_EntityEmergingGrowthCompany-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Emerging Growth Company</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:label xlink:label="dei_AmendmentFlag-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag-label" xlink:type="arc"/>

<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:label xlink:label="dei_EntityCentralIndexKey-label" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity, Central Index Key</link:label>
<link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey-label" xlink:type="arc"/>

</link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>12
<FILENAME>ulbi-20211213_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
<!--Generated by ThunderDome Portal - 12/16/2021 1:11:23 PM-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
<link:roleRef roleURI="http://www.ulbi.com/20211213/role/statement-document-and-entity-information" xlink:href="ulbi-20211213.xsd#statement-document-and-entity-information" xlink:type="simple"/>
<link:presentationLink xlink:role="http://www.ulbi.com/20211213/role/statement-document-and-entity-information" xlink:type="extended">
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityDomain" xlink:label="dei_EntityDomain" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationTable" xlink:label="dei_DocumentInformationTable" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentInformationLineItems" xlink:label="dei_DocumentInformationLineItems" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="dei_DocumentType" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" xlink:type="locator"/>
<link:loc xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" xlink:type="locator"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_LegalEntityAxis" xlink:to="dei_EntityDomain" xlink:type="arc"/>

<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_LegalEntityAxis" xlink:type="arc"/>

<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" xlink:type="arc"/>
<link:presentationArc order="0" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" xlink:type="arc"/>
<link:presentationArc order="1" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" xlink:type="arc"/>
<link:presentationArc order="2" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" xlink:type="arc"/>
<link:presentationArc order="3" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" xlink:type="arc"/>
<link:presentationArc order="4" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFileNumber" xlink:type="arc"/>
<link:presentationArc order="5" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" xlink:type="arc"/>
<link:presentationArc order="6" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" xlink:type="arc"/>
<link:presentationArc order="7" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" xlink:type="arc"/>
<link:presentationArc order="8" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" xlink:type="arc"/>
<link:presentationArc order="9" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" xlink:type="arc"/>
<link:presentationArc order="10" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_CityAreaCode" xlink:type="arc"/>
<link:presentationArc order="11" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_LocalPhoneNumber" xlink:type="arc"/>
<link:presentationArc order="12" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_Security12bTitle" xlink:type="arc"/>
<link:presentationArc order="13" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_TradingSymbol" xlink:type="arc"/>
<link:presentationArc order="14" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SecurityExchangeName" xlink:type="arc"/>
<link:presentationArc order="15" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_WrittenCommunications" xlink:type="arc"/>
<link:presentationArc order="16" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_SolicitingMaterial" xlink:type="arc"/>
<link:presentationArc order="17" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" xlink:type="arc"/>
<link:presentationArc order="18" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" xlink:type="arc"/>
<link:presentationArc order="19" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" xlink:type="arc"/>
<link:presentationArc order="20" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" xlink:type="arc"/>
<link:presentationArc order="21" preferredLabel="http://www.xbrl.org/2003/role/label" xbrldt:closed="true" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" xlink:type="arc"/>

</link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>ulbi20211213_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ulbi-20211213.xsd" xlink:type="simple"/>
    <context id="d20218K">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000875657</identifier>
        </entity>
        <period>
            <startDate>2021-12-13</startDate>
            <endDate>2021-12-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="d20218K">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="d20218K">0000875657</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="d20218K">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="d20218K">2021-12-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="d20218K">ULTRALIFE CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="d20218K">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="d20218K">000-20852</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="d20218K">16-1387013</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="d20218K">2000 Technology Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="d20218K">Newark</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="d20218K">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="d20218K">14513</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="d20218K">315</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="d20218K">332-7100</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="d20218K">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="d20218K">ULBI</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="d20218K">NASDAQ</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="d20218K">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="d20218K">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="d20218K">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="d20218K">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="d20218K">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.2</span><table class="report" border="0" cellspacing="2" id="idm139977359123880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Dec. 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity, Registrant Name</a></td>
<td class="text">ULTRALIFE CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document, Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document, Period End Date</a></td>
<td class="text">Dec. 13,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity, Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity, File Number</a></td>
<td class="text">000-20852<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity, Tax Identification Number</a></td>
<td class="text">16-1387013<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity, Address, Address Line One</a></td>
<td class="text">2000 Technology Parkway<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity, Address, City or Town</a></td>
<td class="text">Newark<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity, Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity, Address, Postal Zip Code</a></td>
<td class="text">14513<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">315<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">332-7100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ULBI<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity, Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity, Central Index Key</a></td>
<td class="text">0000875657<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #-#D%,'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  S0Y!3ML=E/^X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*$Y8!R;-I:.G#@8K;.QF;+4UBV-C:R1]^SE>FS*V!]C1TN]/
MGT"M\D*Y@,_!>0QD,-Y-MA^B4'[-3D1> $1U0BMCF1)#:AY<L)+2,QS!2_4A
MCPAU5:W (DDM2<(,+/Q"9%VKE5 !);EPP6NUX/UGZ#-,*\ >+0X4@9<<6#=/
M].>I;^$&F&&$P<;O NJ%F*M_8G,'V"4Y1;.DQG$LQR;GT@X<WIYV+WG=P@R1
MY* P_8I&T-GCFETGOS:;Q_V6=755\X+7!5_M>2/J>]$\O,^N/_QNPM9I<S#_
MV/@JV+7PZRZZ+U!+ P04    "  S0Y!3F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M #-#D%/^A"-3*P0  $X0   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
ME9A=<^(V%(:OM[]"PU4[$V++?.X.88:0I,LL2U@@W6D[O1"V $ULR97$$OY]
MCPS8[-0<DQO\I?/JT3G2:XO>3NE7L^'<DK<DEN:NMK$V_>1Y)MSPA)E;E7()
M3U9*)\S"I5Y[)M6<15E0$GN![[>]A E9Z_>R>U/=[ZFMC87D4TW,-DF8WM_S
M6.WN:K1VNC$3ZXUU-[Q^+V5K/N?V)9UJN/)RE4@D7!JA)-%\=5<;T$_W0=,%
M9"W^$'QGSLZ)&\I2J5=W,8KN:KXCXC$/K9-@</C!ASR.G1)P_'L4K>5]NL#S
M\Y/Z4S9X&,R2&3Y4\7<1V<U=K5LC$5^Q;6QG:O>9'P?4<GJABDWV2W:'MLU6
MC81;8U5R# :"1,C#D;T=$W$6  ,M#PB. 4'&?>@HHWQ@EO5[6NV(=JU!S9UD
M0\VB 4Y(5Y6YU?!40)SM/ZAP"TFV9" C\BBML'LRDH=J0]9ZGH5.7%,O/ K>
M'P2#2X(\O"6T<4,"/Z _AWO E@,&.6"0Z36J ,^HR-]C:$5&EB?F'Z2/1MY'
M(^NC>:&/P[AOR(ROA;&:06\3EO"RP>-"+^/%;# >/3V2X?-L^CP;+$;/$P2P
MF0,V4=U3$F[(8I^6<N'QW?H7A**54[2NI)AR+92;+Q&!65<*5"%UG"6_?/A0
M,4_:.5S[JAJ.9*ATJG0V46[(W (?49H,U59:O8=C5,J+JS\\(HB='+%S%>*3
MB#F9;),EUV4DN(CO^_7 [[8"!*B; W6O EJP-S**H+)B)<+#"KN,ATO2=ITV
MNAV?-A"^CSG?QZOX!E&DN3'Y"<F6_[,L+20N"6\KGRQXN)$J5NL]F3+]NF-[
M!);ZA97Z[\,=.C>%N;=0NW(GQ?4F? =T&-J9R]/WH>7K8JK5#R'#TE16B$[^
MQ-@*@Z?!^]BFRE@6D[]$>G&U5DC29@N=@+1X,U#<T;,2#N![YS(*+M"@+0RD
M> -0W,+'*H2<3#=*8MY1(=)H!/4.]7V,J'@;4-S#%\*"CZD5H<&OR]_(G(=;
M#=DJQ<*5ABI)P'/F5H7H="_>!12WZX5FD9!K,M\G2Q67$N$"+^/[$4926#[%
M[?J4%?+X%FZ87/.+7Q850I/!_&'P#6,J7)_B'OT=@"R7Q*5]*X^.;TJ9<*$5
MBPW'D JCI[@MSU4L0F%=S;Z",6G!RJN&JU3Q!(65![CU3C6OAY >#LZ8?7TN
MN(RX)L^K5?G"J]"K)"N</,!-]W]D(V.V0%8)B,M6 IY]KU]GYX\)UVM7T-]!
MPF[<;$N9++6'"L5*ML+- ]R,!Y"Q*,O:4\S6I2BX0"5*X><!;L6G- V!1H.S
MCZ!\;^0++T\0K@7?-'ZWTVJW.F5HWMGNT.VTOS)7%T-BO@(U_[8#YJP/F]?#
MA55IMF%<*@O;S^QT QM^KET#>+Y2RIXNW!XT_PNA_Q]02P,$%     @ ,T.0
M4Y^@&_"Q @  X@P   T   !X;"]S='EL97,N>&ULW5=M:]LP$/XK0C]@;F)J
MXI$8MD!AL(U"\V%?E5AV!'KQ9+ES^NNGLVPG:75EW8>QS:')W3VZNT=W)YFN
M6W>2_.'(N2.]DKK=T*-SS?LD:0]'KEC[SC1<>Z0R5C'G55LG;6,Y*UMP4C)9
MWMQDB6)"TV*M.W6G7$L.IM-N0V]H4JPKH\^6E :#7\H4)X],;NB62;&W8EC+
ME)"G8%Z"X6"DL<1Y*GQ#%V!IGP*\"!JP'.,HH8T%8Q(RA._]N/P9,&FM5X64
M,\$E#89BW3#GN-5W7AD6#\87$!GEW:GQ#&O+3HOE+3T[##\^R=[8DMLYS8).
MIF(M>05TK*B/\.M,DP#HG%%>* 6KC68#A\EC%'S8 Y?R 5KXK;J*W5<D].)3
M"6T@L-5)](1&,80)"L2_C!9B7X2]_:VPI!&/QGWL_&[TH'_OC./WEE>B'_2^
MFO-CT1=X=-8T\O1!BEHK'O;^RPF+-9O\R-%8\>2SP:0<O(%;2AZY=>)P:?EA
M6;/CO9NFJ:]PSLM_D/.?K7/--;=,7I+VH_\W5_DMC)/Q]%P<T:L#.EL)7(0;
M^A7N5WGF0/:=D$[H43N*LN3ZQ3GUX1W;^PO\*KY?7_**==+M9G!#S_(77HI.
MY?.J>ZC+N.HL?X;[:)'-M[#/)73)>UYN1]76^T$D7O!9QP<<GB-WPQ-',)^
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  S0Y!399!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ ,T.04YE<G",0!@
MG"<  !,              ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  S0Y!3_H0C4RL$  !.$   &               @($-"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ ,T.04Y^@&_"Q @
MX@P   T              ( !;@P  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  S0Y!3EXJ[',     3 @  "P              @ %*#P  7W)E;',O+G)E
M;'-02P$"% ,4    "  S0Y!3.JJBYT !   \ @  #P              @ $S
M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ ,T.04R0>FZ*M    ^ $
M !H              ( !H!$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ ,T.04V60>9(9 0  SP,  !,              ( !A1(
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  SQ,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ulbi20211213_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ulbi.com/20211213/role/statement-document-and-entity-information</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ulbi20211213_8k.htm">ulbi20211213_8k.htm</File>
    <File>ex_316038.htm</File>
    <File>ex_316642.htm</File>
    <File>ex_316643.htm</File>
    <File>ex_316662.htm</File>
    <File>ex_316663.htm</File>
    <File>ex_316664.htm</File>
    <File>ex_316665.htm</File>
    <File>ulbi-20211213.xsd</File>
    <File>ulbi-20211213_def.xml</File>
    <File>ulbi-20211213_lab.xml</File>
    <File>ulbi-20211213_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ulbi20211213_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "local": [
      "ulbi-20211213_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ulbi20211213_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ulbi-20211213_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ulbi-20211213_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ulbi-20211213.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 26,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "ulbi",
   "nsuri": "http://www.ulbi.com/20211213",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "ulbi20211213_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000 - Document - Document And Entity Information",
     "role": "http://www.ulbi.com/20211213/role/statement-document-and-entity-information",
     "shortName": "Document And Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "baseRef": "ulbi20211213_8k.htm",
      "contextRef": "d20218K",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityRegistrantName",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document, Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document, Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity, Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity, Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity, Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity, Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity, Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity, Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity, File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity, Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity, Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity, Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://www.ulbi.com/20211213/role/statement-document-and-entity-information"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001437749-21-028699-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001437749-21-028699-xbrl.zip
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M.=&8=].^RK2;EHGOQ'R^B"L4D#,$/Y\38EB,@>O6H+H&R: <]S-I>C4SFC
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M3 4":8<7X&I6 K*3B):HFX(P2O4U8Q@:Z&"\'9?)X.#=1N7VG6@(-(;<5J>
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M<#A,^_)!FL'^N8VR,C=78]W @-?E+L@X<@?^:(X-QM#)ACG4.(X\Z*<%M=K
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M:7#,+"I'0EO9HZXU-8\7-0\V.R.%5;G\S#:WZ1 97VKQO&,P* <1@G;:55-
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MKE>X>1U#U(,)%]W1K_^G)/^9@LCT]LNQ/5N:%:,F3-FO.%WLC><8>W*62$=
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M%"W>*9.8^6C4;926.:6=Y$M=R)K&<7KG]'@2U56C9V&=)S 'IC!90@-N:8;
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M9]0R*H^J&\@KF_D"#RT;OF>5\OTJC+N]^("6HB#'0F:#:S1'V?+V_&.N;-I
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M6_0!'$!7 MP7RQ(%*+OEXN1^@(GT?CV4UR[7C*)#KE$L)/#=K6>$S&_KG)/
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MJE)BLY,QCV(]UKO>UMEC9A4':4AI'=9!OW?P,-7[:S0-UOH3F-G"%GB'$4W
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M'<;%YW(+%,L>_9PP_P=PB:4F ^Z>(9/<A,!?(O/C:2;(=3;NV\(O-/ "#C=
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MQ?99PXA<MG;,@_QL&VHA-D^PX5M<X[\TR9FO3\(Y25+P*JC]Q8D?$@H43$O
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M\*##CAU[37><W)99_(Q,8D'_D0ZOBK1F3)QBZK)F;L8=2+EW=3SKGU3!"\0
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M%130N0W]+EQ8PW[-@7<='#QD#,_EE-O'1<S C7QC#?FGGLC'A!5]XA+T;KS
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MD[:@03/1,\,W>:"]7[?!^TG1=LT*.TL&G4YJ7T_2J.,<@>^&=NUL!F:*PYM
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MK-LQ:IE4_5N1"L)-D["KPM;;_,7?Y2_F9ZX.:Y3RUR@I"9T%!+KO>I#?L:N
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M<7$0#FER0&J(5"7!@0?%T%SFA$]YDX,C/R7P@>I0*FTD2T$OISC,,H<'RD^
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M=Z>@=%'P8'I.7_:-82^VY#5A[9E?I )2"K+AT2K.W**;NO7 %[7[SVI-GL=
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MF(\H*EX1!'.$%:[+%9:J@^ZI30&Y,/OZX-Y!6,BP2O-XP5U45 R--:98,^T
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M*TV"NKBIQV21=X[02"O ;/$VIE8Y=!TO318_ X^KE2J.G&]K\L74'5B61)-
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M>PB_WWP(L4#F2YG&M>)%MD7J1VY=&UM_=W9K3N'X#30 RK[>4&X\Q<KZ-#8
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MUKF &6@R',OI=.POK3I,<".ZUZ=73J^+P^(CL-S&==?Y8HN_KSM.]\SA:>0
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M/1GO0(5<NJSVL6I.Z</K.!G+/*O:1ZCU#5-W03L-U0DZI$R3D2LH@=H!4R0
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MP^KVWF>APM)0YK.&*%6$#C[TH^$,P+Y+Q\&G_P=02P,$%     @ ,T.04[6
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MBH>?/Z)'[ZJSLF5VRK9Z/8"9E?$ 9H64M[LF5+;JG&R9O;47>7P;)^I&40O
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M!:+F7$4C,*%V89R -=*U6CJ0_TT^?Z. ^-C_UNNI,;I'6\4_+N(14'@_$I<
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MW]KZ+P?S$9/JX>SG)>)4KA_3UJ;H<31I:C,1F::9J-A1&EQ%997#=V%P!4P
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MR*5X_I/.HKMUBR4U%V#&2A-(:X^.:H*^\ED)%F$P4(@-GH0<-"5L4\9B!>8
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MB@EUD=\=KV]N'3NSYY\3HQ3RI0L@+H8R':WIRFP$%J1]F#;411@EP'N=>7K
MBVM(-O>Q'C<G\4%+.M5$VZSG NO):6]7)5BPE-7S%93XM=3B/V#/-$D-<".,
M#O++0QIZ><GRZXATO,"Z<GQWL[#W6]A?N9NQSFQ\#/M\CN?^BS[V:PFOW)[?
MVXXP8O*.L7Q N>G'F"":PXU93G]@FT7XQ^8C,X*9@@D&-Q9Z8LM/^<=NZB6Y
M9HJJBP!2A8' PI3:7E;EV!^I#\JGY')A%@3A/9A<9RQIZ&:('-'-HKR/N;<W
M0 3_UOX&_8+;H<[/XP&X<A5&K7@I*(5TP+A6SHP1V:QMEF:T0B6#'9D+N2#L
MTVV*%R81WKCK[DS>S! O!SV\B/U+[>];]=XA4<GYJQ55X;O)WP2X167,^IWJ
M$[/#FM/#&#!P0Q+=.<N5=^.2H'ID1RB[&2LK4LZ2%3 IF-%?51X7?:[AV"0Y
MW"_)X<43)3F\V"0Y;)(<6J3$U?6CTB?WML;KJ%LWJQO:!2L6F1 $$Z?O\J7P
MNS*9ZG"DZ+<L-\YQBRT#JTZW_$+8JW$9Q(5DG&-%"8(ZV@?T50%O0L*)X!Z'
M9HI4T1 Z7YB;W"_U[$*I^(ETM0>L;QJQB"RS+W'/>:9MSM;,1'[#_AJ>--U(
MQ3/H?KE5G.0O'W,52=D O #7-5*Q %%9A1(OZL>9OF8$4P/)CL-Q-1%.7DO@
M.ZP.-.]$4Z Y%+:(!X1I@?6$_\(D:I2+DI!=U&L2L++ I '6BEQFO#A7N<2W
M+?L5^D5?NBX%%:B;C/8[B1"Q%G=[AZ:.\=(N3"HK:%LFO2&PT9AWN1N/ARJ=
M)/B3PIH<58V"X:2?@XZ6=[/4^QZF2V!59N]LK0OL15YA5XTXT;J KM.P.EI:
M4;9\,*A4XMRIB[QN(@96F:1P!RA1^,6ZL81- /*KK>4"24:4?:!AE04=2&,9
MMT0DF8,R-IR3CX2XNUWD1'>P 2/@Q1/7=G&;_CEH/TXO>%3"MVT-!^XAG;"X
MY)+) 2/BJB\6@GK.\V'V<(+0F!"0:,1CS/)R1Y<;)5EZ0W](/3?'0ZM4_G!+
M3,><>,$%I6H4 Q_P6A)I!"9=#BXLN[%*WOL&"D&#@(.8MI[ :_I8'=.%V5+-
M#'!.ZCG6+4W).6(K8T-/N(O+;\BBX/5MX&U;>^W1;R.OXVP7K3FPLG0'FT'.
M /NF/6E!H^30-LB,@K$$WS"WKS\"S[C!BQKK6,LXE[HX4^B?&:ADX/L\%;#X
MTJ %@RLHH\\JE>1_@3]<*/R]#7.$*?;$/TWN%7?"^+.LU V#C4[\&GL!8];O
MY;XKHU$YU.*E]^!I4 (WS3V\0%[?#&DZ*%OB] TC8]WJK=+;B-]*?J;>T8 S
M"_H6P8^V2I-#X< ]NE#=&IT:8U]</5OXF.RABRUFI;'[EFC\5J);(7.!5]!/
MC[&I)UY/Y5G.P"(\ S'?:_D-NUA=B01E&I)Z3S=0KBXO]/F@DQ,1;'V1U1-T
M2I,K ?.=&9K;FO"-;>1&&_-OCKE=7%P0U.8:2J*IY2!-G?__O'[^,@0#=Q?^
M?[-0L%#H+'](H<V6@W8_#=W5*:T4JD>VKA%9!2@O09:$=_7CHEOEA=*='+!S
M,$)O3NF'6:_Z6C<(2+,]L)X7T:/ZTKQ:RR:O>@$GE *[6<&'K:#N,.&D$W^(
M\Q9LF_N$UM>R1]*IAE=^%#3?X59W':'Y3DLU0@51\.4VY/< \D/WXNCK^D;6
MTCGR>YK=$23<2H%#_@BQNY=/%+M[N8G=;6)W349P%MVU1YT<T#E$<XNYB3:R
M3D[>2,K8_BGI&ZW@<R8AI)D$0D$K%Y8NI/P$OJ,J!5-'.T(%T&SB9B^$P5]5
M_T9[^?ZJTI[!>1H!DZ<ALT9K&?B&) @]H$]NQEZ.K<G8$G3AP) =.GX5D_-@
M?4@$?9A,=C1,GG<WP6@P*-$4>,LI'6P$1<[+[J 763-!=89NQL=U*%_'%N5U
M_$UG =]VW^F,]K<_==_5L29U2Z>*8;1L*%/G]EA\0$;VK.5I]>);A$Z$S<"0
M;])(R<+HX'@,[!G[.]IAMD-$;,P%6&] "P!;B4=IPBE(%$6A'E ]C%!TR0?,
MX64$ >00!HZAD:ZZ"ME2Z,=UX_0V2VZY/)]Z$TB2$I_\Z8?1SVZB;^QZ!.,H
M5>M6'W:6^7$U6!+_QYG@Q0E=$'(KC]#O@]'+"L1A'&"/)J_[DG;:%:%MN[OE
M-^\""5& 3$*QA<UEA5M/5.[WF67) D*,_\#1\E(:;# I &D.$ $3!5S!P:%^
M-(INFCU&B#10&,#[13<W>70KV7W!&/&8D>CUVQ):+H=V\"MZ2%Q2OQ$LFB%:
M OYU&R65[=-&LG:<Z(@/WE!OU>9>TD.\D$&2W3D;HZ,8/ ]<,Q?B$OM2C4L#
MT8M13QCG>ACGXK9C\$-<A2(@ *^HT)T]J*<;MT2D)$F6LG:I9&P_&Y'\LG-O
MAD?ESH9.2,LHE-*Y';9)*L5M::(X6IEP_[&XYASF? N_A_*:G5F=:!1T^L#H
M@!V>##!#IET#I"8N0+-QWJM&.M>'8]# 5'L<6N:L)$7#!%N@Y2>L9"63T&$'
M)[>U(HQMTR]&]X+%&Q!??QC!2:)P&QP(CHC)G.F,R;SE@=68\TM,BRR/CPQ,
M(8@#KPF\>TQ0N*2J(0MH0AF\P<HQW=D&!265D@VS.VQ+R7]30FU*B5?UA"OF
M=%V,W&*V#Y*B46,5LY@T,V]"2V/.'D432%&T.*-31F^/XVJD!4*'EB0 BE/0
MXF+_;ZSYGT('#-Q\(RGT"F:=C>*>G]=LEM)MFJRCPJ$.Q^-+VN4'\ORLI+FW
M/ONZB5ZM8:#3>U:RAD@-EBDQ]14Z8 W44Z%"S:%:Z14YL&/ 9;8AF],>F C
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M%/BH2U56>;J$+'/YZFA>S:ZC064"D71!-&YJ9Q9<U/,:AC\<-=3(#!@F]3#
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MT8)Y6V/F&\6?5>="JT51.>KQS"P17AERYW8P&K"= Z!$1(^W/U5^T^&]FL.
MN=GB2!)"+4(I[>SVF#:N=L;'A9L(K0?7Q@W9F3NZ-D^FQE>)RV3%R,#+<^+
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MK::-B6/\S+6*"84%H)'75M/8B$7>D)D#MM&%,9M(GZ);BO^Z1T4V_L^X#I,
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M95/@'1 8B.J#-+Q<(<8"H.8G56R4(Q2\0U$9^!BZV%^A[BNO1],29R5$Q?>
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M#R#3AO]#=J^D(/,LN(_1E!7XI<;U:FP>#3/J&5ID^ $_@@RP6EAP:NRO?-!
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M#@E5/E!Z!!I7_4R*]+.NM&_-A'3NU<V&B1JANZA?B73O)]Q**S3-6PWM/96
M&N/<:+4T/TN)I2']XJ$NTAPBW8&J2%?Q=D=X!],]G@[^#I?ZH".P?P'GBS@'
M=KOGDQ=E\26%AD>3-^G/95R^MA$N.!#&:7HA4*W3Q#AK@##])(0A;_/%D6]W
MBJN2Y0CA3;#T8)YBU3W041A;;LE[/W/3/J=IGRQ3$+5S._=H0DD_#OK8(M#0
MZP)7TGX"O\:3PG$PR*,8AYJ<M"FCJ2[PJ!D[:$FL!M#%*B73=Q5?;@5,#/%
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M],8PJ3_M$?)PIB/,] ^&F?X0"8%GMY40>#8F!+Z/A,#MH%[?=L->3U^]>@N
MU]-WD]-_?'S]^E^OWW_^GBFG#M"8CW?2 >6YV=K$<?'<.*/Y$B'6&?;;O2MS
M=#?9;]X;0=+1X]4CVBH4=(8P)$9C-BGC %*,!Q!0TBM(6D,/2;RFF1OSSB&)
M.TI..R-T.\-H<!_!<VW*3*?@ERK&ARR-0)Y(@)@IA?;D4@'%0/B^R17E+=S]
M/%TE,\T'QMPN-C?0LEZ5 1W9 2+UB_0/ ?;UU)@NU-2,\@V5L/65*6<2)%\0
M8]>A[='D?5'#[6SDT]P'O-(S#<86HNW'Q/@DD5C"P)1;;UV%_^6CP,1C!(/Y
M 5B8'!O09<H;;A -+QQ1+'3%2THT;3CG\]0882EN%)P)3$5P,QAU6>PXAF4)
MB\VF*.LFMQUYP;$1KP;W1[.Q\TA4F5U;L+7KJIO:=MB1'!]AGD5]3_HVP\B4
M<PVFG%^-!%_ABBRS)5#$YCER'L6J2SR#?5XA@[7:W+3'',818(*PT!7'.]N2
MPW6E\20(YRR@$4563ZIS[$6+C$OPS\DBAN[<0D\($=I3%Z&%S-^7--W /:U&
M0LR?_B#"LB#>K=PUO,PH9JI94K']!Z/:PF8;-K/B=WMK(3W5X*:==%: "TP<
MGZ%4INIQZ,QHA_0#@%KK-^2>53YI+5[%J4\'1M-+RD2MDZIHRD4J@IN30I!>
MRBW_$-]'T*$H/9$EP[U,2-%*X#//5M"8VEDD(+/>UZ%%,WN+QB(S>FX,[3/N
MC;"P'3*RW/ZQ=,*+Q]VFCVT)=#.Q(--G$?4*D=U(K9J5%$7?<D.[".:PJM--
M1129.W;K?K?"CBQ5O$S/&K,#VY/#:&MI=V/&*5D^MQ;1Q#C=9BQ&LU8;<)&A
MF< *,@N\;9<8B**A+K $0R4)M8.NMKS]&(CJ\\IUI\IFDA:AACEZX@6QV)J.
M8)M/$6PI/,ZHEWOR\ZAE,#" )^HWH^BK)%,XY%EP9F"V)/SG-H::TL@;,<N@
M0"?WA].0^6.] 5I4Q$3J?"7P68,=@K8*'BX/-DD;C.P9.DYY7+-<@+]66#;/
MTR3=O7F6K#KE$?)/[)SJS>#DJ3*_%H64W-AP"(NYSKT H5'S&WZPW0)4-6]<
MQ(M43"'_P'=(.% !655;2W74Z6V=/M36\?&NJAJJHW'I/:FM^82]:>J]\13C
M;$/1?IL;6?PC%#?H, # WN$Q4*Z#.836T%]]YP]]D* )L^T)13D 8T\5&\DU
M5 UT0\&_DHL8&WG-8R.*H!U5L6HX&^"R"O+EQHP(8J[\Y^+<O#VZFWA^(4%2
M%O?6\5EN=LD"4]!KHVVQSQNW@1%_#D;HN/Z%LT S_#\GG=E^3R[&<W845^RQ
M#A<3\=<<F3L_U60Z^0_\G)8E,&IN6T_D1UI'&EU-YNXD*9/(O/8$@!=L#>T$
MEK3BP3" BQE26$^HI1I*QK]P"P*0R)H%S&;P.ZBV,>)NX6\7\:I!6?A%]0%*
M%^>Y$9$KZBM49Z)]?<N7?,!>ZQ;BK_"+A5&KX8I0 G=ZX<VHN+#F_G@[UHFN
MHL:'&K2-JOOH)9M/H7\/#3)4&/"Z:6N6]-!4XP>'DU EHE3V&2^<,>$IX&\9
M]_]I!.05HU^O7,,]Z,C@NY!DD1B#"&,-EX1YR^5B.O*1)$G75;KB?I7.Y^30
M&;D#$)C0Y?:N4RP;=CZKFY)4,Q=Q0$9Z\VMCHH$E1(TR 7,G;0PCI).#[[BU
MI W1('M=3#PND:4!]D)V$=[?6CMR?^D8)7\-5N[_N%O._D]MMGT4]#3KW7^D
M9LW41KJ5#/Z-*Y42 V.%WA#D,J$B'>( 19YN,;X 3I@9<,K>;CJOT2WR:T,I
M&4\""/>=UXY9$4-B1S8PWLT^)V_;;G#CNQ=9(@6@2=',:U9HXA_0%G0!WJ)D
M,X*B:[AS>SILFF?,**)GS<(++?O_EOV=@X<)(&LB^."\N(0.#_0W5DR9H]H?
M$+UOQ(!9">H[A"=;^J?J,T\]S"Y1_<0$_*PPHZM2R2LR$."47A;@>:$VG=[_
M7XM>P_ XX3HT5K4B]D:6(8MXDX'G.+412^3:WI)>1F9O68X*[QS;>,,]"$NC
MCXG*B'Z-#RV-I  W4@68P<R!/4\=I=&_K(O%%XA6F'<XX\:GYD'WDC0&NAJX
MF/V_K?&"C%1<-W4#66RL8#Q'$Y+^;53Y!6Q8'CE\"+>#:04W45Z1/[_%9%N/
MW/@1$MD/C_=,9%\]:=V=MWQX_/,FLKMNW-YCAV>Y!U;AZOGN[U-I#FE-J!G&
MF"'U'H*0$)C(M6M'%('S"<$$5'WN6_F4X$'2$Q.D)J)#<]4/.DB**@8CCWK9
MHH\&?KZ55LI83YWX5N=D"CY7Y*"IH+>,#9DMH3WW:[ZAU[ .H$0IQ+E!S17(
M^-12OYZ_ M> \O<GXUSL@?;CGDNV+ME;MP;*M3C/YEF'=IUN9Y :AIM)DXE*
MQ7W \"$/DDLQX.G28;:&& 'R']!T#BQ6SFW>S#MRMM1=C?<$0[V ]GQ()K![
M*!Q._GTFUU#YB7Z K>,"%=R_'M3(CUNQ"7D!O13D,.M)E7V=3!_/P,RKSRM.
M4-E<+B1!73\/&S#V1EYX^\&WQ"#RVA#DS0RAOJ1&<IKN/M$!9ZBUOW.*^Z[+
MKF\JO)@WP3S/2!WT H%=8=Z@(VALKP3^:][C"X!U(PK0992NABU?A2WM83^"
M +SD8-%-WC>N)%SO)?;,I4H*&AO@WA;(W*$G=0'!DW21VN2FG^1E6C"7S4'Y
M13MWIQQ&;(N>/ 8%F+=?!URF"='=+6IYVLG]>W@>W2#5J?0I2/2M7%9J2!X\
M1S2U !AR:,G,6>L5DB@!^]YUUH4:=9I_@UO1?CPZ_N24(' ',"Y1)S/\BWUZ
M-_^X(N'F>@!]8%!2?US>4YT:I60VY+QT<=KNH.9\.[G(RMK%+N5.7!",#JF0
M^2XI$$0JW_O&Z_/@)TL_-?/*7&UF"V+B?M]4%[ORFD/PX0T9J9QR%G7%,2M4
MK"Z:"\\''LLS_KM/>UUOQ./6WKFU%P=O;=S0_S(RBN@8,R_7COM>_DP@G$^A
M"[="W'/X!2>+_EFLB*;]79T<19-'#R:G6) (3) 2=J>O/L>5F97)/U.C.8M-
M#0? ^^+?%*J@3W$@_,7I14;B'+] 4(DDQ5[&I=E_\>0?$&YUV16M<H+Q<F$8
M<68/1L((.8$P.1>D4^4"X>$\<$JCP*Q7KX*CR+"J$P )Z45!3@Y1_5DN2_1@
M)-&R7,9960V_,)_(F'$7VA M4H+R++ @W )RS%+5>%.)?QU-=)+3+Q2W#I;;
M;+;U3"7%W!VOR15,,MED0E]]8CL03' EWN6ZLAL<4R?V2&2J-QKEU4YYE?3*
MJZ[L>4MNQ7;-,)UC^T'0AYS0DU^S3Q8PO'E(4\X#"W6;V]00LTO1+,Z,3-G$
M)29:SV.D@X6N$''.^V@1KQ8-I03A?&*&)D[2_S;F(_/7G%H_(0L(A.OC=8SG
M8F5,[:/)*>I?\YB5#PE6Q@?"K^*$FC=9X@4,-!M;,DN77;1X9#AB)1:>BQ64
M.*JWP\C W'U)'@] &M?"56*V!,Q0EO_6Y(19I,<9LY9B% N/T22V3>%=HTJ
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M1;%Q;03V.ZF^,=5CW"VQ6*35_,B2A FZ?7K"_["\HA5O/>@KPW/O'C[SB8M
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ME?.N9KP7Z8&TWX<.N/4#)4&ZGN:Y\9W3KS9)>UI&$I#]-$[:JW$@#LUA4VQ
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M&,_N[O8PSX;;P[RAHK;):654.+"?56,3M3WG]@UF7@$DP!3<88<T*FB,+*X
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M)D=B JT'#S]C85L/ SW#X;L:U/>XK6_1R56+?M.NH5_I>F@264E*K-$<%_K
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M8C213 65#^ SDLDTS5#:L?6RVK(9$7/GPP9J/F$E8RD9X!^8ERT+;/21TH^
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MR7="!9>*3_"XX#_#7\=!.@CC%$5F=W#E>Q.IA>I\OPKZF*>&O$'=Z[?I9]T
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MG$""1/-C-08WNJMF6)@S3Y  0=839%EV_^J=0PGV;@(:ECN^0DLDP;,\%G6
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M]Y?%*T]JJY\TNZKK'/6:[3/5/6FT6JIQ?M[ZHIS_'#GG/?6YV3M1':=[#H_
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M^CU[I[P<%-D5F"))V.D6((\K6/_6,*K',X"BO54Z*/S2[ FUD1EHO&- "ZU
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M'[VI\%D>1C_!,)JA#Q_^G@53X5&<G$1?/$I1N"3FY(!=1#;8TTYT"84#XC@
M21F@512=^(&\P>$C]#: \ /3L2V;U"&@!3=7(2 NRE8!13#<AQOF(2/HX!81
MM)P_WA%FED^W&$?=%9#4S0N==X:J3L["SO(Q$MUI)+4!?XQ&=_A ])F=L('R
MEAC3=AD@R"!1WX6U[L+P3N["\>+;P$/<^I4XOMM+<?R@KH4-C*V[$P_3?V,,
M\P,9I5;WO%G>&.$7+&/SG)9G[P]J_]'6^8^VFL8O<3;8FDZIQ0/)$"BH,09
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M:0*IL@XI=9=4I\K&>_4);'("[24GH'2JE4Y@^R[!8W  '-V3 ^"H=@ \30?
M&E3D966T8+]@WBP6L?Q$<VKR@WE;0K<&,WUF]AH;U\X'O88K6-%DB5W+'7WX
MCZ22.^^.+]POS_:?.8C)JH6X^1QC.(3Z_.T+KZ:>U)X\1S[Y.TT1&M.O#A6=
M< 8 Y2_8R_QO/_SM;^^2"/[ ?T=Z@?R&:16>OAA=#G9 *\7_WWWK@!1)L:$:
M3/R\6>3AT=Z;O],L,/@]G)JBQ,_>MTRQ#8D=.@,/),Q3ZGIT*?DH[WN%763B
MM!1<R8MD=#<G<G"X]^KO&B$4WN2Q0O^J4*@,:>X96!89.\9$U>TXP@LL A-3
MY.HY'$. X-N.E9UVCL^[7.'B[E&L\1->^AJ)OA6)MF,]QQBTU$5+XG="GX/]
M+>$9VXX?SF?*5-N.97V0,H\:\"^)%4NE"T821!>MBN10) FQ>"QBQWT+%*D8
M>(HE'"@;KK%WM(\B;&-O?_\.K@=N_E%P;ZO7ZINC.P;4EO,@JYCRT?[NZK!8
MXZ;<-QFU.K05#OMQ4X9?(RD2G2J+[6'^@UV>B4"DA,(98--90T,.:AJR+E;=
M.: >#@TY.'KT-*1PV MHR*)#?0!D8E5:\!0N>6.AH/ H;N_F9[PUM[-X2NIV
M_@#_H@*U74;;;;/C']U1UK^@3/_4F/\JS?2?3& <(#_^/+6N6T\>890._Q!O
MG]%]JUV[O7:KWSD_0W!OUB7EN'W6^OBIV?W-.3OO=SYT6DT<;\]!GPXW-S$5
M\6Y$A,&$%& Q',IIH@(TXFD8Q)[*WQR'JD%(6L60:H+BH[[)\LR%RZN"]*.)
M%WAQP@YFS)T<Z#+FF4)5$PJNMK/B/O=.'#8ZAE%I<P#APQL!9X!R/0&L6 A_
M#60PO)I@"H-)[*2$NS3H)#)A;6@$X4XO''5B:D%RU%R((C;FLZKEWUQ)57<<
M'><3BGA3>QE>B4@,84FP6V]H@LDX_"Q=JFLM-+\J.8958(AF1)4-L+A[0B%K
M843_(. QP:^L[*Z^><"U<>E< "B&I?LB<A0(IE&(<6]ICNNU\&<$/ SW#2?>
M$$4(#[Z57#_8S9Y">EPIB'7?U'1,C.>C07T/!ANI+-X1<,RE@]&Y3"-TK2")
M2?"U&/V*7J!*&F.M"'$M8%>,==L7LK!MK.%5)6NPHK4V]M'&'"C.I:R\:.2,
M9U@]%*["922F5W'6;9O4+;B_$P]IVPUED<C!99(^MPY$,C+.W$!3" ;//0T[
MYGKFY97&BY7%5=N'-+!Y-(M4 RJG4,[:%'&A*K%<E "SU6RQ@M.M-:D%E-,]
M(3+UY3+=NW"C5OESH99IK3)7CBZM/U6(HL8<[DP]F3 -P8]U#;9LR?0;? 46
M.TBK+9>U;+V(0O2'"%5^P92XRBVU_17XRPQST%.^.\B5_UU>R/UML81.2<2X
MO4U5G<7Z*JWT96W>+N##"S2]0/@\K1)"A>I^*T$;Q\Q/;55KSI8&K#R6715
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MCCKO#RW= &[75;%,ES-?)&&$-GB0OD"/"$F<-%,::=$J=0"/Z!$[Q]:((@B
M:PV5^QR0: #RI9,VK2!=8T8A69B\)'1M 3_D3*8HT_<Z4/E-H?:!O^A- 87/
M -"NTWA.WFK7.=1_O.(_2&AM'*@/:4I^(@-,')4)M4 F()+%2$2@"7$T%UIV
M_S'SM>?\4)FVK6@!M+1A"T3.T/=1(PA"SB](9R*;O?0X5$L+M/Z<K[&J.8Y4
M>RA)4.<K:6S\P 8 IJ;N +LV#%Q51Q\XQXP*68 T76'\3FA/@X<M&">F =(
MX\H<:CD2Y>!NV<MQKC9 :.Z<3Q'AG38%R>!#*BPXC0=]3@X0F/O8U#L NF'
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M6I=JFRJ9GD&$S-C4.AWCXSM'690LW'%:DT+,=5 /+O<-2(4@$%EH;1:'KR]
M*'(_Z*&Q;DGDQ6FQBFP@PUO,J='+0GKFXA=7L B0Z/@S)[4K4>S:)-@OEBDH
M+H"8W'.V=7(]*7*555,A2QTR2%OB3-.'WZCH@JWDWM(YM :ES/19)+2FY<P
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MR@'?=4R1NN(X1A7Q@C*D06=H/!9#ZFF@%UBCQVT%)5WDG.,7?JYQL4$5.^Q
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M?CB79A7I=<:543UD0D25#\B)IDBP>4Y43EQ-TW7,:TK5Z297W<T;)). L[.
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M.GW#38'KQIUW5;=0YV"OT=*S%9K-AQ$/(47D>]AGU)NH!K;32,)EHX= 8X^
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M)JS\PX<VGA4] ZRT\ZG3QV."@\ 9/IV?=#[\R:>D%)^>WB,?EOFV>=PY15@
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MLKM&2>A$ZJG,#966<#!Q/0BMNR>#X6PRH"L26Z)4?3>>^MTX?,!WH]%8_7*
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M/!!3=SCTP^M]\=(/Q<OM73\\$%X6)U&\+]PLC0ZPSZGN:.+&UWZX-8C2-)K
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MNPUR!O-%:$&M@ZNN "\=^9_?;:BOU&NI'V*4^0TX9YKRNPTFW[GUKUOJI7&
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M[R")1JF*AVA<&:ERN5D_1RB$+T,!-_3)AH(]5^O+(Z%D+7*EU\RBC$FJ#(W
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M2.;*<YJ7;W%7ZP/SW _,Z%D<&,Q&&T-_<I7ZI.OFP3,#-_P49]/4FZG2H%$
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MV<W@X#E;P"D?BTFS-/A7"@@4L8\(%\:"3@+60H,UR4!@@D(F)IJ=L)K;,&9
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M9*C_EEF"D[<A>JHPE6S:V)^=*?25"6'/EMK>-7&QNKU&%)!-4TQ5#"OHN)#
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M34N*K5H6901;:G8<RO37G)GKJ,AGQ^6I\X'XN,"Z6'YS,AN/,0^2#?P(1BZ
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MRGZ^[XNYJ[98=$PK]%+RG_:3"'[!GW[%3[^FF]P$$G_N;?3==WR7R\K!_#<
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MSKS@EY[QQ[!X@V08'/P_4$L#!!0    ( #-#D%//D//;@PP  $A%   -
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M0&,A5/7&( 0#$@!= )7SRXAQ_OJP)(R^]2'4,U'IJ$:(E&:V14RAB!,DRT!
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M3]: B JSGXA<["0!\:,@N^Z2'3"HLA;#<Z"Y,PHP \0!PCK)8R[IM(/)C).
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M#P2.+^P921!U;R0#VM.EC2(^,!$6Z &$Q[BIAB^Q=7(L.P>C"0J_\@EK.DA
M9PMGX):GK:=[+!60L&R)A= L3_C?CHA6]#1!03:7F>IC(7*:EI\%<=-LO!>"
MIUG2^6?)QLU:_YJE66B/E&!0LI9LS6N;BMVH8%6A-?:S4T_2K^ 2!!(>:F0E
MS'^#!\[\$.+I/"V[^.LI_FK#F70'A*AI3AB80)4&L);QY^;,>92X"OTKRO":
ME?3MP(5Y.VFK8C0U6<!,M^&=QT19B):N*HD!29#JI DWJNS;V!R(OF%4I0F/
M/N":X+=\.S/53-#!V9J@%P(670FNS2'KGS?JU0Q7Z3H254%W(M--DU=D[9^
MR[^- 0-):#7;Q0I+;54^CO<4@.6!V<C<-I"1.$@=M]M<0NR4EXXLK)])SRKK
MTE&<$82R% U><>DGR:L[]$</-+\%(A0%Q6EN@6%)<$9Y,4V?/5P[:&8/9W6%
MO,+#,4GDB<6O0B5?*MA\/D684%GB=41@"V4$28DQ-T:N-#E30G(,[#$"H(1
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M  !E>%\S,38V-#(N:'1M4$L! A0#%     @ ,T.04[6 =&9G%0$ 71D(  T
M             ( !]1<! &5X7S,Q-C8T,RYH=&U02P$"% ,4    "  S0Y!3
MN"]G.:%;  "1SP( #0              @ &'+0( 97A?,S$V-C8R+FAT;5!+
M 0(4 Q0    ( #-#D%/JYIU*;24  )/E   -              "  5.) @!E
M>%\S,38V-C,N:'1M4$L! A0#%     @ ,T.04TK^[X,%%0  <9$   T
M         ( !ZZX" &5X7S,Q-C8V-"YH=&U02P$"% ,4    "  S0Y!3SY#S
MVX,,  !(10  #0              @ $;Q ( 97A?,S$V-C8U+FAT;5!+ 0(4
M Q0    ( #-#D%-<TSJU;@,  "@.   1              "  <G0 @!U;&)I
M+3(P,C$Q,C$S+GAS9%!+ 0(4 Q0    ( #-#D%,C^N[^U@0  .8L   5
M          "  6;4 @!U;&)I+3(P,C$Q,C$S7V1E9BYX;6Q02P$"% ,4
M"  S0Y!3NPI6$?8%  !$/   %0              @ %OV0( =6QB:2TR,#(Q
M,3(Q,U]L86(N>&UL4$L! A0#%     @ ,T.04TA%"B5Q!   ?BT  !4
M         ( !F-\" '5L8FDM,C R,3$R,3-?<')E+GAM;%!+ 0(4 Q0    (
M #-#D%.H3BG%9!P  /C2   3              "  3SD @!U;&)I,C R,3$R
?,3-?.&LN:'1M4$L%!@     ,  P Y@(  -$  P    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
